0001472375-14-000279.txt : 20141020 0001472375-14-000279.hdr.sgml : 20141020 20141020170510 ACCESSION NUMBER: 0001472375-14-000279 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20140831 FILED AS OF DATE: 20141020 DATE AS OF CHANGE: 20141020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PEPTIDE TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001357878 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 980479983 STATE OF INCORPORATION: NV FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53230 FILM NUMBER: 141164393 BUSINESS ADDRESS: STREET 1: 601 UNION STREET STREET 2: TWO UNION SQUARE, 42ND FLOOR CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: (206) 452-3995 MAIL ADDRESS: STREET 1: 601 UNION STREET STREET 2: TWO UNION SQUARE, 42ND FLOOR CITY: SEATTLE STATE: WA ZIP: 98101 FORMER COMPANY: FORMER CONFORMED NAME: CREENERGY Corp DATE OF NAME CHANGE: 20100818 FORMER COMPANY: FORMER CONFORMED NAME: ONLINE ORIGINALS, INC DATE OF NAME CHANGE: 20060330 10-Q 1 form10q.htm QUARTERLY REPORT FOR THE PERIOD ENDED AUGUST 31, 2014 Filed by Avantafile.com - Peptide Technologies, Inc. - Form 10-Q

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended 31 August 2014

OR

[  ] TRANSITION REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to ______________

Commission File Number 000-53230

PEPTIDE TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

Nevada   98-0479983
State or other jurisdiction of   (I.R.S. Employer
incorporation or organization   Identification No.)

601 Union Street, Two Union Square, 42nd Floor, Seattle, Washington 98101
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code:  (206) 452-3995

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes  [X]   No  [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes  [  ]   No  [X]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer [  ] Accelerated filer  [  ]
Non-accelerated filer [  ]  (Do not check if a smaller reporting company) Smaller reporting company  [X]

Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes  [  ]   No  [X]

Number of shares issued and outstanding of the registrant’s class of common stock as of 20 October 2014: 156,412,660 shares of common stock.

The Company recognized $9,239 in revenues during the quarter ended 31 August 2014.

1


 

PART I – FINANCIAL INFORMATION

  Page
Item 1. Financial Statements(Unaudited) F-3
          Interim Consolidated Balance Sheets F-5
          Interim Consolidated Statements of Loss and Comprehensive Loss F-6
          Interim Consolidated Statements of Cash Flows F-7
          Interim Consolidated Statement of Changes in Stockholders' Deficiency F-8
Notes to Interim Consolidated Financial Statements F-9 to F-21
Item 2. Management's Discussion and Analysis or Plan of Operations 22
Item 3 Quantitative and Qualitative Disclosure about Market Risk 27
Item 4 Controls and Procedures 27
PART II – OTHER INFORMATION
Item 1 Legal Proceedings 28
Item 1A. Risk Factors - Not Applicable 28
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28
Item 3. Defaults upon Senior Securities - Not Applicable 28
Item 4. Mine Safety Disclosures - Not Applicable 28
Item 5. Other Information 28
Item 6. Exhibits 28
SIGNATURES 29

2


 

PART I - FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

PEPTIDE TECHNOLOGIES, INC.

(A Development Stage Company)

INTERIM CONSOLIDATED FINANCIAL STATEMENTS
(Expressed in U.S. Dollars)
(Unaudited)
AUGUST 31, 2014

Financial Statements

  Page
Interim Consolidated Balance Sheets F-5
Interim Consolidated Statements of Loss and Comprehensive Loss F-6
Interim Consolidated Statements of Cash Flows F-7
Interim Consolidated Statement of Changes in Stockholders' Deficiency F-8
Notes to Interim Consolidated Financial Statements F-9 to F-21

F-3


 

PEPTIDE TECHNOLOGIES, INC.
 (A Development Stage Company)

Interim Consolidated Financial Statements
(Expressed in U.S. Dollars)
(Unaudited)
August 31, 2014

F-4


 

PEPTIDE TECHNOLOGIES, INC.
 (A Development Stage Company)

INTERIM CONSOLIDATED BALANCE SHEETS

    August 31,
2014
    November 30,
2013
 
    (Unaudited)     (Audited)  
ASSETS            
             
Current Assets            
      Cash and cash equivalents $ 11,560   $ 157  
             
      Total Current Assets   11,560     157  
             
Website (net of accumulated amortization of $6,667 and $4,167, respectively) (Note 3)   3,333     5,833  
Intangible assets and intellectual property (Note 7)   -     45,000  
             
TOTAL ASSETS $ 14,893   $ 50,990  
             
             
LIABILITIES AND STOCKHOLDERS' DEFICIENCY            
             
LIABILITIES            
             
Current Liabilities            
      Accounts payable and accrued liabilities (Note 4) $ 651,968   $ 1,662,272  
      Notes payable and accrued interest (Note 5)   105,631     88,850  
             
      Total Current Liabilities   757,599     1,751,122  
             
STOCKHOLDERS’ DEFICIENCY            
             
Capital Stock (Note 8)            
      Authorized:            
           675,000,000 common shares, par value $0.001 per share            
      Common shares issued and outstanding:            
           156,412,660 and 151,123,000 at August 31, 2014 and November 30, 2013, respectively   156,413     151,123  
      Additional paid-in capital   187,899     148,279  
Accumulated deficit   (105,837 )   (105,837 )
Accumulated deficit during development stage   (981,181 )   (1,893,697 )
             
Total Stockholders’ Deficiency   (742,706 )   (1,700,132 )
             
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIENCY $ 14,893   $ 50,990  

The accompanying notes are an integral part of these interim consolidated financial statements.

F-5


 

PEPTIDE TECHNOLOGIES, INC.
 (A Development Stage Company)
INTERIM CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS
(Unaudited)

    For the three-month period ended August 31, 2014     For the three-month period ended August 31, 2013     For the nine-month period ended August 31, 2014     For the nine-month period ended August 31, 2013     Cumulative from re-entering of development stage on June 26, 2010 to August 31, 2014  
Revenue                              
      Revenue $ 9,239   $ -   $ 9,239   $ -   $ 9,239  
                               
Expenses                              
      Consulting   -     75,000     -     227,000     552,975  
      Salaries and bonus (Note 4)   49,224     159,000     364,568     477,000     1,434,652  
      Office and administration   4,185     5,419     15,563     13,963     68,588  
      Professional fees   13,494     5,412     23,255     19,117     174,998  
Supplies and materials   1,909     1,101     9,903     1,101     70,135  
                                    
    68,812     245,932     413,289     738,181     2,301,348  
                               
Net Loss before Other Items   (59,573 )   (245,932 )   (404,050 )   (738,181 )   (2,292,109 )
                               
Other Items                              
      Write down of intangible assets (Note 7)   -     -     (45,000 )   -     (45,000 )
      Forgiveness of debt (Note 6)   -     -     1,361,000     -     1,361,000  
      Foreign exchange gain (loss)   1,523     (1,274 )   3,252     2,898     5,366  
      Interest expense (Note 5)   (1,087 )   (1,097 )   (2,686 )   (2,909 )   (10,438 )
                               
Net Profit (Loss) for the Period   (59,137 )   (248,303 )   912,516     (738,192 )   (981,181 )
                               
Other Comprehensive Loss                              
      Foreign currency translation adjustment   -     -     -     -     (333 )
                               
Comprehensive Profit (Loss) for the Period $ (59,137 ) $ (248,303 ) $ 912,516   $ (738,192 ) $ (981,514 )
                               
Profit (Loss) per share from operations – Basic and diluted $ (0.00 ) $ (0.00 ) $ 0.01   $ (0.00 )      
                               
Weighted Average Number of Shares Outstanding   153,143,767     151,107,016     152,154,135     150,022,908        

The accompanying notes are an integral part of these interim consolidated financial statements.

F-6


 

PEPTIDE TECHNOLOGIES, INC.
(A Development Stage Company)
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

    For the three-month
period ended
August 31, 2014
    For the three-month
period ended
August 31, 2013
    For the nine-month
period ended
August 31, 2014
    For the nine-month
period ended
August 31, 2013
    Cumulative from
re-entering of development stage on June 26, 2010 to
August 31, 2014
 
OPERATING ACTIVITIES                              
      Net profit (loss) $ (59,137 ) $ (248,303 ) $ 912,516   $ (738,192 ) $ (981,181 )
Adjustments for non-cash items:                              
      Accrued interest   1,087     1,097     2,686     2,909     10,438  
      Amortization   833     833     2,500     2,500     6,667  
      Foreign exchange gain (loss)   (1,523 )   1,275     (3,252 )   (2,898 )   (5,366 )
      Forgiveness of debt (Note 6)   -     -     (1,361,000 )   -     (1,361,000 )
      Non-cash consulting expense   -     -     -     -     2,000  
      Share-based payment   5,250     -     5,250     -     13,250  
      Write down of intangible assets and intellectual property (Note 7)   -     -     45,000     -     45,000  
Changes in operating assets and liabilities                              
      Decrease in prepaid expenses   -     -     -     3,494     2,710  
      Increase in accounts payable and accrued liabilities   49,360     225,000     350,696     684,678     2,012,218  
Cash used in operating activities   (4,130 )   (20,098 )   (45,604 )   (47,509 )   (255,264 )
                               
INVESTING ACTIVITIES                              
      Purchase of website   -     -     -     -     (10,000 )
Cash used in investing activities   -     -     -     -     (10,000 )
                               
FINANCING ACTIVITIES                              
      Proceeds from issuance of common shares, net of share issuance costs   4,660     25,000     39,660     45,000     160,774  
      Increase in notes payable   9,500     -     17,347     -     84,559  
      Contribution by related party   -     -     -     -     27,288  
      Cash from financing activities   14,007     25,000     57,007     45,000     272,621  
      Effect of foreign exchange rate changes on cash   -     -     -     -     (333 )
Increase (decrease) in cash and cash equivalents   9,877     4,902     11,403     (2,509 )   7,024  
Cash and cash equivalents, beginning of period   1,683     369     157     7,780     4,536  
Cash and cash equivalents, end of period $ 11,560   $ 5,271   $ 11,560   $ 5,271   $ 11,560  
                               
Supplemental Disclosure of Cash Flow Information (Note 12)                              

The accompanying notes are an integral part of these interim consolidated financial statements.

F-7


 

PEPTIDE TECHNOLOGIES, INC.
(A Development Stage Company)

INTERIM CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIENCY
For the Period from November 30, 2013 through August 31, 2014
(Unaudited)

    CAPITAL STOCK           ACCUMULATED        
                ADDITIONAL           DEFICIT DURING        
                PAID-IN     ACCUMULATED     DEVELOPMENT        
    SHARES     AMOUNT     CAPITAL     DEFICIT     STAGE     TOTAL  
                                     
Balances, 30 November 2012   149,078,000   $ 149,078   $ 105,324   $ (105,837 ) $ (898,221 ) $ (749,656 )
                                     
Shares issued for                                    
      Cash, net of share issuance costs (Note 8)   45,000     45     42,955     -     -     43,000  
      Contractor services (Note 8)   2,000,000     2,000     -     -     -     2,000  
Net loss for the year   -     -     -     -     (995,477 )   (995,477 )
Balance, 30 November 2013   151,123,000     151,123     148,279     (105,837 )   (1,893,698 )   (1,700,132 )
                                     
Shares issued for                                    
      Cash, net of share issuance costs (Note 8)   39,660     40     39,620     -     -     39,660  
      Related party services   5,250,000     5,250     -     -     -     5,250  
Net profit (loss) for the period   -     -     -     -     912,516     912,516  
Balances, 31 August 2014   156,412,660   $ 156,413   $ 187,899   $ (105,837 ) $ (981,182 ) $ (742,706 )
                                     

The accompanying notes are an integral part of these interim consolidated financial statements.

F-8


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

1. NATURE AND CONTINUANCE OF OPERATIONS

  1.1 Organization

  Peptide Technologies, Inc. (the “Company”) was incorporated in the State of Nevada, United States of America, on 18 November 2005. On 29 July 2010, the Company’s name was changed from Online Originals, Inc. to CREEnergy Corporation. Effective 12 October 2011, the Company’s name was changed from CREEnergy Corporation to Peptide Technologies, Inc. The Company’s year-end is 30 November. The Company is currently a development stage Company.

  On 5 August 2013, the Company incorporated Pept Peptide Technologies Inc. (“Pept Peptide”), a wholly-owned subsidiary, under the laws of British Columbia. Pept Peptide currently does not have any transactions from the date of incorporation on 5 August 2013 to 31 August 2014.

  1.2 Nature of Operations and Change in Business

  Upon inception on 18 November 2005, the Company’s business plan was to develop a membership-based website art gallery/auction house specifically focused on displaying and selling original artwork. The Company changed its status from a development stage company to an operating company on 30 November 2009. Management realized that the results of operations from the sale of artwork lacks luster and decided to change the Company’s business focus and plan for other strategic opportunities. Effective 26 June 2010, the Company became a development stage company focusing on a new business.

  On 23 August 2011, the Company entered into an agreement (the “Asset Purchase Agreement”) in which the Company, in exchange for 75,000,000 shares of the Company’s restricted common stock, received all rights and title to proprietary technologies and formulas involving the application of specialty Peptides. The Company has changed its business focus to the manufacturing and distribution of natural peptide solutions to combat the economic burden of bio-fouling. On 14 December 2011, the Company amended the Asset Purchase Agreement (the “First Amendment”). As a result of the First Amendment, the purchase price of the assets was reduced from 75,000,000 shares to 45,000,000 shares, and 30,000,000 shares were returned to treasury (Note 7).

  On 1 May 2014, the Company entered into an agreement whereby the Asset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor (Note 7).

  On 26 May 2014, the Company entered into an exclusive global distribution agreement for its AquaNatural Marine coating with All-Sea Coatings Ltd. (a division of All-Sea Enterprises) of North Vancouver, Canada. This agreement has been replaced with an Asset Purchase Agreement date 14 August 2014.

  On 14 August 2014, the Company entered into an Asset Purchase Agreement with All-Sea Coatings Ltd. All-Sea Coatings Ltd has acquired from the Company the non-commercialized re-formulated assets that were developed by the Company. The Company business is to realize a 3% Royalty of all Gross Sales & Revenue, to be paid to the Company derived from All-Sea Coatings Ltd.

F-9


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

  1.3 Basis of Going Concern

  The accompanying interim consolidated financial statements as at 31 August 2014 and for the nine month period then ended have been prepared on a going concern basis, which contemplates the realization of assets and settlement of liabilities and commitments in the normal course of business. The Company has net profit of $912,516 for the nine month period ended 31 August 2014 (31 August 2013 – loss of $738,192; cumulative loss - $981,514) and has a working capital deficit of $746,039 at 31 August 2014 (30 November 2013 - $1,750,965).

  Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive, or raise additional debt and/or equity capital. Management believes that the Company’s capital resources should be adequate to continue operating and maintaining its business strategy during the fiscal year ended 30 November 2014. However, if the Company is unable to raise additional capital in the near future or met financing requirements, due to the Company’s liquidity problems, management expects that the Company will need to curtail operations, liquidate assets, seek additional capital on less favorable terms and/or pursue other remedial measures. Management is aware, in making its assessment, of material uncertainties related to events or conditions that may cast significant doubt upon the Company’s ability to continue as a going concern. These interim consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

  Although management is actively seeking to add new products and/or services in order to show profitability, and is seeking additional sources of equity or debt financing, there is no assurance that these activities will be successful. The Company has not yet been able to find products and services that would contribute to their business due to the continued economic condition. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The interim consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

  1.4 Unaudited Statements

  While the information presented in the accompanying interim consolidated financial statements is unaudited, it includes all adjustments which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Except as disclosed below, these interim consolidated financial statements follow the same accounting policies and methods of their application as the Company’s audited 30 November 2013 annual consolidated financial statements. It is suggested that these interim consolidated financial statements be read in conjunction with the Company’s audited consolidated financial statements for the year ended 30 November 2013, included in the annual report previously filed with the Securities and Exchange Commission on Form 10-K. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year.

  The information as of 30 November 2013 is taken from the audited consolidated financial statements as of that date.

F-10


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

2. SIGNIFICANT ACCOUNTING POLICIES

  This summary of significant accounting policies is presented to assist in understanding the Company’s interim consolidated financial statements. The interim consolidated financial statements and notes are representations of management who is responsible for their integrity and objectivity. These accounting policies have been consistently applied in the preparation of the interim consolidated financial statements.

  2.1 Basis of Presentation

  These interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) applicable for a development stage company for financial information and are expressed in U.S. dollars.

  2.2 Principles of Consolidation

  These interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary Pept Peptide, a company incorporated in the province of British Columbia on 5 August 2013. All significant inter-company balances and transactions have been eliminated upon consolidation.

  2.3 Organizational and Start-up Costs

  Costs of start-up activities, including organizational costs, are expensed as incurred in accordance with Accounting Standards Codification (“ASC”) 720-15, “Start-Up Costs."

  2.4 Development-Stage Company

  During the year ended 30 November 2010, the Company abandoned its previous business of sale of original artwork and re-entered the development stage with its intended new business, which currently has no significant revenues. Management expects to sustain losses from operations until such time it can generate sufficient revenues to meet its anticipated cost structure. The Company is considered a development-stage company in accordance with the ASC 915, “Accounting and Reporting by Development-Stage Enterprises." A development-stage enterprise is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.

  2.5 Cash and Cash Equivalents

  Cash and cash equivalents include highly liquid investments with original maturities of three months or less.

  2.6 Website

  In accordance with ASC 350-50, “Website Development Costs," expenditures during the planning and operating stages of the Company’s website are expensed as incurred. Expenditures incurred during the website application and infrastructure development stage are capitalized and amortized to expense over the website’s estimated useful life of 3 years.

F-11


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

  2.7 Intangible Assets

  Intangible assets include the cost of acquiring the intellectual property. In accordance with ASC 350-30 “General Intangibles Other Than Goodwill," an intangible asset that is acquired either individually or with a group of other assets shall be recognized. Costs of internally developing, maintaining, or restoring intangible assets that are not specifically identifiable, that have indeterminate lives, or that are inherent in a continuing business and related to an entity as whole, shall be recognized as an expense when incurred. The intellectual property is determined to have an indefinite useful life and is not subject to amortization. The useful life of the intangible asset is reassessed at each reporting period. During the nine month period ended 31 August 2014, the Company recorded a write down of $45,000 related to its intangible assets and intellectual property (Notes 7 and 12).

  2.8 Impairment of Long-Lived Assets

  Long-lived assets include the website and intangible assets and intellectual property. Long-lived assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets not subject to amortization are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount of the asset exceeds the fair value of the asset. There has been no impairment as of 31 August 2014.

  2.9 Research and Development

  Research and development expenses are charged to operations as incurred.

  2.10 Income Taxes

  The Company adopted the ASC 740, “Accounting for Income Taxes." ASC 740 requires the use of the asset and liability method of accounting of income taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the interim consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized.

  2.11 Basic and Diluted Income (Loss) per Share

  In accordance with ASC 260, “Earnings per Share," the basic income (loss) per common share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed similar to basic income (loss) per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings per share are not shown for periods in which the Company incurs a loss because it would be anti-dilutive. At 31 August 2014, the Company had no stock equivalents that were anti-dilutive and excluded in the earnings (loss) per share computation.

F-12


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

  2.12 Estimated Fair Value of Financial Instruments

  The carrying value of the Company’s interim consolidated financial instruments, consisting of cash, accounts payable and notes payable approximate their fair value due to the short-term maturity of these instruments. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest or currency risks arising from these financial instruments.

  Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. At 31 August 2014, cash and cash equivalents of $310 were insured by agencies of the U.S. Government.

  2.13 Foreign Currency Translation

  The interim consolidated financial statements are presented in U.S. dollars. In accordance with ASC 830 “Foreign Currency Matters," foreign denominated monetary assets and liabilities are translated to their U.S. dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenue and expenses are translated at average rates of exchange during the period. Related translation adjustments are reported as a separate component of stockholders’ equity, whereas gains or losses resulting from foreign currency transactions are included in results of operations.

  2.14 Comprehensive Income (Loss)

  The Company adopted ASC 220, "Reporting Comprehensive Income." ASC 220 requires that the components and total amounts of comprehensive income (loss) be displayed in the interim consolidated financial statements beginning in 1998. Comprehensive income (loss) includes net income (loss) and all changes in equity during a period that arises from non-owner sources, such as foreign currency items and unrealized gains and losses on certain investments in equity securities.

  2.15 Use of Estimates

  The preparation of the Company’s interim consolidated financial statements are in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the amounts reported in these interim consolidated financial statements and accompanying notes. Actual results could differ from those estimates.

  2.16 Changes in Accounting Policy

  Effective 1 December 2013, the Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2013-02, “Comprehensive Income." This update requires an entity to present information about amounts reclassified out of accumulated other comprehensive income and their corresponding effect on the respective line items in net income in one place, and in some cases, cross-references to related footnote disclosures. The update applies to public companies for all reporting periods presented, including interim periods, and to nonpublic entities for annual reporting periods. ASU No. 2013-02 will be effective for fiscal years, and interim periods within those years, beginning after 15 December 2012 for public companies, with early adoption permitted. The adoption of this update did not have a material effect on the Company’s interim consolidated financial statements.

F-13


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

  2.17 Recent Accounting Pronouncements

  In July 2013, the FASB issued ASU No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists," which is intended to eliminate the diversity that is in practice with regard to the financial statement presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU No. 2013-11 is effective for fiscal years and interim periods within those years, beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.

  In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers," which provides a five-step approach to be applied to all contracts with customers. ASU No. 2014-09 also requires expanded disclosures about revenue recognition. ASU No. 2014-09 is effective for annual reporting periods beginning after 15 December 2016, including interim periods. Early adoption is not permitted. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.

  In June 2014, the FASB issued ASU No. 2014-10, “Development Stage Entities," which intends to remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the update eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. ASU No. 2014-10 is effective for fiscal years and interim periods beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.

  2.18 Reclassifications

  Certain amounts reported in previous periods have been reclassified to conform to the current presentation.

  2.19 Other

  The Company consists of one reportable business segment.

  The Company paid no dividends during the periods presented.

F-14


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

3. WEBSITE

As at: 31 August 2014
30 November 2013
(Audited)
  Cost
$
Accumulated amortization
$
Net book value
$
Cost
$
Accumulated amortization
$
Net book value
$
             
Website 10,000 6,667 3,333 10,000 4,167 5,833
             
Total 10,000 6,667 3,333 10,000 4,167 5,833

  The Company purchased a website during October 2012 for $10,000. This website has a useful life of three years, and the cost is being amortized over the life of the asset. During the nine month period ended 31 August 2014, the Company recognized amortization expense of $2,500 (31 August 2013 - $2,500; cumulative - $6,667) (Note 9).

4. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

As at: 31 August 2014
$
30 November 2013
(Audited)
$
     
Accounts payable 38,317 574,188
Accrued liabilities 4,000 27,000
Payroll taxes payable 29,652 17,084
Salaries and benefits payable (Note 6) 580,000 1,044,000
     
Total accounts payable and accrued liabilities 651,969 1,662,272

  Trades payable and accrued liabilities are non-interest bearing, unsecured and have settlement dates within one year.

  On 27 May 2014, the Chief Executive Officer (“CEO”) requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 August 2014 (Notes 6 and 12).

  On 27 May 2014, a consultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000 (Notes 6 and 12).

F-15


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

5. NOTES PAYABLE

As at: 31 August 2014
$
30 November 2013
(Audited)
$
During the year ended 30 November 2010, Fotoview Inc. (“Fotoview”) issued a loan of $16,000 to a former director of the Company to purchase 4,000,000 restricted common shares of the Company.  Upon the director’s resignation, the 4,000,000 common shares were cancelled and the Company assumed the loan payable to Fotoview.  The loan is unsecured, bears no interest, and has no fixed terms of repayment. 16,000 16,000
     
On 21 September 2011, PSI Services (“PSI”) issued a loan of $500 to the Company. The loan is unsecured, bears no interest and has no fixed terms of repayment. 500 500
     
On 13 November 2011, PSI issued a loan of CAD$45,000 to the Company.  The loan is unsecured and bears interest at a rate of 6% per annum. Principal and accrued interest are due on 30 November 2014. The loan payable to PSI as at 31 August 2014 consists of principal and accrued interest of $41,445 (30 November 2013 – $42,710) and $6,963 (30 November 2013 – $5,251), respectively (Note 12). 48,408 47,961
     
On 1 June 2012, PSI issued a loan of CAD$20,000 to the Company.  The loan is unsecured and bears interest at a rate of 6% per annum.  Principal and accrued interest is due on 30 November 2014.. The loan payable to PSI as at 31 August 2014 consists of principal and accrued interest of $18,420 (30 November 2013 – $18,982) and $2,486 (30 November 2013 – $1,707), respectively (Note 12). 20,906 20,689
     
On 22 October 2013, PSI issued a loan of USD $3,700 to the Company.  The loan is unsecured, bears no interest, and has no fixed terms of repayment. 3,700 3,700
     
On 21 April 2014, PSI Issued a loan of CAD $8,000 to the Company.  The loan is unsecured, bears no interest, and has no fixed terms of repayment. 7,368 -
     
On 14 August 2014, PSI issued a loan of CAD $9,500 to the Company.  The loan is unsecured, bears no interest, and has no fixed terms of repayment. 8,749 -
Total notes payable 105,631 88,850

6. RELATED PARTY TRANSACTIONS

  As at 31 August 2014, the amount due to related parties includes $580,000 (30 November 2013 - $1,044,000) payable to past directors and employees of the Company in relation to salaries and benefits earned, and $Nil (30 November 2013 - $730) payable to the Chief Financial Officer (“CFO”) of the Company in relation to expense reimbursements. Of the amount due to related parties, $Nil relates to bonuses payable to the CEO of the Company (30 November 2013 - $300,000) (Note 4).

  During the nine month period ended 31 August 2014, the Company accrued salaries and benefits of $364,568 to officers and employees of the Company (31 August 2013 - $477,000; cumulative - $1,434,562).

F-16


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

  On 27 May 2014, the CEO requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 May 2014. As at 31 August 2014, included in salaries and benefits are bonuses of $Nil accrued to the CEO of the Company during the nine month period ended 31 August 2014 (31 August 2013 - $Nil; cumulative - $Nil) (Notes 4 and 12).

  Effective 1 December 2013, the Company and a former related party consultant mutually terminated an Advisory Agreement entered into on 1 November 2012. The Company accrued $Nil of consulting fees to the consultant (31 August 2013 - $227,000; cumulative - $Nil) during the nine month period ended 31 August 2014.

  On 27 May 2014, a formerly related party consultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000. As at 31 August 2014 there is $Nil (30 November 2013 - $545,000) outstanding and payable to the consultant for consulting services received (Notes 4 and 12).

  During the year ended 30 November 2013, the Board approved a commission payment program (the “Program”) equal to 30% of gross sales of fouling prevention coatings. Under this Program, the CEO will receive compensation equal to 20% of gross sales of anti-fouling paint, as recognition of his work in developing the formulas; and an external consultant will receive 10% of gross sales of anti-fouling paint as compensation for sales development. On 28 February 2014, the Board amended the Program to reduce the CEO’s compensation from 20% to 10% of gross sales of anti-fouling paint. On 27 May 2014, the Program was eliminated by mutual agreement from both parties affected. As a result, no commissions will be earned by either the CEO or the applicable consultant on gross sales of fouling prevention coatings. As at 31 August 2014, there were $Nil commissions earned (Note 7).

  During the nine month period ended 31 August 2014, directors and shareholders of the Company made cash contributions in the amount of $Nil (31 August 2013 - $Nil, cumulative – $27,288).

  On 15 July 2014, the Company issued 4,660 shares of the Company’s restricted common stock for cash proceeds of $5,660 (Note 8).

  On 28 July 2014, the Company issued 5,250,000 fully vested shares of the Company’s restricted common stock at a par value of $0.001 per share to two directors of the Company for consulting services rendered. As a result, the Company recorded professional fees of $5,250 when the stock was issued (Note 8).

7. INTANGIBLE ASSETS AND INTELLECTUAL PROPERTY

  On 23 August 2011, the Company entered into an Asset Purchase Agreement to acquire intangible assets and intellectual property known as the Platforms in exchange for 75,000,000 restricted common shares of the Company (issued on 23 August 2011) (Note 1).

  On 14 December 2011, the Company entered into an amended the First Amendment and, as a result, a total of 30,000,000 restricted common shares of the Company were returned to treasury and cancelled in exchange for payment of half of one percent of all gross monies received by the Company in relation to revenue earned from products derived from the use of all the formulae listed in the Asset Purchase Agreement. In addition, a monthly stipend of CAD $15,000 per month is to be paid commencing on the receipt of monies from the first contract signed to purchase products derived from the use of the formulae for a period of five years from the date of the First Amendment. The cancellation of 30,000,000 common shares has been recorded as a recovery of intangible assets and intellectual property (Note 1).

F-17


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

  On 1 May 2014, the Company entered into an agreement whereby the Asset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor (Note 1).

  During the nine month period ended 31 August 2014, the Company recorded a write down of $45,000 (31 August 2013 - $Nil; cumulative - $45,000) related to its intangible assets and intellectual property (Note 12).

  On 20 January 2013, the Board approved the Program equal to 30% of gross sales of fouling prevention coatings. Under this Program, the CEO will receive compensation equal to 20% of gross sales of anti-fouling paint, as recognition of his work in developing the formulas; and an external consultant will receive 10% of gross sales of anti-fouling paint as compensation for sales development. On 28 February 2014, the Board amended the Program to reduce the CEO’s compensation from 20% to 10% of gross sales of anti-fouling paint. On 27 May 2014, the Program was eliminated by mutual agreement from both parties affected. As a result, no commissions will be earned by either the CEO or the applicable consultant on gross sales of fouling prevention coatings. As of 31 August 2014, there were $Nil commissions earned (Note 6).

8. CAPITAL STOCK

  8.1 Authorized common stock

  The Company’s authorized common stock consists of 675,000,000 shares of common stock with a par value of $0.001 per share. On 10 August 2010, the Company increased the number of authorized share capital from 75,000,000 shares of common stock to 675,000,000 shares of common stock with the same par value of $0.001 per share.

  8.2 Issued and outstanding

  On 2 June 2010, and effective 10 August 2010, the directors of the Company approved a forward split of the common stock of the Company on a basis of 30 new common shares for 1 old common share. As a result of the forward stock split, 208,800,000 additional shares were issued. Capital and additional paid-in capital have been adjusted accordingly. When adjusted retroactively, there was an $119,501 shortage of additional paid-in capital; thus an adjustment to accumulated deficit of $104,000 was recorded on 20 May 2010 (the date of issuance of 120,000,000 shares) and $15,501 to the beginning balance. The interim consolidated financial statements contained herein reflect the appropriate values for capital stock and accumulated deficit. Unless otherwise noted, all references in the accompanying interim consolidated financial statements to the number of common shares and per share amounts have been retroactively restated to reflect the forward stock split.

  The total issued and outstanding capital stock is 156,412,660 common shares with a par value of $0.001 per common share. The Company’s common stock issuances to date are as follows:

  o On 10 April 2013, the Company issued 20,000 shares of the Company’s restricted common stock for cash proceeds of $20,000. The Company paid $2,000 in share issuance costs.

  o On 26 April 2013, the Company issued 2,000,000 shares of the Company’s restricted common stock at a par value of $0.001 per share to a third party for marketing assistance with the development of the international markets of the South Pacific quadrant for the Company. As a result, the Company recorded consulting expense of $2,000 when the stock was issued (Note 12).

  o On 18 July 2013, the Company issued 25,000 shares of the Company’s restricted common stock for cash proceeds of $25,000.

  o On 3 December 2013, the Company issued 10,000 shares of the Company’s restricted common stock for cash proceeds of $10,000.

F-18


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

  o On 3 March 2014, the Company issued 10,000 shares of the Company’s restricted common shares for cash proceeds of $10,000.

  o On 11 March 2014, the Company issued 5,000 shares of the Company’s restricted common shares for cash proceeds of $5,000.

  o On 3 April 2014, the Company issued 10,000 shares of the Company’s restricted common stock for cash proceeds of $10,000.

  o On 15 July 2014, the Company issued 4,660 shares of the Company’s restricted common stock for cash proceeds of $4,660 (Note 6).

  o On 28 July 2014, the Company issued 5,250,000 fully vested shares of the Company’s restricted common stock at a par value of $0.001 per share to two directors of the Company for consulting services rendered. As a result, the Company recorded professional fees of $5,250 when the stock was issued (Note 6).

9. GENERAL AND ADMINISTRATIVE EXPENSES

  Three month period ended 31 August 2014
$
Nine month period ended  31 August 2014
$
Three month period ended 31 August 2013
$
Nine month period ended  31 August 2013
$
Cumulative from re-entering of development stage on 26 June 2010
to 31 August 2014
$
           
Administration - - - - 20
Amortization (Note 3) 833 2,500 834 2,500 6,667
Bank charges 64 198 16 170 1,482
Dues and subscription - - - - 575
Filing fees 1,419 7,397 100 3,328 18,867
Meals and entertainment - - 254 254 254
Office 825 1,325 1,755 2,084 8,048
Penalties - - - - 10,000
Transfer agent 100 650 160 400 4,151
Rent 147 638 363 1,101 1,871
Share-based payment - - - - 8,000
Telecommunication 726 2,783 786 1,469 5,777
Travel - - 1,151 2,657 2,656
Website 72 72 - - 221
Total general and administration expenses 4,185 15,563 5,419 13,963 68,588

F-19


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

10. INCOME TAXES

  10.1.1 Provision for income taxes

  Income tax expense differs from the amount that would result from applying the federal income tax rate to earnings before income taxes. During the nine month periods ended 31 August 2014 and 2013, these differences result from the following items:

  For the nine month period ended 31 August 2014
$
For the nine month period ended 31 August 2013
$
     
Income (loss) before income taxes 912,516 (738,192)
Federal income tax rates 35.00% 35.00%
     
Income tax expense (recovery) based on the above rates 319,381 (258,367)
Non–deductible items 15,750 -
Change in valuation allowance (335,131) (258,367)
     
Income tax expense - -

  10.2 Deferred tax balances

  The composition of the Company’s deferred tax assets as at 31 August 2014 and 30 November 2013 are as follows:

As at: 31 August
2014
$
30 November 2013
(Audited)
$
     
Net income tax operating loss carry-forward 1,018,391 1,975,908
     
Deferred tax assets 356,437 691,568
Valuation allowance (356,437) (691,568)
     
Deferred tax assets (liabilities) - -

  As at 31 August 2014, the Company has a total non-capital loss carry forward balance of $1,018,391 (30 November 2013 - 1,975,908), which has expiry dates between the years of 2025 to 2034.

  The Company’s recognized and unrecognized deferred tax assets related to the unused tax losses. A full valuation allowance has been recorded against the potential deferred tax assets associated with all the loss carry-forwards as their utilization is not considered more likely than not at this time.

  The Company is in the process of completing and resolving issues related to its income tax filings and has accrued $10,000 during the year ended 30 November 2013 related to potential penalties associated with these filings. However, there is no assurance that additional interest and penalties will not be assessed (Note 11).

F-20


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

11. COMMITMENTS AND CONTINGENCY

  o On 11 December 2012, the Company formerly engaged BB&T Capital Markets ("BB&TCM") to act as the Company's exclusive financial advisor and agent in connection with developing strategic alternatives for the Company regarding debt financings, licensing of intellectual properties developed by the Company, equity raises, sale of intellectual properties, or other capital markets transactions that may develop over the course of a 24-month agreement (the “Agreement”).

  The Company is to pay BB&TCM an advisory fee of three percent of the face amount of the financial transactions advised upon during the course of the engagement, due and payable at closing of any contemplated transactions under the engagement.

  Additionally, the Company is to defend, indemnify and hold BB&TCM, its parent company, subsidiaries and affiliates and its and their directors, officers, employees, agents and successors and assigns harmless from and against any losses, suits, actions, claims, damages, costs and or other liabilities which any indemnified person may incur as a result of acting on behalf of the Company in connection with this engagement.

  On 19 May 2014, the Company renewed/extended the Agreement with BB&TCM. The extension runs from 1 May 2014 through 1 May 2016 (24 months). All other provisions of the Agreement remain unchanged.

  o On 1 May 2014, the Company entered into an agreement whereby the Asset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor.

  o On 26 May 2014, the Company entered into an exclusive global distribution agreement with All-Sea Coatings Ltd. (a division of All-Sea Enterprises) of North Vancouver, Canada. This agreement has been replaced with an Asset Purchase Agreement date August 14, 2014.

  o On 14 August 2014, Peptide Technologies, Inc. ("the Company") entered into an Asset Purchase Agreement with All-Sea Coatings Ltd. All-Sea Coatings Ltd has acquired from Peptide Technologies Inc. the non-commercialized re-formulated assets that were developed by the Company.

  o The Company is in the process of completing certain of its income tax filings and has accrued $10,000 during the year ended 30 November 2013 related to potential penalties associated with these filings. However, there is no assurance that additional interest and penalties will be assessed (Notes 4 and 10).

  o The Company is committed to making payments related to its notes payable (Note 5).

12. SUPPLEMENTAL CASH FLOW INFORMATION

  The Company made the following cash payments for interest and income taxes:

  Three month period ended 31 August 2014
$
Six month period ended 31 August 2014
$
Three month period ended
31 August 2013
$
Six month period ended
31 August 2013
$
         
Interest paid - - - -
Taxes paid - - - -
         
Total cash payments - - - -

F-21


 

PEPTIDE TECHNOLOGIES, INC.
(A Development stage Company)
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
31 August, 2014
(Unaudited)

  On 26 April 2013, the Company issued 2,000,000 fully vested shares of the Company’s restricted common stock at a par value of $0.001 per share to a third party for marketing assistance with the development of the international markets in the South Pacific quadrant for the Company. As a result, the Company recorded consulting expense of $2,000 when the stock was issued (Note 8).

  During the nine month period ended 31 August 2014, the Company accrued interest expense of $1,743 (31 August 2013 - $2,014) in relation to a loan of CAD$45,000 issued by PSI on 13 November 2011. The loan is unsecured and bears interest at a rate of 6% per annum (Note 5).

  During the nine month period ended 31 August 2014, the Company accrued interest expense of $774 (31 August 2013 - $895) in relation to a loan of CAD$20,000 issued by PSI on 1 June 2012. The loan is unsecured and bears interest at a rate of 6% per annum (Note 5).

  During the nine month period ended 31August 2014, the Company recorded a write down of $45,000 (31 August 2013 - $Nil; cumulative - $45,000) related to its intangible assets and intellectual property (Note 7).

  On 27 May 2014, the CEO requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 May 2014 (Notes 4 and 6).

  On 27 May 2014, a former related party consultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000 (Notes 4 and 6).

  On 15 July 2014, the Company issued 4,660 shares of the Company’s restricted common stock for cash proceeds of $5,660 (Notes 6 and 8).

  On 28 July 2014, the Company issued 5,250,000 fully vested shares of the Company’s restricted common stock at a par value of $0,001 per share to two directors of the Company for consulting services rendered. As a result, the Company recorded professional fees of $5,250 when the stock was issued (Notes 6 and 8).

13. SUBSEQUENT EVENTS

  There have been no reportable events which have occurred during the period from the nine month period ended 31 August 2014 to the date the interim consolidated financial statements were available to be issued on 20 October 2014.

F-22


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS

The following discussion should be read in conjunction with our unaudited financial statements and notes thereto included herein. In connection with, and because we desire to take advantage of, the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, we caution readers regarding certain forward looking statements in the following discussion and elsewhere in this report and in any other statement made by, or on our behalf, whether or not in future filings with the Securities and Exchange Commission. Forward-looking statements are statements not based on historical information and which relate to future operations, strategies, financial results, or other developments. Forward-looking statements are necessarily based upon estimates and assumptions that are inherently subject to significant business, economic, and competitive, uncertainties and contingencies, many of which are beyond our control and many of which, with respect to future business decisions, are subject to change. These uncertainties and contingencies can affect actual results and could cause actual results to differ materially from those expressed in any forward-looking statements made by or on our behalf. We disclaim any obligation to update forward-looking statements.

The following discussion of the plan of operation, financial condition, results of operations, cash flows and changes in financial position of our Company should be read in conjunction with our most recent interim consolidated financial statements and notes appearing elsewhere in this Quarterly Report, on Form 10-Q filed April 11, 2014, on Form 10Q/A filed July 23, 2014, and our Annual Report on Form 10-K filed on February 28, 2014.

The independent registered public accounting firms’ reports on the Company's financial statements as of November 30, 2013, and for the year then ended, include a "going concern" explanatory paragraph that describes substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to the factors prompting the explanatory paragraph are discussed below and also in Note 1 to the unaudited quarterly financial statements.

Discontinued Operations and New Developments

Since inception, the Company’s business plan was to develop a membership based website art gallery/auction house specifically focused on displaying and selling original artwork.  The Company changed its status from a development stage company to an operating company on November 30, 2009.  Management realized that the results of operations from the sale of artwork was lack-luster, and it was decided to change the Company’s business focus and plan for other strategic opportunities and discontinued the sale of artwork to be effective June 25, 2010.  Effective June 26, 2010, the Company started to focus on a new business development.  On July 29, 2010, the Company's name changed from Online Originals, Inc. to CREEnergy Corporation.  The name change was intended to convey a sense of the Company's new business focus as it looked to pursue other opportunities.  Specifically, the Company intended to obtain leases for the exploration and production of oil and gas in northern Canada and the United States.  These objectives have not been realized and the Company has abandoned its efforts in this area.

On August 23, 2011, the Company entered into an Asset Purchase Agreement in which the Company, in exchange for 75,000,000 shares of the Company’s restricted common stock, will receive all rights and title to proprietary technologies and formulas involving the application of specialty peptides.  On December 21, 2011 the Asset Purchase Agreement was amended and 30,000,000 of the 75,000,000 shares issued were returned to treasury and cancelled. Having done this, the Company has changed its business focus from obtaining leases for the exploration and production of oil and gas in areas of northern Alberta, Canada, to the manufacturing and distribution of natural peptide solutions to combat the economic burden caused by the zebra and quagga mussels to the hydropower electricity industry.

On December 14, 2011, the Company amended the Asset Purchase Agreement. As a result of the amendment, the purchase price of the assets was reduced from 75,000,000 shares to 45,000,000 shares, and 30,000,000 shares were returned to treasury and cancelled in exchange for payment of half of one percent of all gross monies received by the Company in relation to revenue earned from products derived from the use of all the formulae listed in the Asset Purchase Agreement.  In addition, a monthly stipend of CAD $15,000 per month is to be paid commencing on the receipt of monies from the first contract signed to purchase products derived from the use of the formulae for a period of five years from the date of the Amended Asset Purchase Agreement.  The cancellation of 30,000,000 common shares has been recorded as a recovery of intangible assets and intellectual property.

22


 

On May 1, 2014, the Company entered into an agreement whereby the Asset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor.

On May 26, 2014, Peptide Technologies, Inc. entered into an exclusive global distribution agreement for its AquaNatural Marine coating with All-Sea Coatings Ltd. (a division of All-Sea Enterprises) of North Vancouver, Canada.  This agreement has been replaced with an Asset Purhcase Agreement date August 14, 2014.

On August 14, 2014, Peptide Technologies, Inc. ("the Company") entered into an Asset Purchase Agreement with All-Sea Coatings Ltd.  All-Sea Coatings Ltd has acquired from Peptide Technologies Inc. the non-commercialized re-formulated assets, that were developed by the Company, in consideration of $10,000, (ten thousand dollars) and a 3% Royalty of all Gross Sales & Revenue, to be paid to Peptide Technologies Inc., derived from All-Sea Coatings Ltd, until such a time should occur that Formulas and or All-Sea Coatings Ltd (the company) is sold.  All-Sea Coatings Ltd shall cover all costs, expenses and capital, including all monies for additional research and development etc., required to commercialize all of the coatings.  All-Sea Coatings Ltd shall pay 10% of the gross sale to Peptide Technologies Inc. derived from any formula sold, out right, and or, if All-Sea Coatings (the Company) is purchased, 10% of the gross sale of All-Sea Coatings Ltd will be paid to Peptide Technologies Inc.

Business of Issuer

The Company business is to realize a 3% Royalty of all Gross Sales & Revenue, to be paid to Peptide Technologies Inc. derived from All-Sea Coatings Ltd, until such a time should occur that Formulas and or All-Sea Coatings Ltd (the company) is sold.

The Company has developed a non-commercialized, incomplete, re-formulated anti-fouling coating formula which has been sold to All-Sea Coatings Ltd.  All-Sea Coatings Ltd. shall cover all costs, expenses and capital, including all monies for additional research and development etc., required to commercialize all of the various coatings that will be produced. 

Facilities and Properties

We do not own our own facilities and are presently renting an identity office in Seattle, Washington.

Employees

Our officers, directors, and employees are responsible for planning, developing and operational duties and will continue to do so throughout the early stages of our growth.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Material Changes in Financial Condition

At 31 August 2014, our cash balance was $11,560. Cash on hand is currently our only source of liquidity. We do not have any lending arrangements in place with banking or financial institutions and we do not anticipate that we will be able to secure these funding arrangements in the near future.

At 31 August 2014, we had a working capital deficit of $746,039 compared to a working capital deficit of $1,750,965 at 30 November 2013.  The reduction of our working capital deficit was caused by a $1.36 million dollar adjustment resulting from the forgiveness of wages and fees due to the CEO and an external consultant, and a $45,000 write down of intangible assets.  (See Notes 4, 6 and 7 within the financial statement section of this report for additional detail).  At 31 August 2014, our total assets consisted of cash of $11,560 and a website with a net carrying value of $3,333.  This compares with total assets at November 30, 2013, which consisted of cash of $157, a website with a net carrying value of $5,833 and intangible assets and intellectual property of $45,000.

23


 

At 31 August 2014, our total liabilities decreased to $757,599 from $1,751,122 at November 30, 2013. During the nine months ended 31 August 2014, accounts payable and accrued liabilities decreased by $993,523. The decrease was primarily caused by the forgiveness of accrued wages, bonus, and consulting fees by our CEO and an external consultant.

We believe our existing cash balances will not be sufficient to carry our normal operations over the next three (3) months.  Our short and long-term survival is dependent on sales of securities as necessary or from shareholder loans, and thus, to the extent that we require additional funds to support our operations or the expansion of our business, we will attempt to sell additional equity shares or issue debt.  Any sale of additional equity securities will result in dilution to our stockholders.  Continuing events in worldwide capital markets may make it more difficult for us to raise additional equity or capital.  There can be no assurance that additional financing, if required, will be available to us or on acceptable terms.

Result of Operations

For The Three Months Ended 31 August 2014 Compared To The Three Months Ended 31 August 2013.

We recognized $9,239 revenues from operational sales during the three months ending August 31, 2014.

During the three months ended 31 August 2014, operating expenses were $68,812 compared to $245,932 for the three months ended 31 August 2013.  The decrease of $177,120 was due to a decrease in consulting fees of $75,000 due to the mutual termination of that contract on 30 November 2013, and a decrease in salaries of $110,000.  Operating expenses during the three months ended August 31, 2014, consisted of salaries expense of $49,224, professional fees of $13,494, general and administrative expenses of $4,185, and supplies expense of $1,909, compared to salaries expense of $159,000, consulting fees of $75,000, professional fees of $5,412, general and administrative expenses of $5,419, and supplies expense of $1,101 incurred for the three months ended 31 August 2013.

We recognized net loss of $59,137 for the three months ended 31 August 2014, compared to a net loss of $248,303 for the three months ended 31 August 2013.  The difference of $189,166 was a result of a reduction in accrued wages and a decrease in consulting expenses of $75,000 due to the cancellation of that agreement on 30 November 2013.

For The Nine Months Ended 31 August 2014 Compared To The Nine Months Ended 31 August 2013.

We recognized 9,239 revenues from operational sales during the nine months ending 31 August 2014.

During the nine months ended 31 August 2014, operating expenses were $413,289 compared to $738,181 for the nine months ended August 31, 2013.  The decrease of $324,892 was due primarily to a decrease in consulting fees of $227,000 due to the mutual termination of that contract on November 30, 2013 and a reduction in accrued salaries of 112,432.  Operating expenses during the nine months ended 31 August 2014, consisted of salaries expense of $364,568, professional fees of $23,265, general and administrative expenses of $15,563, and supplies and materials expense of $9,903, compared to salaries expense of $477,000, professional fees of $19,117, general and administrative expenses of $13,963, and supplies and materials expense of $1,101, incurred for the nine months ended 31 August 2013.

We recognized a net income of $912,516 for the nine months ended 31 August 2014, compared to a net loss of $738,192 for the nine months ended 31 August 2013.  The difference of $1,650,708 was a result a result of the write-off adjustment of $1,361,000 of accrued wages and consulting fees, and the decrease in consulting expenses of $150,000 due to the cancellation of that agreement on 30 November 2013 offset with the write-down of $45,000 for intangible assets.

Off-Balance Sheet Arrangements

We currently do not have any off-balance sheet arrangements.

24


 

Critical Accounting Policies and Estimates

The preparation of the Company’s interim consolidated financial statements in conformity with generally accepted accounting principles in the United States ("U.S. GAAP") requires management to make assumptions and estimates that affect the reported amounts of assets, liabilities, revenues and expenses as well as the disclosure of contingent assets and liabilities at the date of the interim consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The following is a summary of the significant accounting policies and related estimates that affect the Company’s financial disclosures:

Principles of Consolidation

These interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary PEPT Peptide Technologies Inc., a company incorporated in the province of British Columbia on 5 August 2013. All significant inter-company balances and transactions have been eliminated upon consolidation.

Organizational and Start-up Costs

Costs of start-up activities, including organizational costs, are expensed as incurred in accordance with Accounting Standards Codification (“ASC”) 720-15, “Start-Up Costs”.

Development-Stage Company

During the year ended 30 November 2010, the Company abandoned its previous business of sale of original artwork and re-entered the development stage with its intended new business, which currently has no revenues.  Management expects to sustain losses from operations until such time it can generate sufficient revenues to meet its anticipated cost structure.  The Company is considered a development-stage company in accordance with the ASC 915, “Accounting and Reporting by Development-Stage Enterprises.” A development-stage enterprise is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.

Cash and Cash Equivalents

Cash and cash equivalents include highly liquid investments with original maturities of three months or less.

Website

In accordance with ASC 350-50, “Website Development Costs,” expenditures during the planning and operating stages of the Company’s website are expensed as incurred.  Expenditures incurred during the website application and infrastructure development stage are capitalized and amortized to expense over the website’s estimated useful life of 3 years.

Intangible Assets

Intangible assets include the cost of acquiring the intellectual property.  In accordance with ASC 350-30 “General Intangibles Other Than Goodwill," an intangible asset that is acquired either individually or with a group of other assets shall be recognized.  Costs of internally developing, maintaining, or restoring intangible assets that are not specifically identifiable, that have indeterminate lives, or that are inherent in a continuing business and related to an entity as whole, shall be recognized as an expense when incurred.  The intellectual property is determined to have an indefinite useful life and is not subject to amortization. The useful lives of intangible assets are reassessed at each reporting period.  During the nine month period ended 31 August 2014, the Company recorded a write down of $45,000 related to its intangible asset and intellectual property.

25


 

Impairment of Long-Lived Assets

Long-lived assets include the website and intangible assets and intellectual property.  Long-lived assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets not subject to amortization are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount of the asset exceeds the fair value of the asset. There has been no impairment as of 31 August 2014.

Research and Development

Research and development expenses are charged to operations as incurred.

Income Taxes

The Company adopted the ASC 740, “Accounting for Income Taxes."  ASC 740 requires the use of the asset and liability method of accounting of income taxes.  Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the interim consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized.

Basic and Diluted Income (Loss) per Share

In accordance with ASC 260, “Earnings per Share," the basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding.  Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive.  Diluted earnings per share are not shown for periods in which the Company incurs a loss because it would be anti-dilutive.  At August 31, 2014, the Company had no stock equivalents that were anti-dilutive and excluded in the earnings per share computation.

Estimated fair value of financial instruments

The carrying value of the Company’s interim consolidated financial instruments, consisting of cash, accounts payable, and notes payable approximate their fair value due to the short-term maturity of these instruments.  Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest or currency risks arising from these financial instruments.

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents.  At 31 August 2014, all cash and cash equivalents were insured by agencies of the U.S. Government.

Foreign Currency Translation

The interim consolidated financial statements are presented in U.S. dollars. In accordance with ASC 830 “Foreign Currency Matters,” foreign denominated monetary assets and liabilities are translated to their U.S. dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenue and expenses are translated at average rates of exchange during the period. Related translation adjustments are reported as a separate component of stockholders’ equity, whereas gains or losses resulting from foreign currency transactions are included in results of operations. 

26


 

Comprehensive Income (Loss)

The Company adopted ASC 220, "Reporting Comprehensive Income."  ASC 220 requires that the components and total amounts of comprehensive income be displayed in the interim consolidated financial statements beginning in 1998.  Comprehensive income includes net income and all changes in equity during a period that arises from non-owner sources, such as foreign currency items and unrealized gains and losses on certain investments in equity securities.

Use of Estimates

The preparation of the Company’s interim consolidated financial statements are in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the amounts reported in these interim consolidated financial statements and accompanying notes.  Actual results could differ from those estimates.

ITEM 3. QUANTATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We believe our market risk exposures arise primarily from exposures to fluctuations in interest rates and exchange rates.  We presently only transact business in Canadian and U.S. Dollars.  We believe that the exchange rate risk surrounding the future transactions of the Company will not materially or adversely affect our future earnings. We do not believe that we are subject to any seasonal trends.  We do not use derivative financial instruments to manage risks or for speculative or trading purposes.

ITEM 4. CONTROLS AND PROCEDURES

As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our Chief Financial Officer, of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the 1934 Act). Based on this evaluation, the Chief Financial Officer concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the 1934 Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the company in accordance with as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Management’s assessment of the effectiveness of the small business issuer’s internal control over financial reporting is as of the quarter ended 31 August 2014.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended August 31, 2014, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

27


 

PART II – OTHER INFORMATION

ITEM 1.                LEGAL PROCEEDINGS

None.

ITEM 1A.             RISK FACTORS

Not applicable.

ITEM 2.                UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On July 15, 2014, 4,660 shares of the Company’s common stock were issued for cash proceeds of $4,660.

Exemption From Registration Claimed

The above sale by the Company of its unregistered securities was made by the Company in reliance upon Section 4(2) of the Securities Act of 1933, as amended (the "1933 Act").  All of the  individual  and/or  entity  that purchased the unregistered securities was known  to  the  Company  and  its  management,   through  pre-existing  business relationships,   as  long  standing  business  associates  .   All purchasers  were  provided  access  to  all  material  information,  which  they requested,  and all  information  necessary to verify such  information and were afforded access to management of the Company in connection with their purchases. All purchasers of the unregistered securities acquired such securities for investment and not with a view toward distribution, acknowledging such intent to the Company.  All certificates or agreements  representing  such securities that were issued contained  restrictive legends,  prohibiting further transfer of the certificates or agreements representing such securities, without such securities either being first  registered  or  otherwise  exempt from  registration  in any further resale or disposition.

ITEM 3.                DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4.                MINE SAFETY DISCLOSURE.

Not Applicable.

ITEM 5.                OTHER INFORMATION

All information required to be reported in a report on Form 8-K during the third quarter covered by this Form 10-Q has been reported.

ITEM 6.               EXHIBITS           

Exhibit
Number   
Description
31.1 Section 302 Certification – President.
31.2 Section 302 Certification – Chief Financial Officer.
32.1 Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 – President.
32.2 Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 – Chief Financial Officer.

28


 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on this 20th day of October, 2014.

  PEPTIDE TECHNOLOGIES, INC.
     
Date: 20 October 2014 By: /s/ Dennis Cox
     
  Name: Dennis Cox
  Title: President
     
Date: 20 October 2014 By: /s/ Baxter Koehn
     
  Name: Baxter Koehn
  Title: Chief Financial Officer

29


EX-31.1 2 exhibit31-1.htm CERTIFICATION Filed by Avantafile.com - Peptide Technologies, Inc. - Exhibit 31.1

EXHIBIT 31.1
CERTIFICATION PURSUANT TO 18 U.S.C. ss. 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Dennis Cox, certify that: 

1. I have reviewed this quarterly report on Form 10-Q of PEPTIDE TECHNOLOGIES, INC.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

  (c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

  (d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. As the registrant’s certifying officer, I have disclosed, based on the most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):

  a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and

  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls.

Date:  20 October 2014

By: /s/ Dennis Cox
  Dennis Cox
  President


EX-31.2 3 exhibit31-2.htm CERTIFICATION Filed by Avantafile.com - Peptide Technologies, Inc. - Exhibit 31.2

EXHIBIT 31.2
CERTIFICATION PURSUANT TO 18 U.S.C. ss. 1350,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Baxter Koehn, certify that: 

1. I have reviewed this quarterly report on Form 10-Q of PEPTIDE TECHNOLOGIES, INC.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

  (c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

  (d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. As the registrant’s certifying officer, I have disclosed, based on the most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):

  a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and

  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls.

Date:  20 October 2014

By: /s/ Baxter Koehn
  Baxter Koehn
  Chief Financial Officer and Principal Accounting Officer


EX-32.1 4 exhibit32-1.htm CERTIFICATION Filed by Avantafile.com - Peptide Technologies, Inc. - Exhibit 32.1

EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PEPTIDE TECHNOLOGIES, INC. (the "Company") on Form 10-Q for the period ended 31 August 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Dennis Cox, President of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

  (a) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

  (b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:  20 October 2014

By: /s/ Dennis Cox
  Dennis Cox
  President


EX-32.2 5 exhibit32-2.htm CERTIFICATION Filed by Avantafile.com - Peptide Technologies, Inc. - Exhibit 32.2

EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PEPTIDE TECHNOLOGIES, INC. (the "Company") on Form 10-Q for the period ended 31 August 2014, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Baxter Koehn, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

  (a) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

  (b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:  20 October 2014

By: /s/ Baxter Koehn
  Baxter Koehn
  Chief Financial Officer and Principal Accounting Officer


EX-101.INS 6 pept-20140831.xml INSTANCE DOCUMENT 0001357878 2014-10-10 0001357878 2013-11-30 0001357878 2014-08-31 0001357878 2014-06-01 2014-08-31 0001357878 2013-06-01 2013-08-31 0001357878 2012-12-01 2013-08-31 0001357878 2010-06-26 2014-08-31 0001357878 2014-05-31 0001357878 2013-05-31 0001357878 2013-08-31 0001357878 us-gaap:FiniteLivedIntangibleAssetsMember 2014-08-31 0001357878 us-gaap:FiniteLivedIntangibleAssetsMember 2013-11-30 0001357878 PEPT:FotoviewIncMember 2014-08-31 0001357878 PEPT:FotoviewIncMember 2013-11-30 0001357878 PEPT:PSIServicesMember PEPT:Sep212011LoanMember 2014-08-31 0001357878 PEPT:PSIServicesMember PEPT:Sep212011LoanMember 2013-11-30 0001357878 PEPT:PSIServicesMember PEPT:Nov132011LoanMember 2014-08-31 0001357878 PEPT:PSIServicesMember PEPT:Nov132011LoanMember 2013-11-30 0001357878 PEPT:PSIServicesMember PEPT:Jun12012LoanMember 2014-08-31 0001357878 PEPT:PSIServicesMember PEPT:Jun12012LoanMember 2013-11-30 0001357878 PEPT:PSIServicesMember PEPT:Oct222013LoanMember 2014-08-31 0001357878 PEPT:PSIServicesMember PEPT:Oct222013LoanMember 2013-11-30 0001357878 PEPT:PSIServicesMember PEPT:Apr212014LoanMember 2014-08-31 0001357878 PEPT:PSIServicesMember PEPT:Apr212014LoanMember 2013-11-30 0001357878 PEPT:PSIServicesMember 2011-09-21 0001357878 PEPT:PSIServicesMember 2011-11-13 0001357878 PEPT:PSIServicesMember 2012-06-01 0001357878 PEPT:PSIServicesMember 2013-10-22 0001357878 PEPT:PSIServicesMember 2014-04-21 0001357878 2010-06-25 0001357878 us-gaap:CommonStockMember 2013-12-01 2014-08-31 0001357878 us-gaap:CommonStockMember 2012-12-01 2013-11-30 0001357878 us-gaap:CommonStockMember 2013-11-30 0001357878 us-gaap:CommonStockMember 2014-08-31 0001357878 us-gaap:CommonStockMember 2012-11-30 0001357878 us-gaap:AdditionalPaidInCapitalMember 2013-12-01 2014-08-31 0001357878 us-gaap:AdditionalPaidInCapitalMember 2012-12-01 2013-11-30 0001357878 us-gaap:AdditionalPaidInCapitalMember 2013-11-30 0001357878 us-gaap:AdditionalPaidInCapitalMember 2014-08-31 0001357878 us-gaap:AdditionalPaidInCapitalMember 2012-11-30 0001357878 us-gaap:RetainedEarningsMember 2013-12-01 2014-08-31 0001357878 us-gaap:RetainedEarningsMember 2012-12-01 2013-11-30 0001357878 us-gaap:RetainedEarningsMember 2013-11-30 0001357878 us-gaap:RetainedEarningsMember 2014-08-31 0001357878 us-gaap:RetainedEarningsMember 2012-11-30 0001357878 us-gaap:ComprehensiveIncomeMember 2013-12-01 2014-08-31 0001357878 us-gaap:ComprehensiveIncomeMember 2012-12-01 2013-11-30 0001357878 us-gaap:ComprehensiveIncomeMember 2013-11-30 0001357878 us-gaap:ComprehensiveIncomeMember 2014-08-31 0001357878 us-gaap:ComprehensiveIncomeMember 2012-11-30 0001357878 2013-12-01 2014-08-31 0001357878 2012-12-01 2013-11-30 0001357878 2012-11-30 0001357878 PEPT:PSIServicesMember PEPT:Aug142014LoanMember 2014-08-31 0001357878 PEPT:PSIServicesMember PEPT:Aug142014LoanMember 2013-11-30 0001357878 PEPT:PSIServicesMember 2014-08-14 0001357878 2014-05-27 0001357878 PEPT:PastDirectorsAndEmployeesMember PEPT:SalariesAndBenefitsEarnedMember 2014-08-31 0001357878 PEPT:PastDirectorsAndEmployeesMember PEPT:SalariesAndBenefitsEarnedMember 2013-11-30 0001357878 us-gaap:ChiefFinancialOfficerMember PEPT:ExpenseReimbursementsMember 2014-08-31 0001357878 us-gaap:ChiefFinancialOfficerMember PEPT:ExpenseReimbursementsMember 2013-11-30 0001357878 us-gaap:ChiefExecutiveOfficerMember PEPT:BonusesMember 2014-08-31 0001357878 us-gaap:ChiefExecutiveOfficerMember PEPT:BonusesMember 2013-11-30 0001357878 PEPT:OfficersAndEmployeesMember 2013-12-01 2014-08-31 0001357878 PEPT:OfficersAndEmployeesMember 2012-12-01 2013-08-31 0001357878 PEPT:OfficersAndEmployeesMember 2010-06-26 2014-08-31 0001357878 us-gaap:ChiefExecutiveOfficerMember 2014-05-27 0001357878 PEPT:ConsultantMember PEPT:AdvisoryAgreementMember 2013-12-01 2014-08-31 0001357878 PEPT:ConsultantMember PEPT:AdvisoryAgreementMember 2012-12-01 2013-08-31 0001357878 PEPT:ConsultantMember PEPT:AdvisoryAgreementMember 2010-06-26 2014-08-31 0001357878 PEPT:ConsultantMember PEPT:ConsultingServicesMember 2014-08-31 0001357878 PEPT:ConsultantMember PEPT:ConsultingServicesMember 2013-11-30 0001357878 PEPT:ConsultantMember PEPT:ConsultingServicesMember 2014-05-27 0001357878 PEPT:DirectorsAndShareholdersMember 2013-12-01 2014-08-31 0001357878 PEPT:DirectorsAndShareholdersMember 2012-12-01 2013-08-31 0001357878 PEPT:DirectorsAndShareholdersMember 2010-06-26 2014-08-31 0001357878 2011-08-01 2011-08-23 0001357878 2011-12-01 2011-12-14 0001357878 2010-08-01 2010-08-10 0001357878 2010-08-10 0001357878 2010-05-20 0001357878 2013-04-10 0001357878 2013-04-26 0001357878 2013-07-18 0001357878 2013-12-03 0001357878 2014-03-03 0001357878 2014-03-11 0001357878 2014-04-03 0001357878 2014-07-15 0001357878 2014-07-28 0001357878 2013-04-01 2013-04-26 0001357878 2013-04-01 2013-04-10 0001357878 2014-07-01 2014-07-28 0001357878 PEPT:WebsiteMember 2013-12-01 2014-08-31 0001357878 PEPT:WebsiteMember 2012-12-01 2013-08-31 0001357878 PEPT:WebsiteMember 2010-06-26 2014-08-31 0001357878 2011-11-13 0001357878 2012-10-01 2012-10-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD 156412660 675000000 675000000 75000000 0.001 0.001 0.001 0.001 0.001 151123000 156412660 20000 2000000 25000 10000 10000 5000 10000 4660 5250000 151123000 156412660 151123000 156412660 149078000 5833 3333 3333 5833 10000 10000 10000 10000 4167 6667 6667 4167 574188 38317 27000 4000 17084 29652 1044000 580000 88850 105631 16000 16000 500 500 48408 47961 20906 20689 3700 3700 7368 8749 0.06 0.06 0.06 0.06 500 45000 20000 3700 8000 9500 6963 5251 2486 1707 41445 42710 18420 18982 88850 105631 1662272 651968 50990 14893 45000 5833 3333 157 11560 151123 156413 148279 187899 20000 25000 10000 10000 5000 10000 4660 5250 -105837 -105837 104000 1893697 981181 -1700132 -742706 151123 156413 149078 148279 187899 105324 -105837 -105837 -105837 -1893698 -981182 -898221 -749656 15501 50990 14893 4167 6667 -59137 -248303 -738192 -981181 912516 -995477 912516 -995477 75000 227000 552975 227000 833 833 2500 6667 2500 2500 2500 6667 39660 45000 40 45 39620 42955 39660 43000 2000000 2000 2000 5250 5250000 5250 5250 9436 5419 13963 73839 20813 72 221 72 1151 2657 2656 726 786 1469 5777 2783 13250 147 363 1101 1871 638 100 160 400 4151 650 10000 825 1755 2084 8048 1325 254 254 254 1419 100 3328 18867 7397 575 64 16 170 1482 198 833 834 2500 6667 2500 -258367 -335131 15750 -258367 319381 0.3500 0.3500 -691568 -356437 691568 356437 1975908 1018391 PEPTIDE TECHNOLOGIES, INC. 0001357878 10-Q 2014-08-31 false --11-30 No No Yes Smaller Reporting Company Q3 2014 <p style="margin: 0pt"></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 11pt"><b>2.</b></font></td><td style="text-align: justify"><font style="font-size: 11pt"><b>SIGNIFICANT ACCOUNTING POLICIES</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; letter-spacing: -0.15pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; letter-spacing: -0.15pt; text-align: justify">This summary of significant accounting policies is presented to assist in understanding the Company&#146;s interim consolidated financial statements. The interim consolidated financial statements and notes are representations of management who is responsible for their integrity and objectivity. These accounting policies have been consistently applied in the preparation of the interim consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; letter-spacing: -0.15pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 22.65pt"></td><td style="width: 45pt"><font style="font-size: 10pt"><b>2.1</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Basis of Presentation</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; letter-spacing: -0.15pt; text-align: justify; text-indent: -27pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.15pt; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"></td><td style="text-align: justify">These interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;U.S. GAAP&#148;) applicable for a development stage company for financial information and are expressed in U.S. dollars.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.2</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Principles of Consolidation</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -27pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.15pt; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"></td><td style="text-align: justify">These interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary Pept Peptide, a company incorporated in the province of British Columbia on 5 August 2013. All significant inter-company balances and transactions have been eliminated upon consolidation.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.3</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Organizational and Start-up Costs</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Costs of start-up activities, including organizational costs, are expensed as incurred in accordance with Accounting Standards Codification (&#147;ASC&#148;) 720-15, <i>&#147;Start-Up Costs.&#34;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.4</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Development-Stage Company</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">During the year ended 30 November 2010, the Company abandoned its previous business of sale of original artwork and re-entered the development stage with its intended new business, which currently has no significant revenues.&#160;&#160;Management expects to sustain losses from operations until such time it can generate sufficient revenues to meet its anticipated cost structure. The Company is considered a development-stage company in accordance with the ASC 915, &#147;<i>Accounting and Reporting by Development-Stage Enterprises.&#34;</i> A development-stage enterprise is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.5</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Cash and Cash Equivalents</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Cash and cash equivalents include highly liquid investments with original maturities of three months or less.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.6</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Website</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">In accordance with ASC 350-50, &#147;<i>Website Development Costs,&#34;</i> expenditures during the planning and operating stages of the Company&#146;s website are expensed as incurred. Expenditures incurred during the website application and infrastructure development stage are capitalized and amortized to expense over the website&#146;s estimated useful life of 3 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.7</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Intangible Assets</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Intangible assets include the cost of acquiring the intellectual property. In accordance with ASC 350-30 <i>&#147;General Intangibles Other Than Goodwill,&#34;</i> an intangible asset that is acquired either individually or with a group of other assets shall be recognized. Costs of internally developing, maintaining, or restoring intangible assets that are not specifically identifiable, that have indeterminate lives, or that are inherent in a continuing business and related to an entity as whole, shall be recognized as an expense when incurred. The intellectual property is determined to have an indefinite useful life and is not subject to amortization. The useful life of the intangible asset is reassessed at each reporting period. During the nine month period ended 31 August 2014, the Company recorded a write down of $45,000 related to its intangible assets and intellectual property (Notes 7 and 12).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.8</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Impairment of Long-Lived Assets</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Long-lived assets include the website and intangible assets and intellectual property. Long-lived assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets not subject to amortization are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount of the asset exceeds the fair value of the asset. There has been no impairment as of 31 August 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.9</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Research and Development</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Research and development expenses are charged to operations as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.10</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Income Taxes</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">The Company adopted the ASC 740, &#147;<i>Accounting for Income Taxes.&#34;</i> ASC 740 requires the use of the asset and liability method of accounting of income taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the interim consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.11</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Basic and Diluted Income (Loss) per Share</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">In accordance with ASC 260, <i>&#147;Earnings per Share,&#34;</i> the basic income (loss) per common share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed similar to basic income (loss) per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings per share are not shown for periods in which the Company incurs a loss because it would be anti-dilutive. At 31 August 2014, the Company had no stock equivalents that were anti-dilutive and excluded in the earnings (loss) per share computation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.12</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Estimated Fair Value of Financial Instruments</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">The carrying value of the Company&#146;s interim consolidated financial instruments, consisting of cash, accounts payable and notes payable approximate their fair value due to the short-term maturity of these instruments. Unless otherwise noted, it is management&#146;s opinion that the Company is not exposed to significant interest or currency risks arising from these financial instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. At 31 August 2014, cash and cash equivalents of $310 were insured by agencies of the U.S. Government.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18.35pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.13</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Foreign Currency Translation</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">The interim consolidated financial statements are presented in U.S. dollars. In accordance with ASC 830 <i>&#147;Foreign Currency Matters,&#34;</i> foreign denominated monetary assets and liabilities are translated to their U.S. dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenue and expenses are translated at average rates of exchange during the period. Related translation adjustments are reported as a separate component of stockholders&#146; equity, whereas gains or losses resulting from foreign currency transactions are included in results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18.35pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.14</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Comprehensive Income (Loss)</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">The Company adopted ASC 220, <i>&#34;Reporting Comprehensive Income.&#34;</i> ASC 220 requires that the components and total amounts of comprehensive income (loss) be displayed in the interim consolidated financial statements beginning in 1998. Comprehensive income (loss) includes net income (loss) and all changes in equity during a period that arises from non-owner sources, such as foreign currency items and unrealized gains and losses on certain investments in equity securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18.35pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.15</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Use of Estimates</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">The preparation of the Company&#146;s interim consolidated financial statements are in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the amounts reported in these interim consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18.35pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.16</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Changes in Accounting Policy</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">Effective 1 December 2013, the Company adopted Financial Accounting Standards Board (&#147;FASB&#148;) Accounting Standards Update (&#147;ASU&#148;)<b> </b>No. 2013-02, <i>&#147;Comprehensive Income.&#34;</i> This update requires an entity to present information about amounts reclassified out of accumulated other comprehensive income and their corresponding effect on the respective line items in net income in one place, and in some cases, cross-references to related footnote disclosures. The update applies to public companies for all reporting periods presented, including interim periods, and to nonpublic entities for annual reporting periods. ASU No. 2013-02 will be effective for fiscal years, and interim periods within those years, beginning after 15 December 2012 for public companies, with early adoption permitted. The adoption of this update did not have a material effect on the Company&#146;s interim consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.17</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Recent Accounting Pronouncements</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><font style="font-weight: normal">In July 2013, the FASB issued ASU No. 2013-11, &#147;<i>Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,&#34;</i> which is intended to eliminate the diversity that is in practice with regard to the financial statement presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU No. 2013-11 is effective for fiscal years and interim periods within those years, beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company&#146;s interim consolidated financial statements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><font style="font-weight: normal">In May 2014, the FASB issued ASU No. 2014-09, <i>&#147;Revenue from Contracts with Customers,&#34;</i> which provides a five-step approach to be applied to all contracts with customers. ASU No. 2014-09 also requires expanded disclosures about revenue recognition. ASU No. 2014-09 is effective for annual reporting periods beginning after 15 December 2016, including interim periods. Early adoption is not permitted.&#160;The adoption of this update is not expected to have a material impact on the Company&#146;s interim consolidated financial statements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">In June 2014, the FASB issued ASU No. 2014-10, <i>&#147;Development Stage Entities</i>,&#34; which intends to remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the update eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. ASU No. 2014-10 is effective for fiscal years and interim periods beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company&#146;s interim consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 27.35pt"><font style="font-weight: normal">&#160;</font></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.18</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Reclassifications</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -27pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Certain amounts reported in previous periods have been reclassified to conform to the current presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.19</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Other</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">The Company consists of one reportable business segment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">The Company paid no dividends during the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 10pt"><b>3.</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>WEBSITE</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>As at:</b></font></td> <td colspan="3" style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p></td> <td colspan="3" style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">30 November 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Audited)</p></td></tr> <tr> <td style="vertical-align: top; width: 19%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; width: 11%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Cost</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 16%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Accumulated amortization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 13%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Net book value</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 11%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Cost</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td> <td style="vertical-align: bottom; width: 16%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: right">Accumulated amortization</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td> <td style="vertical-align: bottom; width: 14%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Net book value</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Website</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>10,000</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>6,667</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>3,333</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">10,000</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">4,167</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">5,833</font></td></tr> <tr> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Total</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>10,000</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>6,667</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>3,333</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">10,000</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">4,167</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">5,833</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">The Company purchased a website during October 2012 for $10,000. This website has a useful life of three years, and the cost is being amortized over the life of the asset. During the nine month period ended 31 August 2014, the Company recognized amortization expense of $2,500 (31 August 2013 - $2,500; cumulative - $6,667) (Note 9).</p> <p style="margin: 0pt"></p> 1751122 757599 516000 516000 516000 300000 300000 300000 545000 545000 580000 1044000 730 300000 364568 477000 1434562 545000 27288 75000000 30000000 15000 2000 2000 30 208800000 120000000 119501 10000 2014 10269 1743 45000 0.06 153143767 151107016 150022908 152154135 0 0 0 0.01 -59137 -248303 -738192 -981514 912516 -333 -1087 -1097 -2909 -10438 -2686 1523 -1274 2898 5366 3252 1361000 1361000 -45000 -45000 -59573 -245932 -738181 -2292109 -404050 68812 245932 738181 2301348 413289 1909 1101 1101 70135 9903 13494 5412 19117 174998 23255 4185 5419 13963 68588 15563 49224 159000 477000 1434652 364568 9239 9239 9239 157 11560 1683 369 5271 4536 7780 9877 4902 -2509 7024 11403 333 14007 25000 45000 272621 57007 27288 9500 84559 17347 4660 25000 45000 160774 39660 -10000 -10000 -4130 -20098 -47509 -255264 -45604 49360 225000 684678 2012218 350696 3494 2710 45000 45000 5250 13250 5250 2000 -1361000 -1361000 -1523 1275 -2898 -5366 -3252 1087 1097 2909 10438 2686 <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 11pt"><b>1.</b></font></td><td style="text-align: justify"><font style="font-size: 11pt"><b>NATURE AND CONTINUANCE OF OPERATIONS</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>1.1</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Organization</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -27pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Peptide Technologies, Inc. (the &#147;Company&#148;) was incorporated in the State of Nevada, United States of America, on 18 November 2005. On 29 July 2010, the Company&#146;s name was changed from Online Originals, Inc. to CREEnergy Corporation. Effective 12 October 2011, the Company&#146;s name was changed from CREEnergy Corporation to Peptide Technologies, Inc. The Company&#146;s year-end is 30 November. The Company is currently a development stage Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -27pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">On 5 August 2013, the Company incorporated Pept Peptide Technologies Inc. (&#147;Pept Peptide&#148;), a wholly-owned subsidiary, under the laws of British Columbia. Pept Peptide currently does not have any transactions from the date of incorporation on 5 August 2013 to 31 August 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -27pt"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>1.2</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Nature of Operations and Change in Business</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -27pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Upon inception on 18 November 2005, the Company&#146;s business plan was to develop a membership-based website art gallery/auction house specifically focused on displaying and selling original artwork. The Company changed its status from a development stage company to an operating company on 30 November 2009. Management realized that the results of operations from the sale of artwork lacks luster and decided to change the Company&#146;s business focus and plan for other strategic opportunities. Effective 26 June 2010, the Company became a development stage company focusing on a new business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -27pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">On 23 August 2011, the Company entered into an agreement (the &#147;Asset Purchase Agreement&#148;) in which the Company, in exchange for 75,000,000 shares of the Company&#146;s restricted common stock, received all rights and title to proprietary technologies and formulas involving the application of specialty Peptides. The Company has changed its business focus to the manufacturing and distribution of natural peptide solutions to combat the economic burden of bio-fouling. On 14 December 2011, the Company amended the Asset Purchase Agreement (the &#147;First Amendment&#148;). As a result of the First Amendment, the purchase price of the assets was reduced from 75,000,000 shares to 45,000,000 shares, and 30,000,000 shares were returned to treasury (Note 7).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">On 1 May 2014, the Company entered into an agreement whereby the Asset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor (Note 7).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">On 26 May 2014, the Company entered into an exclusive global distribution agreement for its AquaNatural Marine coating with All-Sea Coatings Ltd. (a division of All-Sea Enterprises) of North Vancouver, Canada. This agreement has been replaced with an Asset Purchase Agreement date 14 August 2014.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">On 14 August 2014, the Company entered into an Asset Purchase Agreement with All-Sea Coatings Ltd. All-Sea Coatings Ltd has acquired from the Company the non-commercialized re-formulated assets that were developed by the Company. The Company business is to realize a 3% Royalty of all Gross Sales &#38; Revenue, to be paid to the Company derived from All-Sea Coatings Ltd.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>1.3</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Basis of Going Concern</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -27pt"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">The accompanying interim consolidated financial statements as at 31 August 2014 and for the nine month period then ended have been prepared on a going concern basis, which contemplates the realization of assets and settlement of liabilities and commitments in the normal course of business. The Company has net profit of $912,516 for the nine month period ended 31 August 2014 (31 August 2013 &#150; loss of $738,192; cumulative loss - $981,514) and has a working capital deficit of $746,039 at 31 August 2014 (30 November 2013 - $1,750,965).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive, or raise additional debt and/or equity capital. Management believes that the Company&#146;s capital resources should be adequate to continue operating and maintaining its business strategy during the fiscal year ended 30 November 2014. However, if the Company is unable to raise additional capital in the near future or met financing requirements, due to the Company&#146;s liquidity problems, management expects that the Company will need to curtail operations, liquidate assets, seek additional capital on less favorable terms and/or pursue other remedial measures. Management is aware, in making its assessment, of material uncertainties related to events or conditions that may cast significant doubt upon the Company&#146;s ability to continue as a going concern. These interim consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -27pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Although management is actively seeking to add new products and/or services in order to show profitability, and is seeking additional sources of equity or debt financing, there is no assurance that these activities will be successful. The Company has not yet been able to find products and services that would contribute to their business due to the continued economic condition. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The interim consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 49.5pt"><font style="font-size: 10pt"><b>1.4</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Unaudited Statements</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><font>&#160;</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; letter-spacing: -0.15pt; text-align: justify">While the information presented in the accompanying interim consolidated financial statements is unaudited, it includes all adjustments which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Except as disclosed below, these interim consolidated financial statements follow the same accounting policies and methods of their application as the Company&#146;s audited 30 November 2013 annual consolidated financial statements. It is suggested that these interim consolidated financial statements be read in conjunction with the Company&#146;s audited consolidated financial statements for the year ended 30 November 2013, included in the annual report previously filed with the Securities and Exchange Commission on Form 10-K. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; letter-spacing: -0.15pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 45pt; letter-spacing: -0.15pt; text-align: justify">The information as of 30 November 2013 is taken from the audited consolidated financial statements as of that date.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 10pt"><b>4.</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 60%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>As at:</b></font></td> <td style="vertical-align: bottom; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">30 November 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(Audited)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Accounts payable</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>38,317</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">574,188</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Accrued liabilities</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>4,000</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">27,000</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Payroll taxes payable </font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>29,652</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">17,084</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Salaries and benefits payable (Note 6)</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>580,000</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,044,000</font></td></tr> <tr> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Total accounts payable and accrued liabilities</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>651,969</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,662,272</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify; text-indent: -4.5pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">Trades payable and accrued liabilities are non-interest bearing, unsecured and have settlement dates within one year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">On 27 May 2014, the Chief Executive Officer (&#147;CEO&#148;) requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 August 2014 (Notes 6 and 12).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">On 27 May 2014, a consultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000 (Notes 6 and 12).</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 10pt"><b>5.</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>NOTES PAYABLE </b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 71%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt"><b>As at:</b></font></td> <td style="vertical-align: bottom; width: 14%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">30 November 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(Audited)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">During the year ended 30 November 2010, Fotoview Inc. (&#147;Fotoview&#148;) issued a loan of $16,000 to a former director of the Company to purchase 4,000,000 restricted common shares of the Company.&#160;&#160;Upon the director&#146;s resignation, the 4,000,000 common shares were cancelled and the Company assumed the loan payable to Fotoview.&#160;&#160;The loan is unsecured, bears no interest, and has no fixed terms of repayment.</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>16,000</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">16,000</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 21 September 2011, PSI Services (&#147;PSI&#148;) issued a loan of $500 to the Company. The loan is unsecured, bears no interest and has no fixed terms of repayment.</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>500</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">500</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 13 November 2011, PSI issued a loan of CAD$45,000 to the Company.&#160;The loan is unsecured and bears interest at a rate of 6% per annum. Principal and accrued interest are due on 30 November 2014. The loan payable to PSI as at 31 August 2014 consists of principal and accrued interest of $41,445 (30 November 2013 &#150; $42,710) and $6,963 (30 November 2013 &#150; $5,251), respectively (Note 12).</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>48,408</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">47,961</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 27pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 1 June 2012, PSI issued a loan of CAD$20,000 to the Company.&#160;The loan is unsecured and bears interest at a rate of 6% per annum.&#160;Principal and accrued interest is due on 30 November 2014.. The loan payable to PSI as at 31 August 2014 consists of principal and accrued interest of $18,420 (30 November 2013 &#150; $18,982) and $2,486 (30 November 2013 &#150; $1,707), respectively (Note 12)</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>20,906</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">20,689</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 22 October 2013, PSI issued a loan of USD $3,700 to the Company.&#160;&#160;The loan is unsecured, bears no interest, and has no fixed terms of repayment.</font></td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>3,700</b></font></td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">3,700</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 21 April 2014, PSI Issued a loan of CAD $8,000 to the Company.&#160;The loan is unsecured, bears no interest, and has no fixed terms of repayment.</font></td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>7,368</b></font></td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 14 August 2014, PSI issued a loan of CAD $9,500 to the Company.&#160;The loan is unsecured, bears no interest, and has no fixed terms of repayment.</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>8,749</b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Total notes payable </b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>105,631</b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">88,850</font></td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 10pt"><b>6.</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>RELATED PARTY TRANSACTIONS</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">As at 31 August 2014, the amount due to related parties includes $580,000 (30 November 2013 - $1,044,000) payable to past directors and employees of the Company in relation to salaries and benefits earned, and $Nil (30 November 2013 - $730) payable to the Chief Financial Officer (&#147;CFO&#148;) of the Company in relation to expense reimbursements. Of the amount due to related parties, $Nil relates to bonuses payable to the CEO of the Company (30 November 2013 - $300,000) (Note 4).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">During the nine month period ended 31 August 2014, the Company accrued salaries and benefits of $364,568 to officers and employees of the Company (31 August 2013 - $477,000; cumulative - $1,434,562).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">On 27 May 2014, the CEO requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 May 2014. As at 31 August 2014, included in salaries and benefits are bonuses of $Nil accrued to the CEO of the Company during the nine month period ended 31 August 2014 (31 August 2013 - $Nil; cumulative - $Nil) (Notes 4 and 12).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify; color: blue">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">Effective 1 December 2013, the Company and a former related party consultant mutually terminated an Advisory Agreement entered into on 1 November 2012. The Company accrued $Nil of consulting fees to the consultant (31 August 2013 - $227,000; cumulative - $Nil) during the nine month period ended 31 August 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">On 27 May 2014, a formerly related party consultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000. As at 31 August 2014 there is $Nil (30 November 2013 - $545,000) outstanding and payable to the consultant for consulting services received (Notes 4 and 12).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">During the year ended 30 November 2013, the Board approved a commission payment program (the &#147;Program&#148;) equal to 30% of gross sales of fouling prevention coatings. Under this Program, the CEO will receive compensation equal to 20% of gross sales of anti-fouling paint, as recognition of his work in developing the formulas; and an external consultant will receive 10% of gross sales of anti-fouling paint as compensation for sales development. On 28 February 2014, the Board amended the Program to reduce the CEO&#146;s compensation from 20% to 10% of gross sales of anti-fouling paint. On 27 May 2014, the Program was eliminated by mutual agreement from both parties affected. As a result, no commissions will be earned by either the CEO or the applicable consultant on gross sales of fouling prevention coatings. As at 31 August 2014, there were $Nil commissions earned (Note 7).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">During the nine month period ended 31 August 2014, directors and shareholders of the Company made cash contributions in the amount of $Nil (31 August 2013 - $Nil, cumulative &#150; $27,288).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">On 15 July 2014, the Company issued 4,660 shares of the Company&#146;s restricted common stock for cash proceeds of $5,660 (Note 8).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">On 28 July 2014, the Company issued 5,250,000 fully vested shares of the Company&#146;s restricted common stock at a par value of $0.001 per share to two directors of the Company for consulting services rendered. As a result, the Company recorded professional fees of $5,250 when the stock was issued (Note 8).</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 10pt"><b>7.</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>INTANGIBLE ASSETS AND INTELLECTUAL PROPERTY</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify">On 23 August 2011, the Company entered into an Asset Purchase Agreement to acquire intangible assets and intellectual property known as the Platforms in exchange for 75,000,000 restricted common shares of the Company (issued on 23 August 2011) (Note 1).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify">On 14 December 2011, the Company entered into an amended the First Amendment and, as a result, a total of 30,000,000 restricted common shares of the Company were returned to treasury and cancelled in exchange for payment of half of one percent of all gross monies received by the Company in relation to revenue earned from products derived from the use of all the formulae listed in the Asset Purchase Agreement. In addition, a monthly stipend of CAD $15,000 per month is to be paid commencing on the receipt of monies from the first contract signed to purchase products derived from the use of the formulae for a period of five years from the date of the First Amendment. The cancellation of 30,000,000 common shares has been recorded as a recovery of intangible assets and intellectual property (Note 1).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify">On 1 May 2014, the Company entered into an agreement whereby the Asset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor (Note 1).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify">During the nine month period ended 31 August 2014, the Company recorded a write down of $45,000 (31 August 2013 - $Nil; cumulative - $45,000) related to its intangible assets and intellectual property (Note 12).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify">On 20 January 2013, the Board approved the Program equal to 30% of gross sales of fouling prevention coatings. Under this Program, the CEO will receive compensation equal to 20% of gross sales of anti-fouling paint, as recognition of his work in developing the formulas; and an external consultant will receive 10% of gross sales of anti-fouling paint as compensation for sales development. On 28 February 2014, the Board amended the Program to reduce the CEO&#146;s compensation from 20% to 10% of gross sales of anti-fouling paint. On 27 May 2014, the Program was eliminated by mutual agreement from both parties affected. As a result, no commissions will be earned by either the CEO or the applicable consultant on gross sales of fouling prevention coatings. As of 31 August 2014, there were $Nil commissions earned (Note 6).</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 10pt"><b>8.</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>CAPITAL STOCK</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>8.1</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Authorized common stock</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; letter-spacing: -0.15pt; text-align: justify">The Company&#146;s authorized common stock consists of 675,000,000 shares of common stock with a par value of $0.001 per share. On 10 August 2010, the Company increased the number of authorized share capital from 75,000,000 shares of common stock to 675,000,000 shares of common stock with the same par value of $0.001 per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>8.2</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Issued and outstanding</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; letter-spacing: -0.15pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; letter-spacing: -0.15pt; text-align: justify">On 2 June 2010, and effective 10 August 2010, the directors of the Company approved a forward split of the common stock of the Company on a basis of 30 new common shares for 1 old common share. As a result of the forward stock split, 208,800,000 additional shares were issued. Capital and additional paid-in capital have been adjusted accordingly. When adjusted retroactively, there was an $119,501 shortage of additional paid-in capital; thus an adjustment to accumulated deficit of $104,000 was recorded on 20 May 2010 (the date of issuance of 120,000,000 shares) and $15,501 to the beginning balance. The interim consolidated financial statements contained herein reflect the appropriate values for capital stock and accumulated deficit. Unless otherwise noted, all references in the accompanying interim consolidated financial statements to the number of common shares and per share amounts have been retroactively restated to reflect the forward stock split.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; letter-spacing: -0.15pt; text-align: justify">&#160;</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 35.45pt; letter-spacing: -0.15pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The total issued and outstanding capital stock is 156,412,660</font> <font style="font: 10pt Times New Roman, Times, Serif">common shares with a par value of $0.001 per common share. The Company&#146;s common stock issuances to date are as follows:</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 35.45pt; letter-spacing: -0.15pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 38.8pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 10 April 2013, the Company issued 20,000 shares of the Company&#146;s restricted common stock for cash proceeds of $20,000. The Company paid $2,000 in share issuance costs.</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 38.8pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 26 April 2013, the Company issued 2,000,000 shares of the Company&#146;s restricted common stock at a par value of $0.001 per share to a third party for marketing assistance with the development of the international markets of the South Pacific quadrant for the Company. As a result, the Company recorded consulting expense of $2,000 when the stock was issued (Note 12).</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 38.8pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 18 July 2013, the Company issued 25,000 shares of the Company&#146;s restricted common stock for cash proceeds of $25,000.</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 38.8pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 3 December 2013, the Company issued 10,000 shares of the Company&#146;s restricted common stock for cash proceeds of $10,000.</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 38.8pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 3 March 2014, the Company issued 10,000 shares of the Company&#146;s restricted common shares for cash proceeds of $10,000.</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 38.8pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 11 March 2014, the Company issued 5,000 shares of the Company&#146;s restricted common shares for cash proceeds of $5,000.</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 38.8pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 3 April 2014, the Company issued 10,000 shares of the Company&#146;s restricted common stock for cash proceeds of $10,000.</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 38.8pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 15 July 2014, the Company issued 4,660 shares of the Company&#146;s restricted common stock for cash proceeds of $4,660 (Note 6).</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 38.8pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 28 July 2014, the Company issued 5,250,000 fully vested shares of the Company&#146;s restricted common stock at a par value of $0.001 per share to two directors of the Company for consulting services rendered. As a result, the Company recorded professional fees of $5,250 when the stock was issued (Note 6).</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 10pt"><b>9.</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>GENERAL AND ADMINISTRATIVE EXPENSES</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: bottom; width: 29%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; width: 14%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Three month period ended 31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 13%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Nine month period ended 31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 14%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Three month period ended 31 August 2013</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 12%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Nine month period ended 31 August 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td> <td style="vertical-align: top; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Cumulative from re-entering of development stage on 26 June 2010</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">to 31 August 2014</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Administration</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">20</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Amortization (Note 3)</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>833</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>2,500</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">834</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,500</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">6,667</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Bank charges</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>64</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>198</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">16</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">170</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,482</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Dues and subscription</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">575</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Filing fees</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>1,419</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>7,397</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">3,328</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">18,867</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Meals and entertainment</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">254</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">254</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">254</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Office</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>825</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>1,325</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,755</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,084</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">8,048</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Penalties</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">10,000</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Transfer agent</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>100</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>650</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">160</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">400</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">4,151</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Rent</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>147</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>638</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">363</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,101</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,871</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Share-based payment</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">8,000</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Telecommunication</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>726</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>2,783</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">786</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,469</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">5,777</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Travel</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,151</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,657</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,656</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Website</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>72</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>72</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">221</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt"><b>Total general and administration expenses</b></font></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>9,436</b></font></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>20,813</b></font></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">5,419</font></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">13,963</font></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">73,839</font></td></tr> </table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt/115% Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top"> <td style="width: 14.2pt"></td><td style="width: 21.25pt"><font style="font-size: 10pt"><b>10.</b></font></td><td><font style="font-size: 10pt"><b>INCOME TAXES</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 13.65pt"></td><td style="width: 36pt"><font style="font-size: 10pt"><b>10.1.1</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Provision for income taxes</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Income tax expense differs from the amount that would result from applying the federal income tax rate to earnings before income taxes. During the nine month periods ended 31 August 2014 and 2013, these differences result from the following items:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 348px; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; width: 102px; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>For the nine month period ended 31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">For the nine month period ended<b> </b>31 August 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Income (loss) before income taxes</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>912,516</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">(738,192)</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Federal income tax rates</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>35.00%</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">35.00%</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Income tax expense (recovery) based on the above rates</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>319,381</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">(258,367)</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Non&#150;deductible items</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>15,750</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Change in valuation allowance</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>(335,131)</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">(258,367)</font></td></tr> <tr> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Income tax expense</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 22.65pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>10.2</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Deferred tax balances</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">The composition of the Company&#146;s deferred tax assets as at 31 August 2014 and 30 November 2013 are as follows:</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 64%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>As at:</b></font></td> <td style="vertical-align: bottom; width: 17%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>31 August </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">30 November 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(Audited)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; line-height: 115%">Net income tax operating loss carry-forward</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>1,018,391</b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,975,908</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Deferred tax assets</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>356,437</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">691,568</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Valuation allowance</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>(356,437)</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">(691,568)</font></td></tr> <tr> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Deferred tax assets (liabilities)</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">As at 31 August 2014, the Company has a total non-capital loss carry forward balance of $1,018,391 (30 November 2013 - 1,975,908), which has expiry dates between the years of 2025 to 2034.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">The Company&#146;s recognized and unrecognized deferred tax assets related to the unused tax losses. A full valuation allowance has been recorded against the potential deferred tax assets associated with all the loss carry-forwards as their utilization is not considered more likely than not at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">The Company is in the process of completing and resolving issues related to its income tax filings and has accrued $10,000 during the year ended 30 November 2013 related to potential penalties associated with these filings. However, there is no assurance that additional interest and penalties will not be assessed (Note 11).</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 10pt"><b>11.</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>COMMITMENTS AND CONTINGENCY</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 11 December 2012, the Company formerly engaged BB&#38;T Capital Markets (&#34;BB&#38;TCM&#34;) to act as the Company's exclusive financial advisor and agent in connection with developing strategic alternatives for the Company regarding debt financings, licensing of intellectual properties developed by the Company, equity raises, sale of intellectual properties, or other capital markets transactions that may develop over the course of a 24-month agreement (the &#147;Agreement&#148;).</font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 18pt"></td><td style="text-align: justify">The Company is to pay BB&#38;TCM an advisory fee of three percent of the face amount of the financial transactions advised upon during the course of the engagement, due and payable at closing of any contemplated transactions under the engagement.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 18pt"></td><td style="text-align: justify">Additionally, the Company is to defend, indemnify and hold BB&#38;TCM, its parent company, subsidiaries and affiliates and its and their directors, officers, employees, agents and successors and assigns harmless from and against any losses, suits, actions, claims, damages, costs and or other liabilities which any indemnified person may incur as a result of acting on behalf of the Company in connection with this engagement.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify; text-indent: -18pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">On 19 May 2014, the Company renewed/extended the Agreement with BB&#38;TCM. The extension runs from 1 May 2014 through 1 May 2016 (24 months). All other provisions of the Agreement remain unchanged.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 1 May 2014, the Company entered into an agreement whereby the Asset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor.</font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 26 May 2014, the Company entered into an exclusive global distribution agreement with All-Sea Coatings Ltd. (a division of All-Sea Enterprises) of North Vancouver, Canada. This agreement has been replaced with an Asset Purchase Agreement date August 14, 2014</font>.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">On 14 August 2014, Peptide Technologies, Inc. (&#34;the Company&#34;) entered into an Asset Purchase Agreement with All-Sea Coatings Ltd. All-Sea Coatings Ltd has acquired from Peptide Technologies Inc. the non-commercialized re-formulated assets that were developed by the Company.</font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">The Company is in the process of completing certain of its income tax filings and has accrued $10,000 during the year ended 30 November 2013 related to potential penalties associated with these filings. However, there is no assurance that additional interest and penalties will be assessed (Notes 4 and 10).</font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 18pt"><font style="font: 10pt Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-size: 10pt">The Company is committed to making payments related to its notes payable (Note 5).</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 11pt"><b>12.</b></font></td><td style="text-align: justify"><font style="font-size: 11pt"><b>SUPPLEMENTAL CASH FLOW INFORMATION</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 18pt">The Company made the following cash payments for interest and income taxes:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 29%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Three month period ended 31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 17%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Six month period ended 31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Three month period ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">31 August 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td> <td style="vertical-align: bottom; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Six month period ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">31 August 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Interest paid</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Taxes paid</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> <tr> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Total cash payments</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">On 26 April 2013, the Company issued 2,000,000 fully vested shares of the Company&#146;s restricted common stock at a par value of $0.001 per share to a third party for marketing assistance with the development of the international markets in the South Pacific quadrant for the Company. As a result, the Company recorded consulting expense of $2,000 when the stock was issued (Note 8).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">During the nine month period ended 31 August 2014, the Company accrued interest expense of $1,743 (31 August 2013 - $2,014) in relation to a loan of CAD$45,000 issued by PSI on 13 November 2011. The loan is unsecured and bears interest at a rate of 6% per annum (Note 5).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">During the nine month period ended 31 August 2014, the Company accrued interest expense of $774 (31 August 2013 - $895) in relation to a loan of CAD$20,000 issued by PSI on 1 June 2012. The loan is unsecured and bears interest at a rate of 6% per annum (Note 5).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">During the nine month period ended 31August 2014, the Company recorded a write down of $45,000 (31 August 2013 - $Nil; cumulative - $45,000) related to its intangible assets and intellectual property (Note 7).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">On 27 May 2014, the CEO requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 May 2014 (Notes 4 and 6).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">On 27 May 2014, a former related party consultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000 (Notes 4 and 6).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">On 15 July 2014, the Company issued 4,660 shares of the Company&#146;s restricted common stock for cash proceeds of $5,660 (Notes 6 and 8).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">On 28 July 2014, the Company issued 5,250,000 fully vested shares of the Company&#146;s restricted common stock at a par value of $0,001 per share to two directors of the Company for consulting services rendered. As a result, the Company recorded professional fees of $5,250 when the stock was issued (Notes 6 and 8).</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 18pt"><font style="font-size: 10pt"><b>13.</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>SUBSEQUENT EVENTS</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">There have been no reportable events which have occurred during the period from the nine month period ended 31 August 2014 to the date the interim consolidated financial statements were available to be issued on 20 October 2014.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 22.65pt"></td><td style="width: 45pt"><font style="font-size: 10pt"><b>2.1</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Basis of Presentation</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; letter-spacing: -0.15pt; text-align: justify; text-indent: -27pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.15pt; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"></td><td style="text-align: justify">These interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#147;U.S. GAAP&#148;) applicable for a development stage company for financial information and are expressed in U.S. dollars.</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.2</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Principles of Consolidation</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -27pt">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; letter-spacing: -0.15pt; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"></td><td style="text-align: justify">These interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary Pept Peptide, a company incorporated in the province of British Columbia on 5 August 2013. All significant inter-company balances and transactions have been eliminated upon consolidation.</td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.3</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Organizational and Start-up Costs</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Costs of start-up activities, including organizational costs, are expensed as incurred in accordance with Accounting Standards Codification (&#147;ASC&#148;) 720-15, <i>&#147;Start-Up Costs.&#34;</i></p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.4</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Development-Stage Company</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">During the year ended 30 November 2010, the Company abandoned its previous business of sale of original artwork and re-entered the development stage with its intended new business, which currently has no significant revenues.&#160;&#160;Management expects to sustain losses from operations until such time it can generate sufficient revenues to meet its anticipated cost structure. The Company is considered a development-stage company in accordance with the ASC 915, &#147;<i>Accounting and Reporting by Development-Stage Enterprises.&#34;</i> A development-stage enterprise is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.5</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Cash and Cash Equivalents</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Cash and cash equivalents include highly liquid investments with original maturities of three months or less.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.6</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Website</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">In accordance with ASC 350-50, &#147;<i>Website Development Costs,&#34;</i> expenditures during the planning and operating stages of the Company&#146;s website are expensed as incurred. Expenditures incurred during the website application and infrastructure development stage are capitalized and amortized to expense over the website&#146;s estimated useful life of 3 years.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.7</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Intangible Assets</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Intangible assets include the cost of acquiring the intellectual property. In accordance with ASC 350-30 <i>&#147;General Intangibles Other Than Goodwill,&#34;</i> an intangible asset that is acquired either individually or with a group of other assets shall be recognized. Costs of internally developing, maintaining, or restoring intangible assets that are not specifically identifiable, that have indeterminate lives, or that are inherent in a continuing business and related to an entity as whole, shall be recognized as an expense when incurred. The intellectual property is determined to have an indefinite useful life and is not subject to amortization. The useful life of the intangible asset is reassessed at each reporting period. During the nine month period ended 31 August 2014, the Company recorded a write down of $45,000 related to its intangible assets and intellectual property (Notes 7 and 12).</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.8</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Impairment of Long-Lived Assets</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Long-lived assets include the website and intangible assets and intellectual property. Long-lived assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets not subject to amortization are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount of the asset exceeds the fair value of the asset. There has been no impairment as of 31 August 2014.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.9</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Research and Development</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Research and development expenses are charged to operations as incurred.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.10</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Income Taxes</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">The Company adopted the ASC 740, &#147;<i>Accounting for Income Taxes.&#34;</i> ASC 740 requires the use of the asset and liability method of accounting of income taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the interim consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.11</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Basic and Diluted Income (Loss) per Share</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">In accordance with ASC 260, <i>&#147;Earnings per Share,&#34;</i> the basic income (loss) per common share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed similar to basic income (loss) per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings per share are not shown for periods in which the Company incurs a loss because it would be anti-dilutive. At 31 August 2014, the Company had no stock equivalents that were anti-dilutive and excluded in the earnings (loss) per share computation.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.12</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Estimated Fair Value of Financial Instruments</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">The carrying value of the Company&#146;s interim consolidated financial instruments, consisting of cash, accounts payable and notes payable approximate their fair value due to the short-term maturity of these instruments. Unless otherwise noted, it is management&#146;s opinion that the Company is not exposed to significant interest or currency risks arising from these financial instruments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 18pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. At 31 August 2014, cash and cash equivalents of $310 were insured by agencies of the U.S. Government.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18.35pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.13</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Foreign Currency Translation</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">The interim consolidated financial statements are presented in U.S. dollars. In accordance with ASC 830 <i>&#147;Foreign Currency Matters,&#34;</i> foreign denominated monetary assets and liabilities are translated to their U.S. dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenue and expenses are translated at average rates of exchange during the period. Related translation adjustments are reported as a separate component of stockholders&#146; equity, whereas gains or losses resulting from foreign currency transactions are included in results of operations.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18.35pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.14</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Comprehensive Income (Loss)</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">The Company adopted ASC 220, <i>&#34;Reporting Comprehensive Income.&#34;</i> ASC 220 requires that the components and total amounts of comprehensive income (loss) be displayed in the interim consolidated financial statements beginning in 1998. Comprehensive income (loss) includes net income (loss) and all changes in equity during a period that arises from non-owner sources, such as foreign currency items and unrealized gains and losses on certain investments in equity securities.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18.35pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.15</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Use of Estimates</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">The preparation of the Company&#146;s interim consolidated financial statements are in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the amounts reported in these interim consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18.35pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.16</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Changes in Accounting Policy</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">Effective 1 December 2013, the Company adopted Financial Accounting Standards Board (&#147;FASB&#148;) Accounting Standards Update (&#147;ASU&#148;)<b> </b>No. 2013-02, <i>&#147;Comprehensive Income.&#34;</i> This update requires an entity to present information about amounts reclassified out of accumulated other comprehensive income and their corresponding effect on the respective line items in net income in one place, and in some cases, cross-references to related footnote disclosures. The update applies to public companies for all reporting periods presented, including interim periods, and to nonpublic entities for annual reporting periods. ASU No. 2013-02 will be effective for fiscal years, and interim periods within those years, beginning after 15 December 2012 for public companies, with early adoption permitted. The adoption of this update did not have a material effect on the Company&#146;s interim consolidated financial statements.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.17</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Recent Accounting Pronouncements</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><font style="font-weight: normal">In July 2013, the FASB issued ASU No. 2013-11, &#147;<i>Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists,&#34;</i> which is intended to eliminate the diversity that is in practice with regard to the financial statement presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU No. 2013-11 is effective for fiscal years and interim periods within those years, beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company&#146;s interim consolidated financial statements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify"><font style="font-weight: normal">In May 2014, the FASB issued ASU No. 2014-09, <i>&#147;Revenue from Contracts with Customers,&#34;</i> which provides a five-step approach to be applied to all contracts with customers. ASU No. 2014-09 also requires expanded disclosures about revenue recognition. ASU No. 2014-09 is effective for annual reporting periods beginning after 15 December 2016, including interim periods. Early adoption is not permitted.&#160;The adoption of this update is not expected to have a material impact on the Company&#146;s interim consolidated financial statements.</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">In June 2014, the FASB issued ASU No. 2014-10, <i>&#147;Development Stage Entities</i>,&#34; which intends to remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the update eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. ASU No. 2014-10 is effective for fiscal years and interim periods beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company&#146;s interim consolidated financial statements.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.18</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Reclassifications</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify; text-indent: -27pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45pt; text-align: justify">Certain amounts reported in previous periods have been reclassified to conform to the current presentation.</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 12pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top"> <td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt"><b>2.19</b></font></td><td style="text-align: justify"><font style="font-size: 10pt"><b>Other</b></font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">The Company consists of one reportable business segment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 45.35pt; text-align: justify">The Company paid no dividends during the periods presented.</p> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>As at:</b></font></td> <td colspan="3" style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p></td> <td colspan="3" style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">30 November 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Audited)</p></td></tr> <tr> <td style="vertical-align: top; width: 19%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; width: 11%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Cost</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 16%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Accumulated amortization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 13%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Net book value</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 11%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Cost</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td> <td style="vertical-align: bottom; width: 16%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0; text-align: right">Accumulated amortization</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td> <td style="vertical-align: bottom; width: 14%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Net book value</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Website</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>10,000</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>6,667</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>3,333</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">10,000</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">4,167</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">5,833</font></td></tr> <tr> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Total</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>10,000</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>6,667</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>3,333</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">10,000</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">4,167</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: -2.3pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">5,833</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 60%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>As at:</b></font></td> <td style="vertical-align: bottom; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">30 November 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(Audited)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Accounts payable</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>38,317</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">574,188</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Accrued liabilities</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>4,000</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">27,000</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Payroll taxes payable </font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>29,652</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">17,084</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Salaries and benefits payable (Note 6)</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>580,000</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,044,000</font></td></tr> <tr> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Total accounts payable and accrued liabilities</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>651,969</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,662,272</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: bottom; width: 29%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; width: 14%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Three month period ended 31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 13%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Nine month period ended 31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 14%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Three month period ended 31 August 2013</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 12%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Nine month period ended 31 August 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td> <td style="vertical-align: top; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Cumulative from re-entering of development stage on 26 June 2010</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">to 31 August 2014</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Administration</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">20</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Amortization (Note 3)</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>833</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>2,500</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">834</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,500</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">6,667</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Bank charges</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>64</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>198</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">16</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">170</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,482</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Dues and subscription</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">575</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Filing fees</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>1,419</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>7,397</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">100</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">3,328</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">18,867</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Meals and entertainment</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">254</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">254</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">254</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Office</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>825</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>1,325</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,755</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,084</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">8,048</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Penalties</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">10,000</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Transfer agent</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>100</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>650</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">160</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">400</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">4,151</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Rent</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>147</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>638</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">363</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,101</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,871</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Share-based payment</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">8,000</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Telecommunication</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>726</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>2,783</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">786</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,469</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">5,777</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Travel</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,151</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,657</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,656</font></td></tr> <tr> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Website</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>72</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>72</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">221</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt"><b>Total general and administration expenses</b></font></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>9,436</b></font></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>20,813</b></font></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">5,419</font></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">13,963</font></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">73,839</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 348px; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; width: 102px; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>For the nine month period ended 31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">For the nine month period ended<b> </b>31 August 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Income (loss) before income taxes</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>912,516</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">(738,192)</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Federal income tax rates</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>35.00%</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">35.00%</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Income tax expense (recovery) based on the above rates</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>319,381</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">(258,367)</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Non&#150;deductible items</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>15,750</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Change in valuation allowance</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>(335,131)</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">(258,367)</font></td></tr> <tr> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Income tax expense</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 64%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>As at:</b></font></td> <td style="vertical-align: bottom; width: 17%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>31 August </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 19%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">30 November 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(Audited)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; line-height: 115%">Net income tax operating loss carry-forward</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>1,018,391</b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,975,908</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Deferred tax assets</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>356,437</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">691,568</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Valuation allowance</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>(356,437)</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">(691,568)</font></td></tr> <tr> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Deferred tax assets (liabilities)</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> </table> <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 29%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Three month period ended 31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 17%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Six month period ended 31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Three month period ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">31 August 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td> <td style="vertical-align: bottom; width: 18%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Six month period ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">31 August 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Interest paid</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">Taxes paid</font></td> <td style="vertical-align: top; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> <tr> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: top; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-top: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Total cash payments</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td> <td style="vertical-align: top; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; border-bottom: Black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> </table> 1750965 746039 10000 <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="vertical-align: top; width: 71%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt"><b>As at:</b></font></td> <td style="vertical-align: bottom; width: 14%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>31 August 2014</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>$</b></p></td> <td style="vertical-align: bottom; width: 15%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">30 November 2013</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">(Audited)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">$</p></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">During the year ended 30 November 2010, Fotoview Inc. (&#147;Fotoview&#148;) issued a loan of $16,000 to a former director of the Company to purchase 4,000,000 restricted common shares of the Company.&#160;&#160;Upon the director&#146;s resignation, the 4,000,000 common shares were cancelled and the Company assumed the loan payable to Fotoview.&#160;&#160;The loan is unsecured, bears no interest, and has no fixed terms of repayment.</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>16,000</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">16,000</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 21 September 2011, PSI Services (&#147;PSI&#148;) issued a loan of $500 to the Company. The loan is unsecured, bears no interest and has no fixed terms of repayment.</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>500</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">500</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 13 November 2011, PSI issued a loan of CAD$45,000 to the Company.&#160;The loan is unsecured and bears interest at a rate of 6% per annum. Principal and accrued interest are due on 30 November 2014. The loan payable to PSI as at 31 August 2014 consists of principal and accrued interest of $41,445 (30 November 2013 &#150; $42,710) and $6,963 (30 November 2013 &#150; $5,251), respectively (Note 12).</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>48,408</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">47,961</font></td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 27pt; text-align: justify">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr> <td style="vertical-align: top; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 1 June 2012, PSI issued a loan of CAD$20,000 to the Company.&#160;The loan is unsecured and bears interest at a rate of 6% per annum.&#160;Principal and accrued interest is due on 30 November 2014.. The loan payable to PSI as at 31 August 2014 consists of principal and accrued interest of $18,420 (30 November 2013 &#150; $18,982) and $2,486 (30 November 2013 &#150; $1,707), respectively (Note 12)</font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>20,906</b></font></td> <td style="vertical-align: bottom; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">20,689</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 22 October 2013, PSI issued a loan of USD $3,700 to the Company.&#160;&#160;The loan is unsecured, bears no interest, and has no fixed terms of repayment.</font></td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>3,700</b></font></td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">3,700</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 21 April 2014, PSI Issued a loan of CAD $8,000 to the Company.&#160;The loan is unsecured, bears no interest, and has no fixed terms of repayment.</font></td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>7,368</b></font></td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&#160;</td> <td style="border-right: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt">On 14 August 2014, PSI issued a loan of CAD $9,500 to the Company.&#160;The loan is unsecured, bears no interest, and has no fixed terms of repayment.</font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>8,749</b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td></tr> <tr style="vertical-align: bottom"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-size: 10pt"><b>Total notes payable </b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; background-color: #D5DCE4; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt"><b>105,631</b></font></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">88,850</font></td></tr> </table> EX-101.SCH 7 pept-20140831.xsd SCHEMA DOCUMENT 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Interim Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Interim Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Interim Consolidated Statements Of Loss And Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Interim Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Interim Consolidated Statements Of Stockholders' Deficiency (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Nature And Continuance Of Operations link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Website link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Accounts Payable And Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Intangible Assets And Intellectual Property link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Capital Stock link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - General And Administrative Expenses link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Commitments And Contingency link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Supplemental Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Website (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Accounts Payable And Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - General And Administrative Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Supplemental Cash Flow Information (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Website (Detail) - Website link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Accounts Payable And Accrued Liabilities (Detail) - Accounts Payable And Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Notes Payable (Detail) - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - General And Administrative Expenses (Detail) - General And Adminstrative Expenses link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Income Taxes (Detail) - Provision For Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Income Taxes (Detail) - Deferred Tax Balances link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Supplemental Cash Flow Information (Detail) - Cash Payments For Interest And Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Nature And Continuance Of Operations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Website (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Accounts Payable And Accrued Liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Intangible Assets And Intellectual Property (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Capital Stock (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Commitments And Contingency (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Supplemental Cash Flow Information (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 pept-20140831_cal.xml CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 pept-20140831_def.xml DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 pept-20140831_lab.xml LABELS LINKBASE DOCUMENT Total [Member] Finite-Lived Intangible Assets by Major Class [Axis] Fotoview Inc. [Member] Related Party [Axis] PSI Services [Member] September 21, 2011 Loan [Member] Related Party [Axis] November 13, 2011 Loan [Member] June 1, 2012 Loan [Member] October 22, 2013 Loan [Member] April 21, 2014 Loan [Member] Common Stock Equity Components [Axis] Additional Paid-In Capital Accumulated Deficit Accumulated Deficit During Development Stage Aug 14, 2014 Loan [Member] Past Directors And Employees [Member] Salaries And Benefits Earned [Member] Chief Financial Officer [Member] Expense Reimbursements [Member] Chief Executive Officer [Member] Bonuses [Member] Officers and Employees [Member] Consultant [Member] Advisory Agreement [Member] Consulting Services [Member] Directors and Shareholders [Member] Website [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets Cash and cash equivalents Total Current Assets Website (net of accumulated amortization of $6,667 and $4,167, respectively) Intangible assets and intellectual property TOTAL ASSETS LIABILITIES AND STOCKHOLDERS' DEFICIENCY LIABILITIES Current liabilities Accounts payable and accrued liabilities Notes payable and accrued interest Total Current Liabilities [us-gaap:Liabilities] STOCKHOLDERS' DEFICIENCY Capital Stock Authorized: 675,000,000 common shares, par value $0.001 per share Common shares issued and outstanding: 156,412,660 and 151,123,000 at August 31, 2014 and November 30, 2013, respectively Additional paid-in capital Accumulated deficit Accumulated deficit during development stage Total Stockholders' Deficiency TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY Common Shares, authorized Common Shares, par value Common Shares, issued Common Shares, outstanding Website, accumulated amortization Income Statement [Abstract] Revenue Revenue Expenses Consulting Salaries and bonus Office and administration Professional fees Supplies and materials [us-gaap:CostsAndExpenses] Net Loss before Other Items Other Items Write down of intangible assets Forgiveness of debt Foreign exchange gain (loss) Interest expense Net Profit (Loss) for the Period Other Comprehensive Loss Foreign currency translation adjustment Comprehensive Profit (Loss) for the Period Profit (Loss) per share from operations - Basic and diluted Weighted Average Number of Shares Outstanding Statement of Cash Flows [Abstract] OPERATING ACTIVITIES Net profit (loss) Adjustments for non-cash items: Accrued interest Amortization Foreign exchange gain (loss) Forgiveness of debt Non-cash consulting expense Share-based payment Write down of intangible assets and intellectual property Changes in operating assets and liabilities Decrease in prepaid expenses Increase in accounts payable and accrued liabilities Cash used in operating activities INVESTING ACTIVITIES Purchase of website Cash used in investing activities FINANCING ACTIVITIES Proceeds from issuance of common shares, net of share issuance costs Increase in notes payable Contribution by related party Cash from financing activities Effect of foreign exchange rate changes on cash Increase (decrease) in cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Statement [Table] Statement [Line Items] Beginning Balance Balance (Shares) Shares issued for Cash, net of share issuance costs Shares issued for Cash, net of share issuance costs (Shares) Shares issued for Contractor services Shares issued for Contractor services (Shares) Related party services Related party services (Shares) Net Profit (Loss) Ending Balance Ending Balance (Shares) Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature And Continuance Of Operations Accounting Policies [Abstract] Significant Accounting Policies Notes to Financial Statements Website Payables and Accruals [Abstract] Accounts Payable And Accrued Liabilities Notes Payable Related Party Transactions [Abstract] Related Party Transactions Goodwill and Intangible Assets Disclosure [Abstract] Intangible Assets And Intellectual Property Equity [Abstract] Capital Stock General And Administrative Expenses Income Tax Disclosure [Abstract] Income Taxes Commitments and Contingencies Disclosure [Abstract] Commitments And Contingency Supplemental Cash Flow Elements [Abstract] Supplemental Cash Flow Information Subsequent Events [Abstract] Subsequent Events Basis Of Presentation Principles Of Consolidation Organizational And Start-Up Costs Development-Stage Company Cash And Cash Equivalents Website Intangible Assets Impairment Of Long-Lived Assets Research And Development Income Taxes Basic And Diluted Income (Loss) Per Share Estimated Fair Value Of Financial Instruments Foreign Currency Translation Comprehensive Income (Loss) Use Of Estimates Changes In Accounting Policy Recent Accounting Pronouncements Reclassifications Other Website Accounts Payable And Accrued Liabilities Notes Payable General And Administrative Expenses Provision For Income Taxes Deferred Tax Balances Cash Payments For Interest And Income Taxes Costs Accumulated Amortization Net Book Value Accounts Payable Accrued Liabilities Payroll Taxes Payable Salaries And Benefits Payable Total Accounts Payable And Accrued Liabilities Related Party Transaction [Axis] Notes Payable, current and non-current Notes Payable, interest Loan Amount Principal Outstanding Accrued Interest Administration Amortization Bank Charges Dues And Subscription Filing Fees Meals And Entertainment Office Penalties Transfer Agent Rent Share-Based Payment Telecommunication Travel Website Total General And Administration Expenses Income (Loss) Before Income Taxes Federal Income Tax Rates Income Tax Expense (Recovery) Based On The Above Rates Non-Deductible Items Change In Valuation Allowance Income Tax Expense Net Income Tax Operating Loss Carry-Forward Deferred Tax Assets Valuation Allowance Deferred Tax Assets (Liabilities) Interest Paid Taxes Paid Total Cash Payments Working Capital Deficit Purchased Website Website, Amortization Accrued Salary Forgiven Accrued Bonus Forgiven Consulting Services Fees Forgiven Officer's and Employee's Liabilities Accrued Salaries and Benefits Consulting Fees Consulting Fees Payable Cash Contributions Shares Issued, shares Shares, par value Additional Paid in Capital Intangible Assets And Intellectual Property Purchase, shares Recovery Of Intangible Assets And Intellectual Property, shares Stipend Paid, Monthly Intangible Assets And Intellectual Property Write Down Forward Split, ratio Additional Shares Issued, shares Adjusted Retroactively, Shortage Of Additional Paid-In Capital, dollars Adjustment To Accumulated Deficit Shares, Issuance Costs Consulting Expenses Professional Fees, Share Based Payment Non-Capital Loss Carry Forward Accrued Potential Tax Penalties Accrued Interest Expense Loan, value Loan, interest Changes in accounting. Consulting Development stage company. General and administration expenses . Other. Provision for income taxes. Website. Website. Website. Forgiveness of accounts payables. Purchase of website. Assets, Current Assets Development Stage Enterprise, Deficit Accumulated During Development Stage Stockholders' Equity Attributable to Parent Liabilities and Equity Revenues Costs and Expenses Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Effect of Exchange Rate on Cash ForgivenessOfAccountsPayables Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Effect of Exchange Rate on Cash and Cash Equivalents WebsitePolicyTextBlock Income Tax, Policy [Policy Text Block] WebsiteTableTextBlock Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of Accrued Liabilities [Table Text Block] GeneralAndAdministrationExpensesTableTextBlock Amortization [Default Label] WebsiteExpense EX-101.PRE 11 pept-20140831_pre.xml PRESENTATION LINKBASE DOCUMENT XML 12 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
Capital Stock (Details Narrative) (USD $)
0 Months Ended 1 Months Ended 12 Months Ended
Apr. 10, 2013
Aug. 10, 2010
Jul. 28, 2014
Apr. 26, 2013
Nov. 30, 2013
Aug. 31, 2014
Jul. 15, 2014
Apr. 03, 2014
Mar. 11, 2014
Mar. 03, 2014
Dec. 03, 2013
Nov. 30, 2013
Jul. 18, 2013
May 20, 2010
Equity [Abstract]                            
Common Shares, authorized   75,000,000     675,000,000 675,000,000                
Common Shares, par value   $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001                
Forward Split, ratio   30                        
Additional Shares Issued, shares   208,800,000                       120,000,000
Adjusted Retroactively, Shortage Of Additional Paid-In Capital, dollars   $ 119,501                        
Adjustment To Accumulated Deficit         (105,837) (105,837)               104,000
Beginning Balance         (749,656) (742,706)           (1,700,132)   15,501
Shares Issued, shares 20,000   5,250,000 2,000,000 151,123,000 156,412,660 4,660 10,000 5,000 10,000 10,000   25,000  
Shares, par value   $ 0.001 $ 0.001 $ 0.001 $ 0.001 $ 0.001                
Additional Paid in Capital 20,000   5,250   148,279 187,899 4,660 10,000 5,000 10,000 10,000   25,000  
Shares, Issuance Costs 2,000                          
Consulting Expenses       2,000                    
Professional Fees, Share Based Payment     $ 5,250   $ 2,000                  
EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`CP#15]P$``'D:```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F4%OVC`8AN^3]A\B7RMB M;+.NJP@];.MQJ[3N![CQ!XE(;,MV6_CWR&"V-_[X,-S\#N_ MVO1=\4`AMLY63)135I"MG6GMJF*_;Z\G%ZR(25NC.V>I8EN*[&KQ\ZH5['TGFR^Q.&-_\.>-KW,Q]-:`T5-SJD'[K/&'S3\4<7UG?.K;#X61XL_````__\#`%!+`P04``8` M"````"$`M54P(_4```!,`@``"P`(`E]R96QS+RYR96QS(*($`BB@``(````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````(R2ST[#,`S&[TB\0^3[ZFY("*&ENTQ(NR%4'L`D[A^U MC:,D0/?VA`."2F/;T?;GSS];WN[F:50?'&(O3L.Z*$&Q,V)[UVIXK9]6#Z!B M(F=I%,<:CAQA5]W>;%]XI)2;8M?[J+*+BQJZE/PC8C0=3Q0+\>QRI9$P4P>J/OH\^;*W-$UO>"_F?6*73HQ`GA,[ MRW;E0V8+J<_;J)I"RTF#%?.&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;',@ MH@0!**```0`````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````````````````"\F%OH/1OE%TKR8S4\:932G,MIT^@+&5.$QB&TO]R=M7A&`WT)YNS-D$+!/Y MX]KG)\[3\Z_3L?@1QGCHN]*XU=H4H:O[YM#M2_/M]?.'!U/$5'5-=>R[4)IS MB.9Y^_[=TY=PK%+^4FP/0RSR+ETL39O2\-':6+?A5,55/X0NG]GUXZE*^7#< MVZ&JWZI]L+)>;^SXYQYF>[-G\=*49GQIG)KB]3SD2_]_\WZW.]3A4U]_/X4N M_>4:]F<_OL4VA)0WK<9]2*69EJ*]G'&ZRLS&_@,GSX.+\X!P9$/&D0W"T4Z@RAV[63C8+)2=GPKSTR^:GS&=C_FW_&Q^EV-D-(M>?K*XF6!:NKH> M3&_VDP(?%,<>C8.S$7:S$=ALA-UL!#8;97N>0L]3=GPKC&^_:'RG_!XPS`J_ M'-K+)W0Z=F;CR,[\S/>/L,XXMK0=E+9C2]M!:0M;2P*UI(MJ:8K'64_3TC4Q M%3X[RI:50ET)VX<%^K!GEST_6:"]^2]E^QL``/__`P!02P,$%``&``@````A M`%%LN.CD`P``(0T```\```!X;"]W;W)K8F]O:RYX;6R4E]UNVS@0A>\+]!T$ MW;>V),=M@CA%FJ1;`XO46'N;2X*1QC81BM225&R__8ZD6!Z)J9I>.=3/T9F9 M;X;,Y9=]+H-G,%9H-0NCC^,P`)7J3*C-+/QW]>W#YS"PCJN,2ZU@%A[`AE^N MWK^[W&GS]*CU4X`"RL["K7/%Q6ADTRWDW'[4!2B\L]8FYPZ79C.RA0&>V2V` MR^4H'H^GHYP+%38*%^8M&GJ]%BG'6Y%A)^-A$% MO"CN>8Z^]S(,)+?N+A,.LEEXADN]@\X%4Q9?2R'Q[GDR3L+151ODP@09K'DI MW0K#.ZICON))'$^K)ZM4_!2PLZ>7JF6P?Q`JT[OJ44SMH5TE:&!7WWH0F=OB M_?%XW%[[#F*S=<>+*#\B^G4&\3OU;Z#J\(X985@I=J><<`195QJG*7#DP(FPKEUREP)9$)28J\9^IH('6 M3$)DZGS_ULS2H:>J]$1E0E0F;S+3JE`SF/PV,V=_)H/I:&.:$IF:#!K3/7>E M`7:-1<(<.Z'*.K4_UNQ'`8:H3&AJ/O7=+,5&"6P$KAR[3E-=5E(;ML":I0*H M#,W-Y[[,`SQ:[`;Z/$W">?_YET]9MN`'_BB;./"B*1&3OZD,34(T[NO<:P>M M"'WM$\E=Y-'Y3]7G^*4%-TCWRG!E>5HW/M7`>=66,7J-3:XVHC9O+3A;UZ+B M7DI(JC\URXJGN:L!L$-SCO#U2$HA?Y M[)5%(>L6Q#ANN-VR;SA(C\.&ZE#V(@^^9?EHX;\2S;"[Y\H2?95B&'D<#N/? MZ6D*(@[@WKQ[:0#,(P+1,4!)C#T2AQNA8X#B&'LX=CKA%1L4PMB#<)@F:F-* ML8P]+.>XXQ]Q\EU,*8NQQ^)R$(B."XIGLVW2X7BLQBTX+B3SIU/Y%P.J6M$GN<#M>'&DIH?7#1X[13GQ<_"Z.?175J8\10 M0DN%BS?HW,(:C,&QNJ(ZM%*)A^UPR3N!T0PE'L'#^R%E)Z'3!!>]R+KL6';/ M33-7:5!TJN#YJR<5<:V*LZR:$\ M)Q[/G+Q_`J&)YG.,8+B//%P'MB'T!WQ,Z$XXZ*7Z&$, M:<4FE&=HU,N4SS?5S_5`;EV.SK^=W/U/P```/__`P!02P,$%``& M``@````A`!VF,`9,!@```AL``!@```!X;"]W;W)KHS7&`F9G]^]336/3 M57B`??&%.GWH\/I27U[W^S]_IQM>U MMLLNA^Q<7XJ]_KUH]4_//__T]%XW7]I3470:,%S:O7[JNNO.,-K\5%19NZVO MQ04BQ[JIL@[^-J]&>VV*[-`WJLX&-TW7J++RHDN&7;.&HSX>R[R(Z_RM*BZ= M)&F*<]9!_]M3>6UO;%6^AJ[*FB]OUTU>5U>@>"G/9?>])]6U*M_]]GJIF^SE M#+J_,3O+;]S]GPE]5>9-W=;';@MTANSH5'-@!`8P/3\=2E`@;->:XKC7/[-= MRBW=>'[J#?JW+-Y;Y;?6GNKW7YKR\'MY*]W0-O&@ARU^?'??)^`J)R0=(^`#B84AT@X@T"-KX M=F&D9;A)[A/*"^I]^/TV M?>>C*<(),"2>0@A),D50DG0*&4F08.M'!`LP#';%1]?$O0\EQ%8@#D9$BXAX M$9$L(M(Y!#(`NKH^XP*\U\'<^T":&"`A?C_>`VZ1[$8R#)]W!HM,BGB>(5EF M2#]D0,IAY5FO7(!)ZLFT"R5$E493OXB(%Q')(B*=0R`#8&E;;X``D]2/4ZJ? MW*&$J`;0W$82XO:CPW-,DTR?>)DB42DX]R8A-B=4PM[A#Z!,US@+&2&60 MHKAG!\$'LAD4B.N3W:.)<+)"AP-F4!Z8))\1CC.3K)0QB@>!2?.-XFS2/D5Q MSV36:!U*.!.%S^IAWJ.)'6I5,<@3@MA-8!!$CA,TL[A/[$H3P M+)_YQ,`4(;@%#M@?)5]40NLMD'43VN!'8KG*,XF1%FR

&P"(K%- MVW3(5I!@EL0B8QL]O^"DP\8(9Q94^+@V0%2SK'@HT09=)Z M(V11A8P@DS(4C]"P9,"&!O)#=(4!Q64+)(I2CN6.ZX@V'EHF!:KUR6 M5T@Y418RM03;,-,G.TA$`0$!Q!C`77_L>[^J)`0PV7Y3#&"F;8WV8/FB<%HO M7Y992#[)6\C44@PV!V81>1%&<-NWZ/8?(T@`QT%L8@&ZC=@;`C)"4D2R"7RF M[J+8!5%(K7=!EEWJUJ`\8`Q;I,2H*\%8H0Q;PR(D9HN09!F2SD*0#YS4B>+8 MRX)K\P\'?2M<-7DD7>&`4?V8/!FNP,0K,,D*3'K'B$.YC66-DQ@;0LK'E8:( M5L00,@E"+C'RE.3A-,&(A],$01Y.$X38/)PF&`+3Q&'CG,9NP,17I\E*-T0K MXL:X&LGIPB5&ND'*BV@N&`_!H#]/,+?T02.9:YP.0754CK,42Q>EGK)"K)0N M"T2T7M(B$H[YA3W#7N]8\-#NN62T1`0$#T3PS$/F6$Q`G,$3I_)<)+<.`C)- MJ)E-D@[QZH'6,=07^6I!GIE71?-:1,7YW&IY_29>&UB0COO5^RN-SUP<%)/K M(=O!"??T>LQV<(P-UXU[`W@#<BS^RYK6\M-JY.,*MS*T'%54CWV'(/UU] M[4_P7^H.WCWT/T_PKJF`LW-S"^!C77>W/^(&][=7S_\#``#__P,`4$L#!!0` M!@`(````(0#75PX@<`(``#<&```9````>&PO=V]R:W-H965T9_T!X/Z55ZRW6DZ/&F9/,22:3N3PCI9982@-X^_>S M`6V\3!Q?5.SB8^T-=/)ZD!7:<6V$JC.<1#%&O&8J%_4ZP[]^+E^&&!E+ZYQ6 MJN89/G*#7Z>?/TWV2F],R;E%D%";#)?6-F-"#"NYI"92#:_A2:&TI!:&>DU, MHSG-_219D4X<]XFDHL8A8:R?R5!%(1A?*+:5O+8A1/.*6O`WI6C,.4VR9^(D MU9MM\\*4;"!B)2IACSX4(\G&[^M::;JJH.Y#TJ/LG.T'=_%2,*V,*FP$<22( MWM<\(B,"2=-)+J`"UW:D>9'AMV0\3S&93GQ_?@N^-Q>_D2G5_HL6^3=1^Y^XOF$SN9B_]!GS7*.<%W5;VA]I_Y6)=6MCM%`IR=8WSXX(; M!@V%F*CC-9BJ0``^D13N9$!#Z,%_[T5NRPQW^U$ZB+L)X&C%C5T*%XD1VQJK MY)\`)4ZJ#>F<0KI@?WH.RPW3).W_/X4$(U_@@EHZG6BU1W!H8$W34'<$DS$D MN\JZT)]_5P8V;LZ;F^2G`FU@-W;37C*:D!VTD)V8V8F)NZ?G@U%\3O]98'H73'I-S!\15VZPT/-N#LXP9+=N MO][,P;=FR75/9H'I>[,N>-V9/0"NS.#, M/V_FX%NSSHU98&#YMJ^W^QF(4U=[Z:5[4`MW/UR-AJ[Y!]5K41M4\0)"XV@` M"3K<_#"PJO%78*4LW%C_LX07-(?[$4<`%TK9\\"]6]I7_O0O````__\#`%!+ M`P04``8`"````"$`<^P#6D$#``"_"@``&0```'AL+W=OC\B*(Q#Q,DHXDZRFVPV^W%=H4@S0$E; MQYE_OZ=44&!66"]0VN>\/7U[:KM\?,LSXY5P05GA(VLR108I(A;3XN"C7S_# MNP4RA,1%C#-6$!^]$X$>5Y\_+4^,OXB4$&F`0B%\E$I9>J8IHI3D6$Q820KH M21C/L817?C!%R0F.JZ`\,^WIU#5S3`ND%3P^1H,E"8U(P*)C3@JI13C)L(3\ M14I+4:OET1BY'/.78WD7L;P$B3W-J'RO1)&11][SH6`<[S.8]YLUQU&M7;WT MY',:<298(B<@9^I$^W-^,!],4%HM8PHS4+8;G"0^>K*\G8O,U;+RYS!HY594!AN"WZOM$8YGZ:#9#QIX( M&5(EA8SH*"3+_^A.ZRRA@^US,'R?@RUG,K>=^X4%@XU5@?&J%-R+BOW_*O=G M%?BN'!50(J^KN35;FJ^PKM&966L&GE?,O,UL^CK.?1L):D2MM!I[6S=<=*UV M2%@3=[H&#E0CW.6C=IYO"D*]A%H-U[/+;>=_EHSBZIP MK"E\VOT;W3^_TNBX&`P2VT$B'"1VMXB60Y#J>(<4W'6H4_5KS=QP8%,3:O,M M9IW-%]SLW>I>M_+?=KKVA[>[=]?=KNM>4F]9`G^7XRU1<->2RPZM-LY:,S!X M4UB=HM@,$L$@L1TDPD%B=XMH>00'Q'B/%-SUZ.*]]D@SMSP:)()!8JL)O7T_ M*)_;W7!W4//0T1^4C[X8Z#,K)_Q`-B3+A!&QHSKT9U"S36MS'WFRU7]PIWUC M>7!X]-NWE@,R?I%#=!TH%!696]T:E M/GU[SGM.6V8/KT5NO!`N*"OG)AK;ID'*A*6TW,_-7S\WHZEI"(G+%.>L)'/S MC0CS8?'YT^S$^+,X$"(-4"C%W#Q(6466)9(#*;`8LXJ4\$_&>($E//*])2I. M<%I/*G++L>V)56!:FEHAXO=HL"RC"8E93]BCR<--KUPT"^H`EG@F5R#'*6 M#G288 MB`0,!9FQ4X>1L!P"@$^CH*HSP!#\6G^?:"H/<].=C/W`=A'@QHX(N:%*TC22 MHY"L^*,AI()J19RS",PXBR!G[#E^,/T?EM4TQEG@QX^QD M0.M!Y*+"JI%1!,J-/SJ;UK&/#(,DE!J2/AA%XF'2$]D/23Z(ILAXMK==;9#Y+). MQQ.WZXEJ&>_#+=5XHR;!YKDNB^-V(UAJQKMB_"ZQNDG$-XGU36)SD]C^B^AX M!0.'-*,="KR) M[?8VU$H#$&!K>RN7=.+5!^E+3IW5!^)ZL M2)X+(V%'=6&YT`+M:'N7/CKJ].F-+U$$1^MP/$81G)\P;K43X.ZK\)Y\PWQ/ M2V'D)(.E['$`P7)]>^H'R:KZ[M@Q";=>_?,`+SD$#FU[#'#&F&P>U`+M:]/B M+P```/__`P!02P,$%``&``@````A`/5L=W#>`@``S@@``!D```!X;"]W;W)K M&ULE)9=;YLP%(;O)^T_6+XOG_EH44A50KI5VJ1I MVL>U`P:L`D:VT[3_?L92RA,4_V M%:V5$1&T)`KBEP5K9*=6)=?(540\[YN;A%<-2.Q8R=1;*XI1E01/>*0OD;!/HV/.=?6>#TGJ5,G"@TXX$S4+\X`;;!;;7 MJS8_OQ@]R)-G)`M^^"18^H75%)(-9=(%V''^K-&G5$_!8GNT^K$MP#>!4IJ1 M?:F^\\-GRO)"0;7G8$C["M*WF,H$$@HREC?72@DO(0#X1!73)P,20E[;[P-+ M51%B?V'-EX[O`HYV5*I'IB4Q2O92\>JW@=RCE!'QCB*PXBCB>M;,FR]OKU"Q M342MP9@HLEX)?D!P:&!/V1!]!-T`E+4S'_)CXNB]OF<5/&J1!ZT2XB5&L%Q" M>5[6,V>YLE\@I\F1B<;,_`S9=(C.H-:-NXF_NNY0==L1NGQ@J?<%V3KU]>]* M=>%K6(??[1N9"=#N_7C#?3=C8GXW1.(Q) M"]_UAT%&AIF=,/,AL9DDXDEB>XD8^(1`KB^;AD,,2>RK-'-NA]%'ACGUYR^& MR&8:B:>1[45DX!'^9M=[U/"YQ[.#%AGFHL=I))Y&MA>1@Z!_AP__6S?7MZ\/3M M>/Y&-I9.V_W"Z"=-"2G7XG(62U123/8RK&64!)A&I(9*-ZTE_J. M*V@D[6,![PT4;E/'`CCC7'4#?6?V;R+K/P```/__`P!02P,$%``&``@````A M`!_$?DV@`@``)@<``!D```!X;"]W;W)K&ULE)5; M;^(P$(7?5]K_8/F=.'(-D[EH-AG^\_M^-,%(&]KDM)(-S_`K MU_AF\?7+?"?5DRXY-P@4&IWATIAV1HAF):^I]F3+&_BGD*JF!I9J0W2K.,V[ MHKHBH>^GI*:BP4YAIJ[1D$4A&+^3;%OSQC@1Q2MJP+\N1:L/:C6[1JZFZFG; MCIBL6Y!8BTJ8UTX4HYK-'C:-5'1=0=\O04S90;M;G,G7@BFI96$\D"/.Z'G/ M4S(EH+28YP(ZL+$CQ8L,WP:S58K)8M[E\U?PG3[ZCG0I=]^4R'^(AD/8,"8[ M@+643Q9]R.U/4$S.JN^[`?Q4*.<%W5;FE]Q]YV)3&IAV`@W9OF;YZQW7#`(% M&2],K!*3%1B`3U0+^V1`(/2EN^Y$;LH,1ZF7C/TH`!RMN3;WPDIBQ+;:R/J? M@X*]E!,)]R)PW8L$H1>'R7CR&95HKP+7-Y4KK1#75I?2'35T,5=RA^#)`^.Z MI?8Y#F8@;..)(.3WXX%<;,VM+>I*@=8PTN=%[(=S\@QS8'MF>I.0V[')R^8L#$U@U)L+QY->MVM@Z9CXB$F&Q.H2,?`&-SKV=EV`MBC# M<(_>8^Q'0P=+QTRZ>`,_F$338$BL!L1TG$S]MSX''J'18X^7\[/PJ;=X>.>E M8]+.6Y2D<30>`JMC()T&2?J!,]A#USNS\*FSD[DM'>.4L_X\W" MI][282A+QT`T_=2C$P1.0BOS`>)FZHXZMXE;NN&/5&U$HU'%"]#UO3$TJ-Q! MYQ9&MMUF74L#!U3WM83W$8>=['L`%U*:P\(>I?T;;O$?``#__P,`4$L#!!0` M!@`(````(0`.-B.]MP,``-<,```9````>&PO=V]R:W-H965TL9%PBU:X1+^ M.5)6)`(NV2XHBFEP*70HDPG"<" M]L_/I.*-6I$^(EOS*2_45*#&9#FF0"#I2^2/1[)H=@LCV8'=<)^,&,#!^32RY^TNLW M3$YG`=GV(2`9USI[CS!/P5"0L5Q?*J4TAPW`IU$061E@2/)6?U]))LY;TUM8 M_M+Q$.#&`7,1$REI&NF%"UK\JR!TDU(B[DT$9MQ$D&O-77^Y^HS*XJ8"WXW* MXF$56\55VQ0E(MEM&+T:4'JPI,K67)H& M>,$AR:\[+_`W]BMD)KTQX9#QEWWDN4%D'J1NU`S<=5%_RKXAFBFQ&H#/=BO^ MJIUC0]1MZ)"6;N@?ET03H81EA,TZH1KHKN.VR]2;?QX2?M!'HB&BB>R'A"X2 M#Y&[2"]@[S,!2QBJO>.CN[P;64<8*F;>8;2D/T\2T22QGR3B,:+G`&SU\91+ M>&N"NVTE><&BG\!0,:NZY&=^@#R]I'N`.U]YCM>7B+I$``<"TM;8=X'9TENA MX)[?.@]QCPA6R$?S=I%>_'`"/1Z_A/7XM?!"Q<#ZK4=Z!4P2D2*0X]8N.I:G M2>RG@'ALC5[\<,)UXY>GG0?/E/%;7T[2?=#O!,6,^3!)1(I8J.,3!9#H-HEU MFO==8.;Z*V^AI2,>6Z1G!!S572/ "P;H!VDH6*&3-@DH@4H0Q`_M)WM/B' M"IYVK\1#Y%Y,/0-D?]=Y[HT;(.&^`7-'VURHF#$#)HE($?YR--+H$=\ M6`)CJ_0<"#[C@(1U![2]A8H9YV=2XZW^@5O]^^[77S97TKRT)XP[#13J M=JN?NNZR-HRV..$J;U?D@FM`#J2I\@X^-D>CO30XW_>#JK-AF:9G5'E9ZTQA MW2S1((=#6>"$%*\5KCLFTN!SWL'\VU-Y:0>UJE@B5^7-R^OE6T&J"T@\E^>R M^^A%=:TJUC^.-6GRYS/X?D=.7@S:_8>9?%46#6G)H5N!G,$F.O<<&J$!2KO- MO@0'-.Q:@P];_0FM,Q3HQF[3!^C?$E];X7^M/9'K;TVY_UG6&*(-ZT17X)F0 M%TK]L:>/8+`Q&YWU*_!GH^WQ(7\]=W^1Z^^X/)XZ6&X7'%%CZ_U'@ML"(@HR M*\NE2@4YPP3@MU:5-#4@(OE[__=:[KO35K>]E>N;-@*Z]HS;+BNII*X5KVU' MJO\8"7$I)F)Q$1C!19"U(M5#.:K#U.2=_ENTY"K!KD' M,V\O.HFPX-)%\FJZ<`8AF3L`?P>I^(&XQ@#7(_685E$ZY^GQ."0 MDJG#X3T1>R"^QQI?TT\^GC/<4*8D4ZQ MC"HS3ACJ]6,MUS3EP>E].!-AS_.FVB&M,-2PY7XI6?9K!U,<^UT<,0XS["F. M8A%$GNPGD5MQ57\ MF)(\IJ2/*=E`H:>)ZT]Y*"TW[=.$X^M^#:=D)0*A$OB(<8;`(R5`,8-9-B`U M@Q-QL&^'4XKVJ92*L&U;2D9D(HR"X%:&AU^Q3,FJ9>4(C1CG[J(/%+H6EJOL M@F1`;V=-.E`^%I5+$$VYYRS"<2[-E*(4LYS%<3F9,M M;IN]G..!L"UEV[3#66Z;LN6\MT-EXA%BI/MY_YB3+-!)%W`RSN&1@`HR)9`< M"MK\+`\%:Y7D#)@.4%X"&(GEO6^IQSS]D@SAY'"@P`F'V<0M/U`"G4HX0<^=YBE'@+9!RR/`FB8Q`DC]VA$AL;/RE7H8C^CM^"0CAU8/52$= MT=L*V=H2">:'VXG[;1[<)\TKP:P`,A+[YA8ZLS:7BS#<==1& M,)%P.-O1;`>(+T!VJ!91>NU%I\G>X-N!/>T1%@1VJ<5N:RK<''&,S^=6*\@K MO;"RX6O4^'2\3'NRZ`V%\CQ":[A:F3]/T!KN3^"Y,0Z`NZ]+?L1_Y,VQK%OM MC`_P*G/E0S5HV.T9^]"12W]W]$PZN/7J_SW!+2>&2QMS!>0#(=WP@;Y@O#?= M_0\``/__`P!02P,$%``&``@````A`$:HWTHC!@``AR(``!D```!X;"]W;W)K M&ULG-I9U]26*?SY.FZ=.LK]]_GT^E7VX0>OZE+BEE62JY M%\??>9=#75JO.M\LJ11&]F5GG_R+6Y?^N*'T_>W??UX__>!G>'3=J`09+F%= M.D;1]:52"9VC>[;#LG]U+Q#9^\'9CN!C<*B$U\"U=_&7SJ>**LM&Y6Q[%XEG M>`E$>X+=_Y.+N7B"<)W),=0?_#HW<-[]G.CDBZLQW\_+A^<_SS%5*\ M>RT[@A_X^*D.Z"N]H=IMK ME5H%,KV][CS8`C;LI<#=UZ4?RLNV)E7>7N/QV7CN9YCXNQ0>_<]NX.U&WL6% MP8;=Q';`N^__9+2_8TWPY4KFVYUX!\R"TL[=VQ^G:.%_]ESO<(Q@;U=A@]AV MO>S^M-S0@0&%-&6URC(Y_@DZ`#]+9X_-#!@0^W?\^]/;1<>ZI!GEJBEK"O#2 MNQM&'8^EE$K.1QCYYRU'RBT53Z+>DL#O6Q)%+>MJU;2>R:+=LL#OKRS/=D6_ M)8'.WY*H:MFJ5G7#,L4WR+B/"FSW/8WR_!8I]X%1OK9)T\J*+AM/C*YRWR:V M7V^]T=2RJ<@U[8EM4AX;93[2J$99M:I*]:GNP,K!ITSMD4>3GQ\<%>9ZG$=- M#++Y/_+90WJS3@K\.!,L@0E MF68%3C++$I1DGA4XR2)+4))E5N`DJRQ!2=99@9-LL@0EV69%(DD%:NI16%"N M3Q06TZRPV)&+55J#-\"_>U219ACIN=(4,*T\8Z;SM`5,)\_4TGFZ`J8G8/H" M9B!@A@)F)&#&`F8B8*8"9B9@Y@)F(6"6`F8E8-8"9B-@ML4F55UPI'JBNIA. M51=OX&=WK-R:N*%U;RBHO[:`Z>08$QWLN@*FEV/P>M`7,`,!,Q0PHQQCHO5I M+&`F>0:M3U,!,\LSZ%@_%S"+/(/6N:6`6>48"^WWM8#9Y!ET?K(M-JFZ@7/L M)^J&Z53=\(9$W>"&%FYHXX8.;NCBAAYNZ..&`6X8XH;1O:&@?L<"9B)@I@)F M)F#F`F8A8)8"9B5@U@)F(V"VQ28U/^'2+S4_V76^!E=0Q9!S&XM%)=%[?)46/ M%'U2#$@Q),6("SZ853P2X\+H)!G5+5U&J_0T%3=K!MI/LV1*""F<0&ANS<-;@H& MJ4F*%BG:I.AP8<33I999H+O)L)4YDO62X>P*V4^&X2D(7D$'R;@._QP=*(<\ MKL>=R_1M=(_^YV%R3(H)*::DF)%B3HH%*9:D6)%B38H-*;9%(E4S['F:^/UB MIG'-H$-*@YNBFB%%BQ1M4G1(T25%CQ1]4@Q(,23%B!1C4DRXX&N(KN@ZVF_3 M5%R%QS3INX&S9%RQ=!7%Y^EX#9^P+WB\8%XL2;$BQ9H4&U)LBT2J>.!)TA/% MPS0N'G0RV>"F8)":I&B1HDV*#BFZI.B1HD^*`2F&I!B18DR*"1?\`LFH&>A$ M>YH,5]4JOL1)AE7=0CM]G@PKIHQNERUXN&!.+$FQ(L6:%!M2P`L#;(;G]Y07 M#G\A@#^Q/+O!P6VZIU-8OPJP2,`[P%<[8,[MH.# M=PE+)W&ULE)5=;YLP%(;O)^T_6+XO8+X3):F: M5-TJK=(T[>/:`1.L`D:VT[3_?LJ5C*:=YOJRO4]+W9KRAML'>;R&@]1 M%#QC]R+;UZS1UD2RBFK@5R5OUN3,7G%:+G$,%)G8D6;'$ M=V2^2;"[6G3Y_.;LH`;W2)7B\$7R_!MO&(0-;3(-V`KQ;*2/N?D*-KL7NQ^Z M!GR7*&<%W5?ZASA\97Q7:NAV!`69NN;YVSU3&00*-HX?&:=,5```GZCFYF1` M(/2UNQYXKLLE#F(G2KR`@!QMF=(/W%ABE.V5%O4?*R)'*VOB'TW@>C0AOA/Z M49)^Q"4XNL#U['(EBFO+ZE*ZIYJN%E(<$)P\`%>8S,'8Q!/^-Q[(Q>RY M,YNZK:!6T-*751#-%NX+]"$[:M:7&G^LV%PJ`J^7N,#70T)N0\A_]^X$9\30 M)8QZ.#)+>]^N@+75A`---%9LWE.,V.!%U[,9\1*#=\\6Q.>:+9O5I#;6-"#) MA&RX'B4A2<_%C<"@NNO!C'@*1L8O7EM-W(&%GC?AW@R7_62X/L*"PW4]EA%/ ML2;':&TU%LN?Q=%D?3-<)XF7AGU9(Z[X(UQ&/.4*>E_;1ZNQ7%$*>4P#&PJ( M%XXB':$E8S3S&PU@$+[_,S";IHCGTBVBU=BC%D=D%I^/4B>`P6Q,K(#$L>\G MYW0MHAV\=J2T=,>>J-SQ1J&*%8#I.0G$+^W8M0]:M-WHV`H-X[*[+>'?D<%< M\1P0%T+HTX,9[/W_[>HO````__\#`%!+`P04``8`"````"$``(SRQ5T*``"Y M4```&0```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`\?*]-_HU@SB\Q([=U[=<[MK34:_/]H*NWG.)HN1^QG M!RP[4GF5[[S,_9!M*3L6#ZR7^?5@Z).[T2_6,ZQKLVB;Z5PFRS/A_0"O:YXG M?-35Y$6LLS@O8HL)[-_+JDROY66<,SDOX]()'IW@TPD!G1#2"1&=$-,)"9V0 MT@D9G9#3"45CPHBUZ:5AV3$I-6QWAWMN/ZYY^YWWR$),8,4O>U&7=^*R+:8W M,C';A!2QVH(6L=N$%'':PM`->57<+C.5C5>;\40$6)O?C&7AM\3U3!9!U^<0 M$W8935TLJ$+8=B7R\60!"RA,*&PH+"A<*!PH?"$N#YE>:K-QF.R.WP$ M`O@9(101%#$4"10I%!D4.12%2DC191'K$5VN:73)L;401A5=*$PH+"AL*!PH M7"@\(6:GZ$Y8<%O112"`GQ%"$4$10Y%`D4*109%#4:B$%%UVRMPCNER3Z$[( M-^]"&+8"EUYW0KX0EX*(]IY/6\UMXA)6LX2NSULU[":83O6;.>G[G?:'$.%" MX4'A0Q%`$4(101%#D4"10I%!D4-1J(0477:9UB.Z7)/HZN1L92%,,[HD$DLH M3"@L*&PH'"A<*#PH?"'$<3HUV@=J`$N$4$10Q%`D4*109%#D4!0J(66773GW MR"[7)+L3DLR%,**MV$TA0]-G,W(&N!1&D6_S"U4L6,7^0A6G::8ZSQ996['`U?"B"YD=H[54(F_/;\8^:LSL6C\'\1)H_U32=G_S(%YAITYQVDSP_ MD^;S3:`5\I:0*Q1B?G_3->T?J6PQG$S_-^O9Q97BZ M&[04L[O73-PO4A>P8`%;7)C$F`28A)A$F.2U*3^%AT;1NM4 M-<55,DQR3`HED=/,AS"::>;=](3UW:";%B,?T@"%0;Z0%YI`BLPN,3$QL3"Q M,7$P<3'Q,/$Q"3`),8DPB3%),$DQR3#),2F41`XV']YH!AL$6HR&2(&>M+KI M]I!)Z^8O?VB$]?>*T)L=A):Q.@RY)6)W$%K&Z3"DC(N)AXF/28!)B$F$28Q) M1`\Y&0'AVT&#B1.NC6 M(Q'\44P4:$A,7,7"Q,;$P<3%Q,/$KTE]?='Q]$2`BX281)C$F"28I)ADF.28 M%$HBYYF/CO3(LQA,D?/1,3"Q,;$P<3%Q,/$[\F(L]= MCU0$N$B(281)C$F"28I)ADF.2:$DL'_?$(=UR4F)B86 M)C8F#B8N)AXF/B8!)B$F$28Q)@DF*289)CDFA9)(@=;IZ*&ZCSYQ>K>#/KE9 M(\6=N24F9DWJ_F%F3&=D=-*2A#'O>'A3$IHQ847(&9*#U\3%Q,/$QR3`),0D MPB3&),$DQ23#),>D4!(YSG3,\&OGTGK'V*%!OJ47-5+&6M11$!-7L3"Q,7$P M<3'Q,/$Q"3`),8DPB3%),$DQR3#),2F41`XV.X?H<>*AHBXF'B8])@$F(281)C$F"28I)ADF.2:$D M)GY-Q!=+ MYY^6X"(A)A$F,28))BDF&28Y)H62R'GN-W[(7R-"\VS0!Z%KU,PS/6E8=ACR M=6]V$%K&ZC"DC-U!:!FGPY`R+B8>)CXF`28A)A$F,29)33X_`E-<),,DQZ10 M$CG2_880]8XA1(/)CXF`28A)A$F,28) M)BDF&28Y)H62R(&F8XC@-E[7V"%]"$_'8X>8F!V$]JW6%XQ=&_%>"GVN7Y/C MS^DH0HX_%Q,/$Q^3`),0DPB3&),$DQ23#),<$_[&N,^'.D2@Q1OAQ+NFMN7^ MN5R6KZ^'P;KZR=_VQE^Q1/==YV_@(A,7VBW[+U0[>FF=LM>_L2FCRX+ ML!?'O:V>RVBU?][L#H/7\HE]U/AJSLYD]N+5<^*78_5V>O/5C^K(7AEW^O&% MO2*P9&^<&E\Q_%15Q_,O_`,N+QU\^!\```#__P,`4$L#!!0`!@`(````(0"+ M$L?>BP,``!@-```9````>&PO=V]R:W-H965T,..$Y@O3&=BF@?.01B0_+,S?OX*'J6EP@?((I33'"_,# M<_-I^?7+_$39*T\P%@8HY'QA)D(4,\OB88(SQ`>TP#E\$U.6(0&W[&#Q@F$4 ME9.RU!K:]MC*$,E-I3!CG]&@<4Q"[-/PF.%<*!&&4R1@_SPA!:_4LO`S$)/6T:B;R3' M8#:D229@3^FK1%\B.023K<[LH$S`#V9$.$;'5/RDIQTFAT1`MCT(2,8UBSY\ MS$,P%&0&0T\JA32%#<#5R(BL##`$O9?O)Q*)9&&ZXX$WL5T'<&./N0B(E#2- M\,@%S?XJR#E+*9'A6<2%W9^_]P:CH3>9WJ,R.JM,+BK#^U6@KLN`X+W:R_C3 M*I9RIS3;1P(MYXR>#"A@B)\72!X'9P;*E,TV36-QAGU&3\[EK>I(EL*D16A=Q?4`UQP+W:0BB2:PMO%VCEE(2E4]4Z*S5PO<[(&]8+E=M? MWV+<)N-WF9;*IDMXCTV1H(NT1+9=HBVRZR(7D89Q<*JNC9.UY\+O1+^!F(L;EP9]X=OEJ&NYK139:(M`26RVQZR,:=L)#XGX[Y:2VG5[3 MB95BE%FN\JKU4[E6"&RUSDI+Q-<2&RT1:(FMEMCU$0T[QTT[^\^XA-LVCELV M*J;'H[4BIF55.K(JFPJ^5F&C)0(ML=42NSZBX2$\7^\O23FI[67K>;E23)^7 M6L+O$FXK91L]$BA$Y0Q:B';.MGH)Z$EEP+@^#^4#NS7N.S/H-+KC@3.#=@+&K7H"-*8%.N#OB!U(SHT4Q["4 M/9C`\6&JM54W@A9E2[:G`EK2\F,"_T`P]##V`."84E'=R`7J_S3+?P```/__ M`P!02P,$%``&``@````A`'^YQSDD!P``QRD``!D```!X;"]W;W)K&ULI)I;DZ(X&(;OMVK_@\7]*$'`0[6]-9<<\W.Z4'ZFI?+;\Z^_/+WGQ;?RD*;5`!3.Y4(Y M5-5E/AJ5VT-Z2LIA?DG/D+//BU-2P=?B=51>BC39U3>=CB--5'[%*V:J?M9^1.2?'M[?)EFY\N(/&2 M';/J9RVJ#$[;N?]ZSHODY0CM_D'T9-MJUU\>Y$_9MLC+?%\-06[$*OK8YMEH M-@*EYZ==!BV@W3XHTOU"^4KF&V(JH^>GNH/^SM+W\N[SH#SD[VZ1[<+LG$)O MPSC1$7C)\V\4]7/=SMU"/P>S'8I?OD[5C]D;][:?9ZJ&"X#6@1;=A\ M]]-*RRWT*,@,-8,J;?,C5`#^#TX9M0;T2/*COKYGN^JP4,;FT)BH8P+XX"4M M*R>CDLI@^U96^>D?!I%&BHEHC0A<&Q&B#8FNFCTTQHT&7&\:NF9,IGUJHC_<.8]\)<;F.Z8W?8_I6G_MZU9L@00OW:!/M;X+EAU,6.>L3H83>S_#F8L#*SS MR(Q5OBCW$1$J[#T2$+UY%;^+$<8^Z&(FO,ZZBQ$<'78Q,UXG>F3$AL>/B"XR MFX91QVQRP1)\JPSG&XA5/7Q#:5C5[VRBZ<*X+!D#P>MJ):'/5RAAH82-$@Y* MN"CAH82/$@%*K%$B1(D()6*4V,@(SC0PN#U,0^F%`HZ\&4*8[DN&R#S#"+.V M\\10ZS]^ZEBHB(T2SGTQ9G&+H M81Q*"\810OR2(5#^S5N\*U:,F-7&(?87<<&29]OR;$>>[D7N&TJ)GQ$<9QL@\@Q(62M@HX3""3:`O1#6F M8^%=UT4)#RW%1XD`)=8H$:)$A!(Q2FP8T80<58>(=<0 M51B+90/);(,C%H[8..(T2&.=B3XS#6$KQ141;2+NM'EX03Z.!#BRQI$01Z(& M:>?+1%6)N',6XS(;3H88]^L![R&Z`7B_:,D##V'[A?]G4UT;5X!,G6BF^`CG M<9#^D.]S^80^)/!5"3B`-H?/7W/Y'0(A!D0-(.G5F-.H.Y6OQ4:JP1N';@GV M,`[;0>2-(\SF)?W%!-8U20M6#?+A^S>2;R/Y#I+O(OE>DR]I@H\C`8ZL<23$ MD0A'8AS92!'>-71/L(=KV!8B[YJ')8M!DG`CVXAL?N>YUZ#AAI\7-OT-3NY, MIT%8-8@^U2;"MH'+$]/)="80'D=T19G[:G8$B8`3Z(HRB$#("724$#6`Q.`Q MI]$9962]R?L%RNGC%XKSCSBZ*6S1+>D/H0#=_,*/]:K)E[30PA$;1QP<<7'$ MPQ$?1P(<6>-(B",1CL0XLI$BO(/H/F&/B,.V%;F(8PJ_."[I+]7R:+#"$0M' M[`;YR*H.+N'BB(P?10PKXO@Z9A&46LIBBV^].U>J$2#B=!'Z;YH.@V^9*@Z.&(CR,!CJQQ),21 M"$=B'*'GYSX.!C^5@F[_1LV_T%_5KZO5-GJ40 MTI=D#B=4'M,M,H=#*)`^NMX`Q^@NR6L:)<5K=BX'QW0/1:G#"02N@AW$8U^J M_%(?PGG)*SA`5W\\P(')%,Z^J$.`]WE>M5]H`=FFA,$``"/#@``&````'AL+W=OM#$^KCTW//O;X7KSZ\U)7QC#M:DF9MHH5M&KC)25$V^[7YZ^?#760: ME&5-D56DP6OS%5/SP^;]N]61=(_T@#$S@*&A:_/`6+NT+)H?<)W1!6EQ`RL[ MTM49@\=N;]&VPUG1;ZHKR['MP*JSLC$%P[*;PT%VNS+']R1_JG'#!$F'JXR! M?GHH6WIBJ_,Y='76/3ZU=SFI6Z#8EE7)7GM2TZCSY9=]0[IL6T'<+\C+\A-W M_S"AK\N\(Y3LV`+H+"%T&G-LQ18P;59%"1%PVXT.[];F1[1,461:FU5OT.\2 M'^GHNT$/Y/BI*XNO98/!;<@3S\"6D$<._5+P/\%F:[+[H<_`]\XH\"Y[JM@/ M[S'-P5&@63@^9\I)!0+@MU&7O#3`D>RE_SR6!3NL M33=8^*'M(H`;6TS90\DI32-_HHS4?P0(22I!XD@2^)0DR%EXCA]&_\+B2A;X M'%AF2K%$6+U+]QG+-JN.'`TH/1!.VXP7,EH",;?'!9,OVP.^\#T?^:9^*Z`I MY/1YX\0KZQG2D$M(<@&B(M(IPK7/$`ODG36";6.-M[5Q,,1@&F=M+CK3]O(3 M`?%&$%]%I+<0BC3X/_.EK8B" MR.:+XF!-E'NF%7X)2'!5E%CWQ/HU47!:QJ)XH7E7S^&IT/@F39RGB1,0(:0`$1^CW?MH>,*PI#5>'M M,\#!FK*A5$1.!43FU(MBW;?QNF_'\159?$R.VL=M61RL'C56W> MD!6158F1:;7]0.]]J8*(HL@?*%1MVF"XG5DDFOFXM7EZUY48H2WT0S_6G$T5 M!`I]A)QKSO$&/;OND&CGT#O/Q]`;B*5S`G.K\B3-98AJ'F_3(WF\]N*WIZIH M[HJ)VK%,D,#(!/N!AS1$JB'`PP&ABH1`QB+?R#!':]6GMV(D,%)<%$;3#"L( M+W+"H094<;QOCQQ\0]QT3GA:WTCX2Q\$(,3=(1N&@=83TYL05=Y_#0PTG1B> M-@X2B9$RXPBA2#M(J0I!T+N#>`A%U?E/8P--YX8W$,MS,AX,=Z'GA+860BII M3DZ'MHW&PO M=V]R:W-H965T&ULE)5=;YLP%(;O)^T_6+XO8+[RH9"J2=>M MTB9-TSZN'3#!*F!D.TW[[W=LIS20+4IR$7#\^N4YKYW#XO:EJ=$SDXJ+-L/$ M"S!B;2X*WFXS_.OGP\T4(Z5I6]!:M"S#KTSAV^7'#XN]D$^J8DPC<&A5ABNM MN[GOJ[QB#56>Z%@+,Z60#=4PE%M?=9+1PBYJ:C\,@M1O*&^Q,@@;MLELP$:()R-]+,Q/L-@_6?U@-^"[ M1`4KZ:[6/\3^"^/;2L-N)U"0J6M>O-XSE4.@8..%B7'*10T`\(T:;DX&!$)? M['7/"UUE.$J]9!)$!.1HPY1^X,82HWRGM&C^.!$Y6#F3\&`"UX,)";TX3";3 M:URB@PMZKI"`7L^;. M++)+0:U@2Y^7\6SA/\,VY`?)ZE02#A7K4T44]!(?\'I&B.UZ1K,(:L&H9TS> M[6T9*R>)CR4]@%6LSRD&B/"<8\3S\1EQAL'['8T,'[QRDM1FFTZ2P'Z&FO5Y MS0`/:KP*.]6SG)S.*13S?1B.R_TP,H^/]<#F7$(ZC14U=.XC(C21J3 M,$U'6[X>:@@)(TBVIQ_@I=?@&?$(+^YMW6ESDO-X0\U9O,DU>$8\PDM&>$XR M=2N^;J!% M9SO(1FCHFO:V@I"`NA=!O`]/?^]?N\B\```#__P,`4$L#!!0`!@`( M````(0"5P8..>D```,;>```4````>&POMN M'$EVY[\OL.^0$&2W!)`4BZ1NS[$.^+*:+^>\?]'9V'V3Y?+R83.>7OW_P?OAF^\6#K%B-YI/1;#'/?__@ M4UX\^+M7__-__*XH5AGOSHO?/[A:K6Y^\^1),;[*KT?%SN(FG_.7B\7R>K3B M/Y>73XJ;93Z:%%=YOKJ>/=G;W7WVY'HTG3_(QHOU?/7[!WO[O9/#J=\7TU>]6KUXOQNOK?+[*H",[G*^FJT_9T=P'@.[?/5F]^MT3 M/>J/O\R^75.MM_;RO9V>P?-/YZ,5SM9;[?[CR49_7N1 M\57SXX'R=_GEM%@M1\SG>'2=-Y_ZZO3P='CT^C`;'@[^<'SR]N2;H\.SK>SH M>+#3?#1\<`!KEJ,9+)GD/V9_S#\UG_MJ=W>WM__T^8OG+YI_*NK5HO]UFQB:W:F]GHLOF5KRY&LZ+USF"]7#*9[,VT M&#.A/^6CY<;O?[6]W>MM[^\VOWRD=3<1&67?Y[/9]@_SQ<=Y=I:/"B1XDAT5 MQ3I?_EWSM:^.%\V?TB]]MYBMYZO1\A.TS3I>+Y_]JLC>Y3>+Y0H-RLY6H]6Z MR,*TVF/^*2^:@P;:;91L`%\O%\OV@IY=CV:0D0PU6%S?C.:M)\/G^.OU`B:L M%N,?MK*SJ]$R+[*3]'1 M?(5L76>#Q;Q8S*83N##)OA[-1O-Q#O%8D2)[]/[L=?;P<7/DX\4'M-L5N$56 M%*]14?")YJN#47%E%F:L?\G_93W],)KE\_:#P\4*X8P?ZW=^[/O\O)BN\NS1 M/%]EBXML-,:$K6B'!UN]9\^W,I;G)A^O MIA_RV:?6'&'/:'XY/9_EF<_$7IW"-&1BO%I#W,T2*[Q#+LO\WZ9V>'P[/FW^(L9]/1^70V74W;$ML?FQ4OLIO1IY$1A45@OLLUJW;+ M>\>+%4+8]9*F`@=636+JC'^[F:2SX?OZ\-W95]GKPS='@Z/#X\&? MFA\_R9X]?[J%U=3_X:1,>0K3FBTH7F9(QCK/ M'N[N8%@S.)W9'Q'8Y,EL*DL#*V#'HE*UWV2]I\^V#GI[+/JN_;'WM+?5V]NW ML48KR+A[6838@S6`X; MABBC)9TNB&^/^E\?O3T:XO:R_O'K[+Z+>2^K<8KE(S;(5U,GB[0:2GM/_7/Y<''J__5Y&CT*7V1$RW?KH+7_Z?BD/ M-E'TA!I@E.M>ITG>&R)]UGW.3/7\)#]OF1(>R:>7\RS_<7S%Q_+LDBP@>S1# M@+J\G#D!'K:E:PZG.8JQTU7V2'-]G#'5C(EF'JPTG_>)MD6T^5RD<6RQZ/A3 MIE"]P'-+\4>3?\8VRS(T7ZM_^',(JS];.9.+Y>(ZDQNWH8MLFQ"HF(Y-WB;3 MV9J@J$G$]W#W2L%2GY0._AH"S60$([ MPX9^$F\UWSV.GQZ7AF"3P!D'M\]'!?PE:ND2@CLTQI9.5-X9IPU,/0J4+DH` MWC8)]FX)JU[G8Y+M(M>[6&/Y_SBCEO(?S:MGB=B4>7='9+>,9S*Q%E/JQ"IZ M[8P7CXZ_.SR[0T1.UTLL!)-`.^.3KN'P]N M%TUT<9SG$\1.RB=G:SD'5(S3T&XK"V%](3]?/3>686X2FC)YGL:\S0?Q1:OE M]'QMEN;\$TF`YPO$!NU(WJ9O5%YX?'+KW`\O+L@,Q$V,9-T$8U[R#&9CCK'; M"A2+JR9EY10>38)T/=9JZU&3:?N76S(F(U9^LOG@5G8.&C*?:^4@#F,'I-`< M_9:W@1@VOW*?/F!^*4EK^]2L=OX5,O]-J<'+J15W3#Y M^E^S33S`JY:X17.`CLG=Q9^-XW1\J\VHC6]WR5Y[=O8ZR\;G!SC)=YCLP^S MDS=9B"Q.CL]N(ZGYM]/\9C6=Y-DP'U_-%[/%)5$V8.I\O),]4JSX'__V?Q2Y M@9S]Q[_]W\?9QY%\[GBQ!,'#+II/TV-&NRS-_GL@W^NX6[P)U+ MBZQ,V`&[G^YD)_-L[V7V]^O9)\'.P%/Z:#GPOQ?9'"381A^;)9ZX M`SJ9SZ9SPO?E%"-)1A`H7RVRP;O#PWF^O/S$5YQ8%F`G$7)BITL>5!_\PA[!4]&;20AL/*IQ$C86;[M9G5%T\T=Q(>!(#%3Q^1!)`89Q^!*F:?MLE[6.%B#9`WF8+\ M;E&@`,$P1LY&A,"(P]>D2%.OMI:(6&=^G`EA%(L_JG-60NRWTNX<-!B4]!M/E7ILOGJ@6=>N.^O MUP725;0

P&E-8$&1(#/`1+KPV]*JZF M-R&`#D%=1FA#$B@L^].3T=JXD5TM"""9U8":! M\FPV&O]09#,23:1-41-!%S:,#RY"H-92YI+]QBA[R19"4<.",?#VN'V*">2/ MBQN5)RBV",RP4YJ9EH0C2QK)/MW'+!K:%($LF//Y8BD1+-$\PAON) M\-:-$_5'I7$RO;X"H\ME[IR-%ML@]ZS,$?KQ`3/A"/;'J^GX*N71%A^K0`9S3($[XK%U4)1=F(I M(9OT]@;PR`I&J\3UV%.,KU*`/,V'Q>R#F*:11\*`QJ7C-/D?S2AU!M/+6@TK M`C$D6-#@+"36#1&`"'WT>C1?7V!E/"(P81),%;,,)CU7$``N=1,\)147RT`* M$[?%]7D0XIP,>7&-_)ROEY/<(*'SZ6+[8K&6_IF+ZQT`[HX=J&XYG0P)4CW6 MR-JT@J53?C-=@H'C5+V&J)7=R?IP.2A37*[&*W'D&(JV!8%>'=0P?\N'S@&%ACX/58%@MA\1%:A"1[*6XCKRK[7%`H?'9/L M9<\?=\E_#X-AH(OL?4>*:'"%%!HB)]*B239?([-Z M\,,"9""^@;5822X+?[8V(3Y(6<0B$%H%YA/4Y[:Y84;N-SE00(R<@I7+V>(< M$<2T5Z)9J;WT51+>_Y?UR-P:CWX+-HNI&B_0%_3GXW1UE?4I]E+F187MQR)[ MNYH0YF&U0`2$ODIHXD.'LC+(!YCP8_U^C$V\RKXCW5^L`<\(;;'H$QSZ\(I0 MI2)&:G>>(_]`*QAJ&&ICXRDVKHKY='0C%';0C+:[QB;6G[A=+C:.=0LCXLQ3 M]I@5&8VI=_I>YM M*#],6K`:5N0RW4-4(^V$:F:B;5)=!5<]+?+"13P#'C?#EO9A2RP<+* M+$C0[GW6Y(**[/+ MJM@?MQGO18_Q#A[;3$0/(3X1HM8N5$6QC5;Z]$\=/-O:W7_9L52/ZG%?;Q], M_F%OZ_G3W:V7SYZV#7T2%(Y'#*2L,FA"8QD.=K(_+#Y" M+%9[6HOBE&6NY\8SF9@F*^(L"`Y-HC7"Q=HP$9ASC=16V.I2O%JZ(F]!GDU/ M;X5U,[;,:&`C682E+#2M$-=H(A%8S`Q4R1HSW>XUGP,\&\_62W@SBRS#JFRA MC_JPF.HJNX6^YC^DRQKG@DG`3)+>C#X`8:@=`S^'6P\K3FA$4T+("30=4ML9 M4U7(HFP@$5FYO8^8&0N>KT>F+W+#HJ`H9"D0L`OFQP#ZR%H&2*NJO`)+(ZMC M$Y*MYCU8BCBX'`8>7!,$(;>KK*`J:,D>S5^3Q1H)72L);?+7>U`L-2LER_2Y M9@/-`"'T]S?,DX7EYN2\L[6TD^ROJO35YB**B/YIQX"Y:HCA201Z3#A?V`0\ M9<9ON5=DTGIE=.VUE>YG4VMKLG&ME$*Z-"><+@JUG07]2CBBOU?"?1L_FBZL M/Z/197UYE-?/M^,G$$$7+@0P%.P2SS#J56F=!T%(%%M:GPVC*LI7U'@(Q+"=, M*=9C<>UB/>MP11CA3RBV^=%H&!B/DEXR0\AU;-Q5]:.9-G'8$J>H^E-L;X0] M$H,05X*R&_]J*1/_ZW(?15,IV6*)9)E)$L9$<7TE+7+I'YW3P^&2$Z0,+J5K M#[?C./"E&07XO'\V^4]DTJ&,*E*$3/,^1A[+5!F!3ZWXJBRI.&PJ"]+"GKZ_ MHKW29CJM&GQ9&P.5,2?!5/_$`,P(#'4=S-J*SYG&PT`E14G9V2&$:/W$^<4- M_@J;9"8OFG158Z*&LB2!3HSO=(D>Z;4J$'2WO)A;ZU8''F2V014U.7$,>#`= M<14](*0\&WD!=/.C,#JM/YG3F'`'!N&W%Q]-;S[+`EX`>:*\HK@PJ,>KP;(" M-P2UX[(Y)<=T3"SFXEDT($4M($0?2#UB8'8#,2-R(AY2HR)"?'O0O$/;BO2_ M6%]2H#2/$F"USYH?9H'8U^2'(?\9,35#;>G2)IKOI*UR]IC(=H-DWA.%TK&__ MT77>]=/6)XD2[Y0EL$=%]*M2G*?0@U4T/(K@,UB?^'5$'89Z.`/)\?-8W!G6 M=;1LJ?Z0^:0*C:3PR48OA7_23)4"I18)9TF(0=%, M_EC2?1JDN^4CVX_O%7G::MB99A" ML;Z^EF>'$6GX(],6:"LU#[Z4:F]>F>4G:L(8KE62D/.8F,-N:%^T'7=R[W,= MAFP5XD*<)\%!E-TH66)I2YM$O913M+`\04A76-MR$!C,ARB\1,H]C%J<_S,! MLOHW/D5/V<6.*A/6Q.`$G@1Y-5-4^0AH(DLN/EQ))#AY82@0#T&D]OA(-!4 M1LNBI8JGU300_D'I`C!I_UF6QA!>JQU$)SJKZ)?,FBJ1V5#GJY7P"&#Q45X0 MXMNMPC!1XP=^-PO9+`8*GJF5[4"P,9"ILIM`;LK MAA:SDI;3:FJIE:5(E6KS8(O3:;4>;ZOOGE&46&VO;V!'JUEIR6XK[>KZ37$# MM/G[!UI0(N'\P2M[V$Q5?+T*O*.+DP6B![1L#S#WSACPT,5#';C(BI78U5UI MDM(4]WXE[I#*QK,EX<:`'6FJ!9K3EASWSP8FP<_W=K=[3[MM`-CJ'.[:E2<+,4ED<4:4D\BNALEC"]['$*$$`Q<5N4AE`UABWUQHWTF"+91("(]3YP0T,+2. M)3#/GX0N2J$DLB"=KC/"VLB#V7.!'9)Y\2O+!)YI! MMK^T0`F&!/'/)+I<+(DT6R9N0PBK2.D$:C!>Q\0- MO55S$@I/\DB;A_7>F<)767E+HK4&D6+76YN&+9F*F6I/K>FH&0=O001N5IIM M0$*R-<9':^BU%*W)7XVM)I?"LST$(J=(R4\W,B.PQ*'*G=B'K&_V0,2'>4XVF$.Y]RKBP.EQ38K75>K6RC=\7%K MG]VP@&;;E0;D'R%!"?VTFH`$2R72+*G&&9XH*K/Q=$GA'(]EZ6<`_H3#A^:O M\6BY])9+*V2)'8B:S1+%_&1Z%O39*F,SHNLV.TP;NX7/:`=/$H[1H-R18C']I/D$RF.9S?DD*_2N7MO3/'TI'?*\RJEQ2Y50$YQM$2NG MX.[HN:<(]!1YF4"K?AOC^*0>27PJ1K0P]$]<\$*T18I>$?"DB3\Y+8X`B6&, MK0\9I;@ZKQ3=-C*=5[;+25I3#=\:D<0=8U3)$`#TDD3(U'^\<,/-J#ZX"P:D M5-V7'224=&+QG`;]HGI)V%,/Q\MGS"*QX&E\GI#CB&^M*Z3=6/4.!&/$9C); MM20?JL<@JU>UY])<.%AF5!1*G`.V`DE6D2`:K:C["-"(M'4X^K&YTP9;LWHU M9/:#@"^-)@O#\31_Q=_/#[Y\\)UDDU+#E/I?/5]TEF#UK1/#Q0X]E#$J1<:6 M.=;3/ZF'@W*5F:L*5N)Y#+-69:55V6$S!UG_/;Y1+@H>-C?\B@]$`R&K$`>V M:AGB(@\6U$3<%)5!R?2B\`:S9`;YK;RX'&O2ZMNB@6-)$#1E\QZAAYXZSU;VOK.&'EI.DO\(;BYG'>Q;BWRFPRCH)=E..(M$_%*#F7C& M=J1[L2"TELAB:K1\#FXH$\:7U)"._;&F&+=JPJ.MNX,_&R/".N&A-&-!8^:N MHHFAXDE[2Q>CI*SIE\]],7!.C,12>+L;!K]O=L>!16+.Q4<#WC%QV$5(8',' M+UA45JOT\ADZB`G!VEP(9MU;/MI$>`]E)XZ@(L/8#97O[X[Z%S:X$U=E9^I6 MKQLO&9)-"50+JI(,[SW#L/@W>%?__/*(Z>%HJ78O@,HXB5\[O9%$( M^F/WPJ:$ZMP85"X(17U,\3-]J49N0;&`$HQ%#/>9JIPR M'05EW$>V1`,+Y08%DQ;/*O!W984,ZY82'ROZDP:?E*J0DWDG357W2DXJB:U[ M-Y05R9NL>%`M@DH@:FY0=E0=JQ.Z_3:.Z>W(8AM1><5`S$@EB[[&6F<+3VEA MHOS,=#V)J9F;RE4S=QKIB/BLQ_2<[3%R1/D&LC7#G;3NFP8;N-_M^ZZF. M)B?P4;*2'CWE*V'3J'W0C`2+I04@#G7S6$XK$62?'2N!^)J1ZS0\AR6L\T:1 MV'=VNA%N\DU9\#N:"U0R)+)N?#R$*3T,P*?:"]TC#SRP,>3H#F\UK;Z_91XM M>">^I`B82-3]-_8C.66*%<.#E+_<4(W[T?"IX+J2N#)IT*)-C0J8LGTU+PI& MM2(\?%0?K0:<>.<0L7_9V6DSC`U"I?*$Z4MQ)%JX(^O0 MP3^D(+,Q!F00;`%CCX,YS=@-`0%I";9&<@X&0%+%T6!WC M4I?@S>YS"%_ND%N"A+*['Q-R0[`$-:Z3M1HXKKS3%[_X\O#CFR9KOAVMT(;B MUW;(6%T[FJ)T.K`1+^R[Z#:%J3#=*N4SJ_!Y[(4)2WA?LZ<>A<:1L*#>4^6A M:"@T`:'@QAD\@!^A+$\TH**B-1=E[[S6&.RP87>>(2;$\'KT[_Y]1+<<,<'R MW=,(>PB3J"2UUI,H'^4@FVB3]RF\P\5KDW#*@2KS(B'BP#*%[EK5:XE^>4^' M+GF9B-T3V$]DUH_`\N)K9$YIC&Q*L1-!1`3/;X['7S8K467$G4Y&%J8Z'>S( M,S"/;#]'(:.ABMFR!;1[7SB@?5"56;NF]=>0*N_M[;*R9:H<9'G,(IB@(#[* M\.PHR]B=+C->6R066FERB"?.R7=\\[7;-P5^]S>/U4$OA"N]ER]?"/)/):(^ M6)`QWSQ4_Y,(5P'!==A-C>-3C:QS@ZM^'?-_[Y`@"NO7#BS94,78)TV3KHOI2DL8'>E MV%01CC((]H!4:*7+#U9Y?6W'!,2BBQ\T)-&(4E6:+`]3+<:Z-\%::B(_FZSE M7(KX""G\F--H?,!,P64=*/&%!O9A(,(J"P=C7;(Z(WI08=\)Y&7-H(UC*14> MO$K.U0#YJ+8X[]?#^&B3JO@K^?@9Z+IW,WV]H*G)VO'>],^^MCZFSN?>W\C9 MV(/]L_=ZS@UEDK2?TY?T1;LV6A1\R=&/%SLZG6!_>W?OBP,8=6-U9);QU[;S MUD>\=BDIE1;,GD!`RHW.8CH4D&(CI/$!YK+-)95ZQLU+6'7M.L$:H7+ED:]> MN94*5LX[V&/S((814JAC(#R+M2'GX;0Q3TOU!^OJ94>F=GJZ7<48)/@)_Z5F M']M1K:J#A19%V-:H4NQ86X"WEX+;'`EE;K'8>K%8K.;8!7DG[8(@9XYO-#A!?"A?`(A`0F>&3#L,&`8_04+C#"U_1T@8 ME_T^+GP3CA)@";Q/E>->,%NV)[`N"5*ASW9:G5Z3,IVD.K&:ITOV6JU)7#LP M"C/A1_/R_*5@M65\(YI46PX=E_2%N_A.74]=0:6!M%`3=93E@R%X^==4<'7< MZ??J$1C1K+J*9_L@F&^U$WJ@,BT2S;9-4(I1=A;@/[VM!ZRE8:1B5#;PE#Y] M@ZXC4)=?/0WT+,S01I!`X5OH5]GV+&1'$"SYJIFXT(^""MSH7#N=]V%RO,PO MY61Y52]4L$F9L$?36+)<45[);PH0H(W&;W5O&,-EKZKV+D/^#/=*&%[BK;RN M!P+#];6`H:1OD`V*X0UCT.L),=IL!WXN,\#1(QLUGOTE-,C M@U*IOXJU-)I@1[0(/Y?Z;P9LT/'ZT2,;5/Q@>_?E%P\@(F1@B2)\Z:U78$(.(R:Q_E?4TOU_K>_UE*5L+&P M[<^K!+33*SY+MS$TW#P-F76W&&2_\HY_^;/BC4WN\:]35>)A7Q@"J>=&7=%Y MA:VP_Y?=7Y$T:FC#"DTGAPII":M:A/PR^<>KK0`H"S>R#O ML5.()&\=.Q6M5PP7`\$6![*I4P<)B[W?TI9++/:-W$+8]J>?DQ"F2A#3[2ZV M.';TDPVO(%+O51ZMDG14B)(^3A"J8J=`VLJ2$&8="H39'MU7GZBB5]%=`@/> M0!L.$7%Q"9%?W3$'M;88S*+,6X;'C#SJ/8YNF,A:I4=(WUXMMBWO37,6"W%S M]3!'N!VV>QI"#H"6X.>CO<<9I=E\UN!>\D5`((<-;EW1K>S1 M_N-HK5!YEKX8+Z=&NF1!B].>M4(3/PX;JH-DZ8X/]O(Q*UC\4LVC>IM7"\@9^-THF*W>#IM`>\3#VK`CF^ M+QPMXG%P@.YB7.L8O>TB5YJ?5G@KK.L$05NZW:Q^'")\(2"+)3T'\4G#W1Q8 M'T/9W5SDEYUUMO0[=M8\0F@=$F8T6U4.YNB9#AEEDZ1CJ^9B%BKX#),8]+WY M\/>'7Y\=#0^;/_>)65:M&P(>]<-9WLW'M:VQ^=O#Y@^8Z!(-`34I[VYJ/J>$ M['RQ^,$[&9M_M:MP6C\FJQ!/+03Q+)N%`_^2DWP]>7^(3^8@0@7H:&%L+?:S MK=;UG1F^-R@@`[(M,CNV=X(WSW/YDS`IX3_D5?9`W->AAT-?Z>MJQ\M/[>:. M+:,)$RU_4.<[IO,AYX)QWU+SH"\.V;(_U`[WXD>[-HOCV8^%_;R,+=R5B`?7 M6F2GH66@S^SYT2Z+>+OY]JCPN"/<]CPAZRV;_\.&_[/LM/^G_M=O#S/=6L2/ M[]X?OLZ2VXR:BU_2%QH8.OY^QQU:W5U?T+]DY[5W-Y;=$HP1,J_)OP1$E]R\R<..",-8HP/_)QM0IQ MJQ&;2E$%;34>')X81*_8!F)DAP4Z2/'87ZM0CFR(7:PW#E:L"52YY8=#O+0O M9KX0)('O+`]@FW&0-$H%:'"IHZ"E8`H"**O&.C.:H(]'SH1!0A3@L*UI"V?H M^9UA"1OMHJ(8,23/[H>[S(AQH+W>,^V+763/C*G59HA*DYHLLPTP*AK3E%3. M1%E@VL^EBX[*I89Z@VL5FF+A<6.QYJP-YK!(96BUX<+>CIF]AU\9F0H_- MA:``]6EN.3X6&EN8U7[KTO^\UBQ3D`[!X_LI/ED9KXBXE.;%DC/`/8 MDZ4+2P,X:58T'RZ9 M"F_;QNOW`/,F:'$(ZU?B"^S4MI#!(_KJX_4O6OL9FZ['VD?CFI>,(/=`8YC[ M%9M?5&]Y\L`7(V,(6?8`PETJLM!J=?42-D1U]Q`X[":_F/ZH;]L9=C"&T,2O MWNE4ZQZ'YM!";W<>^0'$IV='_!8D3-K,#QN61*X'DI.I.?YU'Y*#.;)I?`[% M'(24W!0@W%D$M\1ET'\=]SPU*/R+X0XM$HT>9VSDJO2>TY,QD1*P9W^C8)/' MZ-SDT'JLJ^^I3DUR]2;&2?US2%'CR)Z#A$7)LFL2G99&>B_(4R20@-PV*$\\ M/.AM'1P\)2#8K;')S_Y\>+"W];RW^]CF2C#P\MG^IB>?;NT][7&V/R(?2E'4 M.#QNV&#N>N51Z%0:-ZX);2>Z(/*76).__/F.14&)-JW)+[LHO1=;!_26;%@4 M_OKR!;FV!(FP[>#%LXU/;CW??;YQ49J6^`2O7;O2@B).Y[K8O;#[?+MC739H MR\]L@_I(]DQU:O)9D7@4&I9+ZX\Z9P]??(;H_&P$;G>PM7>0GD>\@:M&\DL+ MS^\G[3\7R=U>V\/0N7G[:'>:4XOM=*<<>A+:/X7"8('N_^0M4?^[P[?](0'^ M:?_=\$_9\%W_^$Q7WG7<3V,Y:2/F1,U1S0?DIB&J1'9A;[@IY#JUE1ZEOK]8K$EHE8BYBX6%,6%)[Q3G.GM(I M([QFZS+9(`U(\40%90WDP%S#P&WV67EABS+?D/))E.D+K<5Y>Q[(E(,'@,$8 M"F.3)-)RS<#;A)`.#NWM=8J]<>FSEZ`S"4FQA9C+M%P! M$DL\N=FL/_4$_'$MP9-:K=V_ MD1?@X!+Z:=!O]Y;AEAN!USK,7%\-5X_0O?%>N`5LMLRF+ M)ODQ[S@I1]SK'-&V>Y7#TK&_PO4*)"EKX2+3T%_N,I`Q"A6;LD`(JJ!;AGYK M.H_ZY3^B:[J!.EFD&GF]>Q(B.FI3T5([JY*JD5]Z]R)[DY\OUT+)/""6TPB+ MQ:)H0?5+X)L6``1(.VN#EV*G)57,=%!=^E>6,6VSD1NP MY-87J^*>4RQ%F#PX&YG!5%^[?JFWR:U$3%K8FZV8=-,G6K0 M6!@_U$)N_ZE]S5&&;H+V7MQ!D'`+C_QUM#)G43K^;%S]+`H-^T%TJT,V'N[N M[.[V#`2RSTF=N#@O63_FD/)HLSUWV+:A".FK,EIVD`_\N>#0(,PG9LA\MC.* M67J3G=ZR[4M^$Z%2=3M7W4UKZN"1^K0[\P;"`<[6O3XYG;)EQ;'_G M==E)?$L&>'0\[!]_6#O_4S#B1 MQL^Y`L]FUW'AG18MG,0E]/3>IQ_],-^'TZBU=_X43*_6E:[N1FM'O" MS=FC@%UBNNH3C.E2KULU;[TYKA8EXLG2F^2:5YT1E)BCK$SR""ZMD#=$+;F^ M[;X3,L-9NPZ-O4"TF'\RR:E0\2;O8M#!J)QVQ@%H_*,.=Z[18CKZ3\5[;M[9 MY*@T#S7Q6P5Q$ZGZ\.DT/8]M<<%XFVM"L?QZ#B(1@GA.#XIM1U2#XV#Z)LNJ MJ$"M^%;*XMOZ>9.`-?I^Z.S&5.N`2AJ-"&4H&'-^L]`L#CX5$BI,V1Y1.(EP MGC-C74`OIZ/]NQ2;D0R-:)/EJ`$^$*9?DGQA=_^94U#WJ*H4"A.2,LB=TZU- M5:)<;@EC/+4TAL:7<)V9N2.!/.F:.NY@[EP\0_>^YGC/$QOL>DC02&4T+'V9Y2YDQ M_'>.T@B+V\G2?^#/..O1] MP9OOFQ_T3X^&!&IGPY/!'YMO]]?T@R[M8-QHX[L&&5:FQ]*$4?=KEG?'XN>S M)+:JPOET%-\8@-^Z+6KW:W=WDP(.O=JI*:2&H'@EI-G),3T5C1[^Q_OCS"/> M31RV\+Y3$#EVI]#M,VDR/U;-%&14IR`UGU(@799JF;LPJ6KK#$VJU:6K@3-5 M@AKU--`5#HI/[[@1SDI"NEE M"_8II[_7LJ8X4CF\99=&Q!:0QXNM%[&+I^PFBE&'A:D>>[.O/JB$F)&VXO5E5N>RE2-ECK$=NS,I]G1ZEOAZN:0 M2\)R'&A`ZRE'2\QB%"=&V#END-'S(KV%IZYIH3A-R"J2D62]6K4FAS8L#_L( MU8BH[W7('I$Q,!V<$FR1 M+W>(V*4?MUX#TM>NU>;E'WO)Y1_=Y>CV]IARS)_WZI'ZFMC6L(GVX5DF) MH*IE+69CHL)8TF9:I"(6RNWWPA6AHQJF)M<>+#J,L2QN;'\($>V@#K*%GIG* MZ4G[PC,_`67SS]6FYRDGS2?*2%$*%]DX1$_9#'DSH)'\RNV,5O<6'TC^"13>>_K M(RSRUTNP\`PMNJ(A>JSK=#**'A,.&[(>3K."82(UKU0/*,K<*N#42NEC>1X" M`M=MQZSHVP#F;A4@ND%X'&;XV83'/M_.B!`_?O(PI: M5MNS!(Y1X<6AI;]#,/=QSJ-$1@PT/O1&JUD'US>'SXCCS2MGZ\_O;H^.B,EK#AT7>'V>$_ MGAX>GW5=`EE>VJ/(:LHYU:'"G5:Z#IKVX%AGJ#C&^AEO#:L;@FX9;/\G#=9Z M:U#5Y"R=C#>-&?Q[$0O5YK/P9\H6D-EG51K7I(+0M(X8-!](%ZE]AV`_W6[D MB[[?VMCR]6C^0SC>O;6XK]GW80&P+FJ.>SV;-+SA-G!\H:I:S3]]R^EA_@%# M9I4F:/+-Q[POKOGK*4=FSZJ=SU4[%IMIY@7GX5"F[OC8NX[?ACF!.&#U>AZN MTFN.Q2<))UJ_6OG$KQN@D\F2RDHI6+O@_UOS/O+CXW3NY^Y?PZ$RTUN^,# M_D:2?/U7/:#L5U:LWW4*U2:]267X4ZTN/[8!^ MLF4OLW&2!E[+CA]MCG:\F-,Q@;RM`75T!:Q)3/.I@1^02AHEW,++7^`.?DY^ M\^&VDC6?J%T;$)"6UOR&""@Z$R],[\JRN@[>%Q;5['\QY6FVC&6=R6UE6;61 MM]+:SC-_MEE,082WSH^=4=P"U'SDN[OY6..2?X5#.*L=JRWOU>^8>CUO\[W! M#JIH;V6$GJICC&1"#?5,]B$^[&WMLJ-C_V6OL]V[M_42J/CE[@NV>4P('B`HG,MGID6S/!#KK$&AJ]2*9XY[*/'=D1WZNS&J6AV<3P^!Y MM5E1WPTKQ/\LQH+XPB7N@N=$0<7B*#6LEO5><%`Q^TTY6=3U"AQKSHE*RJRY MITQ?M_N.9M,?@%SY%$BK_HZ06[.A[D-MY:X)]U2##YB@)9HT-,)[*=8L``JP M$P>RF'TPAZ%N&W4AS&P*+(]7.Z/WHFZN",<#&1.GV(\;,JVD??:6?LUT@(J? M-!-XE"-FUK@(!_%Y8>R=[`^+CT`>RPA`&\OTSIIHR-H&A;-4\+B!(8"19@>J M0:PO3[P\]^WM*&K,!WH=]6C$D5/P%+,5F9*"`5@OK*"CX5-3N]-'):[5HVKQ MN%<81!#T[='PV\/CH7<4#4[L-OG#XT%7'Q$9>7HBZ5Y=[=%I]I8B/>%XD>SK MK_]V='WSVV%9)""=!U\JLD(69UP\E]7TFYV912*!6J M3J`9>6.W\=B"48D=4LR-*=8J:VA5TIYJV51^J;M.9L#KPJKH;+,03OH2!D-0 M=(2;1'.2GX-1^64$2.`6W2MTT=C9^$BTUKAYPYN8'49D9>L--5OQ:-[E2"<# M MP;9G;Z.R*\-J%^Q-+?OBU9)\EV:CG_08E>LY^!;V(_FAQ9XTQ-VF<+=W.(EH&??<4#_'Y)D;TYSTCOZ703'<91T1 M\0A[+*_M?@E+0/3EZ&O$)WD- M$TY.MD9&@Y#1\#H;3:_Y83*Z9@C^Q?!L(XS8WL4T"16"7]87(TNF,!Z1*`@1 M):U$.FN22&B3,Z"+V58*F=::Z2"IV+]68W9;PM=QOR6YRS]&$3GJG.:O$W:.75]1`S"C7=V;N$83+V8+8$&R^L<_1*\>A5T#[=@6UNVM/U%&SRV@TQK5^=>%>D MRUDN0MTD1/_%@]I60%ON^MN],Z086YAK?ME.^Y<'"'W,K;R`X!D!CV[>4=6G M[1'.UJ!FMET7PS#0'HDW8`?(AT3`LIYF`+WAC4/_RFWG,)V]/SU]>ZBX&2!^ MT#_[0_;F[6ON7ACSW6,>GM;2 MB0HBR&.!O,(0SJ8__GPH?9/N[H\WGSHR_T/NH\:?YA^'NOJR^R\&]];FWGS9 MW4-9?]NO.XA0'K7ZNQ7+O\CFE?_'W=7UQ'4#T;_BASYL)98F$17I2Z6E+!55 M"MM="`]1'Y""*!4J%9NM%*D_ON>,9VRO[;G<5922]FWA^OJ.QQ]S9GP\_FP[ MY^I"?R$[YYV31)_(EK:CR6EL6WPASJN?P\*"GG-????N$ M:I0%TZHF[8+IX>=GU4HF3U;0-D?'O@R&?>?L(M>H^L0G3^3^/[,5Q.%OMMZA M!93JL)/I;%_X?YED41S>M,1XG9678^Q9N18PK_^A M,YP#FEPA]H+S+?!;PIPG[)M=DZ;`P,',U>71:O[+)8!@F+]E&+7&+\!]\#0R M_QFGMHN5(2J"3.%8\H=8W5$$ M8Z%X;]TP#*RO!@1&%63H(DULNZVR0LR)I#_2_68Q?R@FBYL7SP"#M\!ZTO)'[",Q#O)$0.HM7^.S)=_Z)X'O((9`E_( M\XLK62__!!H'.;-^0?P&%I,?/-.!K9O>(#E%E/H.`6\T$>*^02[LZ1N$EL'B M$2^SKG>)Y@BQCG4?H]N525F7B_=R2Z'NO=P+D#!6)+'5+\[7\?ZQ]Z&X5Q>2 MG8RY5_<2$6.4M3I:K>@59J<(:U3]V>Q*7-T@M`GN^>2".0;631=K!4A@,9PJ MUZW@K$R\Z9;Z$6$^LB:HRI*S4Q"KW'<1YR"Y(_HM7CLR'^0$P=#RE;IKTA8K M*@Q'R..*W:-&Q8XO6GBOKK@R5*'-N&D4I6$X$.X86S\D6NJL8UQ]RNP]TY#^ M)=GMFN[KSAKT:4I;75*@:DUPM_N(::NY,=T,X0OQ!M_]+$DU?ZW?'3]NFE(S5OC9<7&Y04:&'2R;3K.T?+JV1%57D$V4WMZD? MATN>E:.,F5,`:6`IKS&\)4P;_VZ5ST"?#GONJ\55K"XF:L4RLVEYC0H-L.Z? M^P?Y,'5DUEK0JJY_E.G($Z$%HLHZ!>;DT-4M^()E0L7W"B M[:S;+A+QU$IC76C@'%Z(;*1AYH/>([?Y30$V!JEIE+$/B#,US6WGEK2QEC`I M3%MCCL9@J*R,'6"3IR);03`YO+!W]XD`G:WOUSUX=OUA@U',^0L'!_N7\9`I M0+KV`[P>Z]EU.,-EC.B;OVZ0^J:_U%PAB6H@<++@2[)R$A+NGN"TOES2TDCB9+N!&# M=+*/Z;B?-O=`,Z_["$H>XMAR%UX)]GH10=)!W6<@>0%!*9[H/O3>!+<,P"Q6 MVT%MD!;\T"ZDBV`0U^KU\)X\!&^P_U"P:7RHQWDSC"PZIF=BQ3JN->Y>.4]$YLNY&`$LP,?X>^-S&/ M>0&]6:*9DD&[NR9FT'KQ9['@U@+%JTQRA$'K*&4QN[G<2J><2O1K;"]'\:3V M+E.Q\M"&S#U,)OM7_4D5>KO=?G&;TDG)5)>Y;'7=.H`8![//0Z*9,>> MCJN@&)=IP7BB!BXNLJ8X3F4>5FR/#-IXJYVO";%?$"41>+4?'/, MTF@F#B70'G`%SA_OL'`A%<.`Q9%51+W-QDG#+A/6/,>]VT5<,UW>M#>8R+#: M#O5ZU:TT!QK1Q%YL_OW'>K#L\)UP]<@8W3%R\]6U&$*0)#>[=(MBP;!B)A-< M@$$46U=>+':C5L^9I019;J<$65GR#ZBWJ)/JF0)$:QO`7,09)5SYTHKQ^V8M M).MP\<"09HI>.;C(5O%3R_;1#8,5\]+S>C#>EA_9M1.7-%#[;:T+>"\`W)>W\OMW0NCR]=*!)O%8ZKO,FS&@_8Q+;8V M<)&1"*CC(3&&L-3>YHO][A]1K:(D69=.F MTBYZL65S^,TW#PX?EJZ_?PE\[8L;)UX4SO3A^4#7W'`1+;WP::;_]<$^F^A: MDCKATO&CT)WIKVZB?W_SZU]=)^FK[WYZ=MU4`Q%A,M.?TW1]91C)XMD-G.0\ M6KLA?+**XL!)X6W\9"3KV'66"6D4^(8Y&%P8@>.%>B;A*EB("`F<^/-F?;:( M@K63>H^>[Z6O5):N!8NK]T]A%#N//D!]&5K.HI!-W]3$!]XBCI)HE9Z#."-: MK;R%6T!':2)MH@V83K3S?*2EGWR?CG3+W0M4WD>+0'$[_Z] MB=+O?I/]^>8/WWPS^->WW_WC1W?YSY]^7__LIV]UH^@&R00;[)9Y/M@I%C[. M)!NY!C?7JRA$BEP"382MJ\]A]#6TR6?@#*`>^=K-=?*+]L7QX/YK=MDD%ZACY-\+/#`3N6AD/9RVGT>" MIM!I0F`P.HW(%:Q3`"HYY.)NG9R?&W1B^AJW]W4(?TQ?5(O=>DGKJ^X7-0X/ MZ:NT%>HG?GJGX5-%``DXN2QZ$+H[XOO2)O].X2E1L?O,!-M(_N5^W'*'!"0BP>U.BW]QR3.XMN\6EIR"G54DEA MD,L7S\2$?/%EN"'1Y7`Z&-A;X=;9KJ5\E/:;H^L=U%7^M@]2'V[V002X6>`\ MVL2>&Q,'WQ9+*Y)<+/V3@.M[OE^6\R.+%+QPY>8:9A:I&X02A][?3N7RD\^E4ME#3AG^2A;X;DW^2A=KPO[DT3O.XL62!+.5IJ43":3J34:6A8E^3'W:"]E7L541`D56 M10@4655:\9EGX*ERJR($BJR*$)S:JOFTZFY\-[^GA7"],N/7QW0F!W/'QRA> MPKY9N1DT@GE;=NWFVG=7*>LY3%#H^O#2* M%L7?'2UA'PZVW&9Z^NPM/D-GS(I&AC?KXE@]E)G((A6^=6D-+JVQ>9%-HB1U M';A+;Q/4M2O[;O05H)%PVZXXXC`L.\G=H5IJ-(@5S(89"ND,A62[;98E04`JJL%^&VIP0% MZ+J-;L):($MTZ$18?$6P<)/]$`%X:-AO*Q840%R@2J/NE:*>5 MA%MV,X:PV!J@XQN.5;S-!,?76YBKHX>0,!)D->$V%?K2Q/"B+9D)BY<$2;@_ MT=`$':GFPH(KGH2;(!\MVK2Y]2[X^9P)IF`+U_<_D4G1WU?E/`RV&VZN7U;H M]!P<:23'R\CA//(2]O3RE]F<*WL#//`:F=Q&FK->^Z\?-\&C&]OTG"/M@EXE M>X?5NULZ6:S>O_.]IS!PZ8:)GHGY(8Y2=Y'2`YI'^+ MTS_P),S'(?W#@GRC$8$7I?V#NG<%YZKP54[675NI(ZY,V: MP/!%\VSZE$T=P1AT,H7FTN1'R4ZQ>*H]1['W"\PRR8^3%[":ZL8Z^3%[ZBWP ME:^QLWYP7V`NFFW^OZSXB[V`I%C@V/9&%B$74]4_K'OK6I?.I?-S`);#B6C5 MG,[J6U?FMSR#7=UN]9!6$&1U1S4&PG6.0;H+2`H1$KFJ:8)14CD&;"J")U]T MALM,$<'F"AN8(\FG)9L=$*UD=O%_BP6[\,^;)/56KSC-=TZS9`[2&[)D8Y%- MEK!C<0?$UA2,8NKPW@X)HI/8H@L=)N0,J9[:Z!U=$`UAFM`O1-*CN0L=T@UT MB/N>Q%GZ!%"II7`HD=,];*FOD1^ZDE$_.YB_:\K!]2&XW=)6\N*(91=.ZQ@[*>5E5Q5=#&;_.2`IMKU3G-FU"JU96P M%MS4`A^PR5G$,JH-$LI-A#16Y'<`EE=S'(( M5P6_OPZ2ETZ2!E*@_9'6Q&0G8MCB'7LY]#ZE'K<6A?W7_D0<3M`(\9;+UB"+ M9&AUO!&("W>69-"%A2R2>_;R\&(KN=4YQ(##WMG;!`XA^S:!PVF*MPD"U?-*SX.2.FWW/*ES@?<\J7.`]S"K@O:O\=`-_@ER+30F#O/!((X2PEO9Z MA["6)GJ'L+>EG'@\2>!4]L(-V!W-S(_A!<=%#$=]V'%9)L>2RLS3Y=4]5D%( M_FHZ*U7?D!.NV+O1)AX^1ZM<1&D3FU7`00S6)97C)C8N1E'>Q),<5&-A2X@D M46(10)X_DN&?Q2?/'U'W_"JCUO^>_'1=GL'@D/&VUO]:T,E;Z6L-;HR7&]LM M<(5-VWB`0@Y$T(/UMSWMO1]$O"C'MWH-HTBJ4>0+2`N`?:JBH]47,-%<=]V+ MY[V<>(^,R5^8DQ5EDE+6<);]0YQ# MV.%&;*V@9>DYF>.+QZL\@(<0RL4K*U!;LQUV-61>5<7$(60B^$QB(>E0RL#= M2B8>.A`:ELPZG)Z-T5@+GH/NIX3Z/"`KKG!>WV>$YO%:GV3+2U2M[HMSP4D! M[KTB1.@J1TINQ-5)[5G$,6J(,R^BQ/"@0]8.+UB$1F?+1^(3P*;F5R0)^JAP%M]G%_-X3NV1!<&8A:$*MC&7!\D%7 M6>74V80]82P+7*^KK'+?>P3:(EEPI^7.LLI`'<$K+`L6)+KB*@]`C%CNQX+< M6TUVI+?I0G8$E45P85F5'8$YI"-1N:NLRHY@."P+5.XJJ[(C($2R+.BDJZS* MCF`%+`OGTFI;`>O M$$>DZA'A*)-268WU\I&@EV=2*GNQ_FT)^GLA-8[N(@=89&M;_R.T]NXB!UID8-JF2^DE$S/MPO2DM MQ.92,G2+B/C@A9_=)>LY;)8P`:2(I(_N)HWA`?:Y1FQ(F8+$?"0/CBAEL"DB M>]Y]\92+O/[\",^)*+HD\S84.Z3Z%P'^ETV*:"2MD!!R-D%$R(.7PC/64\=>(8< M?;Q(.1\`HI;NRMGXZ4/YX4RO7O^9/KT0G"G_U@_>ERBE(F9Z]?H#>2PD1#'< MQ0#2S8<$'C4(?[5-[,WT_]S?7D[O[FWS;#*XG9Q9(W=\-AW?WIV-K?GMW9T] M'9B#^7^!LL`/DZN7H373G]-T?648R>+9#9SD//`6<91$J_1\`4^;C%8K;^$: MR3J&I)(\NVX:^(8Y&$R-J1$X]$%O(.0J\>%;<:YL#OY3=6VFHS<9?/HL.(`- M=V(HE#`2\BR63Z23F_\!``#__P,`4$L#!!0`!@`(````(0#[8J5ME`8``*<; M```3````>&PO=&AE;64O=&AE;64Q+GAM;.Q93V_;-A2_#]AW('1O;2>V&P=U MBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC@`'#NF&7`;OM,&PKT`*[=)\F6X>M M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C=?7:@XBA0R(DY7';JUVN>HC$/A_3 M.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[[UW%FRHD$4&P/I:;N.V%2B6;E8KT M81C+RSPA,S*A/D%#3=+; MRHCW&+S&2NH!GXF!)DV<%08[GM8T0LYEEPETB%G;`SYC?C0D#Y2'&)8*)MI> MU?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%TS?`4P2AG6NO76U=VJ^>?__J^5/T MZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/BPI???O;GUQ^C/YY^\_+Q%^5X6<3_ M^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[]_;O')?!M@4=%^)!&1*);Y`@=\`AT M,X9Q)2"M.69EN`YQC7=70/$H`UZ?W7=D'81B MIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N#UO5D"53,+ M2L?VW9`X8NXS'"LY1ZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0 M%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ2$@(S$J$'Q+FF/$ZGBD".S1P1%H$B)Z9B1)?7B?-AOZ'&(KA\1J MCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6KZ1$0;?785;30IV96\V(9HJBPRU7 M69O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[-&LX[F)&QMKOU4>86XX6+=)$,\9BD M/M)Z+_NH9IR4Q>Q,O91&\ M\!)0.YF.+"XF)XO14=MK-=8:'O)QTO8F<%2&QR@!KTO=3&(6P'V3KX0-^U.3 MV63YPINM3#$W"6IP^V'MOJ2P4P<2(=4.EJ$-#3.5A@"+-2[\JIB4OR!5BF'\/U-%[R=P!;$^UA[PX7988*0SI>UQH4(.52@) MJ=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_S3E+PZ0UG"35`0V0H+`?J5`0L@]E MR43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A0UT#FWIO]U`(H6ZJ25H&#.YD_+GO M:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N'38-36;_7,2\/5CLJG:]69[MO45% M],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+&J\U,N'`B\L:PV#>$"5PD83T']C_ MJ/"9_>"A-]0A/X#:BN#[A28&80-1?F#R`Y+<&ULG)I;DZ(X&(;OMVK_@\7]J`'1;JOMK5'$\]G=O:856VI4+*"G M9_[]?B&B)-B\LGUA:_+PYO"]"23DY:]?QT/IIQN$GG]J::Q-OO=-[ M2_M[;7][TDIAY)RVSL$_N2WMMQMJ?[W^^N&Y5(X12VM'T4G9N5 M2KC9NTN7H>"=-*#2#1S3\ MW<[;N):_^3BZITB(!.[!B:C^X=X[AXG:8^EX*]_YG+_"V8^_D4F]3G'@$ MWGS_!T<'6YY$%UONG(]#M/0_^Z[WOH\HW":UB#>LN?UMN>&& M>I1DRKK)E3;^@2I`GZ6CQZU!/>+\BO]_>MMHW]*,>MEL5`U&>.G-#2/;XY): M:?,11O[Q7P&QBY00T2\B]/\BPLQR33<;3T54C(M*_::B%U=I7%3H?U*7>G$5 M&AYQMSS?5%AQ%4;A%+U+_9?4A@+Q9#*S7J!_6=+!_$NBHY=9K5I()>E@5DNK M%`TV=Y=H%'VY5:9XHRC.0D<*>.'J)`%GJ8C_GU@E(6?TY=:LHGU,AA&-2CE' M+SZ@$N/H?$*X#+G'!T-%#/)XSK"J8 M#1FQ$H3/7+SL;I)PTV7R)79"))?T1`)]7JMB/LG7]!,DN6:@)@S5A)&:,%83 M)FK"5$V8J0ES-6&A)BS5A)6:L$XE5"CNU^#3W"$%__XM(HDQIWF,DQYIBP02 MO_9BS5"ZOI-E=+FCK2QA/LM(-XLH(G:64$5Z6401Z6>)FJX8='"/,>7J#B], MU1`#@36>E:$PRA!/=5EC?*\U"R>1TCY-,SF=M@MP+BB:2U)*:?[@(H-57H/J/33C*F;V18-TD0MTY@AK,8($N-T$2Q;A4DZ MGU=1[O-I.OO.Y3.0/Y?R3<9T(U/&(LW$W23782GE9YNP$OGT^57,UWF$9&M: M412P-:=56RMWS;9@GF-;L^XW95+OY&=;(CNG:=U\`1L*]/(%^OG9`Z@_A,0( M$F-(3"`QA<0,$G-!?!7,!1180F(%B?67E9"<3&O:`D[FM.+DNO(0U!;,TW6" MED=I1V3G6-6"1!<2-B1ZD.A#8@")(21&D!A#8@*)*21FD)A#8@&))216D%CG M$9*W:>%?P-N<5KS=4-:-;<'DF+<#"0L274&(1QS6J"GW`CN=K5?5S8I>.IM5 M];JR9NK#\@>0&$)B!(DQ)":0F$)B!HDY)!:06$)B!8EU'B'9FK\226^.Y3]3 MK:E`ZE M0<=#Q,(J78S8&.EAI(^1`4:&&!E=$+$5:]Y9EHVQR`0C4XS,,#+'R`(C2XRL M,,)/0GYM.F%Y<=)1G%HZNL&[VW$/A["T\3_X*49^R.*:>CUA^5WGQU24]`YK MTNFA;'J7->F($*57KA?0@?X M#-6;']%1R/CKGHZ^NG0NJ5HF>.?[4?*#%W`]3/OZ'P```/__`P!02P,$%``& M``@````A`$5X^ILE`@``I`0``!D```!X;"]W;W)K&ULE)3;CMHP$(;O*_4=+-]OG!!@`259+4*T*[72JNKAVCA.8A';D6T(O'W' M,4145!7E(HG)/]_\,?W[=/"XRLHZJD MK58\QV=N\4OQ\4/6:[.W#><.`4'9'#?.=2M"+&NXI#;2'5?PIM)&4@='4Q/; M&4[+(4BV9!+'A] MS4NR)$`JLE)`!;[MR/`JQZ_):IUB4F1#?WX*WMN;9V0;W7\RHOPB%(=FPYC\ M`'9:[[WTK?1_03"YB]X.`W@WJ.05/;3NF^X_D\2@AD'VT`&G_WX(/`JL8C1;2.!GY M@\UUT$QO-+-1\8<#P-PZ^'?Q7IQC8(^9I_/%R`V9@V8QM":)X3>^#WG#HH5! M=+3F7ZFIA;*HY150X^@9ML*$-0L'I[NAX3OM8#V&QP:^!ARF$4<@KK1VUX-? MY/'[4OP&``#__P,`4$L#!!0`!@`(````(0#(D,<,80(``.0%```9````>&PO M=V]R:W-H965TQ]C.'L4>31*E M':DC55679X*QC6*,!629?]^+R>9)%:4OP3B'S^>>"\R>#[)".ZZ-4'6"HR#$ MB-=,9:(N$OSKY^IIC)&QM,YHI6J>X'=N\'/Z^=-LK_3&E)Q;!(3:)+BTMID2 M8EC))36!:G@-_^1*2VIAJ@MB&LUIUBZ2%8G#<$@D%37VA*E^A*'R7#"^5&PK M>6T]1/.*6O!O2M&8$TVR1W"2ZLVV>6)*-H!8BTK8]Q:*D633UZ)6FJXKJ/L0 M]2D[L=O)#5X*II51N0T`1[S1VYHG9$*`E,XR`16XV)'F>8)?HNFBCTDZ:_/Y M+?C>7#TC4ZK]%RVR;Z+F$#:TR35@K=3&25\S]PH6DYO5J[8!WS7*>$ZWE?VA M]E^Y*$H+W1Y`0:ZN:?:^Y(9!H(`)XH$C,56!`?A%4KB=`8'00SON16;+!/>& MP6`4]B*0HS4W=B4<$B.V-5;)/UX4'5$>$A\A,!XA41STX\%H_#^4WI$"XX7R MH!7BRVI36E)+TYE6>P0[#XR;AKI]'$T![.+I0W*)V*:@-M'27 M]H?#&=E!']A1,[_5Q%W%XE;1"\\2`O[.)B&W:Y/WS3DQ%('1V5P\&I^Y;0%S MK^E?:09=Q>*>HN,-/O2X-R=.,+#/WOK#4??+`Z9 MA,$(3I7VQ]1/K&K:K;96%HY7^UC";&]\D;FHHH(G03$XU4JLKPZ M1.3[W\]?'H@G%:LR5HB*1^2=2_)U^_-/F[-H7N21<^6!0R4C2 M5TJ;-+Q@"OCE,:_EQ:U,Q]B5K'DYU5]24=9@LZ3NB" M^-M-FZ`?.3]+X[PGS&&(4OP]C_KZ$?&ZG[8_&R_B>G0KUISC_RO/#44&D.:0! ML['.WI^X3&$:(-8DG*-K*@JP@$^OS'$]01K9FZ;+,W6,R'0QF2^#*06YM^-2 M/>=H2;ST))4H_]$BVEEID[`S@>^S?AXN)TL:K*;+\2;3S@2^.Q,*?A\3^'HT M;:*>F&+;32/.'BQ3X)4UPT5/UV!X.QN0!M0^HC@B2YBOB$B8DM=ML/%?(>EI MIXBU`CY[!;45R46!\P8,/0@,83P(BA$$IPG)8GW#C!LZ<8>*::^P0"`+XT%0 M#"O!&.^L=]5D6C$S%'-;D7RDL,C`9#P9BB,"H^YG8F''C;7")%O:BF2HN+); M9+!XQY.AV"9[L./&6F&2K6Q%,E3<(5M\A@S%-AEU%[B6F&C47>%#R1TV**3Q M64.QP^8L\5A+YFUASNC#@_,\T<]-]CM@>%".WA10[(!=*TO7@):8@:E3)LE0 M960IUZC#O-QWS:Q]3CR?WMI-OM`M M6SPA(<=F[-"MVQN:>WRX98_GTQN\Q>>49DR'AT#H5%%R0W./#\9I\HU0=\@T(>G@[AH)"'&I=/M[RZDRMY<^`)+PKII>*$+2R% MW/=W^YZ\:Y;[!]#=UNS`?V?-(:^D5_`]O!I,L!-M='^L+Y2HVSYQ)Q3TM>W/ M(_SYX=!W!1,0[X50EPOLZOJ_4]O_````__\#`%!+`P04``8`"````"$`)/]3 M1:X"```N"```&0```'AL+W=OT51=0-^@%4,_; MM\\Y/93YPWM5HC]G40M)U"7F_!V.:'KWMX,R^XJD42N3:`SOB0,]SOB?W M!)P6\XQ#!J;L2+(\P8_!;#7%9#&W]?G-V5ZUGI$JQ/Z+Y-DW7C,H-FR3V8"U M$%LC?F$JAH&#C MA9%Q2D4)`'!%%3>=`06A[_:^YYDN$CP*O6CBCP*0HS53^ID;2XS2G=*B^N-$ MP<'*F80'$[@?3(+0&X?19'J+R^C@`O=_+@-1B$O+5NF):KJ82[%'T'D`KAIJ M^CB8@?'ELD`]C/;1B.T4R%C!5KXM1M%X3MZ@_NE!LSS7A%W%ZEPQ\D\2`EPG M.*C7<#@C3C!<6W#1R=+NNDNGB2U7 M',>3;GC5#H^#5KA#-;Z%RHC[5+UEET[CJ$;PZU&UP]&T%>Y0P5LRO%9&W*>: M=I==.@TL?MKGWBZO_J?HL,6WL!EQGZVW\M)I7,4N]=?U>(=K<@N7$?>Y^OWE M-%?[JQV^WE_FBSCXJ##B/E6_OYS&O8T7^JL=OM!?[LAWAUE#-^R5R@VO%2I9 M#IWA>Q-H`^D.?#?0HK&'UUIH.*CM8P'?908GF^^!.!="'P?FDW+ZTB_^`@`` M__\#`%!+`P04``8`"````"$`")*)5/L%``#R%0``&0```'AL+W=OKM;^M??UD^M]U#OZ^JP0(/QWYE M[X?AM'"F.@[DI*L.Q0#\^WU]ZJ6WIOR(NZ;H'AY/-V7;G,#%?7VH MAU?NU+::VLESQ!_];50 M47`S\T+T5+8'(`!_K:;&UH",%"_\\[G>#/N5[;NSP`OG,0.\=5_UPUV-/FVK M?.R'MOF/4$SX(B^>\!(`?>$EFH5SU_^`$X<8\0#S8BC6RZY]MJ!KX)7]J<`> M9`MP+",C&F.L;X4*,:*36_2RLN>V!4'T4)^GM1\D2^<)A#LE&R$A;M6B\H07.,SN;H_=]73ZD+77IA<;WH>S4#.@#VBE2 M&/FAJW-*!>@]VB-DI*U:--K@QJ3M1;@7W]BBDBJNXU3E*U*R1+3SL`DSLL10 MZ3'!7NSKX>0$"J!A%5`P@C2RD!B3+`L_F6/TH1,G2^2/[9R1Q5-W)4N,CLX% M*%&(JR"-.'A2B5]H`LBX3"V"=89D`8A,=D86?TIV+C`Q8K1WHY0J<^K]=R-8 M?S=9L"&4^IC[A$!^P`=8`E.516,%:2`)1,01-W,_?C-7D%"5+\W53Q89?>AA MD"71V\P@F0F0QTFZ,]\(,Q??XX9]6FO?:QEG()-J".^GG*-ULL*D%ER8U(I+ MU'G)&8Y_I>:80R^<00VO4"'9@`$D&RWEKG"U5O^Y7MU,H$0#^"R!^NJ07$)$ M!WAA[$>3&SU_J`T*_2ND24DTTF0R2!OS/V.$$J19.#=';2X0'C3OU/Q*:^NL M41H4UE]J7";T1:T`F8Q@C#-")A:*8&Y\/V3^60G(D_^1$J!@*,%<*8&0%Y4U MF?SID)`Q84K&[LJ%"::_.;50EE4"7\LF.C&V%ID"J/U4TL30V(R_?64GP'A" M*847ARSRE<#'193>'J@72D9Y0'`*A;5X/OC1GH"H>/C080&/"13<]':HNK[M M4HERU(VJ(P_%J_DT!IQ,D4<)'@O#)&IBO'&XD"L,)^JH#&WON4XG&T MOBV%*0ZF_`J3JGC"!//8'!?>!<7[]-&0.S%XD2(F:J=ZB7&&S<1"..QC*S"7 MQ7YB;,1<8JA763(/D[>ZU4-A4GKA_?W%T0;K4?_&;A4H+9L"=2&;AI1=(7"N M6=XES4J,#9()E#PUA%'@3R<"VD,20ILL2E@8O;'%/507)6E?VD#C$7HGY#?=X-!95&"N5(`TB%UVR-=$`=5?J5)D5]ANB"_,-4T M`E_+YJA0L@U3[G=E&_)KGL,%ZHK\2A1*J+P\\121I@E%5U-T<]-4W:[*JL.A MM\KV$:^=X`R]7HYFNA-+PT7*Q7'O!W6H%/_9=/,ELVW:0 M#T#6&6]KU_\#``#__P,`4$L#!!0`!@`(````(0"@<"&8&`0``&\.```9```` M>&PO=V]R:W-H965TZ_[XRQ'1MHFGO;EV4Y'H_/G!D/D_7G]ZKT MWFC+"U9O_'`R]3U:9RPOZM/&_^/WYT]/OL<%J7-2LIIN_`_*_<_;'W]87UG[ MRL^4"@\\U'SCGX5HDB#@V9E6A$]80VM8.;*V(@)>VU/`FY:27&ZJRB":3A=! M18K:[SPD[2,^V/%89#1EV:6BM>BB+,2'=.I[599\.=6L)2\EQ/T>SDBF?-_XN3-)P[@?;M13HSX)>N?6_Q\_L^E-;Y+\4-06U(4^8 M@1?&7M'T2XX0;`X&NY]E!GYMO9P>R:44O['KS[0XG06D>PX186!)_I%2GH&B MX&8221H9*X$`_/6J`DL#%"'O\GDM^/%B,E].XQ#,O1?*Q7.!+GTONW#! MJK\ZHQ!)&2>1<@)/Y00IW-D0JPWPU*?>M9\I>WAJ^X=9!EW$4L"4"+)=M^SJ M055"3+PA6.-A`HZUMGX2]\#E3CD_VT;Q>$Z>(.<9>H&+D,]IT-5I:1>NZ:'(R)86DC#DW(>)_FK6@?SCYZ@?I9 M6)R&Z5=&]X@;$T/<1ASBX*9//)I/`+VO,&Z33/4)>X7(_B*+[J"06);QTM4V M58O`R\@?Q;$Q?LE7NV M;'V+^60).?Y&G="32TPA<+:E4_^B&B.CDXTX7$-H'H\+):U=0AJRI!I"J0.Y M!+`76YGZSHH*NY8.O4+'O->0J]6B5U,W*[TQ=2"7++9EB^S]L@J[)NYP4I"M MU@!*]49IY1+`CFL1^%ZU5..VU5*0JU:O31U"8W53RX9I=10VYBCWUZTMMO,6`$ZOT9:6WFT"[`:JB M[8D>:%ER+V,7G"ZA@K9K`W>C[SZ M79G!RFQT90XK8.Q?#=^"FP8\P2T1NV!U!BGW2S9C1Z\!ZZC5!<)?-)& MPEXF\`D9P9\2:.\C^"I)5X@')F(8]QMRHE])>RIJ[I7T"`F;RF;?=C\8NA?! M&D@D#/U,P*`O_SW##SL*X^@4YXLC8T*_X`'FI^+V;P```/__`P!02P,$%``& M``@````A`&QQ_7$6!0``&!0``!D```!X;"]W;W)K&ULK%A=;ZLX$'U?:?\#XOV&0#Z:1$FN&E!WK[176JUV[SY3XB2H@".@3?OO M=\;89@:XZ-^\_? M=U\6KE/5<;&/,UF(C?LB*O?K]M=?UA=9/E0G(6H',A35QCW5]7GE>55R$GE< MC>19%#!RD&4>U_"U/'K5N13Q7DW*,R\8C^=>'J>%VV18E6_)(0^'-!&13!YS M4=1-DE)D<0W\JU-ZKDRV/'E+NCPN'Q[/7Q*9GR'%?9JE]8M*ZCIYLOIV+&09 MWV>P[V=_&B:A'D,YKB/;WO/26'F3:KOHD+[^5Z?Z/M!"@-M0)*W`OY0.&?MLC!).]WNP[ M58$_2V)G]7E)]_5IXTZFHV`Q\V=SB'?N157?I9C3=9+'JI;YOTV4KW,U60*= M!3YU%N1P9<)$3X!/L^S(GX[5FE>F3?4T^#33YJ/9S7CB(]G^1*_9K1(OBNMX MNR[EQ8&.A.U4YQC[VU]!,J-:D\'J^#,903],&,6:*@YX=3O!QUT MC;@-L<0IPHA#FC[QT0W`PP9@.A?G*:IFB9U&E-NH-@PU,E&-/>?B1GH0B%G] M@Z#M;$82!*$DKS/#8,Y,(VW'ACTDH@A;&QY.NC8^Z(LE6J%VBS<_ZYB(\](( MG*1$@H#K%-H@(W1$$485CV3B2==EPF!.1R,+^V"'/22B"%M[R==&F2:+C\B$ MB3@OC<#21*9)1R8;9&6B"*/JPQGY=IU4-"=D(*)4'XH8Q`F@/Y-"?;RG_,;I MP3',MG<&XG)-.W*U469BQ"#.%]V:\+W>6'[C[8Q3`RV(-^@H`D4,X@30=PD! M%&P^42[UW@-7.S@53$-LX^\AGJSX(+=;B!C$^:+]$KZO"*;-FG+24+M:B,=H MEP"%.`$T54(`!?/GLP^UF/9GRLY:-K6PF^XS::/:%J,0)PSJ4\*O*(;1'1/3 M$%6L!T50OE9$3@#]M:/8QQS?UTY-!;/F305;=`6S4:U@%&)\@W>YOHKF@AF( M"-:'(@9Q`@.N'\Q&\)B\T\."OND;"*I%SLC.32)LHZQ>#.)TWV7Z0=_T#43U MTE$M%+$H3@#MM=-@'S-]N#YWN]]`3+!)YXX0ME&M8'W3;Z[6S>TP%^51A"++ M*B>1CWAM#J;P\]?"S9U^%P1PJ0_PT.Z-3,QUOSOBSU=1'?%A#OS>&=B/#W/@E\70"&@`1_[0 M"&@`Y^W0R!1&IH,C,QA1[RWP*C!A*!.69@@'4D.<;J>0?VA@!UP' MJ4(=E=5UB.Z@BH-%A!H.EA`JJ`KHV43P7N8<'\7WN#RF1>5DX@`-.%:'6-F\ MV6F^U/(,W@8O9V0-+V34OR=X`R?@W<$8#>D@96V^0!4\^TYO^Q\```#__P,` M4$L#!!0`!@`(````(0`'=DE/>`4``(<3```9````>&PO=V]R:W-H965T`#;1-I;Z$Y&,\_OS->,;Q^OM+>3:>6=T4O-J8SL(V#5;E?%]4 MQXWYS]_WWV+3:-JLVF=G7K&-^+=>V0ZO,BLHD#ZOZ%A_\<"AR MEO+\J6152TYJ=LY:X-^2OS6]R56?WX=/F6\_("+AZ*<]&^"J>F4>:K M'\>*U]G#&=;]XOA9WOD6/R;NRR*O><,/[0+<641TNN:EM;3`TW:]+V`%*+M1 ML\/&O'-6J>N9UG8M!/JW8-=&^6XT)W[]K2[V?Q05`[4A3AB!!\X?T?3''B$8 M;$U&WXL(_%D;>W;(GL[M7_SZ.RN.IQ;"'<"*<&&K_6O*FAP4!3<+-T!/.3\# M`?@TR@)3`Q3)7L3S6NS;T\9T(34>6-/>%^C*-/*GIN7E?_32D2YHL"L'PU,. M]L)%$-F>`W/=ZL233N`IG2P7OAM$\6><^-()/*43)URX<>`$X<=4+-)$2)QF M;;9=U_QJ0-["ZIM+AKO`68'G3EM2I%?[+;%!971RAUXV9F0:H&<#&?*\=>UX M;3U#5'-ILYO:.+I%TEE@"-%MJ@`6\.U)0S"^@#1Z0=+==+L.4%8Q8MA9=$-2 M!=`80J2_@"%ZV9CPV]->N(JHA$'-U/BBPC@^3+192Z.$U2[*782$35)I&$B$4\D]DC< M5+X$8KW^KKWL(Z"1!$'>(-F>BOQQQ\$%Y/P,8YR;MAKZT`E+9$CD9(*D*J)1 M@CVK4IJ9&HI+-S<:ZW,3$D$][5?OQ,/J23\R"F.AG^_$L=O+0_M<&D32(%1J MAT86.[I2K-XGB\8Z64*`;!?KA)!PJ=)?CMF1$?:,88U+NU^"QA`\J0RIG(HT MO#W"Z$,G3DBT'(A+9$C2E!`7'@K+82D:2P=Z\(2F&RT@E]_75`S4N4D(6U`_ ML>L,\E`*2"O/%R%V0ML>6:2=13ACH9/'KG!S%CC40Z`6=4'?22BB1H^-)I&0 M-T"IA"#L,%`G@$5?(8!!#N:WK;)W'&H5&A&"1M)-NJ+L,:X0)I@*)[W0]E+? MZZRQYBNL/PBT[!"J;`1ILA&DR4;0G&Q8NQ4"8F_EGF%_`?JR::@,B8(&'=YF&#/AHVNJ2>M M9I(.*[A"X';U9.E7N1`T4L_K*YI4CZRD>M#3[%"W2+'!XP)(/=<.E@1IZA$TEWM8PQ4"M&5O.!XX5/PU+@0!%[7@^;HV MB1PHU?.BZ;8E-U(\S4#7#@N[0OT#[:@-:'P)TK0C2-..H!GMW)EF$3@W:"<& MZLU"0B/M1D>J1%I)[2(O'/V52*4!D%5#,*2G)J#[J7XAK$>DJ86H`DHK54`) MS0F(!5J)H$@^%YOM[6<"EXJ\&E<)15#"E,8[^GN0=%9XB'O>QI$_.IRETD`[ M.+C.6UIB=1\MQ0D^>;Z!NX+Q`4="$10492VCL">=%:W%L8/0&\HU%?3.A(Z2 M<1P'PSF#LH*N&>@_<,GJ(TO8^=P8.7_"*P1LHCU*UQN[:+43)Z\1#M<>=RY6 M\Q&^@^L0<8X8XRYZM4U+61_9T/_N=>[/Q5ZL\Y"E=PSL?32N\)KD$N MV9']S.IC437&F1U@C;:(5TT7*?2CY1?(>;C/X"U&PO=V]R:W-H965TZ56JJK;]ID0)T$;<`3LU[_OC,>`[:1[DVI?-LOA,#[SX1G#XNM;=7)> M>-.6HEZZ;.*[#J\+L2OKP]+]Z_OCE]1UVBZO=_E)U'SIOO/6_;KZ^:?%JVB> MVB/GG0,6ZG;I'KON//>\MCCR*F\GXLQKN+,7395W<-DV2A7ESBPVQWY<%ST3Q7/&Z(R,-/^4=Z&^/Y;GMK57%+>:JO'EZ/G\I M1'4&$]OR5';OTJCK5,7\VZ$63;X]@=]O+,J+WK:\N#!?E44C6K'O)F#.(Z&7 M/L^\F0>65HM="1Y@V)V&[Y?N`YMG0>!ZJX4,T-\E?VVU_YWV*%Y_:Q=//\H,_-$X.[[/GT_=G^+U5UX>CAVD>PH>H6/S MW7O&VP(B"F8FP10M%>($`N"O4Y58&A"1_&WI!K!PN>N.2S>,)]/$#QG0G2UO MN\<23;I.\=QVHOJ'2$R9(B.A,@*_RLAL$@73))5&/G@P4@_"[]VK>^2)#$R6 M=_EJT8A7!ZH-M+;G'&N7S<%P'Q&2,<3HOT($L4$C#VAEZ2:N`]ZWD->7%9LE M"^\%@8&'LUF&N"!WD$TQ/\31*,5%-TOM^Z!T8O`4M@S^D8C\U*9N!,LC6$4,WE,`GZ$8K4%"QINFR M'A3I(^$#91"N(X9P,&,+#Z830*_O[;YP\3&IM%]AK1#92&05;A02RKJ.S-AF MZB;H&L+/9K.!9&B$>-@:V722@(GN6!9/:T&]XXIB7)MV&MHP!2LD'>IX$!)`=+3DV>H4"7XTDG\]PS-3(773.S.,-DSA MA$1:A@F)X\&5C)``?C25HRM&'!D,SML#*=FF(`6I&8FM>J.@D&8==6]I(2E4>(H51K*PPC1DUDS*>D8L&=,$ MJW,P8DK&3G^[9)H+AF2"+,EL6$U))I:2'/FV3QE3!%(<)#K#%(P]_G;!:B+H M,2;($CR6E!),+"4XF,53BY$QQ2#%+/'3L8>:BK&Y:XK_U^YA:D+HCA!D.1+: MD2>6LJ4[5!YXD=&?DQ?<"YHOGS0:'6K7IH-NR#3$&1 MW'6F`&SYF@`,9A#CL?:.88,3W-9%4`1EJ.V\,:.J*A2+=EX\9;/8F@J9LAVI M8,9Q$"1CZ9B^X("P?-$'YW=QAO[THU'/:,P8>U)-GFB(Z$:QXA'*#,@4AK/! M$D:GCGO/SS1D#&T*TN=.X-M'.S:P^MZ8&9`I%X>$)O<'14DCQ="D(&T2L0LH M,R!#0&`-'BS*,)5%>6?`I"5S*/60&;#8VN8C:PB8`9EZ[YI3P>6" M_LN!?2>9KZ^M`I\:'N27!IL/2UQ?`1:XIC:<9^$5_"$"^UN96=/"A0K;/(WR8XG"6\_&U:2]$UU]@FH=/7:M_`0``__\#`%!+`P04``8` M"````"$`,Z[2ZL`%``#`%0``&````'AL+W=O1=J75:G;W.1T,1$TP2M+=,W^_Y5L2 MVX%A1MT/I#E4E7W*I^R*-Y^_U6?C#35MA2];TY[-30-=2KRO+L>M^<_7]-/* M--JNN.R+,[Z@K?D=M>;GW>^_;=YQ\]*>$.H,B'!IM^:IZZZ!9;7E"=5%.\-7 M=(%?#KBIBPZ^-D>KO3:HV%.G^FPY\[EOU45U,5F$H'DD!CX/A*N+YN7U^JG$]15"/%?GJOM.@YI&709?CA?<%,]G MX/W-]HI2Q*9?M/!U53:XQ8=N!N$L-E&=\]I:6Q!IM]E7P("DW6C086L^V4%N M^Z:UV]`$_5NA]W;TO]&>\'O65/L_J@N";,,ZD15XQOB%F'[9$PB<+0CF['!G>')GVYLYJX6] M\&&P>YXN]X2G\'0>\_2X)SRYI^O/%LNY:_]@2)@090I/[NBX#SGZW!&>8J[W MT[+D#O#\N2E"YND4X2FFZ,UL;WXCFQ9;2RJ-N.B*W:;![P;4&TROO1:D>NT` M8@E-L)7L57)+)*`.$N2)1-F:0`)TT(*RWW;V8K&QWD"-);<))VQDBTA8$.F1 ML+$*)"J0JD"F`OD(L(!S3QR$^`'$211"7$PY%,"0"4=A*2R$2ZP"B0JD*I"I M0#X"))90-!_`DD39FO`Y+.]J*=,*F0W93WHC10%1;])3UY!$0U(-R30D'R,2 M?RC]#^!/HD"!0%7WW'1]A-^@1H2*(AJ89D&I*/$2D!,!T]`;,EP-/; MOJAHXD<(<6?7%&6E(K"&)AJ0:DFE(/D8D:K`GCJE-4("S2'`@ MQC('AGC2SKI:]UEDZ\",%G.Z#IZ]6BE;3LRCK/M,)-R%G=%DKTTYXO,@_GQ8 M*SI*Q@U89T!<*S'FM\DD"@,=O[2TR,95H,\0<2$4,0/$H@XY(!>1PS5(GG(*GG(*A56D)#;(V8/6>4_LI*S2MJ=43]W7XPV:X[8 M2P>M\I!#L"F)C3_BD#OL_+&`AOTC$=!@E0IHD':F0SF'X%T"1I3)D*YF1.;7 M),):(XDC@\A+P+`Z:K\:V;/8<_N7!B8>'1/=/W?:4G2H0!/R%=5RF8 M5!B0(P!Z9GV,3%CT^[(R1BX,6(C%:C2&G$S2(XV2^0-E\(Z*OHYR93#('9K= MR.;0L$O&`AJ=-0(:K%(.>8-8,@$-DLH%I&^Y-NEW1F1^31F\:1IS9)`'2S\H M8ZWVL73TK>G=40:/XD\RN^PA8[V7Z- M>A?2^2LG&X?\X>R-="C6H42'4AW*="B7(%G^I$-32#J+&4SZ9U]U>:LW5DW? M_8U5X\N[141>'TB"AC*(=2C1H52',ATB-T=#>$:=W02QU_T:-4<4H?.Y-4K\ M2FYY0,6[30^S*ZC0"^!5`O9A%?<#:'$G<'L!=U;TK%`];'"!.4WX+(.0YD#Q MB)8!-&NZ?;H,H-.X7WNB1Y$R<$CNW2;L0R>`]VH] M3N@&\,*IXT]>\,086_T(<']V+8[HSZ(Y5I?6.*,#9'Y.6^&&W<"Q+QVOL6?< MP0T:+;<3W)0B:+/G1*0'C#OQ!4:V^KO7W?\```#__P,`4$L#!!0`!@`(```` M(0#?WXA;I0P``)1!```8````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`7\+:]0%"%X!3K M@9(N$>]2.N(24<3134@TZ+U?6'\EQ>B]UVY'F M10BV5U&"15>"MHA=$A?:2$11M?NTL*3+9;+)F@XAHDP18B2BQE[IL5L[O+*. M?IF&;:=I$")T1,B\U=%5X(^&PE"X**-?RHIFADVS?XUCJ\@85P3]"LW5^M\5JR@_D[M MR)$E7X)D[2+(9!+2M;.>*@BXVDU1ZG>8D!5+)BVDE!5!QNZ=6+PSC"!67GFF M.M9A!;EW.)$?2T[2HEMOM!NE=0]?,*,@71WKFX)`?V61X4HN!$EE$=0I:Z7^ M^*K0"8W2,9FB=JLSM;.V*ZB_4SLR:;E M1W;!C-Q:DB,(A'PI\FE7"IKK+HO]SW!?;OH5W]D@FW?9VN8)FLT[MZUBR"A( M$TC8?);WV`^QY,(-D2$A-H98;,&AP7!I>MB\60WP:K&#(*T@021K_$W:7!XIK'QL\0)D]LC$&]*I_5;8P*TG0'>?T\ M]GJ&A+ABR"A($TAY?9^-<1X[.T-"7`RQN/Q1O147Q[6X?);F:EVZ]TJ6SM#4EV4Q>H*BF6X">98+-@SA_JY]60Q MN9=]WF4'ZHI,O>(L62R9I8MEC580^#_4198M9Y(@I:XB/-3/NRRO+@DIOHM! M7N^R=<$8\M6I8L@H2!-(>'TO=2UB;V=(J(LA5I?73>M='%?J*LX#C-YE M!\4B[Y?%BB###5V6+E;"Z#]TZEK$QL^0%E=XI/=9G;@4I.E:7Q:+X?)J7)"+ M"\$S).M%61XR*DL32'E]GXUQ$5L[0U)0AFX+2YBVV=(:RL\T?LLKRWJ*[$4K`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`.4\0[`D/AL%$-&09I`:@?HI;78[TN" MI-8(ZK06N+_A-EI=9P[[I;7EWN[OL@,OLQT`\E*J.,M#1D&Z6H'[7S[>E+'! M,Z0E%)[H?9:7T%F#7PTR>)>MB\*0KT`50T9!JBBKP.`O%\5E!P3(UG51_)&\ MW?6XH:=I%*0Y#?)PO.L7GA,(DL^=QI!]2=`V;+-:`NU+?^T;:KOZ\%17]&HPB M!2+NK!U%2D1<8:/("I%5:IS5%-S<4@_;+)?7!J>Z!+1BF!^\,5<(C+'.'@8*!6!$O'832*R M``,\_)**8!P\Z9&*0(EXJ"(5P-KJ0AF#@^1)2(SC(,'U5,17&EKN.&:FX%!>^B.(A@'SR6G>H-" M\%1P*H*9P[.YB4@&;GAQ*A4!`[P6E(J`0?MZ5L@MPSCM@22*0"%XM2+1VPPS MAW<>X@C>7/^49H:N$OGWMLPI'$5.J>G3XOH3-KUXX'NKLA2.ZTX6WNX1J7Q4 M(UUT7')[)V;2U0GOQ+^NG^J_KP]/V_UQ]%(_8HN=ND^6A_:M^O:74_.*$P=> MC&].>!G>_?,9__M!C1?UIO8)X<>F.?$ON+1)]_\IW/T/``#__P,`4$L#!!0` M!@`(````(0#]<0`,]08```L>```8````>&PO=V]R:W-H965T&ULK%G;CMLV$'TOT'\0]![+DGR'[6!71-H`#5`4O3QK9=D68EF&I,TF?]\9 M7J094FNO%\E#O#X<#H\.AX>4N?[XO3QYW_*Z*:KSQ@]'8]_+SUFU*\Z'C?_/ MWY\^+'RO:=/S+CU5YWSC_\@;_^/VUU_6+U7]M3GF>>M!AG.S\8]M>UD%09,= M\S)M1M4E/T/+OJK+M(6O]2%H+G6>[F2G\A1$X_$L*-/B[*L,J_HM.:K]OLAR M467/97YN59(Z/Z4M\&^.Q:4QVG*M/[Z?/F05>4%4CP5IZ+](9/Z7IFM M/A_.59T^G>"YOX>3-#.YY1<`:>JNHKAG[> M(02=`Z?W)SD#?];>+M^GSZ?VK^KE][PX'%N8[BD\$3[8:O=#Y$T&BD*:433% M3%EU`@+POU<66!J@2/I=?KX4N_:X\>/9:#H?QR&$>T]YTWXJ,*7O9<]-6Y7_ MJ:!0IU))(IT$/G62,!K-P_$RGD.2*QUCW1$^=O@&TQBIF,>!V)X1&(B<,8PK2!``'P[TJ#Y3R"-69"T&>[1`/U3 M6,^0F`C311"`,83)M1E.7JU0HR)V@EID*L923WE(4D7TK&D"*,) M,V[3Q-1WSCYF@?J9$4[N].N@:\2[D(XX11AQ2&,3CQ8C0(<]P"B,W213,\*C M1J3AR*)+-!*J,N;:"MT(T][)'T:3+HAQ!#THQ^O,,)@STTA?GXF#"(JPL6$I MTK'5LAZA,UVG@?TX#8T0@302*X%&X9C]"SLQU!K6T3"31+&^9!EKW*")&5VG MBL&=UI':&R>/`.\]B/!N)RS2VY M^BC343"(\T6;)GRO%U:H3)UQTA`5S(&$Z2BC.`%T8$(`!8NFM_TJU,Y-Y=$0 M69`FRJQ(:]<2IIVOP46G**>*GDNHWM!*.S0EJ"&JE0.)D$*<`'HL(2"]*YR\ MJ[JT75-V&N+5M>RT4+Z!FR`NXMY*!(,X871A0OB&8MJS*2<-]:,EN)G:!"C$ M":#'$@)2L2G4R;V+47LUI:8A)E<\MN7JHOK%2"'.%G)1MC?DPFC+O31$Y7(@ M`7/7*\@)H+%:$I(_J]=*Y9!5PNFC$9#5<7XZ1MFU2]`:B!::C M>DBP*$X`O9804.[UAK,JGLTL:S`0V1P-9#9'2RQAVH$R*<%7CO01>C#A>D,L M[=A4+`V1S5'FA#7;0X)!7"RT54)`BC6&(K[3O")MSY1:Y]A4B/ZDKG9&TY%. M;=<1RHVS10\F;&_(I1V;`ODH(H%Q1.'O/62+2%DW9=:Y- M%;,/]J9C_PR"08QP?)?=RVAN]P;J1TM<2#"($QBP^S":O\.^8M?N#0132-:: M?;3OHSK[8A#G>Y?=QZ[=&X@*IJ-Z2+`H3L"R^^LU'KN>KB'8@RWBSZJUTOGDF6@Z*K;`O7;=IG7ASS)3Z?& MRZIGO`F`BMBN.UA=4SS&"W-/X;3@#8;\O=]IB:`EPJ7JM,30$@^V3*%%7D0X M?6;0(G<4IV4.+?)(8+=$DQ6>I@881)`-C@Y#+9`-=NZA%M``]L^AEB6TR$.P MS2`>`S=I$79+"-G4VG1:(!N\^`R-`]F4^=E](I@%..@/]8%9@!/X4`O,`IQ_ M!UI"R`8_$0VU0#;X[6:H!;2&7RJ&6F!.X2>!H1:8!?7;D?T\(61?5:WY@@-TU[C;_P$``/__`P!02P,$%``&``@````A`+*T M0DYH"```@#```!@```!X;"]W;W)K\7V'O[7M5=3.E<&R?YN]==WI8+-KM>W78 MM/?-J3JJW[PVY\.F4S^>WQ;MZ5QM=OV;#OM%'$7+Q6%3'^>@\'">HM&\OM;; MBC?;CT-U[$#D7.TWG1I_^UZ?VHO:83M%[K`Y?_TXW6V;PTE)O-3[NOO1B\YG MA^W#[V_'YKQYV:NZO[-TL[UH]S]8\H=Z>V[:YK6[5W(+&*A=<[[(%TKI^7%7 MJPJT[;-S]?HT_\(>9)K,%\^/O4'_J:O/=O3]K'UO/G\]U[M_U<=*N:WF2<_` M2]-\U>CO._V2>O/">K?L9^"/\VQ7O6X^]MV?S>=O5?WVWJGISE1%NK"'W0]> MM5OEJ)*YCS.MM&WV:@#JW]FAUJVA'-E\[[]^UKON_6F>+.^S590PA<]>JK:3 MM9:ZMZY=LSB[+'Q3K[UE86MRJ(E M?I.TF6Q]11;*B*L;:I[';KA[[5*TAG71E[$4\(*ZVK7"^'J9?K1ED.`VD>58 M1-A($F%$VL@P$E2P:LWI!6OX::ZTK_6QB$QA`8SJ]"M#^J`$8MUWR1U;11%+ MAL'U-G&$K-)\F9$I%4%"^@:"+%!CG6Z!AJD%0R_UHR^`\5D`Q!)NE(RQ.(DB M,H4\J"*"A/01R`.UMHP]N*P"_O[7;Z)>D%XM@%'C^&D[``%>)/ER27T(*HBQ M0FH[*7T*R`6U_HU=\%>O85(](V,O@/%5'R1XD!!`@(,JI)!!2)\`*E\MW]/+ MUS`MG^%5J`#&5SX0,/0LSLC0>5!`!`GI(U#Y.CB.=D+_[&N8ED]6L0(8*.XN MRUE"ULIR#.0J4#"RRO$Q<+=*UBPGUQ"(R/,L79&+2$RL&5L/TX3JSV^I7\.T M_H1,/S"F_E4:K^C&7`8)#H2GA032<&XG$B%D(,@"II+/]![H:6I"2DPP$+C` MLF7*8FN-*Z=`W$`^+XB.JZ49`_D)&6$F)`>0U`I!+\^CYQ.W%C8@ATCQ:D30B@H3T#@2[ MH$/5=!<@@F$7R/`*YLMI$)H-,G;!VN4XAGHC+$A,@:1W1-@.-7=C.Z;%)J;? M19:-B.8F`WF;`W32/D6F=.L,"X@KHI_74G*?RNMO7=$-VZ`#UJ@K)MH`L0QU M!]T`"_W`K[SRV@`(=(#6R&CELC,_PQ@D$XPR:0J2P, MY#7!%_+@F2JL(@P"-CB2I%<"NZ!3U\B%B2T!60V[0?),P7R!SBP8082'581! M!C<<;>&[$#9$Q["1(8&V@-"&C1AB&SQF,H"\;3$.?XY\'980841Z$>R"3F+3 M78#1P,&1G$`Z$RD@',\A@*VZ*F+$K8I)05!@([MP^$R!N(&\5L"(+A=S/W@$+H8-N2EI MQHZDR6BD,I"GC#*,\#`BPHCT(M@(-=X;.D/3I#.L!X\8(*\1@)CY3-?QBKC) MC8@AHBR)20.*("&]`\$N_%\14W_08[E!"BD,Y'6#1,R8)#0>UA`&`;_2.,^& MY;#?SJ57`YMQ4\2,IT1,`WE-"$?,L(IP(/;>X;L2=D+GK\EY(H:TAO,$354& M\CIAISY:`P_+B#`BO0AVXJ9\&;ORI14HPOG2Z(S-LIT(RH@),M+!#'<0MD)G MN>E-`S44T%]&8!''JBLQ@0>"3-"? MX4XWH:?)MD$7N<)`G@+*,,+#B`@CTHM@(VZ*EXDC7EK[IX&\1H`.K/9WZK/P M-?WC/SD="S9"1[31;3'MD3R!8(=N#^N/50;R&@(Z8\1:*<(RPH%0 M&>E@AAL-6W)3R$Q<(9,D@<)`XSJ'B_=W>1E&>!@1#L1V`D;L'@QV0C'CYO#_ M>2+1-%DN&-U(#>2^N'$"=,8(K8&'9408D5X$.T&29L`)1\*TGLP3@,9E6CUA M([83-D-DA.-*5$8ZF$$&6W%3SDQ<.9-NI`;R+'IE&.$&\1@JPBK2BV`C2,R< MN'0ZXF9LW25VEAQFP]PE080G042$$>E%L"$WI=9XL M<_+G0(Z9=;Z.J>4BC$B#N!L,.T'"YL36<(1.>U<%R#T(TQHV0N]WGM@,Z3#A M0*B,=#"##+(DO2EZ]C3=2^BN:B"?%6&$AQ'A0"PG',S/G+@I>Z:.[&GMJ@;R M.@$Z8X36P,,R(HQ(+X)[@H1/_ZZ:.D*GM:L::%SF,`UP>Q@$%@SG`9NPB$`B M=\XC-EX5[,--B5,=K[9S%MU2#63.4^;Z@`]YDB_#"#>(QTV!59AK^=4'PO6( MW8,!)^#`-YQ!/E3GMZJL]OMVMFT^]&'N6'V:?7WU>M#\2ZP/V9+72_;`^]/: MB^LOU/GOT^:M^O?F_%8?V]F^>E62T?U*):&PO=V]R:W-H965T&ULG)G;;J-( M$(;O5]IW0-S;IINS%6^/$ M]$?1]5=U=>%^^/3]=R=:6:137?74HK\\[\^^_LE5@&DV;7P_Y MN;H6._-'T9B?'G_^Z>&UJK\VIZ)H#;!P;7;FJ6UOV\VFV9^*2]ZLJUMQA9%C M55_R%K[6SYOF5A?YH;OI[+Q/REW-=54QW;-9C;R(E.?0XWX08L/3X<2O!`R&[4Q7%G?F;; MC`?FYO&A$^B?LGAME/^-YE2]_E*7A]_*:P%J0YQ$!)ZJZJM`OQS$);AY,[D[ MZR+P1VT`C5KS>"OR]6_&TK6RD7YU,2=[FCP]U]6I`[L',FULN,IEM MP?)='^G-H-A[@H%2PLAG865G^J8!6C00Y6^/@?6P^0:!V?=(-$5<'R/Q'1%A M$&:3^X71+,.WI'?B?DLF+\#G,!,W&.[9@-.#YQ`5U?.W,^+NH("%@_?G1/*" M^AP^/*:;?#PEW!`CR10A1M(I08UD4V0T@ARV/^*P@"'9%1T#HGTD$4=!7.Q? MO$@DBT2Z2&1S!!(`IJH?<0'O3!!W2*1@U+6+<"21H,OWE1LRFR8T`K@3V):- M%4I4(H1JP#P,I"JP\NV`A606&2+"@#$E4,A]*#_Z[@N8Q)_,/9((/'Y0B,9_ MD4@6B721R.8()`#4-WT!!$SB[^#81!+QNO@S*Z#1Q\,A&4[48>X%-/!H.+1( MZ MYXUJHA"+ODW9SN:+NH"QOSY97)%$Y)Q7S.748W6<<9_(E:C#*YN[Q'R*QGD0 MCE'L*DR&QEW;&Y,$>1U^Q&L!$Z]I99>(NK+M\H'OZ.Q#G0-1CTS*X0&DV@PJ0:3]4R_A%0YL1"B"=)>!4RV3&BG M&U>7W.EZ1C[8A<6+*V'QAI,TC-240>JX>A))WFJ822;,8+E$"W2Q^60C15\#AM\ M0+:AB,TU7[)2+"/),I(N(]DL@O6`\*EZ+*2%H'&E"$FT(B:9^;189A(-.VG/ MR-2QG9"T)1D:YSX;YXI%$'W3QY-"=EOJ&@GI]B%>L$&P/K=#VQMGT*>$"G#1 M"Q`B029LU_)"L@&EB/`"Q_/)4LT0P2W&.1L1+(7HIA0I%O)!]EY(`K*Q1TSM MSU8.LXF#,0;@5R&Z]R>8<%S/(H%.">&[DRX1$]QUN3<:P1*(_DI?`MF-J:4A M)*U1Q"2C+@G2'L7+2+*,I,M(-HM@'43+I:^#;-!0*HP"]WNG9%0=)MT46V82 M#2;58+*>D:MS)9JR,3>Q%*+UTI="-FI("A+OB"WW>[$&DV@PJ0:3]Z;?,[S) MEH'&W]HQ$&"'$PLI`M[HN#($,,_R_7$I8Q4@R?47!A,JOS9B"43?IUT;N.P246V@G63/S+D8 M:S")!I-J,%G/R)!PGP=CS+`2,.,/*"%HG`Q0@?';5,0E)!_-',LBD8P1\.9B M4"W`<06UD"(+;RX&U0*X[_&QR\/^_Z\V4IR>3'08G]"O"@G!3(87$)KU<6]H MCDDTF%2#R09&''"L;.7G+ZP(Z28UB^2TJV06;2NYVE:&@3])#'7<">G]";J? M06J1IBU%P`I2BRS3#`&^Q=\KD:2=U-1`MHQJG6!TBA&74+\ZO("X$/?C\C=* MVR,.)&B8T3.H%%GW?7J,E:%Q!WZ2&]8NS@'21FKZ/VTGX;?=X0G]JI"0/'9@ M#-X+,!##>:I86Q)PX040CR=H_`T#*0*F!L2![?@`;$"*((]CY3GCI:B?B[@X MGQMC7[V(HU8;?CT>K@['P)^Y.%PCUR.VA5/!Z?6$;>'H#ZYOAAO@U/:6/Q>_ MY_5S>6V,VNG6GGD]5"^>UW;\G.)\OX+S16@-\K*KV M_D4\8#CQ?_P/``#__P,`4$L#!!0`!@`(````(0!&G81>=@0``&\/```9```` M>&PO=V]R:W-H965T MV5S:E5JIJG;;9X+'-@HP%N`X^??]YAH&'-M9]26$XS.'.=]E+LNOKW5EO."V M*TFS,I'EF`9N"K(KF\/*_/$]^[(PC:[/FUU>D0:OS#?M'7>PVM[L+M3B_,=&U17MNLX,[O. MR\;D"E'[B`;9[\L")Z0XU[CIN4B+J[R'^7?'\M1)M;IX1*[.V^?SZ4M!ZA-( M/)55V;\Q4=.HB^C;H2%M_E2![U?DYX749B\3^;HL6M*1?6^!G,TG.O4N M)_6_G(2$%!=QA0@\A0B:68L@\&>+^>,JGE"!IYS*XX-],1B>I^8 M`7R.!0.>0L1%GP[&3(C`4P8CM)#OS.X'U.;)8;E.\CY?+UMR,:"!(/S=*:?M MB"+0E4GF*5%I_RCKD&XJLJ$J*W-N&I#0#DKU9>T%[M)^@?(J!&<[Y2"=$4L& MK24JFXR!=`QD`\`&1\H6U,O_8(NJ4%MR0EL)O/L?S`0=!)TVS`3R]#AO.8?VLDI7H%-B15$^)D@Z0;(AHEF!WAE; M08%%^Z<_EL7SEO"%X(HU#ZJ)UQC5@"J%(E6S]H*Q-4&Z94U1E+4)DDZ0;(AH MUN!30VM7+$!W2@^4S#S(;V\Y,N.K'BWZF",+J`KETPU"/3_)%9*'9CHIY20? M>D0I>6BND[*KI(4B:5XA]H][I63=*T>&7CGBPD/-$(6CEDH>(:6<%"[8XN.C M8.+S!D'S"(O8T"-?$#]9JE1#M\Z1F:>6DE@@,X4D$R3EB!O>"D]VAZ29HV>S MP6I_NU@I67?!$:AG6;XQ1V!9DD@BD/>"3@7"CBJLE3.ALZ"CM/F!T\?G1\GZ M_#A"=T-53AX:M4[,28LAR1VW3L))+%_&3`6P7 MLC*W`O+>]_-80JP2Q9F##_1"-3`5+/^]RC,)L3+7XJCJC(&=ZA9C#LJU0?KW9!M&696J$P[5GPY:2$;ZEUR&:LS'N1G#" MNH)[$9Q7IOC&CS;\6C46\B,X!<``6_T`UYU3?L!_YNVA;#JCPGOPXK#-HN47 M)O[2DQ,D$RX]I(>+#OOW"!=;#-N]8T'<]H3T\H5^0%V5U_\!``#__P,`4$L# M!!0`!@`(````(0`(*9%K1P4``$H5```9````>&PO=V]R:W-H965T0AC/SO[VO[,SSJZ^O^69]U379^7CE,E M)Y;'U82?60%/#KS,XQJ^ED>G.I>9XT^G,R>.TL&6$97E/#'XXI`F+ M>'+)65'+("7+XAKXJU-ZKG2T/+DG7!Z7+Y?SMX3G9PCQG&9I_2Z"VE:>+'\< M"U[&SQFL^\T-XD3'%E]ZX?,T*7G%#_4$PCD2M+_FA;-P(-)FM4]A!2B[5;+# MVGYTEY$7VLYF)03Z)V77ROC;JD[\^DN9[G]+"P9JPS[A#CQS_H*N/_9H@L%. M;_23V($_2FO/#O$EJ__DUU]9>CS5L-TAK`@7MMR_1ZQ*0%$(,Y$8"<\``'Y; M>8JI`8K$;^+SFN[K$XZ>S,,PF,T?(,PSJ^JG%&/:5G*I:I[_J[R0JHGBJ2CP MJ:-XD\`+'^8NS'IKI*]&PJ<:&4Z\>>B&LY&!@1H(GVJ@/YN$#U-?S'B;VY$B M"$VCN(XWJY)?+4A46&5UCC'MW24$UF+*E3?R?J0N"()!'C'*VGZP+="M@I1X MW7C^8N6\PC8FRF?;]W&IQTY[H,X8-C(,#O`VT"#Z%T!C%(36TVVUP5A%AU![ MZ"&182"$L+E?0(A1UC;\;F4-IA1I*WWP`#1.(779-2X-MFDAW)`"7\"-42"A M9@93/Q^4TRWPQJ4!-RT$',+TP2=XH(?K@LY<'"=0]11;91%%2*3A3EE\D=AS M*FZD'@)8H[\7M)E-($$0$_(V&3I3,F69-QF[ZUDBTT+FAL-ISBT/^AT"X3B* MH2R&0,JB!)JTJY?'6#VF$GF-C@03N[11CVY+A,Z435D,B7J6R+20N1=T;I1H MY@N)_F-D\[%R+005!?:YOTZ"6\*I$R>L8M]4T1, M%`!KL[%1=^>3*XLZ%`>]RJTVF2S*JTFI!?GI*!?I"#3%@D9?BHY%VT"_G6.N M+/&$5YF,+-->K2DB)@J`Y=<`$-HM7'Q=42\.]S=>5HT12Z\.\0>O+^CU M.>)^FQ&Q0':36'J-$4NO#G';,ZG&`\WHKCSV^JU'FTQBZ35&++TZQ!_T;Z_3 MC40SN.?DB8&=/%9=R"26IC%BZ=4A;KLLU7B@?;E3V*7;E0+?!SJ]2IM,7NDU MQBN].KQMDY.\\M)%7A#DK#RR'&ULK%E1;Z-&$'ZOU/]@\1[;"QB#E>04@ZX]J96J MZMH^$QO'Z&QC`;G<_?O.[.S"S,+%22Y]:,[?#L,WL[/S#7#]X=OQ,/E:U$U9 MG6X\-9U[D^*TJ;;EZ>'&^^?SQZO8FS1M?MKFA^I4W'C?B\;[36;-9M]<9 M/Y]'LV->GCSRL*I?XJ/:[JSN\/$/8;ZUO_&+@_EINZ:JI= M.P5W,R(ZC#F9)3/P='N]+2$"3/ND+G8WWIU:9:'R9K?7.D'_EL53P_X]:?;5 MTV]UN?VC/!60;=@GW('[JOJ"II^V",'%L\'5'_4._%5/ML4N?SRT?U=/OQ?E MP[Z%[5Y`1!C8:OL]*YH-9!3<3/T%>MI4!R``_Y\<2RP-R$C^3?]]*K?M_L8+ MYM/07RQC!?:3^Z)I/Y;HTYML'INV.OY'5CJDSHMOO(1`WWB)IHOE/'B!DQDQ MT@%F>9O?7M?5TP2J!F[9G'.L0;4"QS8RHM'%^J-0(49T;KRE-X$@&MB? MK[W6%NBC\!V& MUL)>DC%`,`S>A2%Z@5IA:?67L:2T)ANLQB[W"VF2=B8=;8X(WE`"[Y!9]`(% M%3%.PWHP1L\1[TPZXAP1Q,'-D/AT"?#X(;65B]=IJO86:X/HCJ#+,#5(0(4] ME]G-NM5^`_QETAD)EI`1SO)Y:F@LJ1DD[DHV'2`91\2]X73R>]-)?T&&\#I) MPR`L0P81E1J[B3)&L(5=I?JQ&D\4*B=K2\\G"HTE0X.P1`V0C",B48F\-R;* M7TQAFU_9%-&/I&40N#/+@-MC.B-;D1E'!%,%2L;3Q/:TW9>;+^L*[@--="1] M6,RF=Z,3R5/[!8CE;PAE`I*\L'&S[=,IC%`;QZ@`W'&AC@^=PP:_5@1%I(4H M"ZF!8FB^+(^.WF3&"N8";A6.UYO"1NXP5@M].EZ125(#P9Z@*.@"2O6MH*3@ M.'3L5>)406:M8.]'K62^L9\S]B/[S9-LNC]/,D%@9/.>*H*"/N^9@7Q=%I(` M]N67$S!=G!,@""ND"]>/72%39!6$NA,G,/>HJ-M/,S(8DTB;7"V#F.=6DL;. MS4B_[?2@$^?T$)3(PG.(IJC8<&'B:Z+S:>`$FUD#DAUA(,/`CL_"N+#Y1A]X M[@D2FT^0V'QC-;+YV-@9@;YA7J!B!(%3(<@I@Z7+$SP`I< MLD918*S?5KQ&67@P!#G!].,,342*K$PP5T&P4,%@"XS-"[;`=W3L^2W0UO+( M&2CHA_G40DG7TC(#T9.BR*:/(O.SV=1.'%XD7J%0JL39^-1LN=CZI#]*DCI*!J-^@2\) MC.!K()Z[`93AV4=)&W9Z'S6`$7A3T]%.G&-"VH(-L"]M=R1*[84]^TQ`,E>. M*%W(U5"*<#Z#+(3PI^.D8K<1&JN$FERHXM@=Y(Q%M-0Z'ZIHWBN#9(P"P9)[ M@3')B=A=@H!Q-\2AED`0D"9\)^//53_^FJ9B#.!/'R5K4)(A=G3&\&W;3[(@ MB!,4]AN;^@1=&)*M%1@S]OT."/;!JT1&6\LJ-5#,6I^!^)QDH)$A&:Q^/GW: MB<.+1";AE>HGSN-0:BZ$-R+Z]=Q=Q#D@J;&RL^8B"H-^CC19(]\! M';(H48OH!T<A>J$R2&L')J`][:Z-]PA'KH4Q`(E^A(S6X MD4&LWW^]\AVB]B3+TT(R87W'T4TI[:VZA`E(\AU1IC?R)2WBR<07<#1.]B+M M)^X@U5OU?+L+`2*^](6./F`=B_JA2(O#H9ELJD?\^@9/2+?7'4R?!M?!%%X]A]EJLU3%?#%?C4>C=Z!82O M==N]!X8RXF<-@8S%<1>N[JC7NXY"R/R8(XAN-#C876H-G2/X)'O.'XH_\_JA M/#630[&#HIGKE[PU?=2E'ZUY.+ZO6O@6"Z; MUZ)\J@Y95D_`PKFZG1[J^K*:SZOM(3NEU:RX9&<8V1?E*:WA9_DXKRYEEN[4 MI--Q;BT6WOR4YNT?'J^?-D6IPN8>,B/>?U=&9U.3MO5M\=S4:8/1_#[33CI5MM6/WKF3_FV M+*IB7\_`W!P7VO=Y.5_.P=+=S2X'#Z3LDS+;WT[OQ2JQ[.G\[D8)]&^>O5:= MOR?5H7A-RGSW>W[.0&W8)[D##T7Q)*G?=A*"R?/>[%CMP)_E9)?MT^=C_5?Q M^EN6/QYJV&X7/)*.K7;?-UFU!47!S,QRI:5M<80%P/^34RY#`Q1)W]3U-=_5 MA]NI[LJJ.M]0D&?K,!5 M6QF]#7/<4A4AF[1.[V[*XG4":0>;5EU2F<1B!89U:.!&-L'R7JQ`D$@C]]+* M[13F0QA4$.`O=[83W,Q?("BWQ%GW.<)DA)HA(U":W7`@XD#,@:0#S,'%QD\( MNY_@I[0B_=0K7&N@==QB3FF&GK+A0,2!F`-)!S"<@C3X"4Y)*Y#2GJF@TA MB8$J;4"H0R(V?E@N=Y9('SG;4!IG>TC40^(>DG01PUFX.7?6`7G$/:HCV M3TY3_NEUK1$)EDW,AH1`4'4T6)J[N;E&\A8F*;I*8ED=(\F!Q&QOY[$L28@$ M1UN'9#>W,Z2!S>M*\[$@DFP*@DA7$$0LN#0W%TNVPLT84C2&%!,)NJOW;Y<@ MR38VR7.N"P)UMRL(UO!/)H:T8>J$R%*U%BIY0D0\KPFE30^)>DC<0Q)$`DCT MJP(8FRU[T,[Y]/%F2[+I!"*!TRPY1,1NW=H0@NV*/'$UTX.F))-\((4Z*D&3&&2?%2`+O M/[A=TEB2Q[_5E@I#'`$9/GX_%=N4AR"F#W,]U"Q9&%_N`KNM)-18R&7`F>>H M<\=`XE)\#RO/61,063#,CK`!;8W<'XU]9T@ M)DA[-[7>4+-0D$XA(3VH;4)WQ9+U;A%-)SEZ\4'#$"!2+>$S-1,]'>\NG*`M MKJ88LM$9+X9DL^A`B(G!O`D%L3Y.'V(-Y`^Q!A*(6`,9U-J2,KI^F_6F2K)# M&J\2]5/=D$&(J<0Z@%`@RY;-$VRJ(QAAHPF81+Z]9$$7:0)%%4^R6(]C$MFV MQ38JT02*FR!X-XMD'S5>$NJZNI(@9$K"XS@4Q!H('&0-!0ZR**4LMU=A<)QR MJC>>T%JNS#>#1796XY61;)92"#%E6),7RB<#F!A0P;7:T*4"@^-4<(7-"1$9 ML&FK?9=9B#6!*NXB8((EFD!+6'0>0$U%9&LU7A%LQ(R*BQ!3I"UI5'&)!8Y_ M<$;+)Q'0;2A6D#549)`U5&3(%@F]@']-WV#J)-NT\3IA4V?H1'T>!'*K@,^. MXE`0JUE/LQJ*'!P'A609\MQVM6H\HOF4!X(_H\0T3GGD=+Q5\Q,]'^_O"+<- M;5,.V?"-EP/;0T,.A%C8L"@.!;%(#H?5U`V-:SEL5C(C&BMQ3",A M%JV[I`X=0$&D@BY`UE$7(&LHB9`UE M$=G";0K>32+K4_VN8IOEER!#):O3&:A-"S4+E^-;K!_>T+CN=_V`A46D"9AE M?L`,Q'J\J-A,$6U4F"%MO2!/A/.K4'MZW M;H@U$#?$TAG1K1!*_5@3Z&CR^`NE1!-0''B<:Y=KBL/ZWQ]ZDK?Z;3%!AF:" MG["A9ND@8H68AJGR^.R\BVAX(+N(-9!=K2U9\RWKG1($WTR,$O1CK"R ME[R>R^]&JO%"AF\'=IN9&%OX60A?^I^R\C$+L^.QFFR+9_G)1RZN0?%SU-I= MK=4K;H;#9ZI[]4J$X6OX?*5>GG#<@L]:\D&5X_8*7O+V\7L'[%\;6#LK>%$* M$^:-)?@\=4D?LS_2\C$_5Y-CM@=?%NJ=5XD?N/!'75R@?,!7GJ*&#U/JSP-\ MB,S@+<]"ODW=%T6M?\@;-)\V[_X'``#__P,`4$L#!!0`!@`(````(0`OFRB2 M+P4``"H2```9````>&PO=V]R:W-H965TN!S* M)\?'Y2J;Y=>WIK9>6==7O%W9WLRU+=:6?%NU^Y7]S]^/7U+;ZH>BW18U;]G* M_L%Z^^OZUU^6)]X]]P?&!@L8VGYE'X;AN'";]Y85&.W.++!7U3 ME1WO^6Z8`9U#0B_G/'?F#C"ME]L*9H"V6QW;K>P';Y'[GNVLE\*@?RMVZI7/ M5G_@I]^Z:OM'U3)P&]8)5^")\V<,_;9%"`8[%Z,?Q0K\V5E;MBM>ZN$O?OJ= M5?O#`,L=P8QP8HOMCYSU)3@*-#,_0J:2UR``7JVFPM0`1XHW\7ZJML-A9?N0 M&D^L'QXKI+*M\J4?>/,?_2AF,@WVY6!XEX.#>!8E;N#!L^XE"20)O$N2^2ST MHR3]#$DH2>!=DJ2S-(K".$UN*G'($N%P7@S%>MGQDP5I"Y/OCP5N`F\!Q*.U M9,AD]GM>@\E(\H`L*SNQ+;"SAP1Y70=ALG1>85%+&;.YC/'TB&R,P!5$VEP! M'-`[B8:U^`FBD05%CX_;C,!Y%KZA<(P8A^0*H"F$A?X)"I%E9J?-YPVB]7=EX`RT[)@!R03K&BR'=3 M7=-&!GTD>PJ99*N()AMH5-E7Y,%F'?5AL-`W\FX(2:`H3!YZZ5Q7G%%0G(KT M#KTT-9(CEP&)#(B5.6MBP9C[Q6*P+I80$#O*SPB)YZK\N:F.@K#PG>(J/ZTXPGQWYN*IA+;NUFZ_&0&R_#Q^N,X M71DA6,\G;WSO[(V0EE%0$(KE]6+7-0)R&1!?"=!TP^14W1^+Q6!=+"$)=2DL MDQDAP1G)"8'%AAS1GNU!\U4?CDL;09G]6(08I:N0D.'9147'QT&-]84GT85E M(PMM*O5W734V`F6I;ZBEM@$%:-PA&T]VDK-%F814UR1TS3:L\XH`L2/NR36/ M&H2FA2##.6.[9G*@3+CKB0=UFU%P/WNR8*O:B'(<"^8ZACM58^BI'N^.W=C/2(?(\@] MWXV5>J^[AV5=$7_#/6H"VGH3E`2*>P1I[A%T+?>PG;B`6$DI@FRH=USC:9F,4'MU>UVD2 M&D>R7`9HQP7?>\=+WV@BH@I%GSS5"!)C+K*WP)Y0YF(L>R8'PDD:Y^*Y41R< MRS45]#&$#I!IFD;G$P9E!=V0Z?[6L&[/,E;7O57R%[S]XK@)I9OY)EILQ`7' MP.'&_N!C/3+P#=SD18\T<1]N^-?B@T4N]J81_Q`"_U6B<)&'2.1,(^"F?BSV M['O1[:NVMVJV@[FX8ETZNNO3EX$?P7BX<#^,7 M?,#T+\_Z?P```/__`P!02P,$%``&``@````A`$^08#!.!```F@T``!D```!X M;"]W;W)K&ULK%?;CJ-&$'V/E']`O*^AN8-LKXS1 M)"MEI2A*=I\9W+;1`&W1>"Y_GRJJP33V3CS1OHR'\N'TJ4M7E9>?7^O*>.:M M+$6S,MG"-@W>%&)7-H>5^<_?#Y\BTY!=WNSR2C1\9;YQ:7Y>__K+\D6T3_+( M>6<`0R-7YK'K3HEER>+(ZUPNQ(DW\,U>M'7>P6-[L.2IY?FN?ZFN+,>V`ZO. MR\8DAJ2]AT/L]V7!,U&<:]YT1-+R*N]`OSR6)SFPU<4]='7>/IU/GPI1GX#B ML:S*[JTG-8VZ2+X<&M'FCQ7X_,RP(B M"C0+QT>F0E0@`/X:=8FE`1')7U>F`P>7N^ZX,MU@X8>VRP!N/'+9/91(:1K% M67:B_DX@IJB(Q%4D\*E(XH7G^&'T$1)/D<"G(HD6D>][013^IQ*+O.J#E.5= MOEZVXL6`R@/=\I1C';,$B(?HD"]CO'X4+H@3DFR0966&I@&1D)#CY[7K!4OK M&?)2*$QZC6$Z8CL@,`E(FTT,%N@=14,N?H)H9$'1PW'I8+AXXIN$E<61+BDE#%;T&'M?AVQ'R"A[:M%T0PE@]V2-DE#VU:+*!9BK[ACRXK(,^!/?Z M!MZ4+-ZT?ED4ZXJW!`J0YWGML2B:%4>F`*$"!/8E59I8",S]8A&LBR4+B!WD M;\GBP,=8`BR>JU,@&&L3D#WZJ"F$0$P54E/X8!4@ARZ<+%YT$4Z6(!@M&5F< M6%-Y<453B1-ZTKK>3SJ"=3ED43T?V\V6+"ZU[KX!*4PO63L;!-Y_-H+UL\F" M`V1,!JP%8S+Z>[0ED.OU]>1&+IO=H4P!@A[@AUB3(X6FEL'4O%]NC];U*M-, M\%7_QF.@7Y%BSYY[E"D:EQ0[X12A"\;.?W=N&(;$"08A;:D?>#$.,DF"C^7W>&T3C1'"'3S!%W%*$<(91RQ(\@L+-J MRA2WBCVS/2T_>O1Q/$Q\>?]F,35,IM$GDSOI40KEQF..,F7R^ONF"\!&/Q&` MP70"W,\^,(9@J9Q?.V7R(%J3>W?)J`HFO>A1&0<^BX/9+,"%%;D]519!X#CA MI73(%]I(:=FJ>7O@6UY5TBC$&;=-G!*CE3;AU$_2/F(S.VS(&P?#-K.GN#G? MLCL)["4W\&Z2N3?L&R_9T`8^/\!+LGXSM\8O8#,^Y0?^-6\/92.-BN_!%[L? M#2WMUO30B1-T$-B/10<[B&QY`J37^JEK_"P``__\# M`%!+`P04``8`"````"$`]8TL5W@'``"_'@``&0```'AL+W=O59D.19B M6X:D)+M_WR%G*(DC)U+:[,,Z/CP<<0YGAF/QYNOWTW'RDI557IQOIV*VF$ZR M MHH55.<9&L=_G:;8ITN=3=J[12)D=DQK67QWR2Z6MG=(QYDY)^?1\^9(6IPN8 M>,B/>?U#&9U.3NGJV^.Y*).'(_C]73A)JFVK+SWSISPMBZK8US,P-\>%]GU> MSI=SL'1WL\O!`RG[I,SVM]-[L8HM=SJ_NU$"_9UGKU7G[TEU*%[C,M_]FI\S M4!OV2>[`0U$\2>JWG81@\KPW.U([\'LYV67[Y/E8_U&\_I+ECX<:MML%CZ1C MJ]V/35:EH"B8F>$RTN(("X#_)Z=V^(`;\#@E!GQJ(^-7X-%D^-23[8\KZ9,5^-161OLQQ[U5H;))ZN3N MIBQ>)Y!_L'G5)9'9+%9@6,<(;F@3-6\%#>RS-'(OK=Q.83Z$0P61_G)GN?[- M_`6B,R7.NL\1)B/4#!D^TNR&`UL.1!R(.\`<7&S\A/#[!#^E%>FG7N%:`QW' MF5.:H:=L.+#E0,2!N`,83D$Z?()3T@KD=F?S1,`W#SFR>C0[[#)'&TKC:0_9 M]I"HA\1=Q/`6\O<3O)56(-@A%1M/^K%*I/?<;2B-NSUDVT.B'A)W$<-=>#AW MUW)G@%ZOWSH5Y33EGU[7FA!U6*B\"@FQ5:8NS7WLBVAT0]).XBAB-0NK@C M8\26T\RU(Q(LFQ(1$@(YW-&3BWZ-Y"T:T952VZLD5D0C)#F@>OLXSS(MQ42" MEJ)#LAN2(8UL!SLGQ)6]A&-4;Z8DFX(@TA4$$0OVHGFX6+(5;L:0MF-($9'@ MX^W'Q4BRC4WRG.N"+$U!\,C\8-!+&Z9.B"P[68J(YS6AM.DAVQX2]9`8D0#J MZE4!C,T6$!+C=UNQ33<("IQFU2%!=NO:1D/8*LJS?JLAJYD8$60%#10;+'/E M\N0?':<"^P0X!IHR21"LO-7)\O@IIUFRQ#6]CO":2*'&!I!LU"#%! MVJ>I]8:"6"A(I["0'C@,X2+=%VV8:&.3)AS!"!M-P"3R[24+NJTF4%3Q)(OT.":1 M;5MLHV)-H+@)@C>S2/95XR6A+JP;.`B9DO`X#F73#I($H,Q[M1=90X&#+$HI MR^U5&!RGG.J-Q[26*_/-8)&=UGAEL"\S3B6$F#*LZ0L%L:C@6FWH4H'!<2JX MPN:$+1G0)<)WF85($ZCB+@(F6*P)M(2%TT:3J8ALM<8K@HV9H0A"3)&VI%'% M)=9`K"!K*%:0-51DD#549,@6Y=0"_C6]@ZF3;-O&ZX1-GJ$3]7U0U=IL\=E1 M'`IB->MI5D.1@^-T-'ENNUHZFG"<\D#PWRP1V:<\JODQC5/@.<)M0]N0 MP_I08ZK89M4EB(4-B^)0LT@.A]74#8UK.>PVR%$.&BEQ3",A%JV[ MJ(GRHW;7Z[2Y!AA[\M4^H2>]G$;$&LHA8`UE$K($LTK90I>#- M)+)DHSDZB12;1R_L[]1!D^'9@MYF)L877GW(<+@NO%3(#KPTORF/V6E(_YN9HT/UYP$NBC-X$;20K[CW15'K+_(!S=7SW;\```#__P,`4$L#!!0`!@`(```` M(0!K77&PO=V]R:W-H965T77:J'__%7WS5*5IT^J0 M%KA"&_4#->KW[:^_K*^X?FG."+4**%3-1CVW[<77M"8[HS)M%OB"*OCEB.LR M;>%K?=*:2XW20W=366BFKKM:F>:52A7\^A$-?#SF&=KA[+5$54M%:E2D+?2_ M.>>7AJN5V2-R95J_O%Z^9;B\@,1S7N3M1R>J*F7F_SA5N$Z?"_#];MAIQK6[ M+Q/Y,L]JW.!CNP`YC79TZGFEK310VJX/.3@@PZ[4Z+A1GPP_,4Q5VZZ[`?HG M1]=F]+_2G/$UKO/#;WF%8+1AGL@,/&/\0J@_#@2"F[7)W5$W`W_4R@$=T]>B M_1-?$Y2?SBU,MP..B#'_\+%#308C"C(+TR%*&2Z@`_!7*7,2#1B1]+V[7O-# M>]ZH)D3C&35ME!,I5FQ:7_](?#29!;S;9S7!E-R\7MNDL/0/:>E3$8B)P M92+NYT5L)@)7;L-8>(YCN][R\:X`LQL,N#(5PUR8GF,X[B<,N4P%KDS%62P- M?65]HB=+I@'7P8]AZY_I!\QCYP:N@QMGJ5L/S(Y&8]*E;I>VZ79=XZL"2QD" MT5Q24A@,'X1YW&A(^@#>RA\$CX@\$96-"N8@8@TLFK>M93MK[0V"GC%.,.48 M(B/D#))J(KN3@;T,1#(0RT`R`C3PW!N'C/\$XT2%&.==#C@PC(0IN>0,?LM. M!O8R$,E`+`/)"!!NL39#]! MH@D23Y!DC`C^H7Y,_2_(PFW/>?828%H39ZJK!3&FX28:L#Q@^??.#$?R%C#2 M/?L]I;<_0?83))H@\01)QHA@'[HSMC]C$^H@]TG(G4_>OX`B]GA=&]Y*G/B0 MDAR]6_:VX7E2X'=,9=4ODCV[A6X^9*5'#'&9B*M[8BLQ(]`MC]R2,*1;>X)I MF*BQ:5K2/CGG1$,<"XK87N\BI(C3'09HO6*(U7/V#+%[)&+(:IRFE2ZY9:2A ML80B+CT\C.L83,[8[?TI)F31%D7;B69+47#)+&IH3,@+-C4?M2QDA&N)@4L0=YC^DB`E=&[F3%\@CI/TC MI(B1Q'!)S<6/D)+_(0F#"DB-6%G:XLA@P58S_A M1`P9HAQ/D(0B<"2&M@0/!IS4QR:^E(A.1#3'('+<'!(@[QXA8UEDTWG;&CI\ MQ&6RXPR[8[BN*^V_>TZ@$A9\1(6($TC!GVTCYHR^"DMM))Q`)1QOU(8XF.30 M-3I5WD^$08]HL,'R``0,LH:#5H3"E%1-$J&7\G#+(S^=MW#]$D[L'TXV$`D9-SQ@RXJ$AXZ M/FRW4W[D^'!6F,%='W;5*1XL_:"+CZ0/3_Y/76V1\("\$9C3,7TXEL_H6SZ< M5Z?XD^T_T3<+6M\"/-E?TA/Z/:U/>=4H!3K"8.G=6::F[P;HEQ9?8!#A$1VW M\&S?_7N&=S@(SDGZ`DK/$>.6?X&6M?ZMT/8_````__\#`%!+`P04``8`"``` M`"$``'(,SR@#```#"0``&0```'AL+W=O2LI,H1-:O@ETS(DFIXE0>B M:LEH:H/*@LQ<=T%*RBO<((3R/1@BRWC"8I$<2U;I!D2R@FK@KW)>JPZM3-X# M5U+Y=*QO$E'6`+'G!=>O%A2C,@D?#Y60=%]`WB_>G"8=MGV9P)<\D4*)3#L` M1QJBTYSOR!T!I/4JY9"!D1U)ED5XXX5Q@,EZ9?7YP]E)#;XCE8O3%\G3;[QB M(#:4R11@+\23<7U,C0F"R23ZP1;@AT0IR^BQT#_%Z2OCAUQ#M6\A(9-7F+[& M3"4@*,`XLUN#E(@"",`G*KGI#!"$OMCGB:V9T@_<0&*4 M')46Y=_&R6NA&I!9"P+/#L1S`L^]\P,`N1+HMX'P;`,#QYN["W/VE;!Y&P;/ M-LQ?O)&>!I(F::MA3#5=KZ0X(>A+2$O5U'2Y%P)8)UZ#T,OY/S5!1@.R,2@1 M#C`"H11TP//:]]T5>8:R):W/=NKCC3UVG8>ID8&-!P8"?'O2H/('D#8HAG1W MW+8SO&4Q.V/8>70A\<`P8@CE_`"&!B7"\#F0]4RT;>-C&KYWNCUCW;OTM(>6 M$6]H@0_@;5"@H18#3M-^:)VN$>]=>N)#RX@XP$R).^;R79X#7>>:.$NU.V+; M6NS0L6VX:RV^;6S/'ZL;M[\"L[X`OO_6.".6H,B0Y75JQGE,K;4L^Y;=32SQ MT#(Z&V[G\&QST_VE&8GMG'GW93=`8UZM!1;J0((SG7:]4Z/,OH6=8R?TN7T6PIV]X.^'L7_! MOIF'&SLASG'F83R_X+]=A%"!"_A!NP-)#P0[J*8']IW*`Z\4*E@&*;JV966S MQ9H7+6I0&S:1T+!][-<<_FPP&)"N`]7+A-#="QQ,^K\OZW\```#__P,`4$L# M!!0`!@`(````(0!2JG5C!@4``#83```9````>&PO=V]R:W-H965T1J$[3ME7JEJNK',TN#V?.C`^!U=?WLO#>:,US5JU],@I]CU89V^?5<>W_ M]>?SE[GO\2:M]FG!*KKV/RCWOVY^_FEU9?4K/U':>)"AXFO_U#3G91#P[$3+ ME(_8F5:P$T*-.\\F6&9?U(#G8XY!E-6'8I M:=7()#4MT@;X\U-^YCI;F3V2KDSKU\OY2\;*,Z1XR8N\^1!)?:_,EM^.%:O3 MEP+J?B?C--.YQ1/LT(P@72")NC4O@D4`F3:K?0X5H.Q>30]K_XDL MDRCV@\U*"/1W3J_<^-_C)W;]I<[WO^45!;6A3]B!%\9>,?3;'B'8'#B[GT4' M?J^]/3VDEZ+Y@UU_I?GQU$"[)U`1%K;\WUS6OOQ=#29A3&!<.^%\N8YQY2^EUUXP\I_9!!1J6222"6!3Y6$ MD-$XFLSF(LN=G;':"9_Z\J,9"1?Q#*Y^9]]8[8-/O>]AVH&40"B:I$VZ6=7L MZL&80I'\G.+0DR4DUE)*&JVX/](61,4D3YAE[<]\#V3C,!!OFS@,5\$;-#%3 M,5LWAM@1.QV!'<.TB0$$P+-=FICZD]W'+#`_ M4X.3VWX5=(]X&](2-Q&+.*1QB8_P`-V7&/<)JOH26X4(QQ%3MU-(+.:8=!J0 MJ%5@UC8@#F]S8K$$14R6]ZEAL$U-(?-V0G<.DIB(=6TXC.:UY<&&0;A/`G?9 M)!1BZ".1.1S.5H%H/+.',)%!$9R/-B@.XS;(HHKW9<.#[C/$8)NA0@R9'"0Q M$>O:"_O:*--\@;>-`:%PGTU#(I&\2Z!][1PD48BMRKA?%0)^\;@L(MHFI"%# M&!=*+,B2AJ#]>1(Q3-1H/:B(T=+M+*3754E`$E&K+UN?F;30^]UZ!W?VP( M1GQ+ESM/VF&\U!%-KG)YI.R?2IVY1 MVLP2"[+)HI4:9`?44L9K$/J=DY!ABFI MJ`%74E$=6[IYE\T8O=5@/""9S:$N&/FLP'I!,N;))TS1J)9D#):#5CR1#AS4( MH&0/^3F1U@S-T(=IJR%3,ADU)%FOS2_Z)8L^9?,BVK8Q#1D'TX42"[)Z!@;\ MWR03&SM?'G!W_T)`IF>O\5I1-H,?Y MX_D#!Q.>BATN"C(ED]"09#*J(]GMYZID+!^BY2-?2>LCW=&BX%[&+OB`#..^ M6;6P?'J'N\\2;R3006=E#"OCWI4IK(BSX^R9PXH0NKL2A?":0)3MK$2P$O5< M!]XL//7A6WCC('YX.9D@44^>+9385^'3&/+W+6RA\M["H>[>LJ'JWJ()%"V/ M1Y%\A_CW!^RD*OT)#_+UV8*S17_`"[1NOS;\```#__P,`4$L#!!0`!@`(```` M(0`L/`:R0P<``-0?```9````>&PO=V]R:W-H965T-]_'^UU]N7ZOZN=D513L""\?FSMNU[6GE^TV^*PY9 M,ZY.Q1%&ME5]R%KXLW[RFU-=9!LYZ;#WP\ED[A^R\N@I"ZOZ+3:J[;;,BZ3* M7P[%L55&ZF*?M>!_LRM/C;%VR-]B[I#5SR^G#WEU.(&)QW)?MM^E46]TR%>? MGHY5G3WN(>YOP33+C6WY!S-_*/.Z:JIM.P9SOG*4Q[STESY8NK_=E!`!RCZJ MB^V=]Q"L1!1Z_OVM%.B?LGAMK/^/FEWU^EM=;CZ7QP+4ACQA!AZKZAFIGS8( MP62?S18R`W_6HTVQS5[V[5_5Z^]%^;1K(=TSB`@#6VV^)T63@Z)@9AS.T%)> M[<$!^'=T*+$T0)'LF_Q]+3?M[LZ+YN/9S20*@#YZ+)I6E&C2&^4O35L=_E6D M0)M21D)M!'ZUD6`^7LQFT_GB!JRC3>"!#50>E_O(6NW_EY087+L:`GL\43I/1&"_6&I'; MK%P`L48"N:3<%97H4:@?2X]IETGB)(AF.WG>-213US32+X68(0E#4H8(&R'^ MP=[Q=O^03/W3")PE+"G(N M'2MD89=A.%MV9:BV\@%2%,PI*56D*8AF9?&&DL0@:=&12*P![)=VCLX'*]DT M6@W9X6HHA%+NO`R63A](WL1*-6NYD`M\&LP"-]IS#!HJML+_6XZ!ZJ>PQ9HE MLM;0/.J@V$`]*^%0JJ$0\O5CG<0E%HT16Z45XX5TJL9*@E$0%+B)+PX4!)W5 M0(F!^AI/#23/S[*BA89"N5*IF]@'W^ZF[IJ]FNM`07B4ZZ2+`F=)Q9JUL%FA MNZ82S;J!,#M;C)5J%MP/SK"$\0OVED%;5`5LF)8*ZFAYY?X8Z*YKBZ,@*DXX MZ38`U3GUQ$OB*%N7Q%&L2^)HO]XF#O9N2YP+E8QL9V-24&1U9#Q1`2OJ6T=B MH&57W*F&IGV]"P/)>J05CI)G@> MA+"7(/]@4#ZPHKJPLM1I@O0(#?4^Q0&#$@ZE'!($(FZ&SLD$5U8X MPUO#E9PXE'$HY M)`A$W<26;Y7(SVN/AASM-42U[R]EJCN%':O7GD$I9PD"T:"N.G2$_-!A(%M[ MS>JAA+-2#@D"43>Q2[Z+]JK=VBLWU!#5WKT%]JQ>^VZB@5+.$@2B06'GM8*Z M4/?(=JI&0[W0,6[#R.JAA$,IAP2!J)O8*2TW?[[N5Z)A#"8=2#@D"43=!F/?1'@TYU:,AJKUSDXSA MHL*T9U#*68)`-*BK>BW>!%W/66.-#:M/1\*AE$."0,1-?&MJ:W^^1"2;"FP@ M*G#_SD%MZCW+["()AU(."0)1SZ]JJ!%OJ`;JU8PYE'`HY9`@$'43>]=[;"QX MQ7)*Q$!4>_>5B(Z'Y4N>.A!$\1[Z)82-3 M&)'W!38R@Q'YPH.-S&%$GMG9R`V,R*LE&UG`B*PF=R2`.7#9&-`@@#FJC[$Y MH!NI59?9=4?K;Z=/E8M?$V%#0^^_L'7\P)>Z4[P'K*MJM;\`0'X MW??X^_\```#__P,`4$L#!!0`!@`(````(0#+PH@&;`T``&U$```9````>&PO M=V]R:W-H965T/7<^3&Z.R\5Q^;A.-S2Y^_7' MYG7PK=WMU]NW^V%Q=3T/Z[?E^^)]_?_IE.ASL#\NWQ^7K]JV]'_[1 M[H>_/OSU+W??M[LO^Y>V/0R0X6U_/WPY'-YO1Z/]ZJ7=+/=7V_?V#2-/V]UF M><"ON^?1_GW7+A_=I,WK:'Q]W8PVR_7;L,MPNSLGQ_;I:;UJS7;U==.^';HD MN_9U>0#__;U>UOSV_; MW?+S*];]HZB6*\KM?LG2;]:KW7:_?3I<(=VH(YJO^69T,T*FA[O'-59@RS[8 MM4_WPUEQ:Z:3X>CASA7HO^OV^Y[]>[!_V7[_VV[]^(_U6XMJ8Y_L#GS>;K_8 MT-\>+83)HVSV)[<#_]P-'MNGY=?7P[^VW__>KI]?#MCN&BNR"[M]_,.T^Q4J MBC17X]IF6FU?00#_'VS65AJHR/*'^_E]_7AXN1^6S54]N2X+A`\^M_O#I[5- M.1RLONX/V\W_NJ#"I^J2C'T2_/1)BN)J4ES?E!,D.3*Q]!/QTT]LKL;3NJ@; M^^I')E9^(GY>3'O4E[W?;[`#+%(O?O2ROZXA:)J90=C5#1=CY1]J7R>L M0TB@S1'!&Q+X";QM%@BJ89S*,F$U]T''B(>00)PC@CC2Y,2O[%'4NP(IU\YS M5.DEYAYQ+K3&]LA3Y3(SI,T.F3<-41[4A<98CR"`\*JT@1E"F;6F/]\ M$[)9,M7%5W1[.?=!6'2@%;>JV^X00I(P'!'$;S3B9ZC.SI,E]0A3G4=(=;C& MX/\E;<#X:"G"B5[N`H[+ZWUGY*"72RW1ILGD&'>DDV/AHX[I,<;0LHV` M9&EM:\_8GR')PGL"+ZZ'F"@I*JCR1OP72^J69RA0B])'2>HKX.I>AZC_5Q.S&> M+",@R=>V>E:POA=OWC'P@S%+7&YNW=PR`\$0E7;.&!.5&J8!DNRM0V3LSU%J M9RVB#7B(*]5#I-3DLIZKAJR=4Z`.-Z0IK>+_A1\E#I!UCN+[)K)3L['/NJH,D-,9,\AR1Z9X@9>@X9`4D"MLT_H6O]]M)C9-,D/;.HTRO/L8]"_K"3<1^[ MJY$8$]F':8`D>^L%&?MSE.E-A!?70UR9'B)E)NLQ8S\NE1FC!-\M7LE<1J6S\[1B>D::,3:7J(2S.#3,DA20!EYP3<5O>3ILV4D/.0D&:3W@65(2IN M+H6.1!!3)D&DS*BY3IDT+I495RVY)O9T7)E5 M<"$JPYR@N*^+'#("D@14AP%XX;5;E1L.05*8Z2U0C*(U&0%)MK;Y)^>HQX5F MY3T$S2T%Z3-UG]:ZS_[BM+1E5M8*,O9GM$PW4?H105R8-CVB M@C"3!1F:(Y4974"6VG9^1O:$,KU/L+Y4>8@K,X.,B)($5(/IH0[+6'_K3B6W/[:CR M$!>FAX(P$W,R-$<*\X-;H#HQI^,,7;0\.@0Q8>:0$9`H5JWX2Z^;8M M"#L5.E/1)-?E"YH85V`$).E>9#%U;C$$Q5=;Y)`1D"2@6(RE>Z'#U+G#$"2K ME5PJ+F)4.`D"DF1M0__SY[CVOH"&%_=QDEZ44]2Q*,S>9.G@%ET#BR8L8%;'X+86\`Y M9`0D"2@N4]A'#2Y49N,=A9T;@D3;G"1G>1&C@C(%)-DF)M-3F4UPGWAFRBIA M-J>H8\J,,9&]3YZWS49QJ+.4Z28F^^YMBBF3HD+;C)?<7=ND`*G,J%]9:MO] M61,XWC8;&YTP]!#SFAZ0TDWHM:"*G&R:F;:=) M;*:O-(/_<&G&/>K>S'`OAG*#3?#]C+W/Q)IFG):QUSSJG#88RB';(BB`* M/TVDOI+6\TT1,4= MY)#D=)&U3'-K(8@7)7,;(Z(D@<1:3NQ*[A[X8J6KDRQ*O)/H+I]C5"Q*F`BH MX]1]P[+[/N"FW3VWB_;U=3]8;;_:;T]B$0]W`?9?[9Q,;V,.6/U=2J,5.I(C1%WGK-L#4:< MZ+.1"48T!K/)]>T,7JRL%",&%_K:"%CCHE8;*3%2JB-8#R[KM#E8#RZIM!&L M!Q-:@UW@M0YF#$X"T@;03<\-Z&-@)N:K99T^!U;M0Y8(V;=RT; M5(4;56WD!B-:MEE=W<[PAK`R!R,&GP1H(V"`M[BU$=1-S3:K<1;P7IXV!ZSQ M#JXRTD`A>+=2&\%94+/-*KP./FI1YF#$X%-,9:3&Z^"S-VT$KX//C;01[#8^ M?])&H%&5P:S"6<"#!LHJ&+Z(HU:`5>OKN[218S*R!= MO&.JY,*(_8Z;DP0UV_[P6O[A,N9:W?[ONO^7$3WRV'[CBM._,F' M[0%_YL']\P5_UJ/%-YJO[:/83]OM@7Y!B4;A#X4\_!\``/__`P!02P,$%``& M``@````A`+LB:*,Q`0``0`(``!$`"`%D;V-05=$RV'AY\Z\!' M#2%+)!N8=#7:QN@8QD%NP8A0I(9-X;KU1L1T]!OLA'P7&\`E(9?80!1*1(%[ M8.XF(AJ12DY(]^&;`:`DA@8,V!@P+2C^[D;P)OQY84A.FD;'O4LSC;JG;"4/ MX=3>!3T5NZXKNMF@D?PI?EG>/PZCYMKVNY*`>+^?1H2X3*M<:U`W>[Y[\TT6 MPK;"O[-*R<&.20\B@LK2>^Q@=TR>9[=WJP7B):$7.25Y258E9>2*S>AKA8^M M\3Z?@&84^#?Q"."#]\\_YU\```#__P,`4$L#!!0`!@`(````(0#.KU@&`K'19:D:X&M M#>:T?104F4Z$RI(GR5FRKQ]EYV*OBE'D39;(PR/RD%9TN\Y%;P7:<"4'P<5Y M/^B!9"KERIHJICC9UYFFP()Q]&P*`1GU.(MXY^<:6549GN3-0,1AZ`N:5/*M8FCE;U9`;-*]PS_BVF[#'IS M:L#1&00KJCF5%FDYL_JC6HO"6!V_*OUFE@#61"$:U)O5LFG;7//K^/JRLL!5 MV](AU$SPH,UQQJT`\Y1-J;8>RMIR;&NWS\`C MM:4&,L2481(LEV5U]Z>,/&$S>:DE?"$YM@T*A@P94Z5S6Y`I)I!QE.`>VXFI MCO<*<\.M_VP+8N$=E86_OM?@%HJJE4]*&S#25AC+7 M:RT%[_FA#JA<\"JZ,:CS*B%.'4(`\T88T8);*DAB%7OS6GP'"1HM7&Z'::FF)=LP4.R(T7,"EQS%0J0R(C M:I;D3J@_N[8XXC(W\+O$$&2RI,<:>UFEY!MD'VRO%7MSI`_3"M#VRCXJUMQ M]P,GWC`^ES%DH#6V_,SKTIU?/[/NV?:1FACR2'7=LUY6W7*]\OH<'TVN1EZ7 M[O'DOTAK/FVK?[C.D3"'Z?/.PS^\.^81(GBC=%>RE;/64^&_Q\$/+M_,S-*EA05A>^"W?EA([K'AX\6#F2TQ-D/Z<[F_8%[J[W4#]+XXOJ\ M?]7'9UAC+PH/3\_X'P```/__`P!02P$"+0`4``8`"````"$`(\`T5?&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`-=7#B!P`@``-P8``!D`````````````````/Q4``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/5L=W#>`@``S@@` M`!D`````````````````RQX``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+BRU/!G!0``?!4``!D````````````` M````I2@``'AL+W=O&PO=V]R:W-H965T M&UL4$L!`BT` M%``&``@````A``",\L5="@``N5```!D`````````````````HC<``'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`":' MIIH3!```CPX``!@`````````````````4TT``'AL+W=O&PO&PO&UL4$L! M`BT`%``&``@````A`""#5_CX!@``D2L``!D`````````````````)ZH``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`".:4IW#`P``DPT``!@`````````````````2K8``'AL+W=O&UL4$L!`BT`%``& M``@````A``B2B53[!0``\A4``!D`````````````````*+T``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``=V24]X M!0``AQ,``!D`````````````````]LP``'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`/UQ``SU!@``"QX``!@`````````````````_^H``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.URN#0Y!P``'QT``!D````````` M````````!Q0!`'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`/6-+%=X!P``OQX``!D`````````````````8B4!`'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`%*J=6,&!0``-A,``!D`````````````````MS4!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+LB:*,Q`0``0`(` M`!$`````````````````$5`!`&1O8U!R;W!S+V-O&UL4$L!`BT`%``& M``@````A`-RE(J\K`P``P`H``!``````````````````>5(!`&1O8U!R;W!S >+V%P<"YX;6Q02P4&`````#,`,P#7#0``VE8!```` ` end XML 14 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Cash Flow Information (Detail) - Cash Payments For Interest And Income Taxes (USD $)
3 Months Ended 9 Months Ended
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Aug. 31, 2013
Supplemental Cash Flow Elements [Abstract]        
Interest Paid            
Taxes Paid            
Total Cash Payments            

XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Tables)
9 Months Ended
Aug. 31, 2014
Income Tax Disclosure [Abstract]  
Provision For Income Taxes
 

For the nine month period ended 31 August 2014

$

For the nine month period ended 31 August 2013

$

     
Income (loss) before income taxes 912,516 (738,192)
Federal income tax rates 35.00% 35.00%
     
Income tax expense (recovery) based on the above rates 319,381 (258,367)
Non–deductible items 15,750 -
Change in valuation allowance (335,131) (258,367)
     
Income tax expense - -
Deferred Tax Balances
As at:

31 August

2014

$

30 November 2013

(Audited)

$

     
Net income tax operating loss carry-forward 1,018,391 1,975,908
     
Deferred tax assets 356,437 691,568
Valuation allowance (356,437) (691,568)
     
Deferred tax assets (liabilities) - -
XML 17 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Cash Flow Information (Details Narrative) (USD $)
1 Months Ended 3 Months Ended 9 Months Ended 50 Months Ended
Apr. 26, 2013
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Jul. 28, 2014
Jul. 15, 2014
May 31, 2014
May 27, 2014
Apr. 03, 2014
Mar. 11, 2014
Mar. 03, 2014
Dec. 03, 2013
Nov. 30, 2013
Jul. 18, 2013
Apr. 10, 2013
Nov. 13, 2011
Aug. 10, 2010
Supplemental Cash Flow Elements [Abstract]                                      
Shares Issued, shares 2,000,000 156,412,660   156,412,660   156,412,660 5,250,000 4,660     10,000 5,000 10,000 10,000 151,123,000 25,000 20,000    
Shares, par value $ 0.001 $ 0.001   $ 0.001   $ 0.001 $ 0.001               $ 0.001       $ 0.001
Consulting Expenses $ 2,000                                    
Accrued Interest Expense       1,743 2,014 10,269                          
Loan, value                                   45,000  
Loan, interest                                   6.00%  
Intangible Assets And Intellectual Property Write Down         45,000    45,000                          
Accrued Salary Forgiven                 516,000 516,000                  
Accrued Bonus Forgiven                 300,000 300,000                  
Consulting Services Fees Forgiven                   $ 545,000                  
ZIP 18 0001472375-14-000279-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001472375-14-000279-xbrl.zip M4$L#!!0````(`*R(5$6LM=>MRH8```(@!@`1`!P`<&5P="TR,#$T,#@S,2YX M;6Q55`D``Q1Y1504>454=7@+``$$)0X```0Y`0``[%UMN9UDDO3,SJP-'O0"4+3F8&3Y"T;.K\7O2>/1J,S\FORZ-:36'@B0SW#/S^: MP:9D#'#/\UM(T*]6N'XA_;!^%OV8>106/CJ('H7)HQ;(/1>`V>G"?3Y#/Z#G M9:W7EWNJG#SN@_E.R(,S]&OR(`Q<39&'^_2+GDA>6`6]A6EZZQ?F9O!('HY_ M*`"#?O%=&P2%[Y!?"EYR7,=9+8MQ6:%_%KYYX`P]U$-/`1_.DO=N+V\?UF]Y MP`NA!4(P>W)>'T-;!.XI\QB"\G`5QZ-O+_65)4Q.F9ZX3@-92@]>5D'-S,B8YR'_V7 MR%P_"IP0AF_K;]??(^SHESD$OD20@8P]$@I,IG\[^=I']4/5A\;0^'R6?WDC M[JQ07BS-0W9TK0(4A.'AUXT":Q'Q+_GR,R4E7\;V*#62VI,1$5ILI%@!H49" MM<7H;=C;/B/%"H@QTI7O+B,9`Q150K>U!D-&\<,+,P1?-^HD)6U^VWH-.%;J MI;2=DU^XVEE-V5EMOYW5*G96#V!GI8?^>S]VCM5IGIW[F`#*X+W$C5B=!L6- M32.FM\^VV49,%]:(K=.AEAM)/8R16EA+LT82EPYE<\9?XY[:KU?0@2'X`9^! M-760N`5\M,$X"$`8_`R6C\`_FCDW<0PLEB!EA_5/%@+SZMEP!L,(JV1!]&0T MXA`K>+Y'P6]O/YN_N?[$-H-@_`J#DZ\4+T62/I\5`DB#/RM&W^RD.=O]ZEC2 M6I8)DZL_=!BCM@HW3'ND6ITMN#;SJ!.0O1`X@1 MZ5\B3N`AI_,M"WR0,-$1H($$.$($N+V?W@/_&?F':SH? ME!M;QBGG!@<\*0`%3OA8\:FC9T?/-D;/:_=95CMZ'I>>!4[HHF='SXZ>38^> M?UTYN%E1.G8>CYW;/NAB9T?.CIS-CIPWLU!1,*:.G<=C9X$3NMC9T;.C9].C MY]CSR7B&UM'S>/0L<$(7/3MZ=O0\5O24>_U13]D=/3L.'I$`L7,$$P#_IW8$ M:"8!B'.$$D")5E9W!&@B`93LLG=1&4J_IR@=`9I(@-@YHGM06I<#-)0`L7.$ M$B#:C*"W=Z5VK(`8(ZTW5&TV^N17;4_O.P>L>Q2[HXZ3:!.Q6UOF?ZYD.U8 M'5T:0I*[')L61!W6$S[UH36U)F8'@Q- M^T/Q8:\-NJR3->OL*-5D2K4F&^UHU#`:'3E+[?C07#X<(WOM^-!`)F_,93)V9NP0?BA`[]>^RT@IS^AV5&D>EUN2F'7T: M0I_CS_EW/&@8#XZT!J#C0<-X<*1LM65+=%N;RK79SHW-=L([STVHM[-W].SH>:0NE*QU6]D:NI4-.T,FQOCA$K M<-`CZP=BQ+I>>[;Z!K5.93=OT([+79H*N_QS`>)S!V-.QJ_MVA\^0IFJQ`^@T(: M?W.=5?`1>YX9XA;;Z-#$S?CB(T;J5K&J33?0=ZQJ"ZMBYS4H5F4G+&B2M8_$)2YYF<@L7MPD M37EJ-$%&6]E89&[2W7J&@>N_C1<^(%WSC\<;$H/R]CGXO'NQ'[IDC3%9ZWC> M\9R5YVU,'SN>=SQGY7F3$UH:;L??0V?QP5=H'9O*"C:4?3=@Y6I->3W3^9/GAR;0OX'Y6@^\W1#1$P#A%T[&H+N]K8,>_8U19V M-:\['+-+QC+BV$4^*VK+-J=D[!RKPV;G6&_!=MZT$>2SK+7;SA6B9:RWZ&BY MYC/Y++=M0W<^;K#S.=9;Z#!:.VV;O9,M;211%]>AKDV[C805$#S2U==:S:18 M`?%&4@8M-](F`1)EI&%/-EIM)*R`Z(%EU'*W+\O.K4O@.=E95#<[MC.I,YN)JQ8&@(R=8W68AT'3 M<4,0GW=.$/X3/`8P?"='FEY!!^GR`SX#:^J@\+N`CS88!P$(@V]O/YN_N?[$ M-H,@-:B>4;^;_V.<_^O(TQ#RM'%ZKR-/0\C3O-F[N$\@XR5>B8I+/DI*P*7MJ-\,I$?[!01&X$\5%D&PG>[0XX%GY$;MVV+W[U>+8%OAF[! MP5N M@4_>IG-D*E[E`?9/^[AM8!#)">6V8YN(,7D_'GELJ"7K(3ZHC0NNS&-&K(WZ0Z.RC?-C MKM<@O'R=V2O\['?7M5Z@;5-W/M+@^JAF&ZJZ044CB1>ZPDY'#IVJ'AG=VNM[ MAL"W6-`D/?(1HIX>_-GRW7>#@!N;SU7)%=K^-EZX?PC],O">N*M3#'0-5_F*H\K`"!!_UI7Y` M\Q':,(0@J&D)99@);#O+KP6$QAQ:+1S(:KYKVP_F:VV+R,.^H6TA*1!0#PJ- M39310%>J0$F.P(TW5/.CB]S7LHXJE<0%&HVQ=*-?#]FU&X*D^J5VHF]>&#O6 MM>O,ZEG0,`P]A9)-*'_(=&FI/E#EQF%.EE-=N:'[#,'+U)G19'*##$N.K4ON M/+!6ZT)[A_0]\!09+Q)*7=*[MV8W24G:FXA;K22M)Z_=9UEE4%(SM+[1'#5I M?.K*II!HZ+;N&2`0^!6\GZE>T7FY9G@A\*E[2KBC5 M\&53)Q'PR"(L.O+A?0*Y!E:X]4@DD[5J\$:5*D=2K:DG'+CW9`>C0792OP!/ M==2B^M^ZHLOB4(OJ3FO&X/BF9@0M#_M#5M!9]D],WW]#35A)Q1,Q&"5KFKZK M4F9AU55!V$"3,I1WQA6^*@ABO6QHRH$T$%4%C)&A5--@4U]@=@WNYI200>[T M"M;^5YD(-25"%2.BX!@%_EIL'?/!+F+F+@&95!7JCE(I7#Q2*H6+4RATJ>T7 MU);@BA1#W6NPF-"2E625 M%X/U1Z/TTB-2&+T(*J9HQD@M$[%GD=PUJ,R*W+C'?B'U(3'6_O2!,/6V*:1+ MHBV=?IM!4>E9;]:MO/HPSX^]9*]9^619'VQQ?H?`U'84LI&WNHIX-U'A-A=2 M;A6Y5+KB/4$,6!?$25-/&:#,WJ^PXT0QFF)G]V%%\#!941C*$Q M$HIB>P-RZ2"G$!"Y_;X%('3A(/);?4LW%`@AA=H,$'+)NDWQ&+0F&"*WK;>@ MID[J*N07M)_`>;X4+>JL1/%$]2ZIUK& M5LDLJHLDDN+U0L.]R+LE1D8?#*FO71 M0!?0K%.EQ;K>9]([-?B,;Y_EEEKE!IW+Q/"`56&@FA96>GA4R%$&%`)J8J$_ MG(`!RWIF"(11Y?SA!E6G*[.52!_)Z?"<$<`LG6+*,BM=T0RUK_(23S%OF8L@ MJB&/%%[B"T[JIPCN,C_C;U]10IUME\ZJLMF>,=>O+7V?[DSYJ%`['!;)/IO0 M97)"C7$@""6UHD+2,Y(571Z(B5E&'&-ZZ9*,PYJ'@_*DY9VX3K"R MP_R)?/77_5"4SMI0#J/)C5S)#`)9FT8E/L^END36UE#7E=%0KR.QQN*A:J4G M"SWC%TTGS&U[LYYAX/IOXX4/`!YF98MQU=S*"91X-@BVWGKN*95.W\SSJT]X MY-"9\PKWBZL/CC5R'!0<1-&6]-&B8[:C.<);?F,$3SQ[HCA.-U5%F(0,]-KY: M5>W9[CIO/;M.A;M69"F:,%<5G;=7JLPV)*ZZU!IZR*UQ/;8NW`8RLFM/1P.E MT6ZJKIJFC/1&>XW/.([T"]?/62CRCO^LQ.>FIJ:[MP2 M40D#ZRB_KLDCWAA8!_-E-7/&$Q\0K&/V0]50N5N">6B^;\@TED@O`(M_XT%( MO'6_H&A&J36.GZ"44..8"4H)K.PA:UEYF(Z-+R4.2WCTX)O/P!X[%MG:@QLF M/"M:CSAE[0"S3-;()3"\6&S-5,TN?Q6+C<"H+SG?1 M&[.=G03V()=2/U,ZLVCFQ3@&-]',;:PV&/&2S;Q`9YA>5U77Y(PMZM!0*64G MU_5\`PZ8PY"L-\<]P6]F`"R<'R.6UV%A&=-KR>=PYE,M^1Q.?JHEGY63LIKI M*5#+YNRTVN'Q!T""D-`[%(A-FV,N*&NI.ELHI3(4UK"IIGL'?*$PAU$YO7F' M+Q9F"AM#85A8P^Q`-1BAH&XW=*(S%>,G4';A!'/@CQ?1#0(3O'[%@J9S!?CT MM^7LU1M,\@7`9TYX!XV"SUIUM&99G[6V:9GNQO'Q,]=0O;[Y25?S%CBF+>#0 MR_+"ZPXL["V\[IC"WL*90WM_LVIZ73"+H6KG%>3LS>\HJ?%-W.$;6TOHP"#$ MPU'//(><#"6U!H=&*"^@S-%WJ!\)*?/@0^;VV$,B9:6YT=>,8WF?+7KB[D(U MI*2V_@Q00?EQ$Q'QDUH0*_T578OC4:&(:B#85_T+`,$\?B8"1-T=2%?0ALZ" M6Z),)H5R!3/(8XZMZ\:NDCA6&JFJ8M21Q]Y1,]:[]BO:DW%:0!V5R+M81>)1BV(='D\V+!0*JF;-V^H<)@WL![G()@V#7 M[#QK7!FD\I)M"=4PL/>B^6-@'D4:]OF#8(Y*6OIX('[N8$RLTD)^ M1#RQ(&C.A4$:SQMN[@`2,$.I"3'!!;!6LYU+P)C/YE%T0QUD[@0KDJJJRZK,'^:UZUC1.X^VH$4TG!`PMQ4H4^J7&JQ(.B7P';5A'%X!O#+0O@_- M2HKB;O+=URP MJV8:"0[(#J3L?@L9=?8?`UBZ MQJVJO*J#\LEZ4'PD45IF@)L+NPJ@;.VY=!)&>T5)$Y9]P::/F;4AX-]5&?BJOUP-#-V_P;>J*7W\='\^M#`YZOO+"TM[L*=D3M) M']X\>AU19_#O4?GIUXN*C79W7#K6!4.K]77S.2LE4UI:W!C]:I&>G&U2'R?V M=8YX`B()F0+2)7$Y4HIH'=DASO@X5ZW MLR"Y!+VT?X$@0^_"TK:E$C039.X%REJHA=VC<(+>D];%2W@-H>F\I2%DBBZJ M")'+(P)?H>_HE?V[FJT$6R7M%H<9QB8,?RX2MRYI:V\97#AP#F(] M7:X-9Q`$#TCD-]N=_4XM_\]V^,F3@O#-!E].EJ:_@,ZYU/?"DS\OPD_XQS./ M?/J3K,;_0]^%T7V=B..>:5E(/@[^Y._`,V?)WW&A+]`*G\XEN=__KT_2',%" MGQ4OE![@$@32-7B1[MREZ?P4??&3=(\,/?\D15AZH>LA/.L_']TP=)?HFS6^ MT$\$/0/$%F2ZGFDC&YU+Z-63#7;\J)7#M"GE++36!>:?DHV4.;`"R>_X*POQ+L>*`,SM_8Q=Y/OU]/KZ:3\?6#-)Y, M;GZY?IA>?Y=N;WY,)ZAAI,-T%OJ;C]C7VQ3PTFBP=VD]BJQ._L56_239(`R! MWXMIRCG_8:0QSZ7WZDSSH[R3GL9`]/,%`"E9+5-@;`>/.I6!3625S M75LE+ZZN$GK#\T&`:CVP$%\E,PA0EB)!!R59^'SWT'1P]9+")Y`$P=@`VN`3 M>AU/J<,EKNP!*M+"!Z!+<^B@K!Z:-K(#^H)<)'Q*`#V@4JA?D9!HR<%WZ4JF M#R0?Q$#C?:I(.61(EEZ>7*P+>L+#6TAQ=$!Y'H8-?2)RX:.834#@8MW' MWT!TD_';J810!:#0.D_F,Y`>`2!#T=@P2)3])IF>9T.$&ED)VP7A\LQX_SQ" M%98J26"D;=,P(I53_+W$7T4Y'>CIMF9/%-9TBBCGTO?Q^#;YROCT/U'8GIE)VV!*UN8& M/0R=7.87-7$8#'YFHQITT-_+*,CC%@0W2>`5-TE!!(V(M%S;-OTXHA^C1G4A MO5I=8(CGRE'B^>VF:B#*3];UKX%1O0O>;0_>B&KVR@(DW,8A.DA2V[@70((@ M1%^CS!M%Z9[[X@`K2FQ7CP&T(.J$2+M.)D4Z^Z*/Z.H[AZE"A^XR],)UYS MA*H<9N;_M_>FS8TC2:+@]S7;_Q!6D_4VTPQ2$;Q9.3-F3$E9HWZ5DC:E[-[Y M-`:"00FO0("-0TKVKU]WCP@@`(('>((4W\R\2I$@PB/2*>B[L&<7PT0'B.PC5$=J"1O?P1<*GJ8T33^+"!M_:BBE#K,: M0,,C/HB.YD+5-?5](@J](46MKOPA,212$S5]M/]XI6NBG7KMPFP9R<$XVDG" MTX(D?DB2N!1?-)KB7)U=G?"9PVR7PS0/PF&TJ>`78D"Y=_.M;ZE)%1FC#:A'\'([' M`A[H^B'V6!L%_ICYDZ1E(+)!Z=2,8?4(CIYA^JKE23,^XO"*$8ZQYQH`^.8Q MYQ'M"2"#KR>DBB$WACT'L1W%`2<';7+*3BA\L4,ZJ(P-?T''1'"DBN8,W\:S M!7;,>L"`6?([W!%0#8(J MD#P7A M%).%?!1QO#O']%G-W9,0:AU$"%''>+P]]`^<$?P*G,\[(O7VT$(H.4'LBLIX M>H+*-B=`7ISG%V#RK@/?HY+ZRD5U0RA872)FQA8P4M*#A14?<,[&`/=+B-S# M!CP"C4.5W639H/@DS`3-8M<%FS4&E6<2(#?#])X%[!6,^@+WF^PIPU(X M0D;-9L`0!9/V#]\?OCFN6\1G98(1@I+9`L!G16CI"8B!VW"'WN@`>WQUAC%% MND$7$U%Q]ASX\80\!?24/(;P!1X#`PYL-=L'R^U?R&,3KR=%0#Q\$4$A>28< MC@&GCP`Y'OT!JV#+,9_.+0]H*"!%]HI69CCA-AF(")Z#P3OX"ZG2$,^1F8E1 M/5A:!%*`?X(6:D@G:_HVQT.SD@(U%`A""SLFLUKY1X0/Q+54)IK'."7:HB,6 M@TRP9L$!X+?XJ&3U;R_<2P50)NELAC00'PIRL29MA]`WY",'\PPR4H$D4R@. M)J8,,@)4JR,6OHJL)!'22`"1)0I*6,-_4@X!'!2WP/X/$H_#A#)^+YGFD0(4 M2M5=?JO<4Z86'FMF'5-X6(%R%UGL+@XGE#F[KPY_PRP#=%*FV$4N#>))>-+1[QB1 M(\(&\?I,E@*SG<".QYA^;-,'0[0.N!`GI`5@)1?9+6/TUB*]`-\6;'5L38E' M2SD!ZR`9%,$.3ZF4A;E[`-86S>X`K*9$9L,OT%_*_QD+G[LS8F7WE,@(N0/G M^87@%RNBF/^N=N*X*!-QOU)>^_C@"W>%$113.EK(QB!88E0T!E.5>!$X89JA M/'N`2G>1"HM/CVGF$<`;DFL<3R,FNXR<4R/7?PMEM$`($(!'^?UI_61CH(S- M6SU!GZ")GS;GPY!$40K"S*H&">L4*W#8P3,7#X+R*,7D+V#",CO/.168`O/L.;X M.4O&%0'('*#N59+V0RB8(#(98B7$SK2PFN[=.E_B8[_$9NU`GB'LGL&>K)_\ MK-.N"H">`V`-?2H(4*'\3K/83=[/5A>@"J>??7'`7KR/H3KG!"(?0"EC@YI)+D`?+(T&(1+<9^8$$=OD/ZR1>])]G54'9ZP)?HZKGZ MD9-4QR7ZCJQ[4]H2_A`S)D@]I738*`J<02SH2'K*(S[&=-Q@RH;.:(2.&GQR MP*,WU&B65[3IR<,YI8KT'_[3"45*1>$6$EM$U.MA%9_H2D/0#RS,KF#7*QY% MHOFB8^F9<<\2>BG\*J"2$5U5Q<##E)1=ZV=R(!)O,C&9P@!I>@:@*.1S#DQ% M0S1%6%H@(D\#8(Y*0L@M@..&+=->0/\OC\/(0%X-W!MA6 MBQ<2AM39I3([`X@(E9SEUO'+K<.5%-I"]73<&"E+Q5%P474RECPD]&&A\H\\"3'(O MQLQ)%`7ZZB`;XDC5F%\F9%4"Y-`9`U`!\3CC?I)E/J2AMSS*7B! M+AY2\-$K+WWAFN,LW8.5C,/.;2?QY;SYL3O4"DVT?:)_B$+O/I:3.S/O>+&& MXC<.#4<6WCBI?,Q;]PT]$$,\/A":(NRA#I-+HJ%S$`>01'=>,`B`^H*()62D MG)9RB18/"#=*_P30;`OU(2=B8I,#3LF;%\GRK"_.8%%,`C>)"8A(/YGT)L(* M;2?S4CH%0!PB(RD92K:F85KL4-"'5L5SEG?'+.\.4W)YDS@>OZ+K[^_*]?]+]KAEWZFR:D>3F"RT/)\6!H=IT2/L+'<5&6L`X ML:9TX]*^(LDGDTG@_R1D2Q,D=?:*8'K,E78-3#.(+C!JK-(JIW(#5&*9`(,& MGTMY_QC"?\-,;UQT:"#G1`=]DFFOIR-AP!Z-@D0X76D5C3+V#(J]+\733`4D MV`\4=:`"`'O*`B?\"^T2AVPA2MP7D!8>X*X[D526*+\6G89`0B*F95Y%$BO2 MI!DI1*#">9%R%"+U45-2PH"BRS2GWYTJ`BW,\D49.A/3QX<22WDF+QAC^0VS M)F0G["()_CP#(229OUST*?@#;5*:@[-+\7C9.$M(*2'I*'8K)`]3T?K5#T#7 M]]B5XC@TP]"M7&."C6EQ#V*Q5->86G"@:=6`^V?8NG2BR>+I0*. M9BFE3R5!=%GY#Z(:J\OP&#%^3N5-THX0P9X\0)BJ)NW50#6725;5DZ9E7M9W ME3.ED3SQYV3,1-*Z#'0&F:O&0M$M3!@I<&(B[IRQI!.%@(XCFF)='T>CE#U; MCB>*-D0I'N`_=J-$MLNS$C5P"I69W@X/$>=6CJ\*.;6JH<"OP(8+FL&NY]?*:?H.-:?"'H1XY4F=3YH< M2ETXX9Q"I8#^GD\ILF5H52:D9/1*!@M@ARFBJO@R:5ZB-$Z MMFS$0!$E=+E=LKY(*59ZIXTQ!.%CHT"Z\E%AD#T!^LS73H6O':9(^2J5Y5I[ M#^I97ZF^.$?`XY*!4B]3D% MF+G@Y+Y0I+5L*A>KQX3FZ7BZ_@M_@?XN\@I=7D;%%>L^);%<.*(1,]T^LTD'L#%D\T@\3/JQNNZ M:>6;2G"@F'3BX])ZN"5R2#YD2+L#57#Y>L)#\G8JUY@IK4-Q]/B#`5TP21,, M*SO!HA#9_PFMBU[`.!9#I(.I\\D`05*9)"4*+_E<:IQ8(WB:F:W,M:F+\'ON M1`QZE8#!"EQYE9!^)EBM&$680_9$"0'R![X'_[9YQ0+J%4\B*SQUD8#U.S`! MD#RN3#8CB/X6`S])!#9#8:LRC3*\T#0+2@9DE:_(N<+N'H0DJ"6E?D.=JI'+[DMF#^96`%_QK5DZ+^`![))[CQB M_3`H>UD<1BA*TRV2NFFC%4JILO73P`B!.`EAFL$KW/0T*)M;G(;^*Y%@G1=G MIDDIQ7.EV*I"3&3V+19D32&S6)&\"FD@RV*)E>8V)$G+.>$EC&:06*4%V)R) M-#-LI8I)8M5B'M^LJ9;,-X=W-"]JO4+=6L7@R,2_\C%;PE:]RJX`*-`UYT0< M5;#/?W70F+^#O1-$JKN:SX/Y_>C)S:YDJY4N\T##TZ&? M*O-`BQ9Q#TVGE0J\;):HRBY$GB%"DG_CS/V;IXDN4Q3;"[3?2W:3N75ZLE"J M,*:TMMD]9&O=P25*Y'N_A[<>^UL,QMG(Z[W`DOZDHL(FN4OI M_5)RDH2DM.;&_JL4D*(!BI+R!2VXA*$K\"KSRM@W*T3:_0,E%B8"2`_HTE[9 MLD'I8"I`4('VE%[2^S*D_#Z*9JL")>$^+`;0D2Y/84:GKTG-0X0]<:6*O`F9 M9BT0(2]&5G^03$*X.N%>+P,!#O>C^4ES"6`*.BP!ML.%N'>:DT!&P#1G:E), M9N2JWX08C)P@CT8=YSBL\ M'_0C[YGG!OIH8"B/#"EZJ.4YP(=E55>DI=M[Q7V7@<.T`OJ>>$:%@#@&=\`&0XYV MW4U8Y@\4Q?54H_H,KTH+EW07MKQ`".($ZGIX3)Z@.1Y.FI?-2DW#WIP!CRY\J7!.SW MY"86!5)$62Q922()+$DUG@E2[>3P5CF;XL7F#U3_]]_*#7178^`?;AZ>?I<- MJ,_3W@\U[7V&1S;V,NU]MOW[S9?'VZ>;ZC#G30O-4EK3:2M/>Z6!S%#E`-NQ MXK!"U[4F(9RK^E>.?H+D3[QY6>P54%_RXD!81U]<"VZF"<"1(9=\K8AZYGNY M0_7[UF43SU)]ZO)1^N%6B*>/S6A^7X%V>>Q\^/Z);,)M9%-2#V+`)NF">7X0:9X<*X>O#^`EBCE9VRO<;C:4#**^.T; MN1_[\1"'<7\J1J3&\M?G:8IS]GY=CJ,E*-X&?\M2<3'%+J%2M2-SCSO:-5$2 M`/F*GS#?F'+7I%D`Q8>2W&9%W+5/&W=]+0%1[XA\LOALG#8^,05GX/M_R986 MIXK%T^2H"2/='Z(^G#RO_,TT6[]N?$X+^>21HJM9171M?$0%'/#@^-F*?EQM MG72GW`Z0J^R;U,*. M9_O5&)>>075TR@.9$UL\H=,S.(Z(?/9ODI1F,"=@M%1ES_LR:ZJRW]*&3SYU MN,Y!"*@'.]P8_H;1I2?X@!=\1,.PSR85^F5S'-3_NUF@A,@%RG_:(] M;+LTAI-Y4:U#15>*10-R]`'&^DAJV;N:VOW7C5:MQCYF7M-@%_(+@1T9G\1* M1?B"!,TG]O$.6S7U/A4GJY?/)"_,"5<)XRK-_,^T$_B5K!K2L\;[X?U(=JVX M:-1^8;'GB"]^/%[_PH;<=L:6&V+V[7^:G99IUNMI!OOLJ]=;7*6I+UJ\T^JT M>KU5UJ93Z=MV$//AH^5:P?2K#V?XRKTY:[>6K=V".UBKR?,N?/,&:]<[AUS[ M?^1Y_L_5B\-'-S^Y37.?[D4^UUZ\"G&7WX7B3S?CB>M/.9?#"F;95=\;WOF>O90KJ@T\6&%T[8!\BOP@ MA!^K!<+L/NGNP2KPA.P'%>+\0CY<9;M=03CK[6'[)R"%TAY/P*PUFY4Z`D4$ M&9Z0=/;,\`2U_QNAJGSGSG@0!Z'H&E"\]Y^A\[OGN/_Q2P0\XA?VV^Y0N!OX MLQI"H^IX*^;E:M_$HN>QI0-A:@.("T72=M!S*T>%7G/QWUMO_OM6+)%46Y+[ M+&`OB_?7;K;:W71_92#<]N[JVNX:6]E=L]/)8.^0NZM=U-H7]?86<6[T35*@%B5G&TPA?J;><,8C%RJ=S% MUQ6+Q[2W4\D#7AV4!;=TWZ`LN%+E0,D@M-ZI=[M*=COAAP5K`'$^&6QTG_KCC^Z]>!*/&/G*/$8'!U\Q%V7TPB&AP#;D$;3XEVD1$'_-IO+=R%D M:V*FE`8DLXW'R`'M:_A@.<-OZ#ESY\"YZ+0+6*QF1LVND"<&`&S$PY`&;@/, MJF.E8B92/RR^W[6F=JF:0-6+:32#_-76G8'6FI*&>C]*B`>GX&'UR!P>E(/1 M7.QUR\&X8+7"2R4O[`VUIT/_(WWZ.`'Q!1ND;KR^]QV=G.8;O^O:N]=8MW517V%=LUZ;X3$+ MUNVG(PR?_'XR=AXORZUW94V<"(PF.9F@)*X*;J79:]5,3>2NNGB!3N>/^9/U M\^:G1!.%YR0O5V;Q>`%'6261P?:#9*P?&G[ST_\6",WRW6/$VD%'.QD,DI MD,4O7P0"R'HLLK>>^1=NH?#_ZOSD0[6/[V)VZ`J@%7+%VF6M70S<\F7S0/^# M^C#R85],3;V+41F[=MP8/A/Y.S/-6J=FMJN\L\6,:N[.:K5ZO5?K5GEGBSG.W)W5 MS5;3;+2VOC,A;'`H`L*'^J#CQ?"+^V1B+]S=+U;HV*`NZJ\O?].`G3W,V=^, M]%L#H)WN;/%-.^:=+54)CG9G2V7[W)U=ZBKCUC:7F?\EWGK'H_L1CB%9YS+E M=(.+5L]L:.)JP7(;0K;T,N0AJS>[C5IC'Z"557`O.HVNV:OO`[2R.N]%KPNB MNKD?A);3@GMFO:7K#R4@>TH'VJ="Z6LLNNY;[I.?3)"^DO.,\Z[J/W!6W":W M9IGG>-<@KG!]#@WB"M?HT""6ODZ-AL:!M@G=_NEGZ6U=AIRJM/0!8V6^6V-+0)6^*&:MV>CN'G_E M1`[LH-LN`13YX;_Z`5A)WLU/FZ;T_F$Y'LV(VP*1@T76D-[^.:NL"TEYRJYW MFKL!I;2[L-OK[@:2LD3<:K3;NT)/.<)MU%OUU2!1M(T.LULO!-:-@B,O&\@[ MC2V'=J/\K+_X%M2:]1??@L*R_N*EO=F-MIGQXZZV]#915=+KO1V`*41[.YY8 M3H`_NP(C^;DX`V8+A+SZ8EL@W-47VP*AKKY8:=&?3U`I7&F3DRXI]->"9[G# MY@L?`2M.XFP8]XX"RP^&CF<%TUN<8H[A%`R.^ZX+/U7JQI;\-*U.HXQ_:6UP M#WPR:_B)6KU&_3TUNU\PX:[-+K`-"62:5YU';@*$L-\@S@VW`4/;:U1L` M:[.[;624H^^FV0";. MYX!%3P7]"_*/RU)GT^QJ`"U9<`OPK4&ZO7W"5YJP&[UV8Y\`EB7[=K?5[>X7 MPR6]5ZW6!B>HE=K^PUK?796]$[UZ7>/8^276`:&TVM#J93.VMP!#6=+.U]QM M`X;23+O9:+9;]6TCHV2,(%=:N0R&[_R5>_%V:+%7;VC\3[VYS(I;\)\N>OT6 M/*:+7E^68+9Q7B45S)56Q/HSK.B!_V`5RJOE8I%#/[JR@F`*9OK?<3C%VA4* M+3VQ;)65M@;>2I?8;+5K!P1P:1L7L]UM'`J^QBIM9O3JBKV#MUQ'JW?,0\$G M^$-K25E&HWTH^.HK7-].I[N;ZR%*1_/QOZV(I6YG*W@ND*]2')9>2UHG9K"V5#:N!?C,:<3NZ'ZD$$ZRKNO>* MW[BCJ/NF(&Q!E]P4A"WHFYN"4);Z,ZFM91;?/OHV3DV]XQ$N]!#XK\Z0#[], M?X18*2C[*7G/?1N,];FM4TK[3INUFB9G5E]\NV"7#D)E\R(.!79I@[\:8)<. M=77J[;IY>+C+BI969TO$+7L"/5A!-*7L=HLB'"K*AN!I'X?_<*(7_2<[DC4[ M@&HKKHRM0[45#\C6H5KC%NE^X@TAV@LQ;*'.(M]F"WN#Y!H^;<5<:BUN7E:P M[-9@W<*E67OM+5R-M=P&ZS5:K=S@DE6UTT6AV-@06)(W-^9`NG^KBU[@B.HFQ7>4&D+HU5K]]J[W\]#P">6,]PL'[B\!V;YLCMQ.BU?MNQ% MRJ;F+UMQ&Q"6=\N:"QG7]B';0%^\]-V8VQZ^(?O#]\%,8MN$_W12&LA2;=FWEHUUY%CL\&W=(+EO?NJEY,R]?;].Q+NJ76 M@&QYWN%6',*B6=_RQ38#JW0)7KW3VCU4Y9/`N[H7>E=@E:9[T=%O]S@L2?2B MO5]YL'(-++>2R[JH[>H:ZY>FYT4=5M=8OW3WR47-5-=8O_R0FD5]4]="0,GB M_T4M4F=B%E84!_Q^E';^616$__Q?;O0Y0C[.;.ZZ$VN(1BI"0'^'$\M6?X?1 MU.7_\?F<@'7[]S$:P"OR[/HG8DS,&V7/'W]AW?VQYAOC`8(\\<$:? MV=@"$>)=1/[D=U9+_ASX4>2/X9-?_M=S])E@"=1"KSR('-MR+RS7>?9^9_!3 M\=2_F0WQZ#`'4_J6WZ)A\L+\4V9W$B4/X@;4]_COB]#Y%X=G3.V9`?[#O*3W M#I(5\.F%R^'Q*]BQ<[0SFI9?]J[_]./[#>O?7;.K^[NGV[L?_;NK&W;_E=T_ MW'SO/]W>WSVN!MAO49#^$Q&>GJ4ZT(D.$J)X5;3"T=/_--J3Z#-;M'$!IC6> M?/XWLUW[G`-],@O3J=!FANH6D6>]LP)YUF;)T]P'?Q\\6Y[S+V(ZU:'# M9FL.'1,^3LB=LOGN_ZSPZ^Z-:S+]G' MZ(4S"6"S\QF]!)8W51]T/W\B&-^LD#F>[0<3/\!4:/B#X0\?(QP$YH\`S%=K M:!GL!P@=^)H^#_&+_AC`M>$;WP,R97?^*TU+96#DMB[9O#QXGL(+ M!=Q`1I=,:%Y@<,#M9?=VY`MH3'/AXDQ;F`"AQ0N7P+47'/A3\2)3;@47W(.3 M#5FCEIQ3YGG\3HYNA M,W2L8&J`KC8$*D0`7.N-[LV7P(D<,#VN?#<>#QSKDEZ9@()0)*3`AC[`X?D1 M>[&`KA'^2"MA$!<%7SZ4MS7='=*KGSL))."&J7W2/'I:.@OZ%05]_2""7I@8 M2)F:D6$!,[PBCHO2YDL<.N@B.FH]H()L\,<$KC_P`^0I@A?DI;1!H,R1C0.) M%C9Q+8^$)#`/*9.`X8WI->&+,[F@@`1[D^FC5A"Q9\MU>3#]S1)M$-F+'X-Y M&T[`4AWAM0#&-O+M&'\&WPZ=$-;`MA-"\@%UA)SZRC)?"G]\ZYL?_)45FDI= M<*(0)6042X98)#MM^1O8!&S'5XEQR><`AR:<"1!,QKQDWRS/$O$7%G`XYG_! M@M&+%1';!>,Z=B-BZWY*WPE7#BV7:%]"#R+`_BMD+B`),(#[1-M]B"_TY6;F M:"H$3X(1.COZ/>%FY`?,IVG)U,>,/SLV0(/SA=!1`(),5XWJ;5#*0*V:4X>*$&P^>]8!2%5R5DB6'5LQ1_VUHDC:KA#).GAFA@#B>($KK M.>""T'*J.^4",)6IS?KJ.4T'04;Z]N+8+_HJ!G[*I1^2R*33,FJU&OX?"VGP M(5+G`I)#YQ$H^1$-ML9:%3@TW_[+`,*W.9#3D,%E9@&.(14$&3D1D#SL9Q+X MD\#A$2A!<$::4H5/`2CCV"7+X]5W7Y&:$`AK,G&!/0AV-1+\PG*CJ:X;A5D6 M\*)9#<@&A,,_XY@UBMY:&<`CXSD1I8",J9N,QX M-?WQP(H29LEMW_/'<,D&<0!TAS\?./[%R(^19Y'I8S;9-9S0N-`"87#-/+KU M\-D\W.9IX*L3`"'U\9WH#7\\%T,?W0;9RE`H&0(3XT9%X,MQ=0W')^.0EEH,&].],+ZKGOQR"U8DSX,V9_1$&Q7$.;.JQ-*)BQ')2F7NN"Q!?]"FASK+_&3N!8N_ZTOAO MS_9+R4V4D=2*9'1(B4I<& MH=7X%8YUBG*>5&7@2#3[DCU:F)4@,-;H"@S)SI<&OF$`G,IR$I:DUAD"4E[5 M!@M/I[(\ZNS+6-&7T3B(+P,'?)/"_(>/?/?*!]LZ..[P107=%L@S+%M:G'C. M#O)$9XRA:=#*G6'BN!V)KD4@$='X)YX(#`[^-\HY.97-(7@2)L+HJ:CU%O0@V9_`+( MW1)+1K),X=F(P$(B_@U?N%I)$'Z+S->)Q$YD(,8#SFMAWGD&/)`58'N-''K_AYY9-UIF>\'NQ<9S!_8Q\W=#V2$MX!@N\F9\=:?1- M_3.S8Q(-P'4)&GK@`I;NFK!T\Q-MC&0/0R<(':0U<2)4>OC(L26DG6;;J#5Z M!=C[J#EF!#CP=M/HM&I&K]UZOSJGYIFR+0^#!!-1_XGT!IHB$*NT6:6W2M$) M%3*`H>B,@6!=L$?M%P<$JZ0;$D*:-PLH9\!Q%!2L$KZPD>N_L8D?.HAP`[\- M+-`B&4HL,=T:T#H@^^,W^)*#OB$M>(GUC$MMP%U<.F1Y('57I"(7L"?A%MCP M=/@"QO8050!K""N@@DEV.LVRXII[#VEO;`$+@?]3#L:,GT"ZS$!O$,X!!&'D MA"#O*'"GKD>6`IN7[+_\-TYZLI-QH*!V$WMTA*CDY$]&[D3J=^)&XBJC6+C) M`S:&^SM2[=A@QZ2N$4,P`$2>TW;T4W(=>!96FB(>`8`Q_&*%V5'#0 MQ,:0(CPN/9%Q`,?E:C1@R)?C.0M>9@`CXW\5;`WYI4L.&.O5#\1!<+0E)3U, M@(TAALA?B3L;.O(\QN070`>/1A]H>[P!'R97UM@B[N$0FP?#)11N#>`>2,@! M2H(8.30BFUAJ(-I[X:90<8R(F(%*!-#R+,9@M`%E"_]."+>,?-1HM_@QT'&, M;O0Y1RZ8]S1#>\3H,O*"&'7("P49*Q)B!,G0I[B?XV$%D`C]6.H_#+0S1MR=O8M:1 MK%V!1>=R]A>GS+SO1G"2SR_ZE47B)Z\]\&B\;HJ!H5TX')+O?2)F3277*^3! MJX,<$JZ+'U#HV4<X,3*!W!)A!.()*,4GSQ$.LD>KMPY MHV!E*[S9NVRM9X)@FHPGZK[X5GMEH`5%F8-[==73!`.7!A:1E MD(&U2W,AR/]X<5R>\#K'0U>@4!/`1@[18YDD#2ZUVXM9F]"9!4Y!T4N87$C> M0%WK(7-;\%RI$Q)SFX!R+U2<5'H:FI)"\4B"%3B[$[A3J>8K6(0YXWO&G(`^ MJ4C*^,'88I`$`]4NA34=IF=RR6Y^8NX%LOXA&!1@%J.'E,,;#"D?5S^AD>^B MV25R"L;BH&,4+4(AF,"O;>5#``OB!2$1T@B$H!Y6M<*YNJR\4S/&-IB6,3D@ ME@`IXI"WI+:$\?,S#R,M5:+4=@?D02&R@H?_#P@K`IXES"%@5[(BS.W"6,?5A_@7J;*&9%=%M\ M*2QYI2T14=-0I/4!FZGH*2@J7MH3Z%JP*WC3$VSYBUNB)>JY,&A%)::YE\*@ MF67[5U?W/^Z>'ME#_[_[7_X4)4+PX?>(L#62&;`=D:E_8(*6M20@'K_Z5([`@^1/O9!:]!>29K-+6%E$D_@63 M"1G&QXEO)-]3,E;!UW*WZOO691//57WJ\E'ZX78H#0,QOZ]`1ZL=A]AV^T$8^[7G=#\5DHTF8]5GH'MAB5@:M1?/+2!G^?@Y`<1NBD/&#W]F_ M7;>NKVZ::V]`N\:[!W]',!X+?:P@-I5:#F\FO7Q+TO*09%5&66ATC8;9V;JR ML'.R7&&/K4[3,+O=5=3H$R!BM"3UK)9W1L=-3'T_23*N=Y*MG3@5/UC3`,PW M%ED_><*/V3LCY'K/:+=6*1D]/DHV@9*[S?=`R8^6:P4J+##@'A\YJ88A:S;: MG]X99;>ZM9-ETJ91:S;WQJ?7,LJK96^MYU.M/R\*L.SVRW3Z+5[U3NA/7'U=KMNU#OU,EP]'X_9 M:2@FGU;93!.*=I]7N3A`]!180[[\[LF4$JJ`22#!M,42-=BH22<.)2-S`/!B7C>*`4LH]'VXZOV3] M)*'5G1KLA=H?/"/BJ((??@+('L#;5)&$/Z(%%&W(A53F!Z5*4YE*RVQ3>;M. M2`/?B\."9QNR%+ZP)HG4[Y"UZ4UF?8=E+$=&,!;E0L0N9MPJK(G["4:Y'T>8 MBHOLE8VX=K$=3Z3$RS9M\A7X6)(2'2"]!%H^CX95T=-@$5(R?=O72:'(M.+6 M1R>?DRP69#ULE&31.DR2Q=W]TTV:8;$:"!5(I7`W2I8^WNR*CKE"=D7)8'$9 MS*]7&=%M'.3ZVN&>RK'_FO M#AQDOL6J^B+3VBP,4K@6`='O<3@O4-0Z+%FJZ`(*VEYU4R: M4Q7T-2MJAW:IB<+D7S]40:A:4D]#AW?`P5FBF``?2M?,+D2=4VPT/UR7I[V7 MDA9AL.>Q;!%&VU9Z+NQ'G5$A=$_J!U14(B M.ETX`6Q]0..E+M]9;$#0U6F&!MK'$[\]9U6=LZJV(H[0M6"">)Y$>BO&A\=; M%-G"*:"W]WZ\72QV6D+FS+2X6H7?GMEM@7E^HKRV=6:T9T;[WABMV<@H^9+/ MSC#1J_[U!^ELS;'2)3JL3&)!MIKRU`B;WEI1XL)O_XKED52I.;YD#V",V,[$ M^O37V+L0>]%X>0NEJ?%U3?'Y\FEU]#@[H:C>G"Q>&&5)TS2:S59! M;RNMU=:'9MWHF#710>M#V^BU&PM_0'!\:!GUEOF)2IDG7+4/$F0`"FNO5 MVB;:/+0*O#+=P9E5GEGE,6-^9;]['Y105R;U(:.\+5#) MV8?N&BKY$O8H^WZ]+Q;9,1KM]?T<56"1%V?V>&:/!V6/6TNEVMR?D1L2-,^E MP3[TC(*PY`;\DTYNCRKFLJY65>&O7:/37+\"Z3"$=YS\MR*W,,&\*./SJ#(@ MTP[@`(10F>M@UEI&NV&>](7H=HUNJY31EJ;N__MO\^L\\CTYOXM9#@]6$$V? MM/'NYSZW]W/)TWW4/, M#EL,4[\@-&+HM5[#6(Y$\I,!*A.X=0X-S)`]QS_(#A'SYD[)%@N?]+C,Q(+5 M5#ZPZ+>!\\#\*9_)*8:%"`2]6BTL;-0!*IJ'NAK%7N[`E"X$J-/(@I+66WY- MN@@7U5I^U6LM5?Y$%LY,11TVBP;]$3YSQ@.<12::?L.[HDI8^-$_>JV<`%SH6PV@LL@FU&@*&8XRT^& M2R_,LH&(%[24((TL(/XRA&HB8W!4@[&H;@`;V_.J$/9)O.2I:#E1D-5?8Q M7T27)_7L,"I)0"*9`2D*R$Z\W28E`*F@$3J]4)>1R2R$@T2".O,S3YU MWJAH`W`OJ8,@F:$0Q>EVWSL`^9@@W9E6#\F@M/E:G'S)IPR0>`ERFEUV:T6@ M2N72YC0%NP*,J!H$M+0RD0!)F=$7WPJ&.#HG\%_)Z6JGDUND)Q3'TCT'UIA] MQ!]H=23B8[V6!&>4NHC#1NU7))IGFG`>TH1S^'/DQRY"AS-E4![+(2*VG%I^ MR7YX-,H/);-\>ZH>T&@]B7"$$M5T0J7T][58NNPK'P0QJBNI_B31.!;HQD_D^0DK91C;7!UD9N*L?HPTJP6/ M$'X"P*M#6;H!`59>HU/KO\'VN.LHL3682FG&K$1HT<(#'\6"-%(MDJ!\*&8M MH>(D1_H8Z,M/230=N"B,2'P]=T@I3%0B.054#(@-(UVNU9<:IXK(L]7IT?H M^R6)CV@$P6-S+F:\?6C12\4M>M\X`!&P'`=8'B-,49QV-F6OHL78VDBA5'#@ MS^S582Q5,PV(3;ZS]%@1V@>,,1 MOYR8*XB1D73)4#U0C;V]<'';!=1O,M`K8\H%U)/VNRH1GLA'-O[P_2%*HKXW MO/5`LCP[V#"+QE"?@QN[#VYT#A/:/G8 M@VJ)DGI(\&O[GS'Z`IWDJJJ1\30M'-[FNL#!4$D%5@/\#6SMOSS_+1DK^@", M`@T"4BVXFGFIQJ5V6F7[K["/DC_Y^8TJK[^Y0X&W[/3W(/)6(`"SF?&EF;.^ MM(SO"TA`MX:^.@&<:!\_(2H`1!MB6+F2-!90!N8_T#C+T@A$S5]Z)**8U'T4 MA@&W@/%/Y5Q=U0,G1S.)F8T&J.6.:"PJJ,=`=[;\&+TZPDX!"!R2EM+O,9C. M'$/.RT-V3)P82&1K)7/F0>32:Y(QG7'(U8*:UT3H):T?A#:!@/V)!!J2ODA+MYW9,J+&4N8)6H9H#4PIGRSYW5"4QA61F#!= MT=TJ,2\PDB6O+$UA5N^`GG%Y@H4U=(JSV+(&3#$AX;,PX'#^."K[Z1-L":)&"EF'SCR.W!@HX!5 MN,1#(,BS--A.'#B]8>PM<.!(ARC>J6&![)!;'`C+13B4-UM%;@!K&$=.;ZG@ MABO=U-VZK8\`K:CEU=C?+$_Y-@M=U$G^A'(PEO8YLZWXFU5^S;H^9Q6!WL#? M3"!LQ>?,-O(WSZ!D;9_S2L`O]#>+,]G(Y\PV]#@#T537&ML[=C]]Z.[F&\'5?]A]NG_I_L\>G^ MZG\?C3^CQ-STXZ:X#"TM(CKL4[,.T:V2`[]]JNO'T0LHP?_*N:.K0W^-UF6S M=6#-*H'!Y1%H"1>28)004CA%&$(VYHXZ,DA$;\<0-`\ M%FU#.!/2K5!L`12?)3O:!:[7]]">F=R*3&Z54:`[""3(BD?TCJ5Y417D<:7Y M2Z69'YH1U$]+Y4351!$"3_,WLSPITPY]Q@>L)5&!.?6&!E((!D"DGLMPG=QO M)9^QV,`"YBJ\A,R#`\AZ"-%,,QDHW9G/,Q:+YL<4(-!R!(@!N^@:796AG&1+ MZ[W:M6CI);N2G)1,T/1Q],]>@,FJ&"T-"B/'I37$\^64)NT'2,3N])+]XT7_ M*N!1X%NR759BR:"GTV,?3!/K?$4^:`AL/;*>A4-Z[NJ`WI>8?BQ62(,\TE4# M2P[YR+$=V0ZL1F4MM&+B!?+)]2`-RAHENA$(RK^+!Z+2QLUZ+2FC6R91SD7M+=Y&SGC\*='V`]0F4AN?_YH2<"C\Q*$+N MA!$LY]E5H]`$L"POO-@V;`52:Y734;JD=(HA M^3F%,BU'G<#JS%;;:)IU3.[)B#FV$2RZ[B:9VV(]-,M/B]7B+`=7/($HG!@% M$3!>0M?UW\+?9Z7VL1'BX=5&?,-6-,=&]W)5W7&A5T:BZ,J/`P?(!K9EJ#\, M]LWW?#P948?B[UZ#E&:3:D#4*,H&8_6\85.<^97PUM53\L2;LT4E%+S]4*R;+ZI-EO;V4+`M,[C4H<[6\1`N#/($JK4)J!HS^ MQ2D'T0K1GT'DF5CX6A1$PJ5"Q!B$D9JH>$4"^"/(N1?V`!0(*A;[9VP-`U6_ MDAFEL3S!44N05.7(=-UHM`T%.&:R'%DFPW%A`_3S)3N52V:FBSDB:RQH(95T9FY,Q5#O/E,9^^!SKY9@?TRMZIA4R)+/6AG*GN_5&:: MR\AL,Y&YB,K.(O.=$%DCTQ/X+"_/1+8+3K:D$I.M5H6Y!HTUM4K,]MG0?`>T MMJSBE"VL-BVH`]U1Q6D^K)JM-A7A@-U7G&9],>OTX_^`> M#RS,[.P/QX[GP`%3SOJ-\":%Y^3,#6_HW%2.WF&2,_^XN;OYWO^3"E#[U]]N M[VX?G[[WGV[_?L-N_K^'F[O'F]-NN)F2IDZ*>5(M#7>&B&6O7MMW76L2`AK4 MOW+D5F:ZG!ISI=*6>K^NT!MYG0[UNQOKI\ZHF8).M[,^[N5.BN>+.K/UWX9[ALGB_OZ M^\/]2K>]L6<\?]@$J33@-M%YWQ]&K]**7JH8"/@%5853YX%1)A,@Q'34#%`^ M93JHF;RU/>,=BUYGI5&="E)Y8<;-!V529M[7'2 M]BD,,J_\(5;SVJ_@1=%]9+XWUSM2/5Y1QD-TL8+_YWC8S&%VOI_+M<+>YH\P MJQ@GV\->*H.4>LFYQT?!&L<^0/(OT:Q#Q#,:GTZ40W8;>4O]_?#(.D[7/#T^ MV6TT3XA3ID@ZC?VTC7:[>7BBK+*=]V>_'TYI]M:?/EY9 M/FFV3XBMF)U-F61U\&(TN_73XY#7L2S\#N-!:`?.Y&QWGR"G/-O=E6:3)V-W MMSJMTV.17QUJ"8FYAB?*&$&VF;UWRQP[1J/7.3T&:9Z4@=HP&O7NR:"F:W1/ MT=S^QBU7CFC&L#WV3,)@_8ERS;,Z>4+ESR^PGSQN;VXA5'QQL;)YCTTV@W3H@WFH99F\]0 MC@PUIM'MG"!W?,2F/1<#&N(DIUZ?*+,\V]DGQ"C/=G8%D=(]43.;NQR[H,4> M@'/":9&=>OO=LLBZT>ENK]2H,C>RTSVI+'*CV>Z="FI:1J=S@JD_3X'URMT3 MY9!G%?*$>*.YT-UU?-RQ;K1;\QG*D2$'-S-?=!TM=_P''X1.=*H)/YU51O6> M)G_U?; M-AM&KW1H[@3VW6D8W<9\?!<(''U@0KFY!VI:@AJS<.O9_I@_63\+)BOL?4;" M;Z;9^G7#D28Z.]ED5H+9O-2GHRP:F%`W+^NM=42H65MY:$+I=]_>7=U_NV%/ M_?^O2A,0FD<_F'L[DSC,QF6[M2)Y-=IKTI9Y::Y*7NJ56YG)\1#XKP[.C*$Q M-`YQ&!99/U=2!8^$$'<,P&UR:,D@Y*$S&O$@%+V:U5QF:PP*6P1_6A%[\V-W M*,?YB*>LR<2=8C4]3ND9\2%IZBD^&,@(&B7$K<"#QT(VX(`QGD'9);N.`_4. M+]\$7(PX*NK[3Q9!,CB M]SIO-+N3G_.4GY5UIS4UHP7'O5%'_EI=V]-[Z>"><-RO&0DLP7QRRBP]Y;G$4)'I#84.MFIX$;?-O8ZT8?UA^\$?"WVLH#)+->\C M&-[AIR+M:S_!@T^0VLLF/W8:7=WD=X'86]-Q&U&^%^+ MC9%]T?LRU;[*64DX*PG541)T7]!''-`, M($]!::"B$E],8K8&\.E>.6EE.*79,QK=5?R=%:/>532'>JMK--J=PVH.>Z+V M.]^3-[I5^PP6;&Q'#OKO[9XU!U]XF> M*NC!.TNC63L"/:LR5\.&KF2^W?[K;:J1=E5*!!#P(?'"@>6BYGE.PUD5@*<7(&]_ M//%#AY1W?T1NEBOXR/*F$KQF^[-(@QGJ9VV%(8]"^`^SHJ+4F$:-W?FO?#S@ M`<5>F15P?%JDPLQ/@3F%#)1V\]?E7N9JF'#)1>HC(G_?NJA4Y][Y=4/5^/A2 M%S3?G;H=N>,]0#;*2>;$*"+KO3\BR[/9/6/T8S\>.A$??MKSNF52:S:N7=M2 M96\)`_Q(_`05,OEWAN0M\X3%(ODS@Z<'#YX6Z`WLH^M8`\=U<$+4WIG0.99ZCJ4>>2"I M7Q`&,C*Q)`3D!:-%P#6PL9+G>Q>V-7'PWZD7@TDOA@KE843J0V+;LX\S4:4+ MEMC$GPSV]N+8+PR7X3\G#KQNB*G";,"C-\X]@@%AFG(K"/'5]5J]A07B]5JC M>;F+HZL&=IX*8WH,DZR?/2#T(4;L")C8TSXLBO<%W(4C'>*AX4G&7AS*!Q") M6$[?9Z/8=8LR`@DQ`T`$K1Q@X:[U;#E>&-&[)G[$O M\,WTRUDO&`4FX2LG8'$$?/U?`A0G!+J+L.]+Z`!;@?>,L2+-=?[B[A2[#'CT MO15)4H'G(SCUG9!&.;PAZ(Y(@I\$OLU#HE^,W;H!NP(EH0J3.CW<`$C/-3QH>__VW53H$Y;L)`3+&3H3C+<*^-[P" MI,,&N&?#\E7H+U2%7)/T+8NR3,SN6EDFYLK]A+::9')U_^W;[=.WF[NG1]:_ MNV97]W=/MW=_W-Q=_?=J\.PXU>2"@B3<3?/0'>>\"UV#6W$VY;SRA5J"V->0"BBWO/UC.PNB]?!,8;W<]/[$JH M5W1FWZS@+S)TY/?-S_JC5]^2CS^AH+#L2`I0M=3_@RJ5[<:A\XJ,VP/&C"S> M&KXZH1^(]I@X/Q*%%+`]C]LD<(G;#X&YN_X$90GU;>//CBWDE0N,W*-&;B'U M4M+W%O!G$.3XHR$?1&I-D!<&R&N;@P2'KT`&HC1P75@O1I$38&R,Q(%<%0YE M,-5?;##^S]B)8`'+`0%A$"2AY?(%+S,8`.>C=&)*9QW+`XUP?*9%NPV%I!I; M4[4XPR(V6MP&(@II"8O5FQ>BDX7U''!.PY(0AH_XG-+/.I_[R9?RH^YG*<#> M(9-9&=`J,IE2?"&G\\%EG``]92\K7#=U\X`'<"[R]H!*C;=0)O*-@%DQ MV4-+?:3NKE!Q=>JE5\)]B2=PG"@L/W0`5GSS18K7,\UOC^;[B6[O M3K,"3MP`M`6]H<$0#6,/?B5,%M\=YBZ&02;.Q`KP#MB*WX?Q`,P]QPIP_+NR MDZP1FA_D'L`_\7?X7V$S#AVP4",_0,8/S]D<_X5D[$\Y'C^).O&#,+;1&H-G MA1`,0]A>"/94,';12A.-ZKS4U%7.$&$O(W2PML'DM3#@`EG.&/X[M,:P#'[@ MAW*M1`AIWDKI\Z##DL?CX!0^`!EN,Y+4S&0=%`E^_/R2?M1F'^M-T44K_'3)^F`O"WJ:J(Z6H:*! M?D8U"?@8B!=8MDT5G\/=.43.)1NG;<[,N06<7#I#U+]]TFY2XD>7D-#@Z;3Z MZ`ID#W$`I!CJMT1R;_;5"8#+]N&SH7@!NI2&^-"0>>B9Q`=??6>8_`*U$[2D M0O%LP*,X\%(?IQ\X@%]0^5_AE7YP2!W\?$5._XK4VRO>D=0>?W;]`=#G$-NB M.X.8IDN2GI,5(<#O+QZY!2^DY-&0_1D-+]E'"WXH^QD#\U!JDP!-Y$_X M^9T?P"O^#K:#'Y.O]LKRK*&%@@A4@G0ES<:VVRF/@Y] M9G1T^?LYE]877,:B3V5LYI^Q@V\G):\(4H*!@*5^J1A>]<=C'J"M3^&\@&-T M;!P+6UR&U$1G;2$BB_UE9WEWOH4[NX4E(IR`L2!"*P3=M$D@4YA+NPAFLI4# MF03#+H*9,T',D(GB6K-V4%?P^5J^KVMI4]A;7HNQ]1=>I(DUI3AX/K_`0S(5 MB0#2*2S"[ZTU*#8-TI<+O,^$[:WPY:OKOSW&$V`F^!;+37\6G@/V6PK8FS,! M^_I>`O8SZS[^>'CX\P8#]OT_V57_\;_8US_O_\%N[[[>?__6?[J]OUL-K'WP M43S9Q9FM@P*&FH*^92_<*J[5A!AT/C&VACP[[(3@L>'NI#'QW M8U&V)ZN.MRE%O5>-IA1;'(K2?7_U_@D_>*)X[Z)9**9=]SYC-$%A%INF<:6C%\RMF&F<*TO7\G57!'5AQ6JE0[SCJ)X\-_!U2 MQ[D?1:7*^&^573NQG+)M>"IW85?8;Z+G[;\H]/1VOA\VL<+>YE>Z5HR=;+27 M$V([3^@Z._.<,\\Y\YQJ[V6;/.<8F[QL#']55?Q3[EYS***K#F:.V/"I7N^= M)^K]D8D)[E6HDEI2Y7=;P#FWWW&I#8\OR=/SE9-A+)/OZY@`24F0V)EGREYYB`E;X8L5\'#^S`^L%HP"Q\9G,0/, M]V`_F"6%"8Q89$D]?D2+IMIEK69B8$&\E7H(8+%@@+7!020J'C'Y0Y3-8P(9 M5DJ&$>5$JE1*E8,\UDJ8*5O$LV2VI*JZEXFBCWX,OWRP;&?DV.R?L34,+/AI MKI7`)`>PEP6NT_Z52-_RO'B<2W<\D\/6R:'3:1810[?76D(* M]=H"4F!_BP%6;+%RIH*]4L%<(DB;Q+&WP('3'/IOA$MUIPN(X,YQ/S,[IB(7 MK(R[4`]_FNV#!K+G&4+T)1W>CD2Q-O[N%<_QF3 M0B$KU^%.8$5@:+E6,,42AC`.)R)!*?8BT%5&<4!%YYX/ZBD'X9SI_D`)I,&S M]O\[I%EMD"BN45UQ)K\:QKM M=FU]0P#U;.'+P8(M/@P%0NBE$AUMNC?O6#G&>]-=`14MH][:M9%FS!AIT9N? M-KM1G#/786[AA12V%5MH5P%UC'@8"@N.;KX@$]AP@5E%4.BF52$1::5!*Q;W MY(N"'N-!B*++BVY>T0]YK@*:<;-LJVUGXS!M.Q]_?'F\^7]_W-P]L9N_8_/. MU:"H+<<<7*W3"^]$#\!?D-ZBY]+WA(QPH.J)` M\>G;-BHH<"`/`#F6*;YO]E)F`G6SM0Z3J5^N,OIM^TR&2`$%FDX,E6`T6H-Q MET=PE2XDS?S.+FJ7YKS.X_DV:NE`\$JT/)R[E4K5>F>FJ)?M_QDN8WU,8WLI MMYX`K[:DC03V+NA>J7/=2OB1*,T&5FT[H"Z%[)E[/$#3&Y_ADRBUL7YX.-F5 M/4;4)!%;`X&Y!^>EFJ%@D]H?EX^7[(]^_T%K4LLL4,3@.:0%5!^MC%L?0'_F MJC=C$A9(M^9X:%?*R0%HN0?8YP[V1ET0`#1:%70CZUBO&I<_,_-C9^9`:FXLR^@ER\[; M_DFWVK<7X('3"__-DQZ$I,WME/I#J291Z*JSDXZN(!9`H;,;HCZP@^C'I`T"OU#[WR@\C\9LST]X%TVX'9MW9'>VK_<<*,-$!(K<(U9%:R74R)`M+>DMG$4&M MK`VETV%$%QO1B0[5%B3Q0Y+$9=+.C\[5R9ZPYB28ST(4MWFX>7CZ_3I5>DGGE?S[K"KN M@>ODFQ_LA^MH&+]X)#-'^>N/A=L<>E#=];(F?2*?K6;6 M[%FMH88/$B?S(K"GL0NAYV>4I0!]J#%7O(9..OG7-\N3;?6).=H1S3X(X7BP MZZ$8%R!\JIB28*DI&I$C7:$QK![!T0.<#%:3EGV$`7B<8>!P#0!JY,9Y).<> MP/UU)I:((86XYR"VHSC@(A4FTPDNF9R7,>LOZ)AD]#>9'I#GY=18_O&*]8`I M:Y-N$M:L\7K$RG?R/>-?@RF;O5Q:A^(BWLWZ]P1T`U"*I`W@0T5X\B M5F3T`95H1TW:JQ@?.(97VIP&,CBB&V7^N>09U0=2]446A%-,%O)1Q''&/UU" MGA2UOL..>?"?FW_&SBO<`OC]60CM00BU#B*$$--T>^@?&L[/0FA5_5:=(*4V M\/0$E7E.@+PXSR_`Y%T'OD?%%>/U,A"%K"X1,V,+&*F8U)),:1(3.)![X(B8 MN5'MI?2`(OCC0(KT?@*=%]<5TX]5+.B,?\.+N6_5-*G MGR9HJX&'DDS?$1.Y9G:>8I^5UG#]\?XC]LH%? MWB99O7U*Z#USPSUPP\Y!N&&*:C%IX:S@K,X$DY.3:>]ZW`$M0)4)**9.*`Y2 MF!A_R1;P5+#<"_QN?XB0,TOA"-D]I80_X01V=9V+F*M,[M6R]\461%M]1YN3 MP1UZH^/A<)MA3!%N4+A$-)QA%>N$W`'TE#R&\,427?3+:S6`PFP9H%!T`I\5["WRE?,Y$Z!,73/-)`?"C(Q9JT'4+?D(\A*PC1C_4B]-@5Q>">?%Y"[MP M`A3X]\&U$T[\T'+O1W_ZWO.?0&K#LR#=FR#M'D:0)OA'>D6\7Q#BSV*U'`!T M"RJLD.2G;9(QK4BH1M803`E$R:IO\%AC<1L<=0LTHDA]P!-BB@K&%: M$87_=[43G+8[I?U**4[IQ2_<%?903,EI(1N#N*%BT<%4I5T$3B@FZQ4?H-)H MI!HC4J`U2PG@#BNH:/-63]`G M:.*GJ.)!`96",+.J02(\Q0H<=O#,A;35U0:M4`O`$1[V.6`DL&;@$"/,':V& M1=O34\:MCI$6G5!(8\L*[4*QN8[PRPO0[SP$\]5&?YWF(;@1&M,YN61W\K)W M$'FIT$T77T/X65"N"$#F`'5_DS0RY)!VY#G$68B[:0$VW>]5=*=7N(\S.C"- MH7FR?I[UW#W<6[-V((\1S1JBAJGGR[HB`'H"@#7TJ4!`Q?$[S6*?>3];;8!* MG'[VQ=%Z\3YJ)^`$(A:.:E5&ZA/'1S'D.)B$59"#F.;%Q*&U-JE.CL#B(B;%*N?<^1.7C[= M6`$Z%\,''CQB[?993.U#3!VNHM`6RJ7CQDA(DGE^_-,/PT]4P$]$<)9AFT5] MZVT47[/Q"7791*F<.NW"6"]>^P'A2_*NCVZ"(]6.@7HMB"FJDUC:YA240"[I MH9LZ\]-,";/>TN'%=T&0":BD>?_&T66!UC8Z*<`&]V)J9B8&)R>KAWKOE]#& M)&>WDSAOWOS8'6IU)7J/&4KA4(FQN=`$;A*3#:FYAI[*E,Y]S[R43@$0A\A(*H22K6F8%CL4 M]*$5[>3$VQ*QE9=R7RTG^#NZ>NY'7Y6&<^MA;L(XS7XZR[J=R+K#5%?>)%Y& MQ#W[N_+S)>AG&OZK(^\VG2>[!YLML08ROM/9]"+)R1<:&4Z*`T.D@(?*U$*O ML)'6*JJ67LA&:!)X^LED$O@_"=G2VD@]NR*>'G.E2`/##*(+#!RK],FIW`!5 M4R;`H&WG4GX_1O'?,*,;%QT:R#71&Y]DU.MI2!BSIU9C2C!=:<6+,OP,.KPO M1=-,L2,V?L00`R7Z`S\*G/`O-$$<,GM4TQ.`I?``3[@1UF*B_%IT&@()B8B6 MJ15)8$B39*(QG`W/*3<@4A\88H!JQ("BRS1WWYTJ`BW,YLW*3QG6QX<2HW@F M_Y3T+SLK%JTYFUY>9A"EPE(3!%"4S#?77$9+-%"*@P4WI:ZF'+ MMYE"M7E\Q@8R$V MQT'E`VT6.#$1=\X8UHF.0,<13;&DCZ.-RIXMQQ/U&J(*3[0[3,2]/"M1_J90 MF>E\(#+T4K-*O("VF@:VBN7$NBQ_MF'-&-#V`B@`.T]XE,0OSJ)B3Z+B,%7) M&;QG78G')"GS\D2:,S-[O>XENUJPH&2` M89'3TY/9LZZKYVX)/JR$@*52G%:L:=B,Y+!*R@DE\>^-,!)L/I:K^]+X:+)`"1DBVOX5N2X>4[](P2C M0'E&PC,_WA4_/DR![@\1TT[P>TQ,>!_J^@H<5W0Z%%'H494V'\0 M;S)9G]P7_SI,%?)5*IZU?AT"Z6=>5@J&&^(&J"B9[)K;R2`J,VYE&6C^T7R6X9RF"[_Q+ M%7-L7-3JA8'TE17<)QSJ$@LH$@Z;%J@!@Y4NEVQ[V($?1QH?M5W@N<[(D>HL M?BE2P\0\($P%HFJ_0J4XS8*R_0`3H7P11>:"8_M"-]8RI%RL%!/*I./I*BW\ M!2JY2!YP+1L;,%)E!^BF8TJC1X*Q`]`Q+P*>I#!1AI&`DK=3$<9,&1V*G<=`#.I/TB\#WXI\VU MB,)9..\CF'Z8BOCO',-C&:F>#B^;2(ZU%KM7OP`I`_K@RKXP@4L-] MY`16%+DJJ2C#$4VS,%M:;T%I>\9/UDWWA'A\Y$?L'IJ5:L,N(W2<= M1-"7QZXPW@_\[PTDNB$KD1]EUA:^`1^BVG2+_KP2D5/]5^P&DX6+8P_"^''2 M_G&`/^-:,M)?P`V5C$K.(]8/ M@_*2Q6&$HAC=(MF;]E.A["E;/PWT_HN3$(88O,)-3X/RM,5IZ+\2J=-YH6:: ME"R!ZRZ^D[:BHG4GN4GJ_E)PD(2EM MNK$O1YG*EB=*RA=TVA+FKL"KFIWUS0J1=O]`B85!?NGO7-H66_8='4P%""J( MGM)+>E^&E,Y',655>J1WN,D#Z$@'IS"FT]>D1B+"GCA.14Z$S*@6B)`7(ZL_ M2"8A')MPKY>!`(?[T?RD.08PVQR6`-OA0MP[S57@J"&#B>LT*1,S'(J=?&QJR\@S&#E!&(GVRG->X?F@'X'YF1O= MHX&A_#*DZ*&6YP`?EO5:D999[Q6W4\Z)";.VNE*5\68<1H&2RO5FS'NY'V!= MDWZV.X'RB]DRY^ELG**'Z4H2O;PF>,VSG-"W((S03=J$W>,?GPVMHT)W6CVQH15_M.'Z;! M""&Y2O?X"$)I>B*6K`00V96>2@1-JLR3AH@A?\ZEY[_WDYM8%.L0Y:EDPHC4 MJR3'=R:.-!NZ*&)118W*GQ`AFS(QG6GEF5KI@\NPNP&V=,3!9JYK34*XI^I? M.:84)'_B#K/^ESM4OV]=-A&YZE.7 MC](/M\*,<+Q[]/L*W"AW!'!<@!SO/WYI_#+O.,0>DRV3O)AW'CL_KE\RFU`; MV=Z@;YO&CF3/-EM]E#OCR0$`6I)<>\;V&H>K32^B&,*^D?NQ'P]QD.^G8D1J M2L3Z/$UQSMZORW&T!,7;X&]9*BZFV"54JG9D[G%'NR9*`B!?'!#F^];MFC0+ MH/A0DMNLB+OV:>.NKR4VZ?U33Q:?C=/&)P;U![[_EZR)/U4LGB9'31CI_A#U MX>1YY6^FV?IUXW-:R">/%%W-*J)KXR,JX(`'Q\]6].-JZ[PKN27@;QR:X@W1 M)>('O[-_NVY=7]TTUX9>DSA;T->/%/QC/OH=4O8[`7!%XMT1C,?"V5;P5NJ3 M$5?P3>[E,E[4+QME\53&,6O6<*Y0><=LA1EIF>VWC79[E33[4T1]PV@T5ND[ MM+-[O*,-:B2]SXZ:ABFI]!3PTS*ZDNZ6A*,WEB=K10P7%$Y+-_DZ0T@SD!HZ4J>]Z765.5_98V?-)D7)D569CTF"_5>+1? M^#!V^?U(5GR$#Z)[>M\;PB=!S(=_IHU=WVL"I5RE7:M&LE$9+KEN,N5J4<&Z M=B*GG5Y7D*UPT%S*O65/O$<4'R2!,EV^*'_R'(_>1P[FD7J4SE&]+8G-?FZJ MS#N+<#6Z1F.E3E(5(\M5].D.6!#=[EY""8EC3%PXY?#^#J+(QV2I530* M6SPPU)JC*I_CD87QR)9I]-JK="@Y;`AJ5UR]W:X;]4Y]W:C,-F(NF;86?X`N M$5@N_FPX=CPGE(-*;^38NW<8KLD[KW=6'KX[N5%0_.XIRWX).&=C>/.+ MFL`E>D"_CYB+7G?\[G!_AU,NWB_JS]=^&>[S23^G@_OZ^\/]2K=]WP'8C0JG M,^UINN\/HU>B])W:ZF);YH!?4&L@``C;X\VTYLT`Y7NLWDZZ:-?VC/?(+Y(R M!Z>[34<89=K%W M-UA5W(#;V_E^+M<*>[LXH>C3IGNI#%+JNXN?'8XU:MV@9.BWL6GHMZHP7,)XW3F2L M*JMLY_W9[X=3FKU5QM@<&9\TVR?$5LS.IDRR.G@QFMU2\?OCX)#7LX^(3YYMKLKB)16IW5Z+/*KXV(`:L1/5H<$V;;2]+#39(X=H]'; M;Z^4_2@L)V6@-HQ&?7X)WK&AIFMT3]'<_L8M5VB3%+;'Z90TB_99G3PA M;EEOG91[Y6^A`454V>58?3XA!GKV1%43*DF:G M1\L9GP++"T<\8-;SZ5K7YGL>%],ZP00@LWU*_LCFQM[5RB"F:9@M\_2XY/<3 MYHW-O7?:JPYO;)Q@TD^C/;]A]_'Q1M,P:_,9RI&AQC2ZG1/DCH\O5L`O!E;( MA_">Z3E,:LG7<":"F970Z)YCZ\Q18K]P]40YY5B%/B#>:"]U=Q\<= MZT:[=8"IS;O;S'S1=;3<40Y4.U'VV-E[F_G*\,K%95(?:NMFTVC%[IT-P)[+O3,+J-^?@N$#@S M,X3+=9C/-*=_"/Q7)X1GO_K!K6?[8_Z$DYS>84]ZO2%LH]F=_)Q'(2L3V)KD ML^WI+=;O:3?-/1;Z6$$]$DH)^^CZ8?B)#?C(#SASQ(<%Z9MUH MF7N/(N]EDQ\[C:YA]NKS6VWN@["W)N(V(_RO?$B^E936&6CU>Z/W9:IO5>Y# MHW4))L'>G>*[H9&2F:SIU@]U5\Y*PEE)J(Z2@#Q2^IW9QX#;/H`\!:6!,F]] MCZP`:P"?[I635H93FCVCT35/4W.HM[I&H]TYK.:P)VJ_\SUYHUNUSV#!QG;D MH,_-B?CXO1&UV3(Z6ZS@JQ)-SX^GGA`M7[U8WC,:=.S5M5UK5/8];WU*L<>UQZ[,JP_ M*;D:L>E2*LA,6'JEV+**1L^.7;_F(QX$?`@_ZH;NYJ9 MOCN>TP^9%?V^];NDSKWS_J:X:L:]&HB:.]X#A*M/,FBNB*SW_HBL46-W_BL? M#WAPB!CXQWX\="(^_+3G=<)BD?R9 MN8['+UZX>)EIMGX57D4>Z;%&?\(QB=![9AAY9[85!-.+D1^\6<&PI-P^E5"C M:=3,KM'HK>]"/X:HHFGT.BVC5]M=F]-S8/$<6*P"?:QP&90-2BS1(BOTG3FE M&ZVVT6SLO0?:7C;9[IE&JWW\C&Z%K?[]'%V1E'RBT15)R^?HRCFZ.Q,Z!UM.-]BR8>@D'X&YQ7EB/(Q$R`9^J3Z0Y8373FB[?A@' M_)V'8.J]:H1@ME@CV'U_WNV$[SR]!'QQ:>!IE@.>PV?1YT?GYSO&_#N\]?,N M^YXQFR&PBA27GFEHQ?,K9AIG"CH:O]D&BM-.^L-5*SI05?#WTR?L''TYO--: M&9[P9J=LT+ER%[;:+I#3VWEEV@F^CQZ/)\1V*$OYS'/./.?,* M7J-*:DF5WVT!YRS*+U@W,2#3>(+WX\7O_"AMQVQI8;8G[`?YJ=5JW7;LEZT\)7K[>XRE58M'BG MV:XU>BNO_1`']@MV(I(#2HK2)>H79DVE2]"_E^V_!O]/5=OFWC^_L+9OVT', MS[6TR2H=.(JR7G\D["[ZWW%SH]EY2>J._T.@ZP M9A`[[4VY%:@\FBRZ:P;[ZD?^JP,'"@6E+!VOXB$C?G#3-@6[#G,1>?T;;!NB-1"_M19U0(W9/Z@1."ZA!R M&_2QH<$&@(V0>3YSI-)FT))P+/CAR/F):_%@3"<0<&E+7KXS5["@JWW;B?NI MZVSO='3T5GG0>T]Q.&<0;$DVSHSVS&C?&Z,U&QDE7_+9&29ZU;_^T&PI M];U8UR[DJ<1`!5M->2K\+S7SIA.#M[=_Q61<>-2+QY?L`8P1VYFH"97"[Z7] M&C3P8Z$31L31)XL71EG2-(UFL\4^ MYDUAEO9VAH?J1L>L?:*W?&CC@+R%/R`X/K2,>LO\9*`I,@'[Q'GE[I1]O/,C MSLSZI_6>4Q8WYE MOWL?E%"7U%/!*&\+5'+VH;N&2KZ$/=+9O#<6V3$:[?7]'%5@D24K/2I]2<[L M\1C9XXXZ,*_CSVCJYOU\EP;[T#,*PI(;\$\ZN3VJF,?2_KMK=)J]7?'72K3^ MK@K_K<@M3#`O:FP\/Z*R8.&+.Q0A5.8ZF+66T6Z<=B_\;M?HMDH9;8O[,B[+ MO/_/__O_^O???@X"U_D=_W_X\_\'4$L#!!0````(`*R(5$5TL0J?L@H``--Y M```5`!P`<&5P="TR,#$T,#@S,5]C86PN>&UL550)``,4>454%'E%5'5X"P`! M!"4.```$.0$``-5=2W/;.!*^;]7\!Y3FL)F#+,MV9B>I>*<798#61$C* MV>EH>G`X0H1YW*=L?CKZ]C@^>SR_OAXA&6+FXX`S`LC\_ MJA]/6!($?)C\^"+IZ6@1AJN/D\GS\_/!\_$!%_/)T>'A=/+'?VX>O059XC%E MBI]'1AF5XE)&-_WPX<,D_C8;:HQ\>1)!=H_C22;.&V?XEM:,STDBZ4<9BW?# M/1S&ZFB\#:HC0^GAZ\2'\$VD/P+]&@X`%Y(#.D?G][N'Z[ MZXJL0NJ3D'@+Q@,^IT12YAUX?#E10R<7W(N6A(5GS+]D(0U?K]F,BV4L.L") M>2\$F9V.%"<087IR^%LBP,\VM.'K"HPMZ7(5@'HF>Y'YFH5$T.4Y9Y('U,L`Z3F6BZN`/^\*S>#C`,MCR+T_%SSP(:Y?D!GU M*,3TUQV!U3/M`N4M#B-!8C^!(,4B-3WN9G]@MH:!;4BRFS?Z:LG8+F1Z((&:V)!?PM>O`C.)/:NYU$37493# M;$Z5Z:2$I`@&5#$J"(@71CBX%QRF$,[?)NHV$G62G:`75B1JE+1WLJAZP$[D]IZYK`SNYJRE<9`<[F=MQZ3A3V(E<2>`@ M#MM)W(I)AQ'C@H28!N-V:XAR(E<1))6FK\7'%K?K.A:E(FV[=*DA=Q&E4G$* MP_9=Z;:[2\=1+A4&5C5KJIKZ5UQL5RW;,>H'S069$2&(#]?2-ND62&J8.(CM MJ5#J&Y@H0@.9 MVSQH#V,7GGUVN=KB:LO'81>L+;0=V7;=)6L+QX:VEUS5Q@*-I+UVJEJKO"TC M9UG6'M.6[.J0>3CPHB`FOX&_-0KR$A+F$S_CHR#M=0,`7%8<#Y-_4S1&&57^ M(V8^2E@@C4=/0*R?ZFM@C@#!V_-)^)QR07DV*.6#4D8IG@Q1P#T-1:!V?G"A M.TD*(M[>,P&`7XB07S;'^FXPK").X&5]ZMI#;\N_XKH&@?Q1`_/P?=?8:+_%P<1J09B M25X$F/.Q,^$A+GPB3D?3P\/L3EAXFF^9.V_2$1,9+1,_'D.!M M:I=O`R9O&9!BA)X)G2]"D-^I)1.$33XW'%M4&*'<4/M3MID,[B_OO_XH=*9R MZE-?OWUKI[RCWI6G"3E0![VB#,2[@7SJ%ZO26U(3+)OH[&QR[,JA[6`/SEKY M?4`J&FZ>G)L6*AOK,J=!QK!JBN"^2;`.LB=`V MM.ZCM+7I[%4Q."M>D#4)^$JME6#1-">7:K6T$E225/(\ED@`NB)%M97WP=O. M"TZ&X`7[4V6)EXS=NDFN7PL+GC:IOIG2?0:U15

,W`H4WSDB?&M:8:0N;< MTBJ5#\>KS/%I4M;&&D:+J_Q]#ZW?==R^WX7>:7Q_<=G1:_7ZAP;\Q`;XACVZ MFR'%#,$=D':+^++#'N`YEW&KO+@CH&SY41RYSY:&4EP4J&Y]15Z7&9;&J0(Y1&OX4;PK(D96:PQ]H)TMW@_" M%F40!V>*9$.!*G*N`&FZ*0I2XF9'U&A*WG+X MEH6@1I!OGFT2JS9KIS=UVO9:$Q;519?-"/:D`!14V?&F*X`G"%8]X^3W7;@@HO9QMRV]^P6(C?7:::/[ M?1Y7$`OHG%V^>`O,YN0+IJPB*JKAE:/=+S!JE5\K^U`G3A9WTX3ZF0O!G]7S MM[JJM)+$_;+#+GTU8!Z>F;1>:P(0D-[-(+?6;K2H)G)?:5A@*ABNW+A#JQ3B MEQE23?K_BV2\C?LJ8EZR,^$K?R`K+E0_-=EPY[T6(_07`?@:C+O?N[BO2MI[ M0Q=Z_EL]Y:H_&DM[SO.^_7,>Q1$E+)VNHN)7Z]2+DJ"YSZ_?I-K1=\W6$+_! MLF=@['7#(]DV//99]=Q'`JH`J+=F]?M<2\:Y#\[M%9\O@RJA#RY85^"\@G4J M\W9SL%(>;KO)'B%^O&:_EC)]I3.WH;&VO]Q$.EB7K3&EV8NV4]#@O+B8V*Y9 M_I2`QC=C+,G=%PD[F[B5H@9GYHI79K-FJ/+;_)NTWVFXR)/4M=MW9#R(OLAN MKK$GY?YM*\B&,TBU8&Z-TWAB,?;.OWMX?*^O12#?6_U'N= M5'H!ET`-?R1LTLU0;XP4VCRKGC#9'6RJ`?JM""C'`VV8H`V7GK`4JT9-Z@]% MJ8VRN6/I6ITIE!=]>E@4/6.%4EZQ+Z7<4.E>TJYG1MGI0AJ&J3$+%`EZH^E) MT,9#4S6ACXI"I^0HIDJ MP3@IPDA)4&%5T;&@UN>M:L*_+PJ?LDDFL<8(F;M-._'4PY]95[+(ULU)&;NS7'9--^<'!I1>;"KAL#(PQLR ME-$-H?:IK8&.C)3<4`.A=]FG_LK5\I-@-1A&5DYIT+N$JC]AMS@#5D-BI&K; M&JE_J#7'QFJ0C&2ME4S]R]WRZ%@-BY&Q+9)>_PBK3YK5P!@9/)\#^Y>ZW6FS M&A(CFS>GD_[QU9]+J^$Q$OU;/$NH?QGHNF^;8VSZ[-H_]V"A+K,+L1B/&\$&L1"S/O=4T850V>HS>0'[C MBH"MF]5,NX-Q-9A&V5,%,^.HOD$;GL-(45L=AZOIP:B5;!+91COQ@.S6J2,D M-T_[(0Z\8NNS=#7%&(673?$8I5DCX3A#L=/:N!L^HS]JF M=2?X6Y_1JV$V:KCJIJM3E+L>UZN!-NJW%HU9IUJP.N57@VK49UKSUK%)F\__ MS6,Y,>JMLO3KQBZMCP+6@!GE4TW'U"G.;8\'UM`:591]]6""3A_6JQ_J?QJ& M*_\'4$L#!!0````(`*R(5$7LD]%C^@X``#K3```5`!P`<&5P="TR,#$T,#@S M,5]D968N>&UL550)``,4>454%'E%5'5X"P`!!"4.```$.0$``.U=6W/;N!5^ M[TS_`T?[T.R#(LMVLDEFW8[CRXXZ7ML39[=]TT`D)*%+$5J0]*6_O@!%2@1) MW"A>H*GRX,@RSN'WG0/@X';`G__QNO*=9TA"A(.+P?C]R<"!@8L]%"PN!K\] M#2^?KB:3@1-&(/"`CP-X,0CPX!]__^M??O91\,<7]F,&0NA0/4'XY35$%X-E M%*V_C$8O+R_O7\[>8[(8G9Z M)7_-BI9*OLZ(GSWC;)3!V6JF?_6BK4"^\(?1YH_YHDBB.@Q>O1JSHZ!J[\0H&T67@W001BMXFP1R350*=TDET M+PF<7PR8)@IA?'[R:0/@!QW9Z&U-ZT6(5FN?FF?4".9)$$&"5EEA!&H0JWKGP?V!\!H19=P@BYP-^72*6RCE@]1?0GJQWAP_P.AR&M M)%=XM29P"8,0/4/V70U^)FI[8'H%PN6MCU_VI5;2TP.7IPB[?RRQ[]$0<`WG MR$6T^W_;DYA<:1LL[T$4$YC4$]I)!3%K'@_SAS4D24>E])2N?!O8G]`B0-1( M@':RKHMC!F#Q2.U*S:8$KB7G<(S)"/(@TSFNAHI?[B"&8/5];5BK)M8/H&?=:P:7R)WKX3$(3`U6I+*KF6 M>CD0+!!S71C2H$@=R/HHWX=N%`/_D6#:E".=?LU$31M,KL`:1Z9H]I>5>+@5#9S7/B*W_WV)2;[2LIZ@;-M=P#@F!'OTN72:MP42B MI(>^/07%_D(;2C+^3RP<00+#*)FC:GNMA4?UL9ZWP1G>`[)I.?NN[XGTM1X# M]2DHQ/J-@_HT]M'9Y2J7*2]3/3VN@IE2VU-MVZMDIG1T9#N)528>4(IVNE)E M;')31;U%67U.-=7)F`'B9N2J"N?Q"$X39(<:V#&"#PG,)55!W'@&AQY:L>U3 MMNB6/BAOO:T6%$0C6G24EAE5*F@?]_9A0P^O`#($79;N`''RI.$*KF:0&,+E M1=O'"GS?#&$BT#ZN`$>7IM`RF4[K))R#V(]J5\I,G,=,OZ9S1M9[W-%?.=SP M-8*!![T,.5/8Z/D?^C73>++Y-W:&3B:5_P@"S]FH<#@=W?#0/M/#<3FE!+:G M$^CG5(N35^.D>IQ,D1V$JL_V<.S.S-DY[SB]/_;(UNBD#\?[7(?W3KWS,'>8 M,H<^P>$>X6R>884)RB>".,X?S#DSC4ZJT@J*BK-!'-^/YGSSZO_F[![@O/LM M`+%')]#>C]FARLP2/G8Y^CX[U8E)99!(.O;03@-[7#!/F3(Y@2OE/9,;8>E#/(& MID`&#B:T>ET,QB<[+#X.H7D4]>JQ1KU M8>6$0N4SWA4"?\DX5[BO5T<5L%ZGTQ21@P3%&W5,>=*D\HK4X%B'@,@YIR<' M[YWIN()#4P[*)A#[]H7[>C`A*7+B6;].9*M..$A&!+^F,VN1`TM%IXW[CI_B M"_PB;R58C=G.SN[2\Q*[`?\1(&\2I$NP*J](Q5IH7HV[2$U`Z*]^'?:-K5X& MT+L!)$#!(E1YJKK\M*H7M\Q%$N3"V-2O;[C9ZV9G0*-[JQ:95G71EGE(#EX8 M>_IU4GX>NB$K&WP7RTX_]N,6@RE2)61AB^F[P62!\FD)"`P?XBA):*7M76M( M4)*RWC]*\,)FTW^KF81A#+WKF+#3S)`@[/T._!ANOK[%A"UI*1J3C@KK?6C& M1.30#S8Z=%,G]_-HA8Y#=:F(BLBG'VWT*5\OGR!Y1KEC"SC76@4)FK6.W;WJMT'FH=T*4FVSWJL1+ENP!EE@N61CT^*R#-5 M3JHKJ4BI-H=3UPVURI0PCL*XU`*8B+.5Z0:G\J(+#O-I$7,J[B3R#J^@LZ,Z M1M==<'S.BGQVVIR-NJ0>Y14Z.XW=$*R\((-C<5YDD8HXJ4PW.+4OR."P?RAB M3]5LVB^GR-EIZJIJE?/$./`?R]6'23BI2$?U0WFC!H>Y%'AS\KGHFVKH*-YJ M7K#!$2E'W)R6W9G!/L[X"F_AX`B4HN].S,GD+!CO2,<]IZ5`K!CW..^R3YT= MV:V^M(-C48K%J8SS;B/5&=8:MW5P1$H!6G='*-2B.:&29W#-KSB M@Z-2BM,:L:YS@N(+03@NI;B=#WV=@S:[$X0C4HKAZC#2.3WYY2$<('Y]^Q7\!Y,K'X2*`^5& M2NP^7E[#'K:=OY10V!&X!RNH.NALK*B?`^IU7*;M=)G%K#O(WI?G;3[\WGGM ML/F0O(R*XE2I4K2O(]IU&Z^^DZT_P%U$_`O!87CSZOHQ.P+X"\;>"_)]L6_U MY*G]JDQ!&4QNV]=NZT)-;K2BMX>LO5^Z6,VS>^I5=$,I9HK094%CFW-'E MMXDM6`@YKN$PN=ISE"RW[>RMSJ,-^6S`PSN=?W::6!_@NO3,?UZ?(=!(`U$ M%25M"$7B9H'5V(4-J&ZG)[#R/7X>GVE9N:+D]/Q`K"S"+K+R><-6_F<<,">? M*HU<+MA75I:QC07012;^V+")']SH])1^?::T<47)Z:<#,;((N\C*GQJV\N6: M)-W5N=+*%25I^#@0,PO!BU<)FS9TO!B?ZQFZ7'(Z/I3P)P0O-'3M`-A08FUN MOR+'%L'P*B9D_"(>4IKIF9[V=).7?FYN#3YV+L86]NRRMV-]A8!E MAV>_?@.19'M$7X?]GC7E8N=L_1K.H@E[%5_RIH-;X,++%:,E]J%(PGZ/R9$+ MQ[P6^><*$/)&:Y>9CWBI0_-3%7J1K_J]]BMK\VF/<*6*==7E[?>/#+=P6F/# M"96&WU.:/XYQ5DIKU$K5VAW2*!6W(8E9\Q6GG"%*F9%\GM>.\5:K0]7VD@AM M]@I4CF4I;5+$,M/(_N+L=%J1Y5;KO:><&4JYECJY<#OC)`6R1Z?58//P]!:% M[NM$[7>FGI:-R>B7V5-)KN?45G MYF+B+@&-UH4K*(I'Y@K%[,W8$:*U,YSE<\`>YL7:(UFHE\K9ZQY]^!K+\8>0 M2J6:JI4NJS'-E^IC,BHZ>ZU'N72AC?C*R>.$]3AA_7^:L!X3I(X)4L<$JU1'!.9\$@ MLJ.,@'CZT;#1T]D/"A9:M_R(BD_' M/:5O&)M=SD!H][-^![79M#^EF]NQ-DLT-=,S/>TI+FAO2];A8^=J[R1P"00A MO(:;_R>!F)O8OR9:[/>N.9N.!E_IR9%D-/AV2RV!GF'5/"7IYZO*6FQ[!6;A M-*,5"R>C$3T#LFR6J/FVXA5-54N=#! M&%H,7K@38=,=#F8C)@UABQUG2D+DP)\:;CT@7+*$0()F<7)\0M1@BN4L-K4$ MK\BJG_K=M\:K%0Z2=U\GVS#A)`SCW=G5BCWK:@&+?:(#7.24HD?!!.4U.0KQ6TF_4\;S$DL!_!,B;!.G+YB61IEK`?D]) M@0N]DYMN]Y=R4'J1$,O^CZ#O0S>**1^"UY!M9FL=P2^]I66GW=FH3_/[=P]P MLB?TF7B0^BMI:GI,2V]A254XB8X^N90NMU!0.2_=8%)UI44O7J']'XJ2#8[M MO0P+&+AZE?&\="%)3E_N0H9$8Y\TM2[K4)$MW4NB?R%'F7/:&[$?,Q!"^LW_ M`%!+`P04````"`"LB%1%R.Z`38`N``"UDP(`%0`<`'!E<'0M,C`Q-#`X,S%? M;&%B+GAM;%54"0`#%'E%5!1Y151U>`L``00E#@``!#D!``#=??MOY$:2YN\' MW/^0Z!W`'D!RM[H]GK4QWD'IY:L;61(DV;Z%L3`H,JO$:199DR35TO[UFYE\ M%,E\UR,S=`.,N[LJ(NI+YL?(5V3$W_[^LLK0,R9E6N0_OCOYYL,[A/.X2-)\ M^>.[7^Z/9_=G\_D[5%91GD19D>,?W^7%N[__Q__^7W_+TOSS#^P_CU&)$;63 MES^\E.F/[YZJ:OW#^_=?OGSYYLNG;PJR?/_QPX>3]__OYZO[^`FOHN,T9_9B M_*[38E9D>B???__]>_YM)RI(OCR2K/N-3^\[.+UE^FVJD1\@*=,?2@[OJHBC MBC\.X\\@I03[UW$G=LP^.C[Y>/SIY)N7,GE'GQZB_VN>("DR?(<7B#?SA^IU M31]QF:[6&0/%/WLB>"$'DQ'RGNF_S_$RJG#"?NA[]D,GW[$?^K?VXZOH$6?O M$)/\Y6ZN;-?W(UNMTGO?8&\Q28OD(M\.]50[$/S[*B+5#@T8ZGMOPD-11=E6 MX(>:WF%?X^V>^$;/_Y.FCA=O]Z0'FF/8&?OPBOYM!!R_5#A/<-)!9[8T#H[_ M%/>[K>W>>A&/[&;,619$^D2XR454/G*[=7F\C*(UM7_R[7N<567WR3'[Y/C# M2>L=_ZW]^(_+-$\K?)4^XV2>4R^]3!\S/"M+7)4_X]4C[G^4M_C'=PYZ[Z>M M8A9FI&M:1&+#\VDEWL<%'3S6U7'6]$2COB#%R@E.^T`+!Z4_LL?^]YJ>H)`4 M#1N)$5P6-8FQ$Q&&K7-]VBW2548UV:0"Y\>_W+_[#^XJT.^-S'_][?W&-DC& MG;[^'/VS(&=95):SE[1T?QJB!2`L5#7-DH]3];?`3`7F*4<;"\?'?6W;>7MP^_'%95,5SBK_,\UCJ_%1"/CBF M!\AH))<(SA0M+($,K1PE0OP-,,=UAS,^=Z23QM<'$N5E%+,5#.7Y\!N-WW(Q MX--MN3=LZ+7LM8-3<6O(4YJV8HC+'=8GW=[/[S%Y3F,LGY"IA+SY)"7`WB<) M$L&)H(4U[6PJASK!O;DD16_?X_7'$_KQR541Y>K^EHIYZW$-R+[/)3(P>ET- M;-KO5++BWZ./)T>(J2"F\S9&)?=A",RXXSC0>!]9GC%Y+/I]`=='''Y$N2Z> M3SZ9?8Q4S)N/T8#L?8Q$!H:/40.;=CN5;%S,R:=#N!@%`_YOG3,7^%%/`)F4 MM_Y70^R[7Q2!T?M*7-/.IX(8-4/+1R_]?A-7'S_2CS_I.UXJYJWG-2#[KI?( MP.A[-;!IYU/)@L\M/G("?/)"@-F:\,G/MWH"2,6\$4`#LB>`1`8&`=3`I@2@ MDFG632V_A3BU/"M6JR*_KXKXL_8L0"+GEB0C;E2R.'N"`, M?MQ7=,JZPGEU\:\ZK5XIP'61TW_J]NX-.CYY8P5_R"&M`A@^V:"<R*3!,,F+3R!1G%< MK^IFP^0<+](XK6#PASE0@I]P7J;/>)['Q0J;9DXJ><\S*#WLR4Q*+@R&2R:$ M%G1"YS6A-*3_?,99L6;#*9UY14M\J(59O3SYUF)A)A/SMS!3@]PLS$29X+PP M`!/H4"_1R;>'6):ICOBBLCI/"8ZI0CG+DXO5.BM>L?;`SZ3B[_C/#OSF,%`O M#X,L=B"%@T*JA7HU1/50KWCP@\,HBTB*&=A3G%,G5I5L*,6)YA#1I.+O0-$. M_.9P42\/@T-V((5#QU:+LZ?30XTBM.VAIQ0O+M,\RN,TRFX6=.#$1#_=T6EX MG?"8H8^F/&KQX%RSQRAL*#$-U*N@5N?0GNKB94UG9O@.IZO'FI1\JT(STFG% MO7DH"]"]=]+(!F>+)4!A?ZC10&,5B/[HX@7'=47G_=;^2*7AW1_IH0O^2"X> MG&'V&.7^J%?QY8].B[PN=7/MB8`WGR,%UGN9T;?!>UT):=K)K"*&"U]-@ M*@"C\Q6HQ./,3NS@00_)K";?3:Y'`P*Z,&) MAT*--.K%/;WX:;XTA]:K97T[`B73G?3(! M;]20`NN9,/H61L?+($W[N94YN$R(E%< M2;EKI>?/.S@T8^,C+)1@$,8!J>`O6M7FM(8KHX'V/G>V2AQ_LRR>WRUGTHS\:%'=XF3+D>74=K?"DU6HQ'Y0R@60,4LD$)XP!F+#SV5!B(XN8 M<#A:G%&NDBB;YPE^^0=^539.D/-+#`7,,3,F0H"H(4>FX$8KC+@THN(AV-'Y ML0=J5M*L\=>^N"`#U5%@^!V(GI<`4@X63"9D+_<)N,ZC2M?=$SG?_2Z%.27` M2`@4$V3(E)1HA.D4(D%,/`0[9A1(PL!<9M%2TJ[)][[8((75L6#T)8C>ER$2 MMJPZ&<2$0O3U64T(PYB6<93])XZ(VAFH17TQP`2V(X-*#@0O#."$[:M&'#7R MB"D$=0[-9.4WG&7_R(LO^3V.RB+'R;PL:V&[PD+>[W32`'L\K50(@R"1#<(I MD^9EMS"-$-,\_LQ44:>+&N6_AR/5KT56YU5$7B_3#)/IS2^-G%\2*6".R3,1 M`D0:.3(=67H-Q%4",J1UAG=X71!^`%!%5:TFBDK<\QI6"WJRE)7*`F*/%J"2 M1%^5J-=`C0IJ+05D$V?S&1U'EP51[X!,I/QR1PIQ3)F1"""FR'`I=CZX*.ID MPQ'BMG[,TO@R*Z+I9KQ"QB\9)/#&5!@(`"*"B$I!@T80<^2^T6M4J>QQN+!DQ&'8T&(")9P%1MK0YR'APUI[DE&FB'W(-K%G;- MML\E_4PVG='(^MZ+4\*=[L<)@B"89$*GW)=KU]_M]AQ7"<\:MAM@QYF!9!C& M"%#E?.G%`+)EBLW$%;Y7LW>F["'/RLWF@L]M4:::(`0WU2!95RP:(TV^HM$+ MSKTMP`H7`#M55`PO9W7:Z/=.'\BMFR9-NX&&4R&OZ5>D`$?Y5D828$@DA26< M1-S?7SS<0Z)"NS]@Q0A!UC\Q%'!%?DP$@=%$CDYU*!%Q'1BL.8O*IUF>L#]8 M&JKG*&-W"V?5643(*YWC_QIE]?18RU'7ZU4^E^:,+O79*()AG0M:@854B8?G MQNPO>*,.@Y"C%\KFI0OHMHSNRBMAJD%E,O-CT]8LZCS5;"^>2A^R/0$[_LIW MF/:P1X>?!W_S)6!40=E?YYA/7Z-!8J5HQ8X1_IM'U;+O_O3=T7??_96[@3]] M>W3RW5^/$$6ZQC&[^YN]_AF&+]"4-[K&*N=@4@)2DFK0`,LJ5%0C.`V=8`H' M6YOR4LT4B/,OS2N<991Y-74\:U*L,:GV>IJQZUBD]:8A1A_UL`-QO%$--#W6?C'%MU)!3MKI@O)(CX"DE MK^:ST_G5_&%^<8]FU^?H_N'F[!__Y^;J_.+N_BMT?G$Y/YM?7)_])SRZVC,S M.`DM^0:96M8L`D<4N]TAG4(@VECL$ZFE(9+(;<UU4N&NLXI&,17SR3P9N2+#A]V`8)`$E%MNB(E)^L!4@!00DB[BU!POMJ.S\ M$6"W8^U=QIN25]#ROZPT`4R'F\\ZX!E'T"MYV! M-[`7X+SZA[W:'T1Q:H]D!;%`M<#4!ZT3&3"$40`3CT]YQ9PF*A;-ZNJI(.E_ MX^0']-U?_W+TX<,']G\4-Z&S)8^9/:*S'H*>F5'TIP_??/AP@M:8-%]V0;:- M)$K9;;*$SXZ*3:#M#^CD+]\=?7OR\>B[[S[P+T_^O8&E&(K)+@,S"IV6$$2B-UT@@[ ME:"$4B2,L)&'2RUSLH@)OXK]Y8?0WQL9+'1G@]L-DX99:?B^96*`/KU\HA`/ M3AI[C(JK*D?*.RHP_%-3O;R_$VXXRE5*^_1*!LA#AZ00#4XK.WSBY1(FC387 M^*%=U;_#SSBOC<':HIC?HP\@3I3`8=V%"J"C#?*CK MT)N*:[)IUO#;`*7OA*GIYJO@_2G'HRYH!\,'W$=91)K]\-^BI7(`$,6\GG@I M0([.NR8RP?E@`";$_;5B/&CJD15(AD&0GW!._5/&+F,DJS3G!9!8Z%;KAA2- M-FKYI(]E$X9L,JB`(9<=3GFEY>;RPT`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`DM>TFQ.V"[+3@I#B M"[L(IYR6*N7]KCH,L,=K!H5P<$K9(I2D+^7RE%A<`0:7J$?,UF M)(,W2F['Y_PN=++[I88(^N>BA$H\WX^17L:E6D\RY/S M-*LKG.CN4.Y@#];QD*'9;H<_"F-@7/&N+9!%9VQXOTGEQ3H!%;U1=(RX47Y2 MGS1F8;P6O]%AXXG=U'FF6)?XNF9YPH8-'U[[VHQ>BL>[M36?K\2.31Z^$%N: M`O,Z[(9?O,K56$.M.=388WNPAZT8O9>*KJP8VF56?#&=9^I5`E5P58)75&X5 MY,%0T@*DME(KKVG'MFR-LQ]Q>W,T>YM<_H=G9P_Q78[D2.%O$ M'R%UD`27;(=XW&#_)3?G*^'>UCC MA+'[_QTPK\L!&R>FJNU_BN]+Y$5^S,O=IBSFZ0<8;^#D_-'NE#+HB:_%.2\8 MMLEQ2;)E`BQ!,LR@<;.8%MA4O5X&):_^TJH!(\^GU0##*BN8`LG`)3:Y6"QP M3!=;743-'5U+W>3,]RK:K5/P&LIK!#Z*XE5*0\M>8$3J,\A)'??61=C=+"8E MPU31;SH%GS%P9N##2#BU-!3>6"/U$":YIS&/CL28>4C]=$@4\UP;4`IR4@!P M)`-G[)(#$^NTM7/EN,^8`"OBC6\K/T9T:<".(RFNYI"=$.8'V9S_]'4C0E\' MGCSJ2T1&XNQ.W(EJ-W*//^!U:WCO#V:TD;PWZV#>B+TW2=BD9MK'7)U5/H03 MC;&Y\2'.8ND<)*O9:O:V2 M\-:'[3N?UD,-M]@MI`(,H9TABQ5>RR=4E_Q4:#ASZ/5`,W:>/^/2Z7A^&T,` M&&S14`LF:ZQ`9[09NN">KW^]N'<(^MGAL."6/H`G=FM_T>;ZEVU@2X2\'0HH M`?8'`8)$<$)H80E1ZJT<6\9_:23?FN/:^7V`ZJAVO.T(7#UOGU[/ILO^/MWC*YQA@G_$(4 MJQY&&T8'E$'U)\6CL=#SG.W5KAF3_*]Z)3!$M$4JN:#&]9H;:6FKR28"<5.L MJVR+=>687Y]HKJ_U^17_*!Z$5/`W=?!Q^5M:/0U5%`]L M9ZM^JP/MY1&,BPKM9!(,\??3#DGIDB;="LOK\/B*2*/"BL)".7:UGS+M/.>" M.AG>;1+\)M9T:MS2-1V??2PZ'7`+.G7,[2Q/V!^L-OUSE+%;)(KGY&8"1J"T MNG%VH=.BOA_N?M]P-\=+YORV"Z968A=J?7$3;&Z\F`9:$VH-Q6UL`77(+%82 M!J'E+6SRL4RG9(I'YV;":Q*>+1HWRLKCH`]F/K$%:.5\^NND%?PSFUKS"%]V M(LO_@C?&`UT"EK=T1H,T[Z+ZB\S.=GW*#+AUB M93UXA![Q,LUS-N92![8VYF-ZN]WZ*4"W7N3:P<<-N$.G8OJI57<&2*3RP!;H MB@A4N`9$)4R,'@D'8(0"5 M,J27@L>2*30-4YAH4_I#2Y>#/O8B_OQ49`DF)7.1\BTA40KF(*[!.>V%TWY8 M/HTRMM,>:E#>'"`(^;ZD8[%&'F:G6"$6NJ?I%/1UHP(D3PMO!#O\P8/*>QNJ"[FPT`E-8WS]DO M=P:@$UN+VH+;[-`NBBD34=GJ@B;QY#W>CL5*(P!H;&B@NW=^*T36P]Z*R6_1 M+[.RK'2\H:TITZ3+DKF+2U`8!$!UAX8[NV^I->BO@'T3IJ_#W3#6XDUZP;8'/2&+*.\3?+)/&R1I4F33BI/;BE, MG%=MUM`VBB[*^E,9TXVA/=GV6FAQGX]C5&MQ'X;!#-S[;(V0XG]@^PB-K/,0 M@Z%]M@'7_P+:_`2\\XX:@$\RD"JDP9#+"%&2 MJ+U50)T&.-]TGR[S=)'&45Z)[7O`+]5IIKY9::OL=9WMU*#1JL!*$PP=G>`* M.Z8;922AZ8$2;/`;=0^%_6326LM;"@[[)O0Y.414'DHAXXTF*G@]*:8","B@0"763P24FJ5+'M_E?(LRTPQ)J^$U%8`9 M^B@)@%H\.'WL,0H7_UL-OK[K=,#-DVP2#)ZG99P5)5U8F"9.6UL+,('?MLF2 MV;VK*3"LW@V_8EU0HM8<7X9V59VN]I=E4C<+:W]:.WXJ!/W.M51`Q].KJ51P MYABAR2=1MV\@;X1I>#6K`4(5'52RO704!'N4@4=TJ?5+#:--#A01QL^.;M5\X:L=3(`AK?; MH)XRM[/!USD;*Z@Q@S9VP/E@J]:;W+"K$7"LUCIC-PMOB]=8P?%-O MYQ94O9TFF,;@A*="7A/A2`&.4MV,),#P20I+"(GA0N"\G!ANQ99D]@[.0=][ MW*E+L_2!<@IE,`QT12PFL^!EFA"W=+$]RUQ'H\.:0SNS-&&UZR"VS1O&GAO;0`,-;=!+68E[FWP M;9B1%TJKQ)M_I:@0.H`5@DL'JCQ?"F+*J-.&YUS;Y@UQ M;]X]8Q2TO;KOW,,NC9HF,K71!4-61\"6A)WGBX*L^&40&$2]KQ]+_*^:XKQX MMO*<*G&_WE(/>NPAY;)@B&8`*!*K$T>-/#C?-VV0<9=;+1^25/I=;)4P6%J9 M'=:$5S#(=!J5:7FS&%[2I+/1G:X8[6;2)R7WT?@A:W>Q!X;8>VB$F/*4FF0W M-8=&8?!_=%^9M^?5O";7J?A=@9O!C]?;:GDP_+,`*18B3.GJ>\UN)%"2C0S` M8!G/)/S+>E//Z*PHJZ9MRD-1C8;G[.4FZ),TYBIQ,`PS8]3E.&C/`KF1XU_6 MZ&P?67`5Q\[G^!EGQ9JOP:MHB<^*U3K*7_5^RDG3VX&S6U/ZTV8[M>#4::-6'88'4Y0(LALP[70!E'FR&$)M%(/3<1NTTAHQ?&>:_>7"KG33 M[M>#+7R;2M+W56&3[Y*+0=IN2[**+M97!7Y\BI]QHD+5[Z,%C8!\!9^E*E>)!01!N?J)"%,I.TQ`D_"O$B(JQN M&JM\RY.^VA'*J.7U'I)=$T87D_0J8/R7'4[9V4/<.*XTJ]D]Y)9W3=)K1*TA M;@X&!2_IJ,_+"`Q2L<[SLB+U:K-T5SP@2UV?='1JSI"45HI@J.F"5KA;5U;I MBE^09U80-\/F?)O,;`-+0$C:%*L_JPEA\8JC-!9YPO^9-0E9[3SH#O:\DGG7 M9H\(OJTQ.*3?L073%Z&UASJ#:&`"!N_9CCS!3W2^3)=BS3#2-,WVX-A6W7,8 MMU.C)@'<5KI@..L(6!*TO5$?3R1@,/27D@Y!W8BBRED^%?+)-CG`(:?&$F"8 M(X4UY0<58D-W+W:@HY*S)_JCN)SGDU`UUOQRFNS>D/6&P5@Y-H&[2" M[VG4J=<1TC\#.2.^QE\&32-%3O\:X\$,V&Z8=#?CM>#"EHTM25`)'(^=VY5L`<[U-/A,!02H5,PIFQW('& MUIOJ"1.+<50NYVW,U,'LQT>94/".-R$38N^8Z(%3TAOSZBH$O2>GU^?5E4I! M.24P(@0=;G(?/^&DSN@:P":QM)90^S'I-09X#XT?!0GO8`\*G??8EE#)Q@_P M9NS\'D!E_6X\V+[I20KQSVE)\5X6I(^%L*&BI:(W!CHUI">>E1:,Y8<+5/&R6:N+J#*" M%\2R<=_G>($)P0D%UT0-TE=B^\'9T5J8D7JK)LN';2=3P6F]'_SBI:3&!L]* MV!;$!D)SEJR:/KRVTGT3.\X_:)W\(!.3#<^W-^S!8;J.S9` M>M^)3EJ;A$>-;V_LM4QP8G5Q7F-]+F#:)+AWK5I0@!" M:8!+&"61AD8I-41)@6XFV:Q683FIB]4Z*UXQ;JM"6CLK"SVO]^QLFS&Z:6=2 M`L,X6Z1"ELLHBPA+S,^V3$YQCA>IW2CI;XHB/9>WG[?HU/_X".4X;1?PTSY] M*%B.Y7T$)1PT"E):IG;VDBKB(97BGCM1'QMI1FE=;1?]SO2`Y#`>EED?M'+# M1LJN:]KKVB'!U8C7,/&M&C@*$G>R`(:S6\'61I`T0=AYZ.U!@(N[2T:IADV-=I@J.L,V4#;M-6`P=-S_%AM M;I)?1C&>K5AS%0]#+>Z3@R;00\:I9,'PRP!PRJ:K(LI1(P&106<1(:_TO7!@ MT50E')/DX-5L&LL#9904I")7-IW1W]0L36W.=LIA\*OSL%:;WRKA$.$8YLUO MN208'FGAJ38LYZ"&-WY-R%#L5]%Z.U6?Q')IS)!F-GI@2.<`5J#@*#P8!@%G MR3_KDA?TNRR(1S2I5PF#V_;Z ML4S0:VR,$N@H]D60`N.'E-#$5'+Y9W3V%)'EP:X0G-<<"RL6%9-T+7$?:C%_ MI1S4(#=U&T29X!UN`"8$/]?M.<90]D#]?IE2F25CH@SS\%MOO2Q"ZCMW\Q6, M/A7P"*G%N`!B$@?JP)]QE#%>7;!)<16E^4IU,XPN92]SV,.?1UD:?C.R'\/'2!R6S9G$2=T55"D:11+AEZM[;B M]YQQJR:.#QJ=3`1GXFZXA>B&5@=Q)1B\O<)1R6(U[EBMS$R_>:60]IU05;L;4-2V=^2AO#UK2L%;IM*`?]$/%UULV2Q=D9 ME<%PSQ6Q$'?'A(^Y='>'$08]V:Y*G;Y1;3:(_QM7-XB%Z48SM*G%`0>`V*!6EM=H21Z=X41`, M,(/%Q6*!61%VW.=@8L&5=YAU=9JEG%.SZA(GC&_W5535%,CK2%@UG]Z'9:_K MG?T]BM%*:'>S8%Z$_;5%.!YJ=`9O"+K;1_F&?87%=2T8-;7_N'6Z[=)QN_=E MS[\1I)+B/A^/M/SB/GX`S-MTB%:I*SQV,P/T-?LY.D]]I<,2WZVXR='#$T:S M1_KI&WCKKHL\P4E-_=!C9@@K=+(`X(W1-[!K-XMR,_/N]ET;S" M*]A,;<&J`\N7B"3&'1^)0I"M M'R5PZ1Z0(`V&3T:(LCQ:`UKU^H@90-S"\65C`@;7A,RXSN1SLN#WEIMST\:7 MWJS5P?#5';,VRW%C`P91U2WIYP+]5,#Y;9:9@.$XU8VSY`("4A1Y M<[LU3923Z*%(F#O$&W#RF\-I`H8T$E#B0J--GLYDH/"@K_2AI<)$*LBZ=`Q1 MNAYM1`!Q0H9+.$)N,Q)"X427\)\N4/B%A7Z`GK&CIE1R2\!)TR=W')HRY).% M&AB.V6.5ARZ,:CP<*G*I()\IHK-HG=*?I$-D&@M[83I!?W%,.J";<":95'!" M&*$)44V-+&J%42M]J!M&M(U/['BK#::2H1=E_-TW4L#;7#N:",#H;P4JX1)2 M)X8L0MD.Z(^'.05N%M-$]3)7K->`=\7/$J\BPO!HKP4@%&]BFZR&YZ5]IY,TG^"J_PQSV/"+L.>X^;/>:Y^`.K=(`<3GK?8G!LWV7^SU@=#X"U`:^=L MK,1#-"CQX'F)-1E*-",AG$63"IAFL-M'OJ)#UB6S&<^L-,-7+#..7!9J8-YV M>ZP&\NVK=)!J:AZ53_07*Y(^UK)(5960OPFX"N#&TTPE@I-`"TM:]'@D&.[J MWJK([ZLB_LQS&93SLJ2CC>Q-5(C"\?2V0*5)'$K42!VADO\S?'_<1N2&L'L? M..&5,F\QX4@-?:-2`]U/1M#R/CM"ZXB@9U,=T4..:DF2LO7[`C-*\.^Z!,8GB#&O>[O.:E12A[$J+)M%+V9U:W"S& MYP.39^)HP^?$:JOF#8GI9"#X.+L+:DFP3'MTTH51L!>:4?@0B:0)OX=<9TCQ-,:`:&P9%=D^@Q&(EZI9]BR&6U_@*&,"$JS MHG3>G`E1>:A\*!2+9AXNJUQG6^N'J4QDV2QYI2*#,A@ZNB(6NSI),XN8A(3F"C10W%+N#`0@I%B@7FI+EY:A)]?48?7Q8;ITS+9 M*GLEG5.#1O2STH1#1!>XFL/IP(E&%7N^_,BH^9@N)+I&.6QURPW`&\.V@R^6 M(MZ0@8<;'#6S;&2=Q_Z`7;RWO"[@.L\"JRSY67=S:I/5!8'*ZC+(@Q2MTIQ? M*NGK$;7!:ZH-,BO50/FIC(U1)*M2ZH$9#!S`JH(1;XN*NHB4TI*E(`!6?FH^ MKD[$BK4KGX1$,D06`@E463*"@1@@-JFPF0J8P\J$=E7DRP=,5JP!QNA*E;#7 M\D]:P*/Z3U)),`S2PIN2Z*J(\B-SR$\8WM#I6,RJ6"WQ*8[8_.PR?<%)QW=- M'FA7(Z%X9M]`%?_,%D#RTAJVG*]=P;P@\?H\DVDYS]OP9+9L*+(T?FW^^X!? MJE/Z?GP6#L-M%?](BMA;A]'?JMGR1%;8:AO4\KRO)0MBBWH#W\"]9P'KV4]Q MJ;<20CS1<_R,LV+-M^38J\Q*?$2Y\3VP4X/5$TZ8Q?QBO3+BVBANU(.\!_): MQD7>[44]L)L2ZMYS4X?5BUMAG_9F5S>(W1N+QG6#<&L'!>E8?JIF>OED0K`Z M28-0N(K*1(,\ZUM2/*=LR^^R((.,889WQTH+5F^X0)9LC#:Z:%$0.@/@N94K MIAZDSU19@KHT/*">^QB4(O5,R,=H@E8 M/:&"I\H#QQ[]ES"O1!_;Q0.FSS2WRX<"@(I/RG$)&^I+BY>8 M'["R$_.;G*5!DA%-+0V()Q8@I]W,'/)1*VU`;]46H&6%,9N*(ZT1 M]/B*OF9V4)K_&?6FT,86K/Z]I(X\C[?M7XDV_/[5@7;LW]Y4^/Y5#Q'L$@[] M@ZU^GJ.,16FXC8.B/J`^W@JVXUC)I]_\+P-C;^]X$H-=K+\T0MJ-;HVRTZLQV.9SY0-5=?1GN?O[. MC0=\1Z6/9#=>O$D6[*7/X75O@.!9($Y[2]2*P%E+,\$2$'>Y22X+,BSL)CV0 M5PD#>C7-&(5C^X$0^OT<+Z(ZJ]`5,QMRVB/)'B'Y&L"3UZ%2S'#4-S>''UW1 MO]&/NX_H?QZC$M-/_@=02P,$%`````@`K(A4190DU/4<(P``*T<"`!4`'`!P M97!T+3(P,30P.#,Q7W!R92YX;6Q55`D``Q1Y1504>454=7@+``$$)0X```0Y M`0``[5U9<^0VDG[?B/T/%3T/ZWF0NZ5N>]R.\4[H[-".+"DD>;S[Y*!8J!)M M%E$&21WSZQ<@656\`"1X5&:IU0_=ZA*0A

WQ^_FX2)UXT]4(>L9_>1?S=/_[[/__C[V$0 M_?&C^NO>B]E$THGB'Y_CX*=W#TFR_/']^Z>GIV^?/G[+Q?S]P8+ M6_^!+;R](%+T?/9NU4M1:>NW__GSY_?9;U=-&RV?[T6X^HZ/[U?#65.6OPT, M[4LCB8,?XVQX%]SWDDPE-Y)]< M@H*'[(;-)NK?7V[.U]^Z9,LDF+*$^0\1#_D\8'$0^=_Z?/%>-7U_POUTP:+D M,)J>1DF0O)Q',RX6V=`E.QGM!\%F/[U3E.00]C]]^"$?P%\@?9.7I00[#A;+ M4(KG_2!C/H\2)H+%,8]B'@93+V'3(R]4`-P^,);$MG%#^V.,_=H34J(/+`E\ M+^S+2"NQ+7%UF\B_U>R(KV87/([E)#GFBZ5@#RR*@T>F/NO`GPM9!$Z/O?CA M+.1/?5EKT$'@Y3;A_A\//)S*=?V$S0(_D&OZ2T_&S$3'X/+22U+!LGDB%ZDH M5>IQ-;M:,I$M5%:DH/W'&/MM,(\"*21/+K*^SU,U@/FUE*L4FW7@H,YCC/I7 M=A\'";.-K]9LC)$4?,N%\,6[#Q6(\A.1LNE%X-T'89``Q.A"8Y3YRQ.V^G+K M7&UI.\:8;EBH%%ON+\G+G?"BV/-!NF3K-](JYT7S0$$7QW)3E`"J-2H,F9^D M7G@MN%3E!+*NN9`9@Y-C;QDD7I@MH;;AMK4=8TQ?6"07PE!IQ7011$&U=AQE=TJ7 MDIKZ4B]<'5@'KQEZ+BB%UO;H8NF.L4L5P:LV&/NFZ?0R44?^,BVZG91BA[7!SPF9,"#:5GQ5FT@Z<&(@@K.W%H-1OI*)DY_], MP@D3+$ZR.RH8M1&^"L.>EX\SOO1$KCE][7LZ>J/O@7`6+-UP]T$X&WUH;M/* MYY4+`M:N6[54.8OJK_A?R@TH4])RR:LNF*D.)I4`\`^;&B^"'_LS_9FZQZE7_THNDD)S$I MTRCX6'$2A_W"<>,O\J/?\C'_\E>3!@TF@)!V*>'@H9K#!A6?-Q) MLNW2K[8`"OV`DM#;>,24]343`9<<3$^\Q"+T6E.@]#]2E'XKUQ@P',K13-6( MSD)OWB[^6A.@V#]1$GLKEQCB/DZ%8O$LB'TO_#_F">/$U[<&@O`=)1!LO.-M MO+_*6^(_(_X4W3(OYA&;GL=QRH1I`]9V`2+S/25D0%+`@^=?/$RE!,7+61`R M$9M@:30%PO$W>G!HN$8\GN;Z>\.67*B;L?*E3(UHZ'H`0?F!'BAF&>!AD\V1 M8[F8SKDP7AQJ#8%(?*:'1"O'>`!)192F\?)-_Q59ID\3U208W+D[$?%!V*5VJ`0##O?/D1,+\#GM\QG(`N3>/5)?2H6'_^V M'NG5["R(Y)@"J2D\#BQF]:([K'=OW>K.7O$T:66DW@[+QNXDUZJ":3@9?J7K MBT9QIH>"TFB.9GH?"AR-`&A@I!XMU6NL_.?TSS1X]$*FWF>38T^(%WF>^9<7 MIFWFLZ(_L#N:)1\$!._"$B40*^P!%0S1TMP!E%8.2\*78\^=]2YRKK4CS(:7 M\,0+LY8=8=,\6M>\DFOOTNO?HMDP>ZQH%08HS7W)@1S31?#(IG47I4MF4`9; M/S3+9O]M!R82&O#EP[*M68B6M*%.`?B+UC"`E3PTY2Y9#O)7NV7R8C_GP2G@ MF2'ZH^XJ)QKJ6!ZU$Y#.F(UVK!@(,^KP@*]5ICY0L$@=10!\4<(,XNMN/[J[ M$(&B.MK9!0`-[\X>)7#;`M>:Z%5;0>$9_GVV*SSZ\#QL^;OH4`]5.1C^C;`K M%M0UHB4&U0@%'(/13GE],*`E_"['\0$.X`<4#W.['+OBQ?71W8MK\DV% M[E_?O+JV<$/*_6T/T^2!B^#?F_EBO"PU.^VNOQ=`%C1.=Z6!2CVY$AG/T^S. M=\U$-G80>/K..^P8YB`<P(76O*@2B2)FC-72L=8G5 MH'@B6H_4?L34=D`U)3ZR*(7XN31;(I\? M+?)OV`7;&:6Q7ZU&9Q<__HE/*\EV@?>^:C\R<<]CAF]L*7)D1O-5U*Z1ATGYL4RW*#;!]^>U"XNT#I[04W7JA)W*[V:_>W+0D M-5MBG\O``&@YH(2$)8.V'AAK1^S8"U><@)*@`=NUX#,6Q]DC\ADS*5"S)7:\ MA2LP.E[)(#%-L]S#QSPVQ5.E+ M.B*A8W;77QKSXZ*ZIM04(=GV6-OG](I1URGI1LW9$C^AQ MNZ\!!4%C@\AB`\\72R\0BK7C!T\8+QZZ]E",1KM_0*7>$AJI99\&1"?L/CE7 MU7FR9#9R+@KF*3>J_-^KY($)8Z`QM#]Z+%8W"-W$,Y*MY$RN_<$\.GWV'[QH MSKYX050VP]<,)]K6Z(%3CA`8F:&D0ZO-MMCNC[@0_$GYJ)H.0-HNZ`%4W33% M*@0:6$EMW1RW]/C4FJ$'4KD=$EJ9W/4C8+;85AX*-SS*,_&U>F^5:"2)".[3 M)*L+RG,?-H`Y?P#:Z(%>CH;_P<1)0[&S@E1A+NWI[VF(Y2R,_C_JXX^NT MNWD4G/]2W\VS5>YJ)IG73Y1AOP4Z949[*QIP$O`1Y41IGK5(2RZWEFEC[`2= M!:/=;MP6#H``=GVKL1MDKIDX\N+`/XRF)T&8*L<9L\]G#Y+HP79N\Z.W\&CH M^:_RWO&@'+D>Y;#G[#)=W#-1'F[9UVZSQNEG0&>"Z)%:;OCW%-RN.*4Q0G.4D201=K#IV"+5IZX5[[LH*_JGRSG`A'+[_$*GW-0>4+(VU?U0CP6C^>P,CX6920$UKL-I#8G6O M\'GD!R&K#/B.`R4#R.,\RK=AQXV,.G?&!(C&%*P9/\%V7WQOT5&Q,5J(:2%8 MCM>XFM43RQJ6`TL_;-?5+>(+$R$-N$]G,^;+4\[J8>E&GGNN(B4'@RN!H0^V M@^P68;:+#C,B0/^$.@\>6<243;&6C]'PD&KJ@^UKNPW(`6+`AWRP1*:"*>RL M>WBS);9W[S87>8V8:"SKF7WIWI.\*2NU'%\!@5`+E9+/T2 M>'5&NX-B0[5=.E2QA"1W=T$81@\]QF$$W%TD26,VP)>[(5Z.,`NE#H6ZN\1( M(WT>/;+8]06A"RWT"(CA7@8!,AO)C_XZ%?Z#Y-$#GD;6`)B<:,#:/%662S)9*Q\!NT/A MW;9_CCN\3O*B`?$-R[(B7GLB>" M[I=-:>?OFHF`3^O[JW[.N%%!#_0:;,YTD1Z-?:5]Y(=2+D*\2!'8BM3!NJ-7 MKAL9:8V\.F\DRVSFR!NM2*@N#<-.D=\.",3U;7>2*)8'F2:G47W_(!T@5BY2 ME)M ME!10R*>2TU6Y9717;FQ-# MQ33CZG??=H9*T1HT:AW]S%00O>',V6R*'8W:!0XMQS3NCIH:TC9P+-VP0S^[ M``62!`W0ZG6C;6CIVF,':G:!RYQKU@_*K2M.Q;K[F&H@UP_,D%9*]W#R?V>+RC\^X,$<\ M.Y#`#H!VTVX7L1!:?9O#+E=J[0IG*PWLZ.:^>!H$0QK0ZCR\9>(Q\(VUNMS( M8$:EJL<@%1[W:!--5=&-/'=;0 MQ`X$'E:AC8(C/0%JD[>-D;Z:WDX3/>9W8+4W28[&#!@W.R#^_7?8Z@%D$KST MLU\X.&R,%W[9PX0QHO?%JS!AN.`[OO6PCQ7CU?K97'I)*E18>)$[(H]JV:2/ M:'>I^=MD;W(2Q'[(8]E;_BU&116_C]J-F8#2] M+LGV:E;X:7GAQB$(4.ED&/*8VV^&7QOP+7MP2UOD%,N#XEO?N;6B(9=5_3:8 M1\$L\+TH*?(^J`.A%(9?#DRH:/(/=4TNT9ALB$S65%"3R=58`B06-O3!/#:9 M@+J3<^`H-`9>0OLCJZ4=L?H1RTDNY/2O'O]?T;3/=4U;M1XP&4,6LGC'W38Q MU1/2<]%LM45FUX(V$Z,G7#SK%JAVP`$V&`Z$T3><0"H-G.O]A$=.2TN M1ZVW:^M^X_*FNJQ4]:O((RRVQ4]M-/7FPW#]5?%T8,C^1N^^U MX$M6SH-1T=*/=2W=4)ODY+*#8YG@9$T1;WZO\B+GO%;8WW!CUV%',H@*#1HI M0*==Z2"K=2><:SK>373DU+R(1:CFN:KH\J>Z+A==\EA:1&V%1L62"G^MOS2J MLYJ3JCF00-8R8%BLHT3(:=`7%C'AJ77@<+H(HD"QFP2/;)5)JEVKOJMK54$F M-ZA4"$W6E+[&&YQ-O+9;G4/_W;OI.0N'G/;DOC-WWK-.4;YO'B55CTG>!34- M8SYPEY.AL1-Z"??*N`!;D;D7\NX#P*>U%+M9".3T1_FV!'EIF;6OQUR;,F6_ MX=]1ZE]R\L@IX'HLM7%5,=G:U11HC)19":*SJ1,"/'VT\+B:0CUQ8+U M1LZ$I@95'N@&'(CW!YP"LMZZ(-F2_F!:4VJ#@EA/]%W05@HF=\C[RH_&-&C)<)V/U\'4"J6`GJ2I@]W5 M33HT,/TEENO0:9P$"R\Q9;&LMT-/LN2,3SNG(]E^CK,:G/%Y5!LFT+X*[P[% M@8B!R%4N-)3DDCV5QBMX)'_T66F[!B^`[I2@`-.Q`765%@VL;Y@?>G&(H^5WI)7Q*GE@`K8*MC>%BIB`247/A%;$)-()9071-"XOC5P. M19_)-WFO;HXMNQX,5!8<-,70SJ=S,#(]L.6)?J(BD](TDD-`TQ7UTZJWO$5- MGQ/_@4W34%X%P)A"O#=[4=VY#$9#"/%5K0^5Q#:&=:"1?J*2".DKV4)'4.0A MU):HDG;;GCLP^`K5TAJ%;%#51G8)0!S\5Z+`3@'Q/*I(NUM4O)[(;JEE%PY? MH5Z68NM-*MA(15&.L*=P,B82:J_1QVO!'X-8@G?&15WB-C4$]MV=4'H'IBA9 M(S<;^$FA]'+(Z[QGO8X\C@2QXR#GB!YDVCENNZ\4R>EY858]457?PSU3 MAO^#1M:4M3$^[_W7KR7I_V`!:?EP[LJYK%MCT"KM;,K3F&@4[B(:7LI>CQ2@ MN*C7T#+`46J+#(E&N&8$2L-?!RKBHB"GDUPZ,F_^>CC'TFP%?>@MVPA=>8"AUZDR(!JX=YC,<]';&-P/X]-D/4U4]N MMO?&3K;065--PB!W.P=5;\JO[IW+FQTTTB?"_84V%_^WDFC;9:8&=Q[M8T^I MU6B_<^Y`9L9I+,!-S8/@H^N"?2CJA)&9?U(P2?ZD,,+L>0Z*4VL?[`-.9Z`, M$J"!U.EB&?(7QHJ24BZ*!>B*?99QQPTL#QKP0NN;ANSJ=?41'0M^>IM^>IM^>IP5'0E;,\>BG_QOPZ MY4)CAU!S88O&VU1Y7+;GI[:V-,!QGY(&X`9Z0])LDV<\X8\!>SJ/?.TCD&K8 MT@[[_JN?*V5_3RV#(X4V7]^>WS+Q&/A,_ZJ6^:$VVV'?=V`"U3)(XTZCT;U. MZ_]K6?`K*_P!G16^-$27Q;ZE&PV,`',/!MBX:_XM6Q[LRX_W+[@7&1>IUI:4 MEBGM#"JO6`9^1]H$+OGC_D>0A%M;8EM)G"5LX'.HO8 MP/!8(D[G^Y]@(FYKB9Y]T%W$>H9I',[+EN,2=QL3^F$TO>21;WMS<*6#?54% M>\5T$Q`-<&LO):L(G"/FB2":K_Y[XR4&J[4+#>QG73"H[H*A`>@)NT\V28G/ M/)\=+A0C>OCT/;"+QX#!LC%-$9IC3X@7.97GV$]=ZM]#-.K%%:3`^GOZ=QDNW*7,#"(0Q=T*X$O5"SRF#W:[V< ML2<9G@6PS5]#J7M5+#=!N2-TEVN1O)$'^S)2C9C0]5<=+>4"*%NW' M:-58TQ;M=M-=O$:N:>S)XQ^O?CM`O/Z,?L)2W.%OW#I7%A9Y83D^K>["LOD] MVHM:=^UJ<$=#HRYY%%1S%V6F?SDA#N>Y_?=8G@#Y-/`BS<:R-B4[$D*K4ME+ MRSK*BP;8%\R+54C!C9)S:%TO-([F(SX(L8V!6@L)!K8JIM6&A7U;O3XU9KA/;OWPJB561HXR-7Z MD87U4ZYU*;1TPRL/V0LGD#!&NF,5*0+UDB]5>W&6,R4[0#NCNV\XNUHR=;>( MYO5WB9:+5[,I7BW'?I1(C0<)?:?=2:$.X8;2\>)T-F-^LAZD')_RL[EA/I?K M3!CD$D[.V%19:=2JD\J!O%0:&P[W0Q#']DUS!W]`F=*8))NA57A8?USL+<4- MI_-T&?AKL.,PW"?.*'(F/84NN3HOI%);[D.[/=R)"+9'W6#PFV1$&MR3?-3& M%VI`5VR_N\&`;,J#&'S5]04`6KT#=N!0#ZC:>=^!6U*I;LN1%\KKH>Z&U*BO MJKLAK2BJWTS6-`G,S]=P.5I?R"]X'&>^N3,NGCPQA9@C6OKLW-7(+@`:JV*C M'E(7Y)R(8`=LN&/9048TP-6/\U]>F.82#T/^I):^+GK91F7W[B-=I$0#7\GE ML9R705(>=7VV&EY/8-UW[V3J)!=RAQ]+<;?B0*1^<^V]9-;QS'*<>S]D1:\L M1N1&Z6E(";C-P2EKL/KJPKR$GSG7MF]^C6+N.=ELZRH1GES- M)AO2J^TOGJRI8Q9#O1)S+RI"?N288QX&TWSV1=/KDORO9FZ1?*L#\3#D,=UG M65$#5!WI]8S6FB'OCX.B6O>/;1,(06?S7[GX0ZY&Q]XRD(N;/+('?JN)-O/@ M:6^+O:^.`J.!7Z*K=:5TK6U1_LY2O+;WNON5Q3N_I0=_2P_^EA[\K7KM6_7: MM^JU[J"/4KW6[&]NS,M7:X-]P.M98[:%HV',)[KXS53X#RH*I_A2C9";S;#E M;$\WU#YN2L:H-8[D`!>5:TD>%E0V[7H^[ZU/XG8 MJXC4]M0EB,WE=^N%GG@YDPQ*:>FRH&C:(EN.'.J9&9@8=190H>X68=LZ86\TCF*'R8"W?7>P]Z1@\]DM\QM8M&_V-Y)V',+VM[?R?&_E^=[* M\W4VX7AQSF3R" M"BU*12]C)VQG(SM($"[(873ZS/Q4'7]=,-)UPO:0=L/(S/I8I:3R[X*O7J8. MV`%XL(7+SO*XA@`O2HP2;C8C54Y*+U@=?V/E2"YM/EE.LP<>2CF8IZ^M$U34 MR',8QCN-=?VMYNM;S5=BEPER-5^5R3_(K*FK1(VGGHC8U%S_U=:+TD4"5@L6 M)H>1-I0B"/^&!8O[5,2Y=YL1`6,/2C<$D/0!_(\D^>PYQG+PK+6A=+8'2;>5 MQ[%>]::/0U[!7LDCPZVRJ2L=[`T8[`[434`TP#V/?*&RE9^P_-_S2,^-'EHW*MC/ M[PXE_]R%,ZZKR1;\><:+\`2Y/KYF/Q[$$K#H[CO6[1S_5`J38I,E@B&'F&Y3 MB*5:>WE+87A25[UJW7+2Z8P7/ZA@>1']A>7=+]Q0 M8E!>BZ]$)IFI2D'&KIG(>`;AJ^^,5UJH!]@V6>P^\(?3::`@\$*53.<\*@+\ M#;N9K@.Z'0V^A9EY?E7Q0/6@IRQ%6\+"D/E)*@4@^)*I1UB0K_KR*8[R:V6(#'7M!65'GD?%\C8)EG)=5UO0S_*P_Q#JP&IKB&V:[8V&GGL:EYSSQ=(+A#I- M-.?+Z;,?IE.Y$JRD8#"XNY'!-OT.L5YVDMRK.G,5Y\ELXX`=K#[7#U8%B4E& M@]C1Z?3/-$A>[&>C>CL:U]M\WSY,DP2379U4(\D9)>M]RK7"BA+U5@A#M M*B`B\(*LNYU,NJ.]L,)@,=MP4 M9;O#?P'NN*'U!G"9F],23R3X(+Z>M\UN-X2W=TVW\_AO!P1>-H>Z7"AF7@OP MK^A=$WA*VN:;)F)EE:O9^D%&E:\%G[$X MSJ9A42I%\;7R[[,6GX;VA^*&>_EWDP8-!#6/G=DVD7]\QL6*`^=78AT9](@@ M^-G753:OZF&C41G9\J[QZ0.D'C*19XVW$LA?;0GD'3T2E0JK>XL@RL"X9G*W M47%.11`)8.H:>V,_G/0J-V^5"KEW]+8VS? MEP%JW+]%S/YR?\#4$L#!!0````( M`*R(5$7[U*T/NPH``#AU```1`!P`<&5P="TR,#$T,#@S,2YX454=7@+``$$)0X```0Y`0``[5W=;]LX$G^^`^Y_$/QRW0='<9)VMT&R MBS0?119I;-0I]MX6M$3;1&722U)N?'_]#2G*DD6)EESWK#LH#X7-^>#,_"B* M,Z39J]]>%Y&WPEP01J][@Y/3GH=IP$)"9]>]+^/^S?CV\;'G_?;K/_Y^)8(Y M7B`/)*BX[LVE7%[Z_K=OWTZ^G9\P/O//3D\'_K\^/8TU7R]AO'R-"/U:QCYX M__Z]KZDIJ\7Y.N%1JOK<5^0)$GBC&:C$P4^HD(@&6_RAW`CDF=_Z"7&+E92R MODM82>^O#E\V.=GA2K?\>"6'EP0\-[ M*HEOM#]]3P27O><',H"L$?;$.(IH40;>IK\#;R^EXKG/R(:>HDN+Z?L MRB^JR2F/!0Z']%?]>-Q<;'7P4P=B&8B;H(KA](D)`=/<+5M` M".:8"K+"JJT2SEK";F`OZ@";]>,-IY[2ZD%7WE9?NKG#>!?&MTC,'R+VK1ZH M&;<;Q;?-452J/:V[`VT7:&/)@J]S%H6P[H9U%@D(K+G7M1"L$'7#^:XYG/E^ M_NEE/7EOOE`4AP0DNAD8^\](QASK>1(6@#16[ZOA=+C$7!MNGLJ=7&[X?E:+ M32*"B`E0`U\2?6;.W&A4L&4Z.W#\,9E1R%P"!*O](&"QBM1L!`,>AK)!QLWB MAN67(BPY95ZFS4O5=8CX?^")@*DCB7WZQ1WE]\4H&[$NFKX98[#P7J-)I.87 M:.$Q#I\(FI`(3$F'>2U.)PZ#TR(.J4[/*-73D5'KY?1V0/G/3.(T]N:-D&]Q M!WY@S?Y*-HUZ%UW_,X[4`@:R0[E^X8@*%.3>O954=]3/BE$W>CRMR,MKZB!0 MZUU$9T1-+4)`K@Y3@5IC1A$.9(RB$6>P+I'9"K<6LQN@\R)`F5HOT:LGI+QF M+U7=(>;?HB61*-++_`26K19W["^*L3>R2=;01=?_B"FLPR/UG@T7T+60:E6^ MPO>O2TQ%^E;>R>5&X6T1!:,O>1%O:?12E1TV,%?!1_R"7O&F9I(UN"/^SIYS ME*BG9;O0^K=LL2!2UQ`VR>XL*VU4D]UAM_+?G*)<$JQ5=2CXXWBY3/;Q4)06 M_*QML%U,;D3LU#>G+BL%=MMA!6`F`O\5@W/W*S5V4R0*K>[06_EP)N\E"KI( MNRL_#2I`]2I!9U9NO*,2Y+U)/W4UU$U1Z$6ELV*K-&2:W,&W\F,C[+U)Q+L0 MUZL4Y>/?@-\-CI5&UZT:=>B5EX_R*)6TN]&P M;2LX%Z`&M!%G*Z)^5_/`N&O380>[&UNK^K&]8,U`W*CW0'^W<;$+O#L\Q9SC M$-K,,?1*X,I8W:!959$JT%+5BI(>A^_PVIE]&&`4!5Y;>I](/U020T2D/F]0 M>!P/J="-O56#J9/)9"-",Z0VF$ZP;'.ZEI0; M<:NT4^?X;HJY\#;==(EL(9$MXE9%=,-CE7P*R6R'P)[9;!&>O23=V%EEH:9Y M:0=NK:.4Y8#6YG:#:%63JH]:=K!]S_'+>62S'$HG MAQLOJQRT=:2S0Z1>VF@_6]4,3CPNK)I-68K8P5'O^&'%TU*;W0V558)Q'$_L MD-L_GR_BUU3(C:)5DZF?E_]_@JG^4;?M?,933]_2]_`FNG;PNHI1%J7;*!I<6Z10B4Z/4##"X_ M-3Y5((E4XJ-<-Y[J1_0\_Q`N1VC2U&40P=$/]/5)Z3^HDS#ZFCI9&+`_R-7; MK)>#.@R/3E.'MY^V'^3OW::3O+OF,B4_NTW)?"_>N'0%CC,N/6I=Y.2Z0RNY M_>N)!5J50T1]ZZ=R?=74'YSUSP2V8J_]201]'4J0MWVF->GC$@,8\Q4)L-BVMHQP=&O'>'DV@-$Y>&*(;MM;3CJZ MQ<]L-3@OM[B<='2+?X^IBN.9;7`IY>CV#@-Y=@9FG=L&EY..;O'-DNNA>F%; M7$XZOL7Q;'!187$IZ>@6CY"0=X3C0#*NJ@GWL+1D:VS-["3Z^A^F),-VV87&X]NI>N&YIN) M.GL:R$W,:_$B\RGUJ;F/"0=H@?%Y."`*$-0Q+*FKR)0T2&/\/@EU_NF!8`J%&$X+QX7R;CF9VNK<*.8` MA,##:>'I+R.TU0G]6Y`7]D`H]$;448/TTMCBS%R'LZWS\@M^E1\B?3/6ULR6 M;]_W-2E3'8="(_T!>-'F*F(;#-_YD^FB,TT$VN#@'5[AB"WU>)=HAM75YHBN M];4?:\N[VMQM<,T\"Q6N5%+;8/JM?A&*1UJXZ:4*EP;\;7!O*.>85[A206N# MV?G+7BIGWO^=68S1K8L?:DYE#JDVN%KQX[1R#^LRM\&QNUC7,-4E6@$GRWPZ M4TYJZ\KL@40P/3W@W$(YW])6LS]A%(DD>\=<0HJBR*D'5<2V.C/"%$7);_3- MDY!K:*O19H8UTT]AWLU:6VL^XU]AF)OCRLE_5+$90%7$EI99TDPPK,@0PT,D MB#^XEF)^;*/WA]9IKKZI3U<0VUH8,O;J+9<*7XJTMKIBU]?5FZ'HU$ZNUKJ' MQ%R=L^9DHH4W4W`9H;4/SV<0``%0`8```````!````I($5AP``<&5P="TR,#$T,#@S,5]C86PN>&UL550% M``,4>454=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`K(A41>R3T6/Z#@`` M.M,``!4`&````````0```*2!%I(``'!E<'0M,C`Q-#`X,S%?9&5F+GAM;%54 M!0`#%'E%5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`*R(5$7([H!-@"X` M`+63`@`5`!@```````$```"D@5^A``!P97!T+3(P,30P.#,Q7VQA8BYX;6Q5 M5`4``Q1Y151U>`L``00E#@``!#D!``!02P$"'@,4````"`"LB%1%E"34]1PC M```K1P(`%0`8```````!````I($NT```<&5P="TR,#$T,#@S,5]P&UL M550%``,4>454=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`K(A41?O4K0^[ M"@``.'4``!$`&````````0```*2!F?,``'!E<'0M,C`Q-#`X,S$N>'-D550% K``,4>454=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``)_^```````` ` end XML 19 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transactions (Details Narrative) (USD $)
3 Months Ended 9 Months Ended 50 Months Ended
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Jul. 28, 2014
Jul. 15, 2014
May 31, 2014
May 27, 2014
Apr. 03, 2014
Mar. 11, 2014
Mar. 03, 2014
Dec. 03, 2013
Nov. 30, 2013
Jul. 18, 2013
Apr. 26, 2013
Apr. 10, 2013
Aug. 10, 2010
Accrued Salary Forgiven               $ 516,000 $ 516,000                  
Accrued Bonus Forgiven               300,000 300,000                  
Consulting Fees    75,000    227,000 552,975                          
Consulting Services Fees Forgiven                 545,000                  
Shares Issued, shares 156,412,660   156,412,660   156,412,660 5,250,000 4,660     10,000 5,000 10,000 10,000 151,123,000 25,000 2,000,000 20,000  
Shares, par value $ 0.001   $ 0.001   $ 0.001 $ 0.001               $ 0.001   $ 0.001   $ 0.001
Additional Paid in Capital 187,899   187,899   187,899 5,250 4,660     10,000 5,000 10,000 10,000 148,279 25,000   20,000  
Past Directors And Employees [Member] | Salaries And Benefits Earned [Member]
                                   
Officer's and Employee's Liabilities 580,000   580,000   580,000                 1,044,000        
Chief Financial Officer [Member] | Expense Reimbursements [Member]
                                   
Officer's and Employee's Liabilities                              730        
Chief Executive Officer [Member]
                                   
Accrued Salary Forgiven                 516,000                  
Accrued Bonus Forgiven                 300,000                  
Chief Executive Officer [Member] | Bonuses [Member]
                                   
Officer's and Employee's Liabilities                              300,000        
Officers and Employees [Member]
                                   
Accrued Salaries and Benefits     364,568 477,000 1,434,562                          
Consultant [Member] | Advisory Agreement [Member]
                                   
Consulting Fees        227,000                             
Consultant [Member] | Consulting Services [Member]
                                   
Consulting Services Fees Forgiven                 545,000                  
Consulting Fees Payable                              545,000        
Directors and Shareholders [Member]
                                   
Cash Contributions           $ 27,288                          

XML 20 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Website
9 Months Ended
Aug. 31, 2014
Notes to Financial Statements  
Website

3.WEBSITE

 

As at:

31 August 2014

 

30 November 2013

(Audited)

 

Cost

$

Accumulated amortization

$

Net book value

$

Cost

$

Accumulated amortization

$

Net book value

$

             
Website 10,000 6,667 3,333 10,000 4,167 5,833
             
Total 10,000 6,667 3,333 10,000 4,167 5,833

 

The Company purchased a website during October 2012 for $10,000. This website has a useful life of three years, and the cost is being amortized over the life of the asset. During the nine month period ended 31 August 2014, the Company recognized amortization expense of $2,500 (31 August 2013 - $2,500; cumulative - $6,667) (Note 9).

EXCEL 21 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]C9CAD,C(W.5\W-#5C7S1E-F9?.&$P-U]C-C8T M8V5B9C$P,V4B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN=&5R:6U?0V]N#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/D%C8V]U;G1S7U!A>6%B;&5?06YD M7T%C8W)U961?3#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DYO=&5S7U!A>6%B;&4\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN=&%N9VEB;&5?07-S M971S7T%N9%]);G1E;&QE8SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-A<&ET86Q?4W1O8VL\+W@Z3F%M93X-"B`@("`\>#I7;W)K M#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-I9VYI9FEC86YT7T%C8V]U;G1I;F=?4&]L:6-I93$\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D%C8V]U;G1S7U!A>6%B;&5?06YD7T%C8W)U961?3#$\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E=E8G-I=&5?1&5T86EL7U=E8G-I=&4\+W@Z3F%M93X- M"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN8V]M95]487AE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U<'!L96UE;G1A;%]#87-H7T9L;W=?26YF;W)M M83(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I%>&-E M;%=O&5S7T1E=&%I;'-?3F%R#I%>&-E;%=O#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H M:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@36EC'1087)T7V-F.&0R,C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)U!%4%1)1$4@5$5#2$Y/3$]' M2453+"!)3D,N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)V9A;'-E/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)RTM,3$M,S`\2!A(%9O;'5N=&%R>2!&:6QE2=S(%)E<&]R M=&EN9R!3=&%T=7,@0W5R'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M)SQS<&%N/CPOF%T:6]N M(&]F("0V+#8V-R!A;F0@)#0L,38W+"!R97-P96-T:79E;'DI/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XS+#,S,SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4@86YD(&%C8W)U960@;&EA8FEL:71I97,\+W1D/@T*("`@("`@ M("`\=&0@8VQA6%B;&4@86YD(&%C8W)U960@:6YT97)E'0^)SQS M<&%N/CPOF5D.B`V-S4L,#`P+#`P,"!C;VUM;VX@ M'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XD(#8L-C8W/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)W9E6QE/3-$)W=I9'1H.B`P)SX\+W1D/CQT M9"!S='EL93TS1"=W:61T:#H@,3AP="<^/&9O;G0@2<^/&9O;G0@'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/CQB/C$N,3PO8CX\+V9O;G0^/"]T9#X\=&0@'0M86QI M9VXZ(&IU'0M:6YD96YT.B`M,C=P="<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU M28C,30X.RD-"G=A28C,30V.W,@;F%M92!W87,@8VAA M;F=E9`T*9G)O;2!#4D5%;F5R9WD@0V]R<&]R871I;VX@=&\@4&5P=&ED92!4 M96-H;F]L;V=I97,L($EN8RX@5&AE($-O;7!A;GDF(S$T-CMS('EE87(M96YD M(&ES(#,P($YO=F5M8F5R+B!4:&4@0V]M<&%N>2!I2X\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z("TR-W!T)SX\8CXF(S$V,#L\+V(^/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2UO=VYE9"!S=6)S:61I87)Y+"!U;F1E2!D;V5S(&YO="!H879E(&%N>2!T'0M86QI9VXZ(&IU'0M:6YD96YT.B`M,C=P="<^ M/&(^)B,Q-C`[/"]B/CPO<#X-"@T*/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C M96QL6QE/3-$)V9O;G0M MF4Z(#$P<'0G/CQB/DYA='5R92!O9B!/<&5R871I;VYS(&%N9"!#:&%N9V4@ M:6X@0G5S:6YE'0M86QI9VXZ(&IU'0M:6YD96YT.B`M,C=P="<^/&(^)B,Q-C`[/"]B/CPO<#X-"@T* M/'`@2!C:&%N M9V5D(&ET2!B96-A;64@82!D979E;&]P;65N="!S=&%G92!C;VUP86YY#0IF;V-U M6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E M;G0Z("TR-W!T)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3VX@,C,@075G=7-T(#(P M,3$L('1H92!#;VUP86YY(&5N=&5R960-"FEN=&\@86X@86=R965M96YT("AT M:&4@)B,Q-#<[07-S970@4'5R8VAA2P@:6X@97AC:&%N9V4@9F]R(#2!H87,@8VAA;F=E9"!I=',@8G5S:6YE2`H3F]T92`W*2X\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU&-L=7-I M=F4@9VQO8F%L(&1I'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S M='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@,3)P="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q.'!T)SX\+W1D/CQT9"!S='EL93TS1"=W:61T M:#H@,C=P="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@=&5X="UI;F1E;G0Z("TR-W!T)SX\8CXF(S$V,#L\+V(^ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^36%N86=E;65N="!C86YN;W0@<')O=FED92!A65A2!I28C,30V.W,@;&EQ=6ED:71Y('!R;V)L96US+"!M86YA9V5M M96YT(&5X<&5C=',@=&AA="!T:&4@0V]M<&%N>0T*=VEL;"!N965D('1O(&-U M2!S M:&]U;&0@=&AE($-O;7!A;GD@8F4@=6YA8FQE('1O(&-O;G1I;G5E(&%S(&$@ M9V]I;F<@8V]N8V5R;BX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z("TR-W!T M)SXF(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^06QT:&]U9V@@;6%N86=E;65N="!I2!S965K:6YG#0IT;R!A9&0@;F5W('!R;V1U8W1S(&%N9"]O2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q M,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`T.2XU<'0G/CQF;VYT M('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB/E5N875D:71E9"!3=&%T96UE M;G1S/"]B/CPO9F]N=#X\+W1D/CPO='(^/"]T86)L93X-"@T*/'`@2!T;R!P2!T:&4@9FEN86YC M:6%L('!O28C,30V.W,@875D:71E9"!C;VYS M;VQI9&%T960-"F9I;F%N8VEA;"!S=&%T96UE;G1S(&9O65A2!I;F1I8V%T:79E(&]F#0IT M:&4@'!E8W1E9"!F;W(@=&AE(&9U;&P@>65A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(&IU'1087)T7V-F.&0R,C'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPO'0^)SQP('-T M>6QE/3-$)VUA6QE/3-$)W=I9'1H.B`Q,#`E.R!F M;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q.'!T)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$Q<'0G/CQB/C(N/"]B/CPO9F]N=#X\+W1D/CQT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$Q<'0G/CQB/E-)1TY)1DE#04Y4($%#0T]53E1)3D<@4$],24-) M15,\+V(^/"]F;VYT/CPO=&0^/"]T6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU0T*;V8@6QE M/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE/3-$)W=I9'1H M.B`T-7!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(N M,3PO8CX\+V9O;G0^/"]T9#X\=&0@2<^/&9O;G0@6QE/3-$)W=I9'1H M.B`R-W!T)SX\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y M)SY4:&5S92!I;G1E6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/CQB/C(N,CPO8CX\+V9O;G0^/"]T9#X\=&0@'0M86QI9VXZ(&IU'0M:6YD96YT.B`M,C=P M="<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS M<&%C:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@,3!P="!4 M:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'!A9&1I;F<] M,T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N M=#H@,3)P="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q.'!T)SX\ M+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,C=P="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0MF%T:6]N86P@86YD(%-T87)T+75P M($-O'0M86QI9VXZ(&IUF%T:6]N86P@8V]S=',L(&%R M92!E>'!E;G-E9"!A6QE/3-$ M)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(N-#PO8CX\ M+V9O;G0^/"]T9#X\=&0@2<^ M/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^1'5R:6YG('1H92!Y96%R(&5N M9&5D(#,P($YO=F5M8F5R#0HR,#$P+"!T:&4@0V]M<&%N>2!A8F%N9&]N960@ M:71S('!R979I;W5S(&)U2!$979E M;&]P;65N="U3=&%G92!%;G1E6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q M,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/CQB/C(N-3PO8CX\+V9O;G0^/"]T9#X\=&0@2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^0V%S:"!A;F0@8V%S:"!E<75I=F%L96YT6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$ M,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@,3)P="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q.'!T)SX\+W1D/CQT9"!S='EL93TS1"=W M:61T:#H@,C=P="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^ M/&(^)B,Q-C`[/"]B/CPO<#X-"@T*/'`@'!E;G-E9`T*87,@:6YC=7)R960N($5X<&5N9&ET=7)E MF5D#0IT;R!E>'!E;G-E(&]V97(@=&AE('=E8G-I M=&4F(S$T-CMS(&5S=&EM871E9"!U6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT M.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/CQB/C(N-SPO8CX\+V9O;G0^/"]T9#X\=&0@2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU2!O M2!I9&5N=&EF:6%B;&4L('1H870@:&%V92!I M;F1E=&5R;6EN871E(&QI=F5S+`T*;W(@=&AA="!A2!A'!E;G-E M('=H96X@:6YC=7)R960N#0I4:&4@:6YT96QL96-T=6%L('!R;W!E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB/DEM<&%I M'0M86QI9VXZ(&IU2X@3&]N9RUL:79E M9"!AF%T:6]N(&%R M92!T97-T960@9F]R(&EM<&%I2!O9B!A2!A(&-O;7!AF5D(&%S('1H92!A M;6]U;G0@8GD@=VAI8V@@=&AE(&-A6QE/3-$)W=I9'1H.B`Q,#`E.R!F M;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(N.3PO8CX\+V9O;G0^/"]T9#X\=&0@ M2<^/&9O;G0@'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0M M2<^/&9O;G0@'0M86QI9VXZ(&IU2!A9&]P=&5D('1H92!!4T,@-S0P+"`F(S$T-SL\:3Y!8V-O=6YT:6YG M#0IF;W(@26YC;VUE(%1A>&5S+B8C,S0[/"]I/B!!4T,@-S0P(')E<75I&5S+B!5;F1E"!AF5D(&9O"!C;VYS97%U96YC97,@871T"!A"!R871E'!E8W1E9"!T;R!A<'!L>2!T;R!T87AA8FQE#0II;F-O;64@ M:6X@=&AE('EE87)S(&EN('=H:6-H('1H;W-E('1E;7!O2!D:69F97)E M;F-E"!A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^ M)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C M:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@,3)P="!4:6UE M6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q.'!T)SX\+W1D/CQT9"!S='EL M93TS1"=W:61T:#H@,C=P="<^/&9O;G0@F4Z(#$P M<'0G/CQB/D)A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^26X@86-C;W)D86YC92!W:71H($%30R`R-C`L(#QI M/B8C,30W.T5A'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2<^/&9O;G0@'0M86QI9VXZ(&IU0T*:7,@;F]T(&5X<&]S960@=&\@6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^ M5&AE(&EN=&5R:6T@8V]N2!-871T M97)S+"8C,S0[/"]I/B!F;W)E:6=N(&1E;F]M:6YA=&5D#0IM;VYE=&%R>2!A M'!E;G-E'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q M,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/CQB/C(N,30\+V(^/"]F;VYT/CPO=&0^/'1D('-T M>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0M'0M86QI9VXZ(&IU2!I=&5M2!S96-U6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E6QE/3-$)W=I M9'1H.B`R-W!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB M/C(N,34\+V(^/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU28C,30V.W,-"FEN=&5R:6T@8V]N6QE/3-$)W=I9'1H M.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)W=I9'1H.B`R-W!T)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(N,38\+V(^/"]F M;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M3PO8CX\+V9O;G0^/"]T9#X\+W1R/CPO=&%B;&4^ M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!A9&]P=&5D($9I;F%N8VEA M;"!!8V-O=6YT:6YG(%-T86YD87)D65A2!A9&]P M=&EO;B!P97)M:71T960N(%1H92!A9&]P=&EO;B!O9B!T:&ES('5P9&%T92!D M:60@;F]T(&AA=F4@82!M871E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L M;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=W:61T:#H@ M,3`P)3L@9F]N=#H@,3)P="!4:6UE6QE M/3-$)W9E6QE/3-$)W=I9'1H M.B`Q.'!T)SX\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,C=P="<^/&9O;G0@ MF4Z(#$P<'0G/CQB/E)E8V5N="!!8V-O=6YT:6YG M(%!R;VYO=6YC96UE;G1S/"]B/CPO9F]N=#X\+W1D/CPO='(^/"]T86)L93X- M"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@&ES=',L)B,S-#L\+VD^ M('=H:6-H(&ES(&EN=&5N9&5D('1O(&5L:6UI;F%T92!T:&4@9&EV97)S:71Y M('1H870@:7,@:6X@<')A8W1I8V4-"G=I=&@@"!L;W-S+"!O"!C6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0M=V5I9VAT.B!N;W)M86PG/DEN#0I-87D@,C`Q-"P@=&AE($9! M4T(@:7-S=65D($%352!.;RX@,C`Q-"TP.2P@/&D^)B,Q-#<[4F5V96YU92!F M'!E8W1E9"!T M;R!H879E(&$@;6%T97)I86P@:6UP86-T(&]N('1H92!#;VUP86YY)B,Q-#8[ M6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^26X@2G5N M92`R,#$T+"!T:&4@1D%30B!I2!R96UO=FEN9R!T:&4@9FEN86YC:6%L(')E<&]R=&EN9R!D:7-T M:6YC=&EO;B!B971W965N#0ID979E;&]P;65N="!S=&%G92!E;G1I=&EE2!I65A65A6QE/3-$)W9E M6QE/3-$)W=I9'1H.B`Q.'!T M)SX\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,C=P="<^/&9O;G0@F4Z(#$P<'0G/CQB/E)E8VQA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&(^)B,Q-C`[/"]B/CPO<#X-"@T*/'1A8FQE(&-E;&QP M861D:6YG/3-$,"!C96QL6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(N,3D\+V(^/"]F;VYT M/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU2!C;VYS:7-T6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI M9VXZ(&IU7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A6QE/3-$)W9E6QE/3-$)W=I9'1H.B`P)SX\+W1D/CQT9"!S='EL93TS M1"=W:61T:#H@,3AP="<^/&9O;G0@2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W9E6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9EF%T:6]N/"]B/CPO<#X-"B`@("`@("`@/'`@'0M86QI9VXZ(')I9VAT)SX\8CY.970@8F]O:R!V86QU M93PO8CX\+W`^#0H@("`@("`@(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W9E6QE/3-$)V9O;G0Z M(#$P<'0O,3$U)2!4:6UEF%T:6]N/"]P/@T*("`@("`@("`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(')I9VAT)SXD/"]P/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9EF4Z(#$P<'0G/E=E8G-I=&4\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/CQB/C8L-C8W/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M6QE/3-$)V9O;G0M6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/C0L,38W/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/C4L.#,S/"]F;VYT/CPO=&0^/"]T6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C,L,S,S/"]B/CPO9F]N=#X\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D M97(M6QE M/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IUF%T:6]N(&5X<&5N6QE/3-$)VUA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C9CAD,C(W.5\W M-#5C7S1E-F9?.&$P-U]C-C8T8V5B9C$P,V4-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO8V8X9#(R-SE?-S0U8U\T939F7SAA,#=?8S8V-&-E8F8Q M,#-E+U=O'0O:'1M;#L@8VAA6%B;&4@06YD($%C8W)U M960@3&EA8FEL:71I97,\8G(^/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H M(&-L87-S/3-$=&@@8V]L'0^ M)SQS<&%N/CPO'0^)SQT86)L92!C96QL<&%D M9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E M.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q.'!T)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C0N/"]B/CPO9F]N=#X\+W1D/CQT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/CQB/D%#0T]53E13(%!!64%"3$4@04Y$($%#0U)5 M140@3$E!0DE,251)15,\+V(^/"]F;VYT/CPO=&0^/"]T'0M86QI9VXZ(&IU M2<^/&9O;G0@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT M)SX\8CXS,2!!=6=U6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXS,"!.;W9E;6)E'0M86QI9VXZ(')I9VAT)SXH075D M:71E9"D\+W`^#0H@("`@("`@(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)W9EF4Z(#$P M<'0G/D%C8V]U;G1S('!A>6%B;&4\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W9E6QE/3-$)V9O M;G0M6QE/3-$)W9E2<^ M/&9O;G0@6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0G/E!A>7)O;&P@=&%X97,@<&%Y86)L92`\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P M<'0G/E-A;&%R:65S(&%N9"!B96YE9FET6QE/3-$)W9E6QE/3-$)V9O;G0M2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D M97(M=&]P.B!";&%C:R`Q<'0@2<^/&9O;G0@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3L@=&5X="UI;F1E;G0Z("TT+C5P="<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU65A6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&IU2`R,#$T+"!T:&4@0VAI968@17AE M8W5T:79E#0I/9F9I8V5R("@F(S$T-SM#14\F(S$T.#LI(')E<75E'0M86QI M9VXZ(&IU6%B;&4@:6X@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6QE M/3-$)W9E6QE/3-$)W=I9'1H M.B`P)SX\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,3AP="<^/&9O;G0@2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^)B,Q-C`[/"]B/CPO M<#X-"@T*/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@ MF4Z(#$P<'0G/CQB/D%S(&%T.CPO8CX\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX\8CXD/"]B/CPO<#X\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!W:61T:#H@,34E.R!B;W)D97(M=&]P.B!";&%C:R`Q<'0@'0M M86QI9VXZ(')I9VAT)SXD/"]P/CPO=&0^/"]TF4Z(#$P<'0G/D1U65A&5D('1E6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!B;W)D97(M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(^#0H@("`@ M/'1D('-T>6QE/3-$)W9E2<^/&9O;G0@ M2X@5&AE(&QO86X@:7,@=6YS96-U M&5D('1E6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!B;W)D97(M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(^#0H@("`@ M/'1D('-T>6QE/3-$)W9E2<^/&9O;G0@ M2`H3F]T92`Q,BDN/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!B;W)D97(M'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(^#0H@("`@/'1D('-T M>6QE/3-$)W9E2<^/&9O;G0@2XF(S$V,#M4 M:&4@;&]A;B!I6%B;&4@=&\@4%-)(&%S(&%T(#,Q($%U9W5S="`R,#$T#0IC M;VYS:7-T2`H3F]T92`Q,BD\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W9E6QE/3-$)V9O M;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V)O M2<^/&9O;G0@6UE;G0N/"]F;VYT/CPO=&0^#0H@("`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`P)SX\+W1D/CQT9"!S='EL M93TS1"=W:61T:#H@,3AP="<^/&9O;G0@2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^)B,Q-C`[/"]B/CPO<#X-"@T* M/'`@6%B;&4@=&\@<&%S="!D:7)E8W1O M65E2!I;@T*6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^1'5R:6YG('1H92!N M:6YE(&UO;G1H('!E'0M86QI9VXZ(&IU2!B92!S=7-P96YD960@=6YT:6P@9G5R=&AE2P@:&4@9F]R9V%V92!T:&4@96YT:7)E(&)A;&%N8V4@;V8@:&ES(&%C M8W)U960@'0M86QI9VXZ M(&IU2!C;VYS=6QT86YT(&UU M='5A;&QY('1E'0M86QI9VXZ(&IU2!R96QA=&5D#0IP87)T>2!C;VYS=6QT M86YT(&9O6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^1'5R:6YG('1H92!Y M96%R(&5N9&5D(#,P($YO=F5M8F5R#0HR,#$S+"!T:&4@0F]A6UE;G0@<')O9W)A;2`H=&AE("8C,30W.U!R M;V=R86TF(S$T.#LI(&5Q=6%L('1O(#,P)2!O9B!G'1E2`R,#$T+"!T:&4@0F]A2!E:71H97(@=&AE($-%3R!O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU2!R96-O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^)SQT86)L92!C96QL<&%D9&EN9STS1#`@ M8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q M,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q.'!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/CQB/CF4Z M(#$P<'0G/CQB/DE.5$%.1TE"3$4@05-31513($%.1"!)3E1%3$Q%0U1504P@ M4%)/4$525%D\+V(^/"]F;VYT/CPO=&0^/"]T'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2`H:7-S=65D(&]N(#(S($%U9W5S="`R M,#$Q*2`H3F]T92`Q*2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE0T*96YT97)E M9"!I;G1O(&%N(&%M96YD960@=&AE($9I6UE M;G0@;V8@:&%L9B!O9B!O;F4@<&5R8V5N="!O9B!A;&P@9W)O65A2!O9B!I M;G1A;F=I8FQE(&%S6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2`R,#$T+"!T:&4@0V]M<&%N>2!E;G1E'0M86QI9VXZ(&IU'0M M86QI9VXZ(&IU2!R96-O'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'1E2`R M,#$T+"!T:&4@0F]A2!E:71H M97(@=&AE($-%3R!O<@T*=&AE(&%P<&QI8V%B;&4@8V]N3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%]C9CAD,C(W.5\W-#5C7S1E-F9?.&$P-U]C M-C8T8V5B9C$P,V4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V8X M9#(R-SE?-S0U8U\T939F7SAA,#=?8S8V-&-E8F8Q,#-E+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQT86)L92!C M96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H M.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M6QE/3-$)W=I9'1H.B`Q.'!T)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C@N/"]B/CPO9F]N=#X\+W1D M/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/D-!4$E404P@4U1/0TL\+V(^/"]F M;VYT/CPO=&0^/"]T'0M86QI9VXZ(&IU6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB/D%U=&AO6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI M9VXZ(&IU6QE/3-$)W=I9'1H.B`Q M,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C@N,CPO8CX\+V9O;G0^/"]T M9#X\=&0@2<^/&9O;G0@2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6EN9R!I;G1E2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,7!T($%R:6%L M+"!(96QV971I8V$L(%-A;G,M4V5R:68[(&UA'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE28C,30V.W,@8V]M M;6]N('-T;V-K(&ES6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2!P86ED("0R+#`P,"!I M;B!S:&%R92!I6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z(#$P<'0@0V]U MF4Z(#$P<'0G/D]N(#(V($%P2!R96-O6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O M;G0Z(#$P<'0@0V]UF4Z(#$P<'0G/D]N(#$X($IU;'D@,C`Q M,RP@=&AE($-O;7!A;GD@:7-S=65D(#(U+#`P,"!S:&%R97,@;V8@=&AE($-O M;7!A;GDF(S$T-CMS#0IR97-T6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0M2!I28C,30V M.W,-"G)E6QE/3-$)W=I9'1H.B`Q M.'!T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T($-O=7)I97(@3F5W+"!# M;W5R:65R+"!-;VYO2<^/&9O;G0@6QE/3-$)W=I9'1H.B`Q.'!T)SX\9F]N="!S M='EL93TS1"=F;VYT.B`Q,'!T($-O=7)I97(@3F5W+"!#;W5R:65R+"!-;VYO M2<^/&9O;G0@2!I6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)V9O;G0Z M(#$P<'0@0V]UF4Z(#$P<'0G/D]N(#,@07!R:6P@,C`Q-"P@ M=&AE($-O;7!A;GD@:7-S=65D(#$P+#`P,"!S:&%R97,@;V8@=&AE($-O;7!A M;GDF(S$T-CMS#0IR97-T6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0M2`R,#$T+"!T:&4@0V]M<&%N>2!I M6QE/3-$ M)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M2!I7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<] M,T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I M9'1H.B`Q.'!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB M/CDN/"]B/CPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=T97AT+6%L:6=N.B!J M=7-T:69Y)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/D=% M3D5204P@04Y$($%$34E.25-44D%4259%($584$5.4T53/"]B/CPO9F]N=#X\ M+W1D/CPO='(^/"]T86)L93X-"@T*/'`@6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M86QI9VXZ(')I9VAT M)SX\8CY.:6YE(&UO;G1H('!E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT)SX\8CY4 M:')E92!M;VYT:"!P97)I;V0@96YD960@,S$@075G=7-T(#(P,3,\+V(^/"]P M/@T*("`@("`@("`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I M9VAT)SX\8CXD/"]B/CPO<#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,3(E.R!B;W)D97(M=&]P.B!" M;&%C:R`Q<'0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SXD/"]P/CPO=&0^/"]T'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!B;W)D97(M'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P M.R!B;W)D97(M'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!B;W)D97(M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/BT\+V(^/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0G/D%M;W)T:7IA=&EO;B`H3F]T92`S*3PO M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P.R!B;W)D97(M'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/CQB/C@S,SPO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/C8L-C8W/"]F;VYT/CPO=&0^/"]TF4Z M(#$P<'0G/D)A;FL@8VAA'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C8T/"]B/CPO9F]N=#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D M97(M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/CQB/C$Y.#PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@ MF4Z(#$P<'0G/D1U97,@86YD('-U8G-C'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB M/BT\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/CQB/C$L-#$Y/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/C$P,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/C,L,S(X/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M6QE/3-$)V9O;G0MF4Z M(#$P<'0G/DUE86QS(&%N9"!E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C@L M,#0X/"]F;VYT/CPO=&0^/"]TF4Z(#$P<'0G/E!E;F%L M=&EE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/CQB/BT\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/C$P+#`P,#PO9F]N=#X\+W1D/CPO='(^#0H\='(^#0H@("`@/'1D('-T>6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/CQB/C$P,#PO8CX\+V9O;G0^/"]T9#X-"B`@("`\ M=&0@6QE M/3-$)W9E6QE/3-$)V9O M;G0M6QE M/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)W9E6QE/3-$ M)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C$T-SPO8CX\+V9O;G0^/"]T9#X- M"B`@("`\=&0@6QE/3-$)W9E6QE M/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/BT\+V9O M;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$ M)W9E6QE/3-$)V9O;G0M M6QE/3-$ M)W9E6QE/3-$)V9O M;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/CQB/BT\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W9E6QE/3-$ M)V9O;G0MF4Z(#$P<'0G/E=E8G-I=&4\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)O'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA"!$:7-C M;&]S=7)E(%M!8G-T'0^)SQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P M86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T+S$Q M-24@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E6QE M/3-$)W=I9'1H.B`S-G!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/CQB/C$P+C$N,3PO8CX\+V9O;G0^/"]T9#X\=&0@6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU6EN9R!T:&4@9F5D97)A;"!I M;F-O;64@=&%X(')A=&4@=&\@96%R;FEN9W,@8F5F;W)E(&EN8V]M92!T87AE M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SY&;W(@=&AE(&YI M;F4@;6]N=&@@<&5R:6]D(&5N9&5D/&(^(#PO8CXS,2!!=6=U6QE/3-$)W9E2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@&5S/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE M/3-$)V9O;G0M2<^/&9O;G0@'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C,U+C`P)3PO M8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E"!E M>'!E;G-E("AR96-O=F5R>2D@8F%S960@;VX@=&AE(&%B;W9E(')A=&5S/"]F M;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C$U+#F4Z(#$P<'0G/D-H M86YG92!I;B!V86QU871I;VX@86QL;W=A;F-E/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE M/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'!A9&1I M;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@ M9F]N=#H@,3)P="!4:6UE6QE/3-$)W9E M6QE/3-$)W=I9'1H.B`R,BXV M-7!T)SX\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,C=P="<^/&9O;G0@F4Z(#$P<'0G/CQB/D1E9F5R"!B86QA;F-E M6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU28C M,30V.W,-"F1E9F5R"!A6QE/3-$)W9EF4Z(#$P<'0G/CQB/D%S(&%T.CPO M8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ M(')I9VAT)SX\8CXR,#$T/"]B/CPO<#X-"B`@("`@("`@/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M6QE/3-$)W9E2<^/&9O;G0@6QE M/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0G/E9A;'5A=&EO;B!A;&QO M=V%N8V4\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE M/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU28C,30V.W,@"!A2UF;W)W87)D2!T:&%N(&YO="!A M=`T*=&AI2!I7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQT86)L92!C96QL<&%D9&EN M9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F M;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q.'!T)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/CQB/C$Q+CPO8CX\+V9O;G0^/"]T9#X\=&0@2<^/&9O;G0@'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@0V]UF4Z(#$P M<'0G/D]N(#$Q($1E8V5M8F5R(#(P,3(L('1H92!#;VUP86YY(&9O'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU2!"0B8C,S@[5$--(&%N(&%D=FES;W)Y(&9E92!O M9B!T:')E92!P97)C96YT(&]F('1H92!F86-E(&%M;W5N="!O9B!T:&4@9FEN M86YC:6%L#0IT6%B;&4@870@ M8VQO6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@ M=&5X="UI;F1E;G0Z("TQ.'!T)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL M<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q M,#`E.R!F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q.'!T)SX\+W1D/CQT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y)SY!9&1I=&EO;F%L;'DL M('1H92!#;VUP86YY(&ES('1O(&1E9F5N9"P@:6YD96UN:69Y(&%N9"!H;VQD M($)")B,S.#M40TTL(&ET2P@0T*;&]S M'1E;F1E9`T*=&AE($%G'1E;G-I;VX@2`R,#$V("@R-"!M;VYT:',I+B!!;&P@ M;W1H97(@<')O=FES:6]N6QE/3-$)W=I9'1H.B`Q M,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q.'!T)SX\9F]N="!S M='EL93TS1"=F;VYT.B`Q,'!T($-O=7)I97(@3F5W+"!#;W5R:65R+"!-;VYO M2<^/&9O;G0@2`R,#$T+"!T:&4@0V]M<&%N>2!E;G1E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@ M0V]UF4Z(#$P<'0G/D]N(#(V($UA>2`R,#$T+"!T:&4@0V]M M<&%N>2!E;G1E6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q.'!T)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q M,'!T($-O=7)I97(@3F5W+"!#;W5R:65R+"!-;VYO2<^/&9O;G0@ M6QE/3-$ M)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E6QE/3-$)W=I9'1H.B`Q.'!T M)SX\9F]N="!S='EL93TS1"=F;VYT.B`Q,'!T($-O=7)I97(@3F5W+"!#;W5R M:65R+"!-;VYO2!I6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T* M#0H\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL M93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@,3)P="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q.'!T)SX\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@ M,3AP="<^/&9O;G0@6QE/3-$ M)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C9CAD,C(W.5\W-#5C7S1E-F9?.&$P M-U]C-C8T8V5B9C$P,V4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M8V8X9#(R-SE?-S0U8U\T939F7SAA,#=?8S8V-&-E8F8Q,#-E+U=O'0O:'1M;#L@8VAA M6QE/3-$)W9E6QE/3-$)W=I9'1H.B`P)SX\+W1D/CQT9"!S='EL M93TS1"=W:61T:#H@,3AP="<^/&9O;G0@6QE/3-$)W1E>'0M M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^)B,Q-C`[/"]B M/CPO<#X-"@T*/'`@6UE;G1S(&9O&5S.CPO<#X-"@T*/'`@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\8CY4:')E92!M;VYT:"!P97)I;V0@96YD960@ M,S$@075G=7-T(#(P,30\+V(^/"]P/@T*("`@("`@("`\<"!S='EL93TS1"=F M;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT)SX\8CXD/"]B/CPO<#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!W:61T M:#H@,36QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT)SY4:')E92!M;VYT:"!P97)I;V0@96YD960\+W`^#0H@("`@("`@(#QP M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(')I9VAT)SXD/"]P/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SY3:7@@;6]N M=&@@<&5R:6]D(&5N9&5D/"]P/@T*("`@("`@("`\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT)SXS,2!!=6=U6QE/3-$)W9E2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/BT\+V(^/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E2<^/&9O;G0@6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M=&]P.B!" M;&%C:R`Q<'0@6QE M/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/CQB/BT\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/BT\+V(^/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O M;G0M'0M86QI9VXZ(&IU M2!I2!V97-T960@2X@ M07,@80T*2!R96-O'0M86QI9VXZ(&IU'!E;G-E(&]F("0Q M+#6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!A8V-R=65D(&EN=&5R97-T(&5X<&5N6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^1'5R:6YG('1H92!N:6YE(&UO;G1H('!E6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3VX@,C<@36%Y(#(P,30L M('1H92!#14\@2!I;B!T:&4@86UO=6YT#0IO9B`D-3$V+#`P,"!A;F0@86-C2`R,#$T M("A.;W1E6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\ M<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E'0M86QI9VXZ(&IU2`R,#$T+"!A(&9O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU2!R96-O'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L M;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`Q.'!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/CQB/C$S+CPO8CX\+V9O;G0^/"]T9#X\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^ M)SQS<&%N/CPO6QE/3-$)V9O;G0MF4Z(#$P M<'0G/CQB/D)A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`M,C=P="<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L M;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!S='EL93TS1"=W:61T:#H@ M,3`P)3L@9F]N=#H@,3!P="!4:6UE6QE/3-$)W1E>'0M86QI M9VXZ(&IU'!R97-S960@:6X@52Y3+B!D;VQL87)S+CPO=&0^/"]T6QE/3-$)V9O;G0M MF4Z(#$P<'0G/CQB/E!R:6YC:7!L97,@;V8@0V]N6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z M("TR-W!T)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL<&%D9&EN9STS1#`@ M8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q.'!T)SX\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@ M,C=P="<^/"]T9#X\=&0@2<^ M5&AE'0^)SQT86)L92!C96QL<&%D M9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E M.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(N,SPO8CX\+V9O;G0^/"]T9#X\ M=&0@2<^/&9O;G0@'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^0V]S=',@;V8@3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQT86)L92!C96QL<&%D9&EN9STS M1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT M.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/CQB/C(N-#PO8CX\+V9O;G0^/"]T9#X\=&0@2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^1'5R:6YG('1H92!Y96%R(&5N9&5D(#,P($YO=F5M8F5R#0HR M,#$P+"!T:&4@0V]M<&%N>2!A8F%N9&]N960@:71S('!R979I;W5S(&)U2!$979E;&]P;65N="U3=&%G92!%;G1E M6QE/3-$)W9E6QE/3-$ M)W=I9'1H.B`Q.'!T)SX\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@,C=P="<^ M/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0^ M)SQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE M/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R M-W!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(N-CPO M8CX\+V9O;G0^/"]T9#X\=&0@2<^/&9O;G0@'0M86QI9VXZ(&IU65A6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q.'!T)SX\+W1D/CQT9"!S='EL93TS1"=W:61T:#H@ M,C=P="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU2X@26X@86-C;W)D86YC92!W:71H($%30R`S-3`M,S`@/&D^)B,Q M-#<[1V5N97)A;"!);G1A;F=I8FQEF5D+B!#;W-T2!IF%T:6]N+B!4:&4@=7-E9G5L(&QI9F4@;V8-"G1H92!I;G1A;F=I M8FQE(&%S2!R96-O2`H3F]T97,@-R!A;F0@,3(I+CPO M<#X\6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q.'!T)SX\+W1D M/CQT9"!S='EL93TS1"=W:61T:#H@,C=P="<^/&9O;G0@6QE M/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M M6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU2!N;W0@ M8F4@'!E M8W1E9"!T;R!B92!G96YE&-E961S(&ET2!W:&EC:"!T:&4@8V%R6QE/3-$)V9O;G0MF4Z(#$P<'0G/CQB/E)E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q.'!T)SX\+W1D/CQT9"!S='EL93TS M1"=W:61T:#H@,C=P="<^/&9O;G0@F4Z(#$P<'0G M/CQB/DEN8V]M92!487AE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!M971H;V0@;V8@86-C;W5N=&EN M9R!O9B!I;F-O;64@=&%X97,N(%5N9&5R('1H90T*87-S970@86YD(&QI86)I M;&ET>2!M971H;V0@;V8@05-#(#2!D M:69F97)E;F-E6EN9R!A;6]U;G1S(&]F(&5X:7-T M:6YG(&%S"!B87-E&%B;&4-"FEN8V]M92!I;B!T:&4@>65A M'!E8W1E9"!T;R!B92!R96-O=F5R960@;W(@2!T M;R!R961U8V4@9&5F97)R960@=&%X(&%SF5D+CPO<#X\6QE/3-$)V9O;G0M2<^/&9O;G0@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU2!T:&4@=V5I9VAT960@879E2!I;F-U2!H860@;F\@'0^)SQT86)L92!C96QL<&%D9&EN M9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E.R!F M;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(N,3(\+V(^/"]F;VYT/CPO=&0^/'1D M('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE(&-A6%B;&4@86YD(&YO=&5S('!A>6%B;&4@87!P'!O'0M86QI9VXZ(&IU0T*2!T;R!C;VYC96YT2!A M9V5N8VEE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q."XS-7!T)SX\+W1D/CQT9"!S='EL93TS M1"=W:61T:#H@,C=P="<^/&9O;G0@F4Z(#$P<'0G M/CQB/D9O'0M86QI9VXZ(&IU2!T6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Q."XS-7!T)SX\+W1D/CQT9"!S='EL93TS M1"=W:61T:#H@,C=P="<^/&9O;G0@F4Z(#$P<'0G M/CQB/D-O;7!R96AE;G-I=F4@26YC;VUE("A,;W-S*3PO8CX\+V9O;G0^/"]T M9#X\+W1R/CPO=&%B;&4^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^)B,Q-C`[/"]B/CPO<#X- M"@T*/'`@2!A9&]P=&5D($%30R`R,C`L(#QI/B8C M,S0[4F5P;W)T:6YG#0I#;VUP6QE/3-$)V9O;G0M2<^/&9O;G0@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^ M5&AE('!R97!A3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQT86)L M92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I M9'1H.B`Q,#`E.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)W=I9'1H.B`R-W!T M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(N,38\+V(^ M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M3PO8CX\+V9O;G0^/"]T9#X\+W1R/CPO=&%B M;&4^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!A9&]P=&5D($9I;F%N M8VEA;"!!8V-O=6YT:6YG(%-T86YD87)D65A6QE/3-$)V9O;G0M2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M M=V5I9VAT.B!N;W)M86PG/DEN#0I*=6QY(#(P,3,L('1H92!&05-"(&ES69O2!T M:&%T(&ES(&EN('!R86-T:6-E#0IW:71H(')E9V%R9"!T;R!T:&4@9FEN86YC M:6%L('-T871E;65N="!PF5D('1A M>"!B96YE9FET&ES=',N($%352!.;RX@,C`Q,RTQ,2!I'0M86QI M9VXZ(&IU28C,30V.W,@ M:6YT97)I;2!C;VYS;VQI9&%T960-"F9I;F%N8VEA;"!S=&%T96UE;G1S+CPO M9F]N=#X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU0T*9G)O;2!T:&4@36%S=&5R($=L;W-S87)Y M(&]F('1H92!!8V-O=6YT:6YG(%-T86YD87)D2!I2!T:&%T(&EN('!R:6]R('EE87)S(&ET(&AA9"!B965N(&EN('1H M92!D979E;&]P;65N="!S=&%G92X@05-5($YO+B`R,#$T+3$P(&ES(&5F9F5C M=&EV92!F;W(@9FES8V%L('EE87)S(&%N9"!I;G1E'0^)SQT86)L92!C96QL<&%D M9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I9'1H.B`Q,#`E M.R!F;VYT.B`Q,G!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W=I9'1H.B`R-W!T)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(N,3@\+V(^/"]F;VYT/CPO=&0^ M/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0M'0M86QI9VXZ(&IU'0M:6YD96YT M.B`M,C=P="<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H M.B`R-W!T)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C(N M,3D\+V(^/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0M'0M86QI9VXZ(&IU2!C;VYS:7-T6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2<^/&9O;G0@6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX\8CY#;W-T/"]B/CPO<#X-"B`@("`@("`@/'`@ M'0M86QI9VXZ(')I9VAT)SX\8CY!8V-U M;75L871E9"!A;6]R=&EZ871I;VX\+V(^/"]P/@T*("`@("`@("`\<"!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT)SX\8CXD/"]B/CPO<#X\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!W:61T:#H@,3,E.R!B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SY#;W-T/"]P/@T*("`@("`@("`\<"!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT)SXD/"]P/CPO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SY!8V-U;75L871E9"!A M;6]R=&EZ871I;VX\+W`^#0H@("`@("`@(#QP('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(')I9VAT)SY.970@8F]O:R!V86QU93PO<#X-"B`@("`@("`@/'`@ M6QE/3-$)W9E2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/CQB/C,L,S,S/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M6QE/3-$ M)V9O;G0M6QE M/3-$)V9O;G0M2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M M=&]P.B!";&%C:R`Q<'0@'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@=&]P.R!B;W)D97(M=&]P.B!";&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!B;W)D97(M=&]P.B!";&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M=&]P.R!B;W)D97(M=&]P.B!";&%C:R`Q<'0@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/CPO='(^#0H\='(^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/CQB/C8L-C8W/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C0L,38W/"]F;VYT/CPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W9E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6%B;&4@06YD($%C8W)U M960@3&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA6QE/3-$)W9EF4Z(#$P<'0G/CQB/D%S(&%T.CPO M8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C,X+#,Q-SPO8CX\+V9O M;G0^/"]T9#X-"B`@("`\=&0@F4Z(#$P<'0G/D%C8W)U960@;&EA8FEL:71I97,\+V9O;G0^/"]T9#X- M"B`@("`\=&0@'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/CQB/C(Y+#8U,CPO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6%B;&4@*$YO=&4@-BD\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W9E6QE/3-$)W9E M6%B;&4@86YD(&%C8W)U960@ M;&EA8FEL:71I97,\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C8U,2PY-CD\+V(^ M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C$L-C8R+#(W,CPO M9F]N=#X\+W1D/CPO='(^#0H\+W1A8FQE/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA6%B;&4\+W1D/@T*("`@("`@("`\=&0@ M8VQA6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT)SX\8CXS,2!!=6=U6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXS,"!.;W9E;6)E'0M86QI9VXZ(')I M9VAT)SXH075D:71E9"D\+W`^#0H@("`@("`@(#QP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2XF(S$V,#LF(S$V,#M5<&]N('1H92!D:7)E8W1O'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB M/C$V+#`P,#PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE M/3-$)W9E6QE/3-$)W9E MF4Z(#$P<'0G/D]N(#(Q(%-E<'1E M;6)E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/CQB/C4P,#PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE M/3-$)W9E6QE/3-$)W9E MF4Z(#$P<'0G/D]N(#$S($YO=F5M M8F5R(#(P,3$L(%!322!I6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI M9VXZ(&IU6QE/3-$)W9E M6QE/3-$)W9EF4Z(#$P<'0G/D]N(#$@2G5N92`R,#$R+"!0 M4TD@:7-S=65D(&$@;&]A;B!O9B!#040D,C`L,#`P('1O('1H92!#;VUP86YY M+B8C,38P.U1H92!L;V%N(&ES('5N'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/CQB/C(P+#DP-CPO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W9E6QE M/3-$)V)O6QE/3-$)V)OF4Z(#$P<'0G/D]N M(#(R($]C=&]B97(@,C`Q,RP@4%-)(&ES2XF(S$V,#LF(S$V,#M4:&4@;&]A;B!I&5D M('1E6QE/3-$ M)V)O2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W9E2XF(S$V,#M4:&4@;&]A;B!I6UE;G0N M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$ M)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W9E2<^/&9O;G0@2XF(S$V,#M4:&4@;&]A;B!I6UE;G0N/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)W9E2<^/&9O M;G0@'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/CQB/C$P-2PV,S$\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)V)O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\ M8CY.:6YE(&UO;G1H('!E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT)SX\8CY4:')E M92!M;VYT:"!P97)I;V0@96YD960@,S$@075G=7-T(#(P,3,\+V(^/"]P/@T* M("`@("`@("`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT M)SX\8CXD/"]B/CPO<#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!W:61T:#H@,3(E.R!B;W)D97(M=&]P.B!";&%C M:R`Q<'0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(')I9VAT)SXD/"]P/CPO=&0^/"]T'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!B;W)D97(M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B M;W)D97(M'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!B;W)D97(M'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(^ M#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/BT\+V(^/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE M/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0G/D%M;W)T:7IA=&EO;B`H3F]T92`S*3PO9F]N M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P M.R!B;W)D97(M'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB M/C@S,SPO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/C8L-C8W/"]F;VYT/CPO=&0^/"]TF4Z(#$P M<'0G/D)A;FL@8VAA'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C8T/"]B/CPO9F]N=#X\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/CQB/C$Y.#PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z(#$P<'0G/D1U97,@86YD('-U8G-C'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/BT\ M+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB M/C$L-#$Y/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/C$P,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!B;W)D97(M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/C,L,S(X/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P M<'0G/DUE86QS(&%N9"!E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C@L,#0X M/"]F;VYT/CPO=&0^/"]TF4Z(#$P<'0G/E!E;F%L=&EE M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/CQB/BT\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C$P M+#`P,#PO9F]N=#X\+W1D/CPO='(^#0H\='(^#0H@("`@/'1D('-T>6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/CQB/C$P,#PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M6QE/3-$ M)W9E6QE/3-$)V9O;G0M M6QE/3-$ M)W9E6QE/3-$)V9O M;G0M6QE M/3-$)W9E6QE/3-$)V9O M;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/C$T-SPO8CX\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)W9E6QE M/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE M/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E M6QE/3-$)V9O;G0M6QE/3-$)W9E M6QE/3-$)V9O;G0M M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/CQB/BT\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W9E6QE/3-$)V9O M;G0MF4Z(#$P<'0G/E=E8G-I=&4\+V9O;G0^/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA"!$:7-C;&]S=7)E(%M!8G-T&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'1A8FQE(&-E M;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@'0M86QI9VXZ(')I9VAT)SX\8CY&;W(@=&AE(&YI;F4@;6]N=&@@<&5R M:6]D(&5N9&5D(#,Q($%U9W5S=`T*("`@("`@("`R,#$T/"]B/CPO<#X-"B`@ M("`@("`@/'`@6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SXD M/"]P/CPO=&0^/"]T'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M6QE/3-$)W9E2<^/&9O;G0@6QE/3-$)W9E"!R M871E6QE/3-$ M)V9O;G0M6QE/3-$ M)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T M=&]M.R!B;W)D97(M'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(^#0H@("`@/'1D('-T>6QE M/3-$)W9E2<^/&9O;G0@6QE/3-$)W9E2<^/&9O;G0@6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ M(&IU6QE/3-$)V9O;G0M"!E>'!E;G-E/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M6QE M/3-$)W9EF4Z(#$P<'0G/CQB/D%S(&%T.CPO8CX\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\8CXR,#$T/"]B M/CPO<#X-"B`@("`@("`@/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!B;W)D97(M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(^#0H@("`@ M/'1D('-T>6QE/3-$)W9E2<^/&9O;G0@ M6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0G/E9A;'5A=&EO;B!A;&QO=V%N8V4\+V9O;G0^/"]T9#X- M"B`@("`\=&0@6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]C9CAD,C(W.5\W-#5C7S1E-F9?.&$P-U]C-C8T8V5B9C$P,V4-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V8X9#(R-SE?-S0U8U\T939F M7SAA,#=?8S8V-&-E8F8Q,#-E+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE"!M M;VYT:"!P97)I;V0@96YD960@,S$@075G=7-T(#(P,30\+V(^/"]P/@T*("`@ M("`@("`\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(')I9VAT)SX\ M8CXD/"]B/CPO<#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!W:61T:#H@,3@E.R!B;W)D97(M=&]P.B!";&%C:R`Q M<'0@'0M86QI9VXZ(')I9VAT)SXS,2!!=6=U6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9EF4Z(#$P<'0G/DEN=&5R97-T('!A:60\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB M/BT\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/BT\+V9O;G0^/"]T9#X\+W1R/@T*/'1R/@T*("`@(#QT9"!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/CQB/BT\+V(^/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W9E M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E M6QE/3-$)W9E2<^/&9O;G0@6UE;G1S/"]B/CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@=&]P.R!B;W)D97(M6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/BT\+V9O M;G0^/"]T9#X\+W1R/@T*/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XV+#8V-SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA&5S("A54T0@)"D\8G(^/"]S=')O M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L"!$:7-C;&]S=7)E M(%M!8G-T'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"!/<&5R871I;F<@3&]S2U&;W)W87)D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#$L,#$X+#,Y,3QS<&%N/CPO M'0^)R9N8G-P M.R9N8G-P.SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6UE M;G1S($9O&5S("A54T0@)"D\8G(^ M/"]S=')O;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N M8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA6%B;&4@06YD($%C8W)U960@ M3&EA8FEL:71I97,@*$1E=&%I;',@3F%R2`S,2P@ M,C`Q-#QB2!&;W)G:79E;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C9CAD,C(W.5\W-#5C7S1E M-F9?.&$P-U]C-C8T8V5B9C$P,V4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO8V8X9#(R-SE?-S0U8U\T939F7SAA,#=?8S8V-&-E8F8Q,#-E+U=O M'0O:'1M M;#L@8VAA2!&;W)G:79E;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E)W,@3&EA8FEL M:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^ M)SQS<&%N/CPO&5C=71I=F4@3V9F:6-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO2!&;W)G:79E;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E)W,@3&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)R9N8G-P.R9N8G-P.SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!!9W)E96UE;G0@6TUE;6)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P M.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2P@4VAO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO6UE;G0\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]C M9CAD,C(W.5\W-#5C7S1E-F9?.&$P-U]C-C8T8V5B9C$P,V4-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO8V8X9#(R-SE?-S0U8U\T939F7SAA,#=? M8S8V-&-E8F8Q,#-E+U=O'0O:'1M;#L@8VAA&5S("A$ M971A:6QS($YA"!$:7-C;&]S=7)E(%M!8G-T"!0 M96YA;'1I97,\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA2`R-RP@ M,C`Q-#QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!&;W)G:79E;CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO XML 22 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Notes Payable (Detail) - Notes Payable
Aug. 31, 2014
USD ($)
Nov. 30, 2013
USD ($)
Aug. 31, 2014
Fotoview Inc. [Member]
USD ($)
Nov. 30, 2013
Fotoview Inc. [Member]
USD ($)
Aug. 14, 2014
PSI Services [Member]
CAD
Apr. 21, 2014
PSI Services [Member]
CAD
Oct. 22, 2013
PSI Services [Member]
USD ($)
Jun. 01, 2012
PSI Services [Member]
USD ($)
Nov. 13, 2011
PSI Services [Member]
USD ($)
Sep. 21, 2011
PSI Services [Member]
USD ($)
Aug. 31, 2014
PSI Services [Member]
September 21, 2011 Loan [Member]
USD ($)
Nov. 30, 2013
PSI Services [Member]
September 21, 2011 Loan [Member]
USD ($)
Aug. 31, 2014
PSI Services [Member]
November 13, 2011 Loan [Member]
USD ($)
Nov. 30, 2013
PSI Services [Member]
November 13, 2011 Loan [Member]
USD ($)
Aug. 31, 2014
PSI Services [Member]
June 1, 2012 Loan [Member]
USD ($)
Nov. 30, 2013
PSI Services [Member]
June 1, 2012 Loan [Member]
USD ($)
Aug. 31, 2014
PSI Services [Member]
October 22, 2013 Loan [Member]
USD ($)
Nov. 30, 2013
PSI Services [Member]
October 22, 2013 Loan [Member]
USD ($)
Aug. 31, 2014
PSI Services [Member]
April 21, 2014 Loan [Member]
USD ($)
Nov. 30, 2013
PSI Services [Member]
April 21, 2014 Loan [Member]
USD ($)
Aug. 31, 2014
PSI Services [Member]
Aug 14, 2014 Loan [Member]
USD ($)
Nov. 30, 2013
PSI Services [Member]
Aug 14, 2014 Loan [Member]
USD ($)
Notes Payable, current and non-current $ 105,631 $ 88,850 $ 16,000 $ 16,000             $ 500 $ 500 $ 48,408 $ 47,961 $ 20,906 $ 20,689 $ 3,700 $ 3,700 $ 7,368    $ 8,749   
Notes Payable, interest                         6.00% 6.00% 6.00% 6.00%            
Loan Amount         9,500 8,000 3,700 20,000 45,000 500                        
Principal Outstanding                         41,445 42,710 18,420 18,982            
Accrued Interest                         $ 6,963 $ 5,251 $ 2,486 $ 1,707            
XML 23 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accounts Payable And Accrued Liabilities (Detail) - Accounts Payable And Accrued Liabilities (USD $)
Aug. 31, 2014
Nov. 30, 2013
Payables and Accruals [Abstract]    
Accounts Payable $ 38,317 $ 574,188
Accrued Liabilities 4,000 27,000
Payroll Taxes Payable 29,652 17,084
Salaries And Benefits Payable 580,000 1,044,000
Total Accounts Payable And Accrued Liabilities $ 651,968 $ 1,662,272
XML 24 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
General And Administrative Expenses (Detail) - General And Adminstrative Expenses (USD $)
3 Months Ended 9 Months Ended 50 Months Ended
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Notes to Financial Statements          
Administration $ 825 $ 1,755 $ 1,325 $ 2,084 $ 8,048
Amortization 833 834 2,500 2,500 6,667
Bank Charges 64 16 198 170 1,482
Dues And Subscription             575
Filing Fees 1,419 100 7,397 3,328 18,867
Meals And Entertainment    254    254 254
Office 825 1,755 1,325 2,084 8,048
Penalties             10,000
Transfer Agent 100 160 650 400 4,151
Rent 147 363 638 1,101 1,871
Share-Based Payment             13,250
Telecommunication 726 786 2,783 1,469 5,777
Travel    1,151    2,657 2,656
Website 72    72    221
Total General And Administration Expenses $ 9,436 $ 5,419 $ 20,813 $ 13,963 $ 73,839
XML 25 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Detail) - Provision For Income Taxes (USD $)
3 Months Ended 9 Months Ended 50 Months Ended
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Income Tax Disclosure [Abstract]          
Income (Loss) Before Income Taxes $ (59,137) $ (248,303) $ 912,516 $ (738,192) $ (981,514)
Federal Income Tax Rates     35.00% 35.00%  
Income Tax Expense (Recovery) Based On The Above Rates     319,381 (258,367)  
Non-Deductible Items     15,750     
Change In Valuation Allowance     (335,131) (258,367)  
Income Tax Expense            
XML 26 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies
9 Months Ended
Aug. 31, 2014
Accounting Policies [Abstract]  
Significant Accounting Policies

2.SIGNIFICANT ACCOUNTING POLICIES

 

This summary of significant accounting policies is presented to assist in understanding the Company’s interim consolidated financial statements. The interim consolidated financial statements and notes are representations of management who is responsible for their integrity and objectivity. These accounting policies have been consistently applied in the preparation of the interim consolidated financial statements.

 

2.1Basis of Presentation

 

These interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) applicable for a development stage company for financial information and are expressed in U.S. dollars.

 

2.2Principles of Consolidation

 

These interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary Pept Peptide, a company incorporated in the province of British Columbia on 5 August 2013. All significant inter-company balances and transactions have been eliminated upon consolidation.

 

2.3Organizational and Start-up Costs

 

Costs of start-up activities, including organizational costs, are expensed as incurred in accordance with Accounting Standards Codification (“ASC”) 720-15, “Start-Up Costs."

 

2.4Development-Stage Company

 

During the year ended 30 November 2010, the Company abandoned its previous business of sale of original artwork and re-entered the development stage with its intended new business, which currently has no significant revenues.  Management expects to sustain losses from operations until such time it can generate sufficient revenues to meet its anticipated cost structure. The Company is considered a development-stage company in accordance with the ASC 915, “Accounting and Reporting by Development-Stage Enterprises." A development-stage enterprise is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.

 

2.5Cash and Cash Equivalents

 

Cash and cash equivalents include highly liquid investments with original maturities of three months or less.

 

2.6Website

 

In accordance with ASC 350-50, “Website Development Costs," expenditures during the planning and operating stages of the Company’s website are expensed as incurred. Expenditures incurred during the website application and infrastructure development stage are capitalized and amortized to expense over the website’s estimated useful life of 3 years.

 

2.7Intangible Assets

 

Intangible assets include the cost of acquiring the intellectual property. In accordance with ASC 350-30 “General Intangibles Other Than Goodwill," an intangible asset that is acquired either individually or with a group of other assets shall be recognized. Costs of internally developing, maintaining, or restoring intangible assets that are not specifically identifiable, that have indeterminate lives, or that are inherent in a continuing business and related to an entity as whole, shall be recognized as an expense when incurred. The intellectual property is determined to have an indefinite useful life and is not subject to amortization. The useful life of the intangible asset is reassessed at each reporting period. During the nine month period ended 31 August 2014, the Company recorded a write down of $45,000 related to its intangible assets and intellectual property (Notes 7 and 12).

 

2.8Impairment of Long-Lived Assets

 

Long-lived assets include the website and intangible assets and intellectual property. Long-lived assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets not subject to amortization are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount of the asset exceeds the fair value of the asset. There has been no impairment as of 31 August 2014.

 

2.9Research and Development

 

Research and development expenses are charged to operations as incurred.

 

2.10Income Taxes

 

The Company adopted the ASC 740, “Accounting for Income Taxes." ASC 740 requires the use of the asset and liability method of accounting of income taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the interim consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

2.11Basic and Diluted Income (Loss) per Share

 

In accordance with ASC 260, “Earnings per Share," the basic income (loss) per common share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed similar to basic income (loss) per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings per share are not shown for periods in which the Company incurs a loss because it would be anti-dilutive. At 31 August 2014, the Company had no stock equivalents that were anti-dilutive and excluded in the earnings (loss) per share computation.

 

2.12Estimated Fair Value of Financial Instruments

 

The carrying value of the Company’s interim consolidated financial instruments, consisting of cash, accounts payable and notes payable approximate their fair value due to the short-term maturity of these instruments. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest or currency risks arising from these financial instruments.

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. At 31 August 2014, cash and cash equivalents of $310 were insured by agencies of the U.S. Government.

 

2.13Foreign Currency Translation

 

The interim consolidated financial statements are presented in U.S. dollars. In accordance with ASC 830 “Foreign Currency Matters," foreign denominated monetary assets and liabilities are translated to their U.S. dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenue and expenses are translated at average rates of exchange during the period. Related translation adjustments are reported as a separate component of stockholders’ equity, whereas gains or losses resulting from foreign currency transactions are included in results of operations.

 

2.14Comprehensive Income (Loss)

 

The Company adopted ASC 220, "Reporting Comprehensive Income." ASC 220 requires that the components and total amounts of comprehensive income (loss) be displayed in the interim consolidated financial statements beginning in 1998. Comprehensive income (loss) includes net income (loss) and all changes in equity during a period that arises from non-owner sources, such as foreign currency items and unrealized gains and losses on certain investments in equity securities.

 

2.15Use of Estimates

 

The preparation of the Company’s interim consolidated financial statements are in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the amounts reported in these interim consolidated financial statements and accompanying notes. Actual results could differ from those estimates.

 

2.16Changes in Accounting Policy

 

Effective 1 December 2013, the Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2013-02, “Comprehensive Income." This update requires an entity to present information about amounts reclassified out of accumulated other comprehensive income and their corresponding effect on the respective line items in net income in one place, and in some cases, cross-references to related footnote disclosures. The update applies to public companies for all reporting periods presented, including interim periods, and to nonpublic entities for annual reporting periods. ASU No. 2013-02 will be effective for fiscal years, and interim periods within those years, beginning after 15 December 2012 for public companies, with early adoption permitted. The adoption of this update did not have a material effect on the Company’s interim consolidated financial statements.

 

2.17Recent Accounting Pronouncements

 

In July 2013, the FASB issued ASU No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists," which is intended to eliminate the diversity that is in practice with regard to the financial statement presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU No. 2013-11 is effective for fiscal years and interim periods within those years, beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.

 

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers," which provides a five-step approach to be applied to all contracts with customers. ASU No. 2014-09 also requires expanded disclosures about revenue recognition. ASU No. 2014-09 is effective for annual reporting periods beginning after 15 December 2016, including interim periods. Early adoption is not permitted. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.

 

In June 2014, the FASB issued ASU No. 2014-10, “Development Stage Entities," which intends to remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the update eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. ASU No. 2014-10 is effective for fiscal years and interim periods beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.

 

2.18Reclassifications

 

Certain amounts reported in previous periods have been reclassified to conform to the current presentation.

 

2.19Other

 

The Company consists of one reportable business segment.

 

The Company paid no dividends during the periods presented.

 

XML 27 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Detail) - Deferred Tax Balances (USD $)
Aug. 31, 2014
Nov. 30, 2013
Income Tax Disclosure [Abstract]    
Net Income Tax Operating Loss Carry-Forward $ 1,018,391 $ 1,975,908
Deferred Tax Assets 356,437 691,568
Valuation Allowance (356,437) (691,568)
Deferred Tax Assets (Liabilities)      
XML 28 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes (Details Narrative) (USD $)
Aug. 31, 2014
Nov. 30, 2013
Income Tax Disclosure [Abstract]    
Non-Capital Loss Carry Forward $ 1,018,391 $ 1,975,908
Accrued Potential Tax Penalties   $ 10,000
XML 29 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Interim Consolidated Balance Sheets (USD $)
Aug. 31, 2014
Nov. 30, 2013
Current assets    
Cash and cash equivalents $ 11,560 $ 157
Total Current Assets 11,560 157
Website (net of accumulated amortization of $6,667 and $4,167, respectively) 3,333 5,833
Intangible assets and intellectual property    45,000
TOTAL ASSETS 14,893 50,990
Current liabilities    
Accounts payable and accrued liabilities 651,968 1,662,272
Notes payable and accrued interest 105,631 88,850
Total Current Liabilities 757,599 1,751,122
STOCKHOLDERS' DEFICIENCY    
Capital Stock Authorized: 675,000,000 common shares, par value $0.001 per share Common shares issued and outstanding: 156,412,660 and 151,123,000 at August 31, 2014 and November 30, 2013, respectively 156,413 151,123
Additional paid-in capital 187,899 148,279
Accumulated deficit (105,837) (105,837)
Accumulated deficit during development stage (981,181) (1,893,697)
Total Stockholders' Deficiency (742,706) (1,700,132)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY $ 14,893 $ 50,990
XML 30 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Interim Consolidated Statements Of Stockholders' Deficiency (Unaudited) (USD $)
3 Months Ended 9 Months Ended 12 Months Ended 50 Months Ended
Aug. 31, 2014
Aug. 31, 2014
Aug. 31, 2013
Nov. 30, 2013
Aug. 31, 2014
Beginning Balance   $ (1,700,132) $ (749,656) $ (749,656)  
Balance (Shares)   151,123,000      
Shares issued for Cash, net of share issuance costs   39,660   43,000  
Shares issued for Contractor services       2,000  
Related party services   5,250      
Net Profit (Loss) (59,137) 912,516 (738,192) (995,477) (981,181)
Ending Balance (742,706) (742,706)   (1,700,132) (742,706)
Ending Balance (Shares) 156,412,660 156,412,660   151,123,000 156,412,660
Common Stock
         
Beginning Balance   151,123 149,078 149,078  
Balance (Shares)   151,123,000 149,078,000 149,078,000  
Shares issued for Cash, net of share issuance costs   40   45  
Shares issued for Cash, net of share issuance costs (Shares)   39,660   45,000  
Shares issued for Contractor services       2,000  
Shares issued for Contractor services (Shares)       2,000,000  
Related party services   5,250      
Related party services (Shares)   5,250,000      
Net Profit (Loss)            
Ending Balance 156,413 156,413   151,123 156,413
Ending Balance (Shares) 156,412,660 156,412,660   151,123,000 156,412,660
Additional Paid-In Capital
         
Beginning Balance   148,279 105,324 105,324  
Shares issued for Cash, net of share issuance costs   39,620   42,955  
Shares issued for Contractor services           
Related party services           
Net Profit (Loss)            
Ending Balance 187,899 187,899   148,279 187,899
Accumulated Deficit
         
Beginning Balance   (105,837) (105,837) (105,837)  
Shares issued for Cash, net of share issuance costs            
Shares issued for Contractor services           
Related party services           
Net Profit (Loss)            
Ending Balance (105,837) (105,837)   (105,837) (105,837)
Accumulated Deficit During Development Stage
         
Beginning Balance   (1,893,698) (898,221) (898,221)  
Shares issued for Cash, net of share issuance costs            
Shares issued for Contractor services           
Related party services           
Net Profit (Loss)   912,516   (995,477)  
Ending Balance $ (981,182) $ (981,182)   $ (1,893,698) $ (981,182)
XML 31 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Website (Details Narrative) (USD $)
1 Months Ended 3 Months Ended 9 Months Ended 50 Months Ended
Oct. 30, 2012
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Purchased Website $ 10,000          
Website, Amortization   833 833 2,500 2,500 6,667
Website [Member]
           
Website, Amortization       $ 2,500 $ 2,500 $ 6,667
XML 32 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accounts Payable And Accrued Liabilities (Tables)
9 Months Ended
Aug. 31, 2014
Payables and Accruals [Abstract]  
Accounts Payable And Accrued Liabilities
As at:

31 August 2014

$

30 November 2013

(Audited)

$

     
Accounts payable 38,317 574,188
Accrued liabilities 4,000 27,000
Payroll taxes payable 29,652 17,084
Salaries and benefits payable (Note 6) 580,000 1,044,000
     
Total accounts payable and accrued liabilities 651,969 1,662,272
XML 33 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accounts Payable And Accrued Liabilities (Details Narrative) (USD $)
May 31, 2014
May 27, 2014
Payables and Accruals [Abstract]    
Accrued Salary Forgiven $ 516,000 $ 516,000
Accrued Bonus Forgiven 300,000 300,000
Consulting Services Fees Forgiven   $ 545,000
XML 34 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
General And Administrative Expenses (Tables)
9 Months Ended
Aug. 31, 2014
Notes to Financial Statements  
General And Administrative Expenses
 

Three month period ended 31 August 2014

$

Nine month period ended 31 August 2014

$

Three month period ended 31 August 2013

$

Nine month period ended 31 August 2013

$

Cumulative from re-entering of development stage on 26 June 2010

to 31 August 2014

$

           
Administration - - - - 20
Amortization (Note 3) 833 2,500 834 2,500 6,667
Bank charges 64 198 16 170 1,482
Dues and subscription - - - - 575
Filing fees 1,419 7,397 100 3,328 18,867
Meals and entertainment - - 254 254 254
Office 825 1,325 1,755 2,084 8,048
Penalties - - - - 10,000
Transfer agent 100 650 160 400 4,151
Rent 147 638 363 1,101 1,871
Share-based payment - - - - 8,000
Telecommunication 726 2,783 786 1,469 5,777
Travel - - 1,151 2,657 2,656
Website 72 72 - - 221
Total general and administration expenses 9,436 20,813 5,419 13,963 73,839
XML 35 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 36 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature And Continuance Of Operations
9 Months Ended
Aug. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature And Continuance Of Operations
1.NATURE AND CONTINUANCE OF OPERATIONS

 

1.1Organization

 

Peptide Technologies, Inc. (the “Company”) was incorporated in the State of Nevada, United States of America, on 18 November 2005. On 29 July 2010, the Company’s name was changed from Online Originals, Inc. to CREEnergy Corporation. Effective 12 October 2011, the Company’s name was changed from CREEnergy Corporation to Peptide Technologies, Inc. The Company’s year-end is 30 November. The Company is currently a development stage Company.

 

On 5 August 2013, the Company incorporated Pept Peptide Technologies Inc. (“Pept Peptide”), a wholly-owned subsidiary, under the laws of British Columbia. Pept Peptide currently does not have any transactions from the date of incorporation on 5 August 2013 to 31 August 2014.

 

1.2Nature of Operations and Change in Business

 

Upon inception on 18 November 2005, the Company’s business plan was to develop a membership-based website art gallery/auction house specifically focused on displaying and selling original artwork. The Company changed its status from a development stage company to an operating company on 30 November 2009. Management realized that the results of operations from the sale of artwork lacks luster and decided to change the Company’s business focus and plan for other strategic opportunities. Effective 26 June 2010, the Company became a development stage company focusing on a new business.

 

On 23 August 2011, the Company entered into an agreement (the “Asset Purchase Agreement”) in which the Company, in exchange for 75,000,000 shares of the Company’s restricted common stock, received all rights and title to proprietary technologies and formulas involving the application of specialty Peptides. The Company has changed its business focus to the manufacturing and distribution of natural peptide solutions to combat the economic burden of bio-fouling. On 14 December 2011, the Company amended the Asset Purchase Agreement (the “First Amendment”). As a result of the First Amendment, the purchase price of the assets was reduced from 75,000,000 shares to 45,000,000 shares, and 30,000,000 shares were returned to treasury (Note 7).

 

On 1 May 2014, the Company entered into an agreement whereby the Asset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor (Note 7).

 

On 26 May 2014, the Company entered into an exclusive global distribution agreement for its AquaNatural Marine coating with All-Sea Coatings Ltd. (a division of All-Sea Enterprises) of North Vancouver, Canada. This agreement has been replaced with an Asset Purchase Agreement date 14 August 2014.

 

On 14 August 2014, the Company entered into an Asset Purchase Agreement with All-Sea Coatings Ltd. All-Sea Coatings Ltd has acquired from the Company the non-commercialized re-formulated assets that were developed by the Company. The Company business is to realize a 3% Royalty of all Gross Sales & Revenue, to be paid to the Company derived from All-Sea Coatings Ltd.

 

1.3Basis of Going Concern

 

The accompanying interim consolidated financial statements as at 31 August 2014 and for the nine month period then ended have been prepared on a going concern basis, which contemplates the realization of assets and settlement of liabilities and commitments in the normal course of business. The Company has net profit of $912,516 for the nine month period ended 31 August 2014 (31 August 2013 – loss of $738,192; cumulative loss - $981,514) and has a working capital deficit of $746,039 at 31 August 2014 (30 November 2013 - $1,750,965).

 

Management cannot provide assurance that the Company will ultimately achieve profitable operations or become cash flow positive, or raise additional debt and/or equity capital. Management believes that the Company’s capital resources should be adequate to continue operating and maintaining its business strategy during the fiscal year ended 30 November 2014. However, if the Company is unable to raise additional capital in the near future or met financing requirements, due to the Company’s liquidity problems, management expects that the Company will need to curtail operations, liquidate assets, seek additional capital on less favorable terms and/or pursue other remedial measures. Management is aware, in making its assessment, of material uncertainties related to events or conditions that may cast significant doubt upon the Company’s ability to continue as a going concern. These interim consolidated financial statements do not include any adjustments related to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Although management is actively seeking to add new products and/or services in order to show profitability, and is seeking additional sources of equity or debt financing, there is no assurance that these activities will be successful. The Company has not yet been able to find products and services that would contribute to their business due to the continued economic condition. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The interim consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

 

1.4Unaudited Statements

 

While the information presented in the accompanying interim consolidated financial statements is unaudited, it includes all adjustments which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Except as disclosed below, these interim consolidated financial statements follow the same accounting policies and methods of their application as the Company’s audited 30 November 2013 annual consolidated financial statements. It is suggested that these interim consolidated financial statements be read in conjunction with the Company’s audited consolidated financial statements for the year ended 30 November 2013, included in the annual report previously filed with the Securities and Exchange Commission on Form 10-K. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year.

 

The information as of 30 November 2013 is taken from the audited consolidated financial statements as of that date.

XML 37 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Interim Consolidated Balance Sheets (Parenthetical) (USD $)
Aug. 31, 2014
Nov. 30, 2013
Statement of Financial Position [Abstract]    
Common Shares, authorized 675,000,000 675,000,000
Common Shares, par value $ 0.001 $ 0.001
Common Shares, issued 156,412,660 151,123,000
Common Shares, outstanding 156,412,660 151,123,000
Website, accumulated amortization $ 6,667 $ 4,167
XML 38 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments And Contingency
9 Months Ended
Aug. 31, 2014
Commitments and Contingencies Disclosure [Abstract]  
Commitments And Contingency
11.COMMITMENTS AND CONTINGENCY

 

oOn 11 December 2012, the Company formerly engaged BB&T Capital Markets ("BB&TCM") to act as the Company's exclusive financial advisor and agent in connection with developing strategic alternatives for the Company regarding debt financings, licensing of intellectual properties developed by the Company, equity raises, sale of intellectual properties, or other capital markets transactions that may develop over the course of a 24-month agreement (the “Agreement”).

 

The Company is to pay BB&TCM an advisory fee of three percent of the face amount of the financial transactions advised upon during the course of the engagement, due and payable at closing of any contemplated transactions under the engagement.

 

Additionally, the Company is to defend, indemnify and hold BB&TCM, its parent company, subsidiaries and affiliates and its and their directors, officers, employees, agents and successors and assigns harmless from and against any losses, suits, actions, claims, damages, costs and or other liabilities which any indemnified person may incur as a result of acting on behalf of the Company in connection with this engagement.

 

On 19 May 2014, the Company renewed/extended the Agreement with BB&TCM. The extension runs from 1 May 2014 through 1 May 2016 (24 months). All other provisions of the Agreement remain unchanged.

 

oOn 1 May 2014, the Company entered into an agreement whereby the Asset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor.

 

oOn 26 May 2014, the Company entered into an exclusive global distribution agreement with All-Sea Coatings Ltd. (a division of All-Sea Enterprises) of North Vancouver, Canada. This agreement has been replaced with an Asset Purchase Agreement date August 14, 2014.

 

oOn 14 August 2014, Peptide Technologies, Inc. ("the Company") entered into an Asset Purchase Agreement with All-Sea Coatings Ltd. All-Sea Coatings Ltd has acquired from Peptide Technologies Inc. the non-commercialized re-formulated assets that were developed by the Company.

 

oThe Company is in the process of completing certain of its income tax filings and has accrued $10,000 during the year ended 30 November 2013 related to potential penalties associated with these filings. However, there is no assurance that additional interest and penalties will be assessed (Notes 4 and 10).

 

oThe Company is committed to making payments related to its notes payable (Note 5).
XML 39 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
9 Months Ended
Aug. 31, 2014
Oct. 10, 2014
Document And Entity Information    
Entity Registrant Name PEPTIDE TECHNOLOGIES, INC.  
Entity Central Index Key 0001357878  
Document Type 10-Q  
Document Period End Date Aug. 31, 2014  
Amendment Flag false  
Current Fiscal Year End Date --11-30  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   156,412,660
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2014  
XML 40 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Cash Flow Information
9 Months Ended
Aug. 31, 2014
Supplemental Cash Flow Elements [Abstract]  
Supplemental Cash Flow Information
12.SUPPLEMENTAL CASH FLOW INFORMATION

 

The Company made the following cash payments for interest and income taxes:

 

 

Three month period ended 31 August 2014

$

Six month period ended 31 August 2014

$

Three month period ended

31 August 2013

$

Six month period ended

31 August 2013

$

         
Interest paid - - - -
Taxes paid - - - -
         
Total cash payments - - - -

 

On 26 April 2013, the Company issued 2,000,000 fully vested shares of the Company’s restricted common stock at a par value of $0.001 per share to a third party for marketing assistance with the development of the international markets in the South Pacific quadrant for the Company. As a result, the Company recorded consulting expense of $2,000 when the stock was issued (Note 8).

 

During the nine month period ended 31 August 2014, the Company accrued interest expense of $1,743 (31 August 2013 - $2,014) in relation to a loan of CAD$45,000 issued by PSI on 13 November 2011. The loan is unsecured and bears interest at a rate of 6% per annum (Note 5).

 

During the nine month period ended 31 August 2014, the Company accrued interest expense of $774 (31 August 2013 - $895) in relation to a loan of CAD$20,000 issued by PSI on 1 June 2012. The loan is unsecured and bears interest at a rate of 6% per annum (Note 5).

 

During the nine month period ended 31August 2014, the Company recorded a write down of $45,000 (31 August 2013 - $Nil; cumulative - $45,000) related to its intangible assets and intellectual property (Note 7).

 

On 27 May 2014, the CEO requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 May 2014 (Notes 4 and 6).

 

On 27 May 2014, a former related party consultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000 (Notes 4 and 6).

 

On 15 July 2014, the Company issued 4,660 shares of the Company’s restricted common stock for cash proceeds of $5,660 (Notes 6 and 8).

 

On 28 July 2014, the Company issued 5,250,000 fully vested shares of the Company’s restricted common stock at a par value of $0,001 per share to two directors of the Company for consulting services rendered. As a result, the Company recorded professional fees of $5,250 when the stock was issued (Notes 6 and 8).

XML 41 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Interim Consolidated Statements Of Loss And Comprehensive Loss (USD $)
3 Months Ended 9 Months Ended 50 Months Ended
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Revenue          
Revenue $ 9,239    $ 9,239    $ 9,239
Expenses          
Consulting    75,000    227,000 552,975
Salaries and bonus 49,224 159,000 364,568 477,000 1,434,652
Office and administration 4,185 5,419 15,563 13,963 68,588
Professional fees 13,494 5,412 23,255 19,117 174,998
Supplies and materials 1,909 1,101 9,903 1,101 70,135
[us-gaap:CostsAndExpenses] 68,812 245,932 413,289 738,181 2,301,348
Net Loss before Other Items (59,573) (245,932) (404,050) (738,181) (2,292,109)
Other Items          
Write down of intangible assets       (45,000)    (45,000)
Forgiveness of debt       1,361,000    1,361,000
Foreign exchange gain (loss) 1,523 (1,274) 3,252 2,898 5,366
Interest expense (1,087) (1,097) (2,686) (2,909) (10,438)
Net Profit (Loss) for the Period (59,137) (248,303) 912,516 (738,192) (981,181)
Other Comprehensive Loss          
Foreign currency translation adjustment             (333)
Comprehensive Profit (Loss) for the Period $ (59,137) $ (248,303) $ 912,516 $ (738,192) $ (981,514)
Profit (Loss) per share from operations - Basic and diluted $ 0 $ 0 $ 0.01 $ 0  
Weighted Average Number of Shares Outstanding 153,143,767 151,107,016 152,154,135 150,022,908  
XML 42 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Related Party Transactions
9 Months Ended
Aug. 31, 2014
Related Party Transactions [Abstract]  
Related Party Transactions
6.RELATED PARTY TRANSACTIONS

 

As at 31 August 2014, the amount due to related parties includes $580,000 (30 November 2013 - $1,044,000) payable to past directors and employees of the Company in relation to salaries and benefits earned, and $Nil (30 November 2013 - $730) payable to the Chief Financial Officer (“CFO”) of the Company in relation to expense reimbursements. Of the amount due to related parties, $Nil relates to bonuses payable to the CEO of the Company (30 November 2013 - $300,000) (Note 4).

 

During the nine month period ended 31 August 2014, the Company accrued salaries and benefits of $364,568 to officers and employees of the Company (31 August 2013 - $477,000; cumulative - $1,434,562).

 

On 27 May 2014, the CEO requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 May 2014. As at 31 August 2014, included in salaries and benefits are bonuses of $Nil accrued to the CEO of the Company during the nine month period ended 31 August 2014 (31 August 2013 - $Nil; cumulative - $Nil) (Notes 4 and 12).

 

Effective 1 December 2013, the Company and a former related party consultant mutually terminated an Advisory Agreement entered into on 1 November 2012. The Company accrued $Nil of consulting fees to the consultant (31 August 2013 - $227,000; cumulative - $Nil) during the nine month period ended 31 August 2014.

 

On 27 May 2014, a formerly related party consultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000. As at 31 August 2014 there is $Nil (30 November 2013 - $545,000) outstanding and payable to the consultant for consulting services received (Notes 4 and 12).

 

During the year ended 30 November 2013, the Board approved a commission payment program (the “Program”) equal to 30% of gross sales of fouling prevention coatings. Under this Program, the CEO will receive compensation equal to 20% of gross sales of anti-fouling paint, as recognition of his work in developing the formulas; and an external consultant will receive 10% of gross sales of anti-fouling paint as compensation for sales development. On 28 February 2014, the Board amended the Program to reduce the CEO’s compensation from 20% to 10% of gross sales of anti-fouling paint. On 27 May 2014, the Program was eliminated by mutual agreement from both parties affected. As a result, no commissions will be earned by either the CEO or the applicable consultant on gross sales of fouling prevention coatings. As at 31 August 2014, there were $Nil commissions earned (Note 7).

 

During the nine month period ended 31 August 2014, directors and shareholders of the Company made cash contributions in the amount of $Nil (31 August 2013 - $Nil, cumulative – $27,288).

 

On 15 July 2014, the Company issued 4,660 shares of the Company’s restricted common stock for cash proceeds of $5,660 (Note 8).

 

On 28 July 2014, the Company issued 5,250,000 fully vested shares of the Company’s restricted common stock at a par value of $0.001 per share to two directors of the Company for consulting services rendered. As a result, the Company recorded professional fees of $5,250 when the stock was issued (Note 8).

XML 43 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Notes Payable
9 Months Ended
Aug. 31, 2014
Notes to Financial Statements  
Notes Payable
5.NOTES PAYABLE

 

As at:

31 August 2014

$

30 November 2013

(Audited)

$

During the year ended 30 November 2010, Fotoview Inc. (“Fotoview”) issued a loan of $16,000 to a former director of the Company to purchase 4,000,000 restricted common shares of the Company.  Upon the director’s resignation, the 4,000,000 common shares were cancelled and the Company assumed the loan payable to Fotoview.  The loan is unsecured, bears no interest, and has no fixed terms of repayment. 16,000 16,000
     
On 21 September 2011, PSI Services (“PSI”) issued a loan of $500 to the Company. The loan is unsecured, bears no interest and has no fixed terms of repayment. 500 500
     
On 13 November 2011, PSI issued a loan of CAD$45,000 to the Company. The loan is unsecured and bears interest at a rate of 6% per annum. Principal and accrued interest are due on 30 November 2014. The loan payable to PSI as at 31 August 2014 consists of principal and accrued interest of $41,445 (30 November 2013 – $42,710) and $6,963 (30 November 2013 – $5,251), respectively (Note 12). 48,408 47,961
     
On 1 June 2012, PSI issued a loan of CAD$20,000 to the Company. The loan is unsecured and bears interest at a rate of 6% per annum. Principal and accrued interest is due on 30 November 2014.. The loan payable to PSI as at 31 August 2014 consists of principal and accrued interest of $18,420 (30 November 2013 – $18,982) and $2,486 (30 November 2013 – $1,707), respectively (Note 12) 20,906 20,689
     
On 22 October 2013, PSI issued a loan of USD $3,700 to the Company.  The loan is unsecured, bears no interest, and has no fixed terms of repayment. 3,700 3,700
     
On 21 April 2014, PSI Issued a loan of CAD $8,000 to the Company. The loan is unsecured, bears no interest, and has no fixed terms of repayment. 7,368 -
     
On 14 August 2014, PSI issued a loan of CAD $9,500 to the Company. The loan is unsecured, bears no interest, and has no fixed terms of repayment. 8,749 -
Total notes payable 105,631 88,850
XML 44 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Notes Payable (Tables)
9 Months Ended
Aug. 31, 2014
Notes to Financial Statements  
Notes Payable
As at:

31 August 2014

$

30 November 2013

(Audited)

$

During the year ended 30 November 2010, Fotoview Inc. (“Fotoview”) issued a loan of $16,000 to a former director of the Company to purchase 4,000,000 restricted common shares of the Company.  Upon the director’s resignation, the 4,000,000 common shares were cancelled and the Company assumed the loan payable to Fotoview.  The loan is unsecured, bears no interest, and has no fixed terms of repayment. 16,000 16,000
     
On 21 September 2011, PSI Services (“PSI”) issued a loan of $500 to the Company. The loan is unsecured, bears no interest and has no fixed terms of repayment. 500 500
     
On 13 November 2011, PSI issued a loan of CAD$45,000 to the Company. The loan is unsecured and bears interest at a rate of 6% per annum. Principal and accrued interest are due on 30 November 2014. The loan payable to PSI as at 31 August 2014 consists of principal and accrued interest of $41,445 (30 November 2013 – $42,710) and $6,963 (30 November 2013 – $5,251), respectively (Note 12). 48,408 47,961
     
On 1 June 2012, PSI issued a loan of CAD$20,000 to the Company. The loan is unsecured and bears interest at a rate of 6% per annum. Principal and accrued interest is due on 30 November 2014.. The loan payable to PSI as at 31 August 2014 consists of principal and accrued interest of $18,420 (30 November 2013 – $18,982) and $2,486 (30 November 2013 – $1,707), respectively (Note 12) 20,906 20,689
     
On 22 October 2013, PSI issued a loan of USD $3,700 to the Company.  The loan is unsecured, bears no interest, and has no fixed terms of repayment. 3,700 3,700
     
On 21 April 2014, PSI Issued a loan of CAD $8,000 to the Company. The loan is unsecured, bears no interest, and has no fixed terms of repayment. 7,368 -
     
On 14 August 2014, PSI issued a loan of CAD $9,500 to the Company. The loan is unsecured, bears no interest, and has no fixed terms of repayment. 8,749 -
Total notes payable 105,631 88,850
XML 45 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events
9 Months Ended
Aug. 31, 2014
Subsequent Events [Abstract]  
Subsequent Events
13.SUBSEQUENT EVENTS

 

There have been no reportable events which have occurred during the period from the nine month period ended 31 August 2014 to the date the interim consolidated financial statements were available to be issued on 20 October 2014.

XML 46 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
General And Administrative Expenses
9 Months Ended
Aug. 31, 2014
Notes to Financial Statements  
General And Administrative Expenses
9.GENERAL AND ADMINISTRATIVE EXPENSES

 

 

Three month period ended 31 August 2014

$

Nine month period ended 31 August 2014

$

Three month period ended 31 August 2013

$

Nine month period ended 31 August 2013

$

Cumulative from re-entering of development stage on 26 June 2010

to 31 August 2014

$

           
Administration - - - - 20
Amortization (Note 3) 833 2,500 834 2,500 6,667
Bank charges 64 198 16 170 1,482
Dues and subscription - - - - 575
Filing fees 1,419 7,397 100 3,328 18,867
Meals and entertainment - - 254 254 254
Office 825 1,325 1,755 2,084 8,048
Penalties - - - - 10,000
Transfer agent 100 650 160 400 4,151
Rent 147 638 363 1,101 1,871
Share-based payment - - - - 8,000
Telecommunication 726 2,783 786 1,469 5,777
Travel - - 1,151 2,657 2,656
Website 72 72 - - 221
Total general and administration expenses 9,436 20,813 5,419 13,963 73,839
XML 47 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets And Intellectual Property
9 Months Ended
Aug. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets And Intellectual Property
7.INTANGIBLE ASSETS AND INTELLECTUAL PROPERTY

 

On 23 August 2011, the Company entered into an Asset Purchase Agreement to acquire intangible assets and intellectual property known as the Platforms in exchange for 75,000,000 restricted common shares of the Company (issued on 23 August 2011) (Note 1).

 

On 14 December 2011, the Company entered into an amended the First Amendment and, as a result, a total of 30,000,000 restricted common shares of the Company were returned to treasury and cancelled in exchange for payment of half of one percent of all gross monies received by the Company in relation to revenue earned from products derived from the use of all the formulae listed in the Asset Purchase Agreement. In addition, a monthly stipend of CAD $15,000 per month is to be paid commencing on the receipt of monies from the first contract signed to purchase products derived from the use of the formulae for a period of five years from the date of the First Amendment. The cancellation of 30,000,000 common shares has been recorded as a recovery of intangible assets and intellectual property (Note 1).

 

On 1 May 2014, the Company entered into an agreement whereby the Asset Purchase Agreement and the First Amendment were deemed null and void and the platforms were returned to the original vendor (Note 1).

 

During the nine month period ended 31 August 2014, the Company recorded a write down of $45,000 (31 August 2013 - $Nil; cumulative - $45,000) related to its intangible assets and intellectual property (Note 12).

 

On 20 January 2013, the Board approved the Program equal to 30% of gross sales of fouling prevention coatings. Under this Program, the CEO will receive compensation equal to 20% of gross sales of anti-fouling paint, as recognition of his work in developing the formulas; and an external consultant will receive 10% of gross sales of anti-fouling paint as compensation for sales development. On 28 February 2014, the Board amended the Program to reduce the CEO’s compensation from 20% to 10% of gross sales of anti-fouling paint. On 27 May 2014, the Program was eliminated by mutual agreement from both parties affected. As a result, no commissions will be earned by either the CEO or the applicable consultant on gross sales of fouling prevention coatings. As of 31 August 2014, there were $Nil commissions earned (Note 6).

XML 48 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Capital Stock
9 Months Ended
Aug. 31, 2014
Equity [Abstract]  
Capital Stock
8.CAPITAL STOCK

 

8.1Authorized common stock

 

The Company’s authorized common stock consists of 675,000,000 shares of common stock with a par value of $0.001 per share. On 10 August 2010, the Company increased the number of authorized share capital from 75,000,000 shares of common stock to 675,000,000 shares of common stock with the same par value of $0.001 per share.

 

8.2Issued and outstanding

 

On 2 June 2010, and effective 10 August 2010, the directors of the Company approved a forward split of the common stock of the Company on a basis of 30 new common shares for 1 old common share. As a result of the forward stock split, 208,800,000 additional shares were issued. Capital and additional paid-in capital have been adjusted accordingly. When adjusted retroactively, there was an $119,501 shortage of additional paid-in capital; thus an adjustment to accumulated deficit of $104,000 was recorded on 20 May 2010 (the date of issuance of 120,000,000 shares) and $15,501 to the beginning balance. The interim consolidated financial statements contained herein reflect the appropriate values for capital stock and accumulated deficit. Unless otherwise noted, all references in the accompanying interim consolidated financial statements to the number of common shares and per share amounts have been retroactively restated to reflect the forward stock split.

 

The total issued and outstanding capital stock is 156,412,660 common shares with a par value of $0.001 per common share. The Company’s common stock issuances to date are as follows:

 

oOn 10 April 2013, the Company issued 20,000 shares of the Company’s restricted common stock for cash proceeds of $20,000. The Company paid $2,000 in share issuance costs.
oOn 26 April 2013, the Company issued 2,000,000 shares of the Company’s restricted common stock at a par value of $0.001 per share to a third party for marketing assistance with the development of the international markets of the South Pacific quadrant for the Company. As a result, the Company recorded consulting expense of $2,000 when the stock was issued (Note 12).
oOn 18 July 2013, the Company issued 25,000 shares of the Company’s restricted common stock for cash proceeds of $25,000.
oOn 3 December 2013, the Company issued 10,000 shares of the Company’s restricted common stock for cash proceeds of $10,000.
oOn 3 March 2014, the Company issued 10,000 shares of the Company’s restricted common shares for cash proceeds of $10,000.
oOn 11 March 2014, the Company issued 5,000 shares of the Company’s restricted common shares for cash proceeds of $5,000.
oOn 3 April 2014, the Company issued 10,000 shares of the Company’s restricted common stock for cash proceeds of $10,000.
oOn 15 July 2014, the Company issued 4,660 shares of the Company’s restricted common stock for cash proceeds of $4,660 (Note 6).
oOn 28 July 2014, the Company issued 5,250,000 fully vested shares of the Company’s restricted common stock at a par value of $0.001 per share to two directors of the Company for consulting services rendered. As a result, the Company recorded professional fees of $5,250 when the stock was issued (Note 6).
XML 49 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
9 Months Ended
Aug. 31, 2014
Income Tax Disclosure [Abstract]  
Income Taxes
10.INCOME TAXES

 

10.1.1Provision for income taxes

 

Income tax expense differs from the amount that would result from applying the federal income tax rate to earnings before income taxes. During the nine month periods ended 31 August 2014 and 2013, these differences result from the following items:

 

 

For the nine month period ended 31 August 2014

$

For the nine month period ended 31 August 2013

$

     
Income (loss) before income taxes 912,516 (738,192)
Federal income tax rates 35.00% 35.00%
     
Income tax expense (recovery) based on the above rates 319,381 (258,367)
Non–deductible items 15,750 -
Change in valuation allowance (335,131) (258,367)
     
Income tax expense - -

 

 

10.2Deferred tax balances

 

The composition of the Company’s deferred tax assets as at 31 August 2014 and 30 November 2013 are as follows:

As at:

31 August

2014

$

30 November 2013

(Audited)

$

     
Net income tax operating loss carry-forward 1,018,391 1,975,908
     
Deferred tax assets 356,437 691,568
Valuation allowance (356,437) (691,568)
     
Deferred tax assets (liabilities) - -

 

As at 31 August 2014, the Company has a total non-capital loss carry forward balance of $1,018,391 (30 November 2013 - 1,975,908), which has expiry dates between the years of 2025 to 2034.

 

The Company’s recognized and unrecognized deferred tax assets related to the unused tax losses. A full valuation allowance has been recorded against the potential deferred tax assets associated with all the loss carry-forwards as their utilization is not considered more likely than not at this time.

The Company is in the process of completing and resolving issues related to its income tax filings and has accrued $10,000 during the year ended 30 November 2013 related to potential penalties associated with these filings. However, there is no assurance that additional interest and penalties will not be assessed (Note 11).

XML 50 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
Nature And Continuance Of Operations (Details Narrative) (USD $)
3 Months Ended 9 Months Ended 12 Months Ended 50 Months Ended
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Aug. 31, 2013
Nov. 30, 2013
Aug. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]            
Net Profit (Loss) $ (59,137) $ (248,303) $ 912,516 $ (738,192) $ (995,477) $ (981,181)
Working Capital Deficit $ 746,039   $ 746,039   $ 1,750,965 $ 746,039
XML 51 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Website (Tables)
9 Months Ended
Aug. 31, 2014
Notes to Financial Statements  
Website
As at:

31 August 2014

 

30 November 2013

(Audited)

 

Cost

$

Accumulated amortization

$

Net book value

$

Cost

$

Accumulated amortization

$

Net book value

$

             
Website 10,000 6,667 3,333 10,000 4,167 5,833
             
Total 10,000 6,667 3,333 10,000 4,167 5,833
XML 52 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Cash Flow Information (Tables)
9 Months Ended
Aug. 31, 2014
Supplemental Cash Flow Elements [Abstract]  
Cash Payments For Interest And Income Taxes
 

Three month period ended 31 August 2014

$

Six month period ended 31 August 2014

$

Three month period ended

31 August 2013

$

Six month period ended

31 August 2013

$

         
Interest paid - - - -
Taxes paid - - - -
         
Total cash payments - - - -
XML 53 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments And Contingency (Details Narrative) (USD $)
Nov. 30, 2013
Commitments and Contingencies Disclosure [Abstract]  
Accrued Potential Tax Penalties $ 10,000
XML 54 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Interim Consolidated Statements Of Cash Flows (USD $)
3 Months Ended 9 Months Ended 50 Months Ended
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
OPERATING ACTIVITIES          
Net profit (loss) $ (59,137) $ (248,303) $ 912,516 $ (738,192) $ (981,181)
Adjustments for non-cash items:          
Accrued interest 1,087 1,097 2,686 2,909 10,438
Amortization 833 833 2,500 2,500 6,667
Foreign exchange gain (loss) (1,523) 1,275 (3,252) (2,898) (5,366)
Forgiveness of debt       (1,361,000)    (1,361,000)
Non-cash consulting expense             2,000
Share-based payment 5,250    5,250    13,250
Write down of intangible assets and intellectual property       45,000    45,000
Changes in operating assets and liabilities          
Decrease in prepaid expenses          3,494 2,710
Increase in accounts payable and accrued liabilities 49,360 225,000 350,696 684,678 2,012,218
Cash used in operating activities (4,130) (20,098) (45,604) (47,509) (255,264)
INVESTING ACTIVITIES          
Purchase of website             (10,000)
Cash used in investing activities             (10,000)
FINANCING ACTIVITIES          
Proceeds from issuance of common shares, net of share issuance costs 4,660 25,000 39,660 45,000 160,774
Increase in notes payable 9,500    17,347    84,559
Contribution by related party             27,288
Cash from financing activities 14,007 25,000 57,007 45,000 272,621
Effect of foreign exchange rate changes on cash             (333)
Increase (decrease) in cash and cash equivalents 9,877 4,902 11,403 (2,509) 7,024
Cash and cash equivalents, beginning of period 1,683 369 157 7,780 4,536
Cash and cash equivalents, end of period $ 11,560 $ 5,271 $ 11,560 $ 5,271 $ 11,560
XML 55 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Accounts Payable And Accrued Liabilities
9 Months Ended
Aug. 31, 2014
Payables and Accruals [Abstract]  
Accounts Payable And Accrued Liabilities
4.ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

As at:

31 August 2014

$

30 November 2013

(Audited)

$

     
Accounts payable 38,317 574,188
Accrued liabilities 4,000 27,000
Payroll taxes payable 29,652 17,084
Salaries and benefits payable (Note 6) 580,000 1,044,000
     
Total accounts payable and accrued liabilities 651,969 1,662,272

 

Trades payable and accrued liabilities are non-interest bearing, unsecured and have settlement dates within one year.

 

On 27 May 2014, the Chief Executive Officer (“CEO”) requested that his salary be suspended until further notice. Additionally, he forgave the entire balance of his accrued salary in the amount of $516,000 and accrued bonus in the amount of $300,000 as at 31 August 2014 (Notes 6 and 12).

 

On 27 May 2014, a consultant forgave all outstanding fees payable in relation to consulting services rendered in the amount of $545,000 (Notes 6 and 12).

XML 56 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Website (Detail) - Website (USD $)
Aug. 31, 2014
Nov. 30, 2013
Costs $ 10,000 $ 10,000
Accumulated Amortization 6,667 4,167
Net Book Value 3,333 5,833
Total [Member]
   
Costs 10,000 10,000
Accumulated Amortization 6,667 4,167
Net Book Value $ 3,333 $ 5,833
XML 57 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 98 171 1 false 25 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://peptidetechnologiesinc.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 00000002 - Statement - Interim Consolidated Balance Sheets Sheet http://peptidetechnologiesinc.com/role/InterimConsolidatedBalanceSheets Interim Consolidated Balance Sheets false false R3.htm 00000003 - Statement - Interim Consolidated Balance Sheets (Parenthetical) Sheet http://peptidetechnologiesinc.com/role/InterimConsolidatedBalanceSheetsParenthetical Interim Consolidated Balance Sheets (Parenthetical) false false R4.htm 00000004 - Statement - Interim Consolidated Statements Of Loss And Comprehensive Loss Sheet http://peptidetechnologiesinc.com/role/InterimConsolidatedStatementsOfLossAndComprehensiveLoss Interim Consolidated Statements Of Loss And Comprehensive Loss false false R5.htm 00000005 - Statement - Interim Consolidated Statements Of Cash Flows Sheet http://peptidetechnologiesinc.com/role/InterimConsolidatedStatementsOfCashFlows Interim Consolidated Statements Of Cash Flows false false R6.htm 00000006 - Statement - Interim Consolidated Statements Of Stockholders' Deficiency (Unaudited) Sheet http://peptidetechnologiesinc.com/role/InterimConsolidatedStatementsOfStockholdersDeficiency Interim Consolidated Statements Of Stockholders' Deficiency (Unaudited) false false R7.htm 00000007 - Disclosure - Nature And Continuance Of Operations Sheet http://peptidetechnologiesinc.com/role/NatureAndContinuanceOfOperations Nature And Continuance Of Operations false false R8.htm 00000008 - Disclosure - Significant Accounting Policies Sheet http://peptidetechnologiesinc.com/role/SignificantAccountingPolicies Significant Accounting Policies false false R9.htm 00000009 - Disclosure - Website Sheet http://peptidetechnologiesinc.com/role/Website Website false false R10.htm 00000010 - Disclosure - Accounts Payable And Accrued Liabilities Sheet http://peptidetechnologiesinc.com/role/AccountsPayableAndAccruedLiabilities Accounts Payable And Accrued Liabilities false false R11.htm 00000011 - Disclosure - Notes Payable Notes http://peptidetechnologiesinc.com/role/NotesPayable Notes Payable false false R12.htm 00000012 - Disclosure - Related Party Transactions Sheet http://peptidetechnologiesinc.com/role/RelatedPartyTransactions Related Party Transactions false false R13.htm 00000013 - Disclosure - Intangible Assets And Intellectual Property Sheet http://peptidetechnologiesinc.com/role/IntangibleAssetsAndIntellectualProperty Intangible Assets And Intellectual Property false false R14.htm 00000014 - Disclosure - Capital Stock Sheet http://peptidetechnologiesinc.com/role/CapitalStock Capital Stock false false R15.htm 00000015 - Disclosure - General And Administrative Expenses Sheet http://peptidetechnologiesinc.com/role/GeneralAndAdministrativeExpenses General And Administrative Expenses false false R16.htm 00000016 - Disclosure - Income Taxes Sheet http://peptidetechnologiesinc.com/role/IncomeTaxes Income Taxes false false R17.htm 00000017 - Disclosure - Commitments And Contingency Sheet http://peptidetechnologiesinc.com/role/CommitmentsAndContingency Commitments And Contingency false false R18.htm 00000018 - Disclosure - Supplemental Cash Flow Information Sheet http://peptidetechnologiesinc.com/role/SupplementalCashFlowInformation Supplemental Cash Flow Information false false R19.htm 00000019 - Disclosure - Subsequent Events Sheet http://peptidetechnologiesinc.com/role/SubsequentEvents Subsequent Events false false R20.htm 00000020 - Disclosure - Significant Accounting Policies (Policies) Sheet http://peptidetechnologiesinc.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) false false R21.htm 00000021 - Disclosure - Website (Tables) Sheet http://peptidetechnologiesinc.com/role/WebsiteTables Website (Tables) false false R22.htm 00000022 - Disclosure - Accounts Payable And Accrued Liabilities (Tables) Sheet http://peptidetechnologiesinc.com/role/AccountsPayableAndAccruedLiabilitiesTables Accounts Payable And Accrued Liabilities (Tables) false false R23.htm 00000023 - Disclosure - Notes Payable (Tables) Notes http://peptidetechnologiesinc.com/role/NotesPayableTables Notes Payable (Tables) false false R24.htm 00000024 - Disclosure - General And Administrative Expenses (Tables) Sheet http://peptidetechnologiesinc.com/role/GeneralAndAdministrativeExpensesTables General And Administrative Expenses (Tables) false false R25.htm 00000025 - Disclosure - Income Taxes (Tables) Sheet http://peptidetechnologiesinc.com/role/IncomeTaxesTables Income Taxes (Tables) false false R26.htm 00000026 - Disclosure - Supplemental Cash Flow Information (Tables) Sheet http://peptidetechnologiesinc.com/role/SupplementalCashFlowInformationTables Supplemental Cash Flow Information (Tables) false false R27.htm 00000027 - Disclosure - Website (Detail) - Website Sheet http://peptidetechnologiesinc.com/role/WebsiteDetail-Website Website (Detail) - Website false false R28.htm 00000028 - Disclosure - Accounts Payable And Accrued Liabilities (Detail) - Accounts Payable And Accrued Liabilities Sheet http://peptidetechnologiesinc.com/role/AccountsPayableAndAccruedLiabilitiesDetail-AccountsPayableAndAccruedLiabilities Accounts Payable And Accrued Liabilities (Detail) - Accounts Payable And Accrued Liabilities false false R29.htm 00000029 - Disclosure - Notes Payable (Detail) - Notes Payable Notes http://peptidetechnologiesinc.com/role/NotesPayableDetail-NotesPayable Notes Payable (Detail) - Notes Payable false false R30.htm 00000030 - Disclosure - General And Administrative Expenses (Detail) - General And Adminstrative Expenses Sheet http://peptidetechnologiesinc.com/role/GeneralAndAdministrativeExpensesDetail-GeneralAndAdminstrativeExpenses General And Administrative Expenses (Detail) - General And Adminstrative Expenses false false R31.htm 00000031 - Disclosure - Income Taxes (Detail) - Provision For Income Taxes Sheet http://peptidetechnologiesinc.com/role/IncomeTaxesDetail-ProvisionForIncomeTaxes Income Taxes (Detail) - Provision For Income Taxes false false R32.htm 00000032 - Disclosure - Income Taxes (Detail) - Deferred Tax Balances Sheet http://peptidetechnologiesinc.com/role/IncomeTaxesDetail-DeferredTaxBalances Income Taxes (Detail) - Deferred Tax Balances false false R33.htm 00000033 - Disclosure - Supplemental Cash Flow Information (Detail) - Cash Payments For Interest And Income Taxes Sheet http://peptidetechnologiesinc.com/role/SupplementalCashFlowInformationDetail-CashPaymentsForInterestAndIncomeTaxes Supplemental Cash Flow Information (Detail) - Cash Payments For Interest And Income Taxes false false R34.htm 00000034 - Disclosure - Nature And Continuance Of Operations (Details Narrative) Sheet http://peptidetechnologiesinc.com/role/NatureAndContinuanceOfOperationsDetailsNarrative Nature And Continuance Of Operations (Details Narrative) false false R35.htm 00000035 - Disclosure - Website (Details Narrative) Sheet http://peptidetechnologiesinc.com/role/WebsiteDetailsNarrative Website (Details Narrative) false false R36.htm 00000036 - Disclosure - Accounts Payable And Accrued Liabilities (Details Narrative) Sheet http://peptidetechnologiesinc.com/role/AccountsPayableAndAccruedLiabilitiesDetailsNarrative Accounts Payable And Accrued Liabilities (Details Narrative) false false R37.htm 00000037 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://peptidetechnologiesinc.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) false false R38.htm 00000038 - Disclosure - Intangible Assets And Intellectual Property (Details Narrative) Sheet http://peptidetechnologiesinc.com/role/IntangibleAssetsAndIntellectualPropertyDetailsNarrative Intangible Assets And Intellectual Property (Details Narrative) false false R39.htm 00000039 - Disclosure - Capital Stock (Details Narrative) Sheet http://peptidetechnologiesinc.com/role/CapitalStockDetailsNarrative Capital Stock (Details Narrative) false false R40.htm 00000040 - Disclosure - Income Taxes (Details Narrative) Sheet http://peptidetechnologiesinc.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) false false R41.htm 00000041 - Disclosure - Commitments And Contingency (Details Narrative) Sheet http://peptidetechnologiesinc.com/role/CommitmentsAndContingencyDetailsNarrative Commitments And Contingency (Details Narrative) false false R42.htm 00000042 - Disclosure - Supplemental Cash Flow Information (Details Narrative) Sheet http://peptidetechnologiesinc.com/role/SupplementalCashFlowInformationDetailsNarrative Supplemental Cash Flow Information (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - Interim Consolidated Balance Sheets Process Flow-Through: Removing column 'Jul. 28, 2014' Process Flow-Through: Removing column 'Jul. 15, 2014' Process Flow-Through: Removing column 'May 31, 2014' Process Flow-Through: Removing column 'Apr. 03, 2014' Process Flow-Through: Removing column 'Mar. 11, 2014' Process Flow-Through: Removing column 'Mar. 03, 2014' Process Flow-Through: Removing column 'Dec. 03, 2013' Process Flow-Through: Removing column 'Aug. 31, 2013' Process Flow-Through: Removing column 'Jul. 18, 2013' Process Flow-Through: Removing column 'May 31, 2013' Process Flow-Through: Removing column 'Apr. 10, 2013' Process Flow-Through: Removing column 'Nov. 30, 2012' Process Flow-Through: Removing column 'Jun. 25, 2010' Process Flow-Through: Removing column 'May 20, 2010' Process Flow-Through: 00000003 - Statement - Interim Consolidated Balance Sheets (Parenthetical) Process Flow-Through: Removing column 'Jul. 28, 2014' Process Flow-Through: Removing column 'Jul. 15, 2014' Process Flow-Through: Removing column 'Apr. 03, 2014' Process Flow-Through: Removing column 'Mar. 11, 2014' Process Flow-Through: Removing column 'Mar. 03, 2014' Process Flow-Through: Removing column 'Dec. 03, 2013' Process Flow-Through: Removing column 'Jul. 18, 2013' Process Flow-Through: Removing column 'Apr. 26, 2013' Process Flow-Through: Removing column 'Apr. 10, 2013' Process Flow-Through: Removing column 'Aug. 10, 2010' Process Flow-Through: 00000004 - Statement - Interim Consolidated Statements Of Loss And Comprehensive Loss Process Flow-Through: Removing column '12 Months Ended Nov. 30, 2013' Process Flow-Through: 00000005 - Statement - Interim Consolidated Statements Of Cash Flows Process Flow-Through: 00000006 - Statement - Interim Consolidated Statements Of Stockholders' Deficiency (Unaudited) Process Flow-Through: Removing column '1 Months Ended Jul. 28, 2014' Process Flow-Through: Removing column '3 Months Ended Aug. 31, 2013' Process Flow-Through: Removing column 'May 20, 2010' pept-20140831.xml pept-20140831.xsd pept-20140831_cal.xml pept-20140831_def.xml pept-20140831_lab.xml pept-20140831_pre.xml true true XML 58 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Intangible Assets And Intellectual Property (Details Narrative) (USD $)
0 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended 50 Months Ended
Dec. 14, 2011
Aug. 23, 2011
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Aug. 31, 2013
Aug. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]              
Intangible Assets And Intellectual Property Purchase, shares   75,000,000          
Recovery Of Intangible Assets And Intellectual Property, shares 30,000,000            
Stipend Paid, Monthly   $ 15,000          
Intangible Assets And Intellectual Property Write Down           $ 45,000    $ 45,000
XML 59 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Significant Accounting Policies (Policies)
9 Months Ended
Aug. 31, 2014
Accounting Policies [Abstract]  
Basis Of Presentation
2.1Basis of Presentation

 

These interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) applicable for a development stage company for financial information and are expressed in U.S. dollars.
Principles Of Consolidation
2.2Principles of Consolidation

 

These interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary Pept Peptide, a company incorporated in the province of British Columbia on 5 August 2013. All significant inter-company balances and transactions have been eliminated upon consolidation.
Organizational And Start-Up Costs
2.3Organizational and Start-up Costs

 

Costs of start-up activities, including organizational costs, are expensed as incurred in accordance with Accounting Standards Codification (“ASC”) 720-15, “Start-Up Costs."

Development-Stage Company
2.4Development-Stage Company

 

During the year ended 30 November 2010, the Company abandoned its previous business of sale of original artwork and re-entered the development stage with its intended new business, which currently has no significant revenues.  Management expects to sustain losses from operations until such time it can generate sufficient revenues to meet its anticipated cost structure. The Company is considered a development-stage company in accordance with the ASC 915, “Accounting and Reporting by Development-Stage Enterprises." A development-stage enterprise is one in which planned principal operations have not commenced or if its operations have commenced, there has been no significant revenues there from.

Cash And Cash Equivalents
2.5Cash and Cash Equivalents

 

Cash and cash equivalents include highly liquid investments with original maturities of three months or less.

Website
2.6Website

 

In accordance with ASC 350-50, “Website Development Costs," expenditures during the planning and operating stages of the Company’s website are expensed as incurred. Expenditures incurred during the website application and infrastructure development stage are capitalized and amortized to expense over the website’s estimated useful life of 3 years.

Intangible Assets
2.7Intangible Assets

 

Intangible assets include the cost of acquiring the intellectual property. In accordance with ASC 350-30 “General Intangibles Other Than Goodwill," an intangible asset that is acquired either individually or with a group of other assets shall be recognized. Costs of internally developing, maintaining, or restoring intangible assets that are not specifically identifiable, that have indeterminate lives, or that are inherent in a continuing business and related to an entity as whole, shall be recognized as an expense when incurred. The intellectual property is determined to have an indefinite useful life and is not subject to amortization. The useful life of the intangible asset is reassessed at each reporting period. During the nine month period ended 31 August 2014, the Company recorded a write down of $45,000 related to its intangible assets and intellectual property (Notes 7 and 12).

Impairment Of Long-Lived Assets
2.8Impairment of Long-Lived Assets

 

Long-lived assets include the website and intangible assets and intellectual property. Long-lived assets subject to amortization are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Long-lived assets not subject to amortization are tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized as the amount by which the carrying amount of the asset exceeds the fair value of the asset. There has been no impairment as of 31 August 2014.

Research And Development
2.9Research and Development

 

Research and development expenses are charged to operations as incurred.

Income Taxes
2.10Income Taxes

 

The Company adopted the ASC 740, “Accounting for Income Taxes." ASC 740 requires the use of the asset and liability method of accounting of income taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the interim consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is established when necessary to reduce deferred tax assets to the amount expected to be realized.

Basic And Diluted Income (Loss) Per Share
2.11Basic and Diluted Income (Loss) per Share

 

In accordance with ASC 260, “Earnings per Share," the basic income (loss) per common share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding. Diluted income (loss) per common share is computed similar to basic income (loss) per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Diluted earnings per share are not shown for periods in which the Company incurs a loss because it would be anti-dilutive. At 31 August 2014, the Company had no stock equivalents that were anti-dilutive and excluded in the earnings (loss) per share computation.

Estimated Fair Value Of Financial Instruments
2.12Estimated Fair Value of Financial Instruments

 

The carrying value of the Company’s interim consolidated financial instruments, consisting of cash, accounts payable and notes payable approximate their fair value due to the short-term maturity of these instruments. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest or currency risks arising from these financial instruments.

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. At 31 August 2014, cash and cash equivalents of $310 were insured by agencies of the U.S. Government.

Foreign Currency Translation
2.13Foreign Currency Translation

 

The interim consolidated financial statements are presented in U.S. dollars. In accordance with ASC 830 “Foreign Currency Matters," foreign denominated monetary assets and liabilities are translated to their U.S. dollar equivalents using foreign exchange rates which prevailed at the balance sheet date. Revenue and expenses are translated at average rates of exchange during the period. Related translation adjustments are reported as a separate component of stockholders’ equity, whereas gains or losses resulting from foreign currency transactions are included in results of operations.

Comprehensive Income (Loss)
2.14Comprehensive Income (Loss)

 

The Company adopted ASC 220, "Reporting Comprehensive Income." ASC 220 requires that the components and total amounts of comprehensive income (loss) be displayed in the interim consolidated financial statements beginning in 1998. Comprehensive income (loss) includes net income (loss) and all changes in equity during a period that arises from non-owner sources, such as foreign currency items and unrealized gains and losses on certain investments in equity securities.

Use Of Estimates
2.15Use of Estimates

 

The preparation of the Company’s interim consolidated financial statements are in conformity with U.S. GAAP which requires management to make estimates and assumptions that affect the amounts reported in these interim consolidated financial statements and accompanying notes. Actual results could differ from those estimates.

Changes In Accounting Policy
2.16Changes in Accounting Policy

 

Effective 1 December 2013, the Company adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) No. 2013-02, “Comprehensive Income." This update requires an entity to present information about amounts reclassified out of accumulated other comprehensive income and their corresponding effect on the respective line items in net income in one place, and in some cases, cross-references to related footnote disclosures. The update applies to public companies for all reporting periods presented, including interim periods, and to nonpublic entities for annual reporting periods. ASU No. 2013-02 will be effective for fiscal years, and interim periods within those years, beginning after 15 December 2012 for public companies, with early adoption permitted. The adoption of this update did not have a material effect on the Company’s interim consolidated financial statements.

Recent Accounting Pronouncements
2.17Recent Accounting Pronouncements

 

In July 2013, the FASB issued ASU No. 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists," which is intended to eliminate the diversity that is in practice with regard to the financial statement presentation of unrecognized tax benefits when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. ASU No. 2013-11 is effective for fiscal years and interim periods within those years, beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.

 

In May 2014, the FASB issued ASU No. 2014-09, “Revenue from Contracts with Customers," which provides a five-step approach to be applied to all contracts with customers. ASU No. 2014-09 also requires expanded disclosures about revenue recognition. ASU No. 2014-09 is effective for annual reporting periods beginning after 15 December 2016, including interim periods. Early adoption is not permitted. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.

 

In June 2014, the FASB issued ASU No. 2014-10, “Development Stage Entities," which intends to remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. GAAP. In addition, the update eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. ASU No. 2014-10 is effective for fiscal years and interim periods beginning after 15 December 2014, with early adoption permissible. The adoption of this update is not expected to have a material impact on the Company’s interim consolidated financial statements.

Reclassifications
2.18Reclassifications

 

Certain amounts reported in previous periods have been reclassified to conform to the current presentation.

Other
2.19Other

 

The Company consists of one reportable business segment.

 

The Company paid no dividends during the periods presented.